{"id": "batch_req_67ce449d3de48190880186193740a1ea", "custom_id": "drug1_effects_timeline", "response": {"status_code": 200, "request_id": "92fd71c951db2f49e5ba9683c1a6f8d4", "body": {"id": "chatcmpl-B9MVEq5RAKLhzrMKaCRnMHpu2CIla", "object": "chat.completion", "created": 1741571152, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might notice an increase in appetite due to MK-677's action on ghrelin receptors, which can lead to increased food intake.\",\n        \"Effect 2: Some users may experience improved sleep quality, as MK-677 has been reported to enhance REM sleep.\",\n        \"Effect 3: Initial increases in growth hormone (GH) levels may be observed, although significant changes in IGF-1 levels might not yet be apparent.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued increase in appetite and potential weight gain due to increased caloric intake.\",\n        \"Effect 2: Users might begin to notice slight improvements in recovery times after physical activity, although muscle growth effects are still developing.\",\n        \"Effect 3: Some users may report mild water retention, which can be an early side effect.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable increases in IGF-1 levels, which can contribute to muscle growth and improved recovery.\",\n        \"Effect 2: Some users might experience enhanced energy levels and overall well-being due to elevated GH and IGF-1.\",\n        \"Effect 3: Potential for mild edema or bloating as a side effect, which may peak during this period.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users may observe more significant muscle growth and strength gains, particularly if combined with resistance training.\",\n        \"Effect 2: Improved skin elasticity and potential reduction in body fat percentage due to metabolic effects of increased GH and IGF-1.\",\n        \"Effect 3: Continued improvements in sleep quality and recovery times.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Sustained muscle growth and physical performance improvements, with potential plateauing of effects if the body adapts.\",\n        \"Effect 2: Long-term users might experience changes in bone density, although this requires more extended periods to manifest significantly.\",\n        \"Effect 3: Monitoring for potential side effects such as insulin resistance or increased blood sugar levels is advisable, as these may develop with prolonged use.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for MK-677 can vary significantly between individuals due to differences in metabolism, dosage, and concurrent lifestyle factors such as diet and exercise. Most effects are inferred from limited studies and anecdotal reports, as comprehensive clinical data is still lacking. Users should be cautious of potential side effects and consult healthcare professionals for guidance.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 582, "total_tokens": 1269, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449d4da08190b59993b06e920a24", "custom_id": "drug2_effects_timeline", "response": {"status_code": 200, "request_id": "4b503883013365e29282a4b3a293bce5", "body": {"id": "chatcmpl-B9MVEdtHEiKn7zz9ybdqCSb4oAmpf", "object": "chat.completion", "created": 1741571152, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvement in workout performance, as RAD-140 begins to interact with androgen receptors.\",\n        \"Effect 2: Some users may notice a slight increase in focus and motivation, potentially due to the compound's action on androgen receptors in the brain.\",\n        \"Effect 3: No significant changes in muscle mass or strength are typically observed yet, as these effects require more time to develop.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Early signs of muscle fullness and slight increases in strength may begin to appear as protein synthesis is enhanced.\",\n        \"Effect 2: Continued improvement in energy and focus, potentially aiding in more intense workouts.\",\n        \"Effect 3: Some users might start to notice minor changes in biomarkers such as increased nitrogen retention, although these are not typically measured outside of a clinical setting.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Noticeable gains in muscle mass and strength become more apparent, as RAD-140's anabolic effects accumulate.\",\n        \"Effect 2: Enhanced recovery times post-exercise, allowing for more frequent and intense training sessions.\",\n        \"Effect 3: Potential slight increase in aggression or assertiveness, inferred from similar compounds affecting androgen receptors.\",\n        \"Effect 4: Possible mild side effects such as headaches or nausea might begin to manifest, although these are not universally experienced.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and strength gains, with some users reporting significant improvements in body composition.\",\n        \"Effect 2: Improved bone density might begin to be observed, although this is more likely in longer-term studies.\",\n        \"Effect 3: Potential stabilization of mood and cognitive effects as the body adjusts to the compound.\",\n        \"Effect 4: Side effects such as mild hormonal imbalances or changes in lipid profiles might become more noticeable, requiring monitoring.\"\n      ]\n    },\n    {\n      \"period\": \"Week 9-12\",\n      \"effects\": [\n        \"Effect 1: Peak muscle and strength gains are typically observed, with users reaching a plateau in benefits.\",\n        \"Effect 2: Sustained improvements in workout performance and recovery.\",\n        \"Effect 3: Potential for increased side effects, such as liver enzyme changes or cholesterol level alterations, necessitating careful monitoring.\",\n        \"Effect 4: Some users might experience suppression of natural testosterone production, inferred from similar compounds.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred effects from similar compounds, as RAD-140 is still under research and lacks comprehensive clinical data. Individual responses can vary significantly, and the safety and efficacy of RAD-140 have not been fully established. Monitoring by healthcare professionals is advised if used in a research setting.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 635, "total_tokens": 1311, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449d5eb48190a621c7296df129c1", "custom_id": "drug3_effects_timeline", "response": {"status_code": 200, "request_id": "807a6ef1cf7217d643ba0732bffd46cc", "body": {"id": "chatcmpl-B9MVDksLsJsqvz89l4FmjIWYTN9yf", "object": "chat.completion", "created": 1741571151, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Physical Effects: Users may begin to notice a slight increase in endurance during physical activities, as the body starts to shift towards using fatty acids for energy.\",\n        \"Mental/Cognitive Effects: Some users report a mild increase in motivation and focus, likely due to increased energy levels.\",\n        \"Biomarkers/Physiological Measurements: Initial changes in lipid profiles may start to appear, with a slight decrease in triglycerides.\",\n        \"Benefits Appearance: Early signs of enhanced stamina might be noticeable during workouts.\",\n        \"Side Effects: Some users might experience mild headaches or nausea as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Physical Effects: More pronounced improvements in endurance and stamina, allowing for longer and more intense workouts.\",\n        \"Mental/Cognitive Effects: Continued improvement in focus and mental clarity, potentially due to better energy utilization.\",\n        \"Biomarkers/Physiological Measurements: Further improvements in lipid profiles, with potential increases in HDL cholesterol.\",\n        \"Benefits Appearance: Enhanced endurance and initial signs of fat loss may become more evident.\",\n        \"Side Effects: Mild gastrointestinal discomfort might occur in some users, but generally subsides as the body adapts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Physical Effects: Significant improvements in physical performance, with noticeable increases in workout capacity and recovery times.\",\n        \"Mental/Cognitive Effects: Users may experience sustained mental energy and reduced fatigue.\",\n        \"Biomarkers/Physiological Measurements: Continued positive changes in cholesterol levels, with potential reductions in LDL cholesterol.\",\n        \"Benefits Appearance: Enhanced endurance and fat loss effects are more pronounced, with some users reporting visible changes in body composition.\",\n        \"Side Effects: Any initial side effects typically diminish, but users should monitor for any new adverse reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Physical Effects: Peak performance benefits, with users experiencing optimal endurance and fat metabolism.\",\n        \"Mental/Cognitive Effects: Stable cognitive benefits, including sustained focus and motivation.\",\n        \"Biomarkers/Physiological Measurements: Stabilization of lipid profiles at improved levels, with potential cardiovascular benefits.\",\n        \"Benefits Appearance: Maximum benefits in endurance and fat loss are typically achieved during this period.\",\n        \"Side Effects: Long-term use may increase the risk of more serious side effects, such as potential liver issues or carcinogenic risks, as suggested by some animal studies.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and limited studies, as GW-501516 is not approved for human use and lacks comprehensive clinical data. Users should be aware of the potential risks, including serious side effects observed in animal studies, and the lack of regulatory approval for safety and efficacy.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 614, "total_tokens": 1303, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449d6cf08190b816e53b54e6553d", "custom_id": "drug4_effects_timeline", "response": {"status_code": 200, "request_id": "6330fe20910af938980956b49a7cfd4c", "body": {"id": "chatcmpl-B9MWFHzvSxW3wFgbFWm9QzBKA0yvS", "object": "chat.completion", "created": 1741571215, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial administration of hCG may lead to a slight increase in testosterone levels in men, which can be measured through blood tests. This increase might not yet be noticeable in terms of physical or mental changes.\",\n        \"Effect 2: Women undergoing fertility treatment might start to experience mild ovarian stimulation, but significant effects on ovulation are not expected yet.\",\n        \"Effect 3: Some users might experience mild side effects such as headaches or fatigue as the body adjusts to the hormone.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Men may begin to notice slight improvements in energy levels and mood due to increased testosterone, although these changes can be subtle.\",\n        \"Effect 2: Women might start to observe signs of ovulation if hCG is used in conjunction with other fertility treatments, such as follicle-stimulating hormone (FSH).\",\n        \"Effect 3: Biomarkers such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels might show changes, reflecting the body's response to hCG.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: In men, further increases in testosterone levels can lead to more noticeable physical changes, such as improved muscle mass and libido.\",\n        \"Effect 2: Women may experience more pronounced ovarian stimulation, with potential side effects like bloating or abdominal discomfort.\",\n        \"Effect 3: If used for fertility, successful ovulation may be confirmed through ultrasound or blood tests measuring progesterone levels.\",\n        \"Effect 4: Side effects such as mood swings or irritability might become more apparent as hormone levels fluctuate.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued use in men may lead to stabilization of testosterone levels, with sustained improvements in physical and mental well-being.\",\n        \"Effect 2: Women who achieve pregnancy may discontinue hCG, while those continuing treatment might experience cumulative effects on ovarian function.\",\n        \"Effect 3: Long-term side effects such as gynecomastia in men or ovarian hyperstimulation syndrome (OHSS) in women could manifest, requiring medical attention.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for hCG can vary significantly depending on individual factors such as dosage, frequency of administration, and whether it is used in conjunction with other treatments. The effects described are based on typical usage patterns for fertility treatments and testosterone support. Use of hCG for weight loss or athletic enhancement is not supported by scientific evidence and is not recommended. Side effects can vary widely, and users should be monitored by healthcare professionals throughout treatment.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 596, "total_tokens": 1281, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce449d7af48190b490da8a2b61882c", "custom_id": "drug5_effects_timeline", "response": {"status_code": 200, "request_id": "13f293b12dd5d8775c9b3070a0284e61", "body": {"id": "chatcmpl-B9MVOYETGZBjBCszQTfouXZpaa8zG", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a slight reduction in inflammation and minor pain relief in areas of injury, as BPC-157 begins to promote healing processes.\",\n        \"Effect 2: Users might notice a subtle improvement in joint mobility and a decrease in stiffness, particularly if used for tendon or ligament injuries.\",\n        \"Effect 3: Mental/cognitive effects are typically minimal at this stage, though some users report a slight improvement in mood due to reduced discomfort.\",\n        \"Effect 4: Biomarkers such as inflammatory markers might begin to show a slight decrease, although this may not be significant yet.\",\n        \"Effect 5: Side effects, if any, are usually mild and may include slight digestive discomfort or headaches as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in pain and inflammation, with more noticeable improvements in recovery from physical exertion or injury.\",\n        \"Effect 2: Enhanced healing of minor injuries might be observed, with users reporting quicker recovery times.\",\n        \"Effect 3: Users might experience a slight increase in energy levels and overall well-being as physical discomfort decreases.\",\n        \"Effect 4: Biomarkers related to tissue repair, such as collagen synthesis, may begin to show improvement, though this is often more evident in controlled studies.\",\n        \"Effect 5: Side effects remain minimal, but users should monitor for any unusual symptoms and consult with a healthcare professional if needed.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in healing and recovery are often reported, with users experiencing enhanced mobility and reduced pain in affected areas.\",\n        \"Effect 2: For those using BPC-157 for gastrointestinal issues, improvements in symptoms such as reduced ulcer discomfort may become more apparent.\",\n        \"Effect 3: Cognitive effects may include improved focus and mood, potentially due to decreased physical discomfort and increased activity levels.\",\n        \"Effect 4: Physiological measurements such as blood flow to injured areas might show improvement, supporting the healing process.\",\n        \"Effect 5: Side effects are generally rare, but users should remain vigilant for any adverse reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term users often report sustained improvements in joint and muscle health, with ongoing benefits in recovery and injury prevention.\",\n        \"Effect 2: Enhanced resilience to physical stress and quicker recovery from workouts or injuries may be observed.\",\n        \"Effect 3: Mental well-being may continue to improve, with users feeling more active and less hindered by previous injuries.\",\n        \"Effect 4: Biomarkers related to chronic inflammation and tissue repair might show significant improvement, though this varies among individuals.\",\n        \"Effect 5: Long-term side effects are not well-documented, but users should periodically assess their health status and consult with professionals.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of BPC-157 can vary significantly between individuals, and the compound is still under research. The timeline provided is based on anecdotal reports and preliminary studies. Users should approach BPC-157 with caution and under the guidance of a healthcare professional. Effects are inferred based on the compound's proposed mechanisms and similar peptides, as comprehensive clinical data is limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 666, "completion_tokens": 722, "total_tokens": 1388, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce449d8a308190952f170d80e0f841", "custom_id": "drug7_effects_timeline", "response": {"status_code": 200, "request_id": "39a4850c14ed5deacfbdea5dc79dbbef", "body": {"id": "chatcmpl-B9MVETowPrTyg469OQEaJdHT2z1KZ", "object": "chat.completion", "created": 1741571152, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Physical Effects: Users may not notice significant physical changes during the first week. However, some women might experience mild ovarian enlargement as the body begins to respond to increased FSH and LH levels.\",\n        \"Mental/Cognitive Effects: There may be minimal cognitive changes, although some users report mood swings or emotional sensitivity as the body adjusts to hormonal changes.\",\n        \"Biomarkers/Physiological Measurements: Blood tests may show initial increases in FSH and LH levels, indicating the compound's action on the pituitary gland.\",\n        \"Benefits: In women, the process of follicular development begins, setting the stage for ovulation.\",\n        \"Side Effects: Some users might experience mild side effects such as hot flashes, breast tenderness, or abdominal discomfort.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Physical Effects: Women may notice signs of ovulation, such as changes in cervical mucus or mild pelvic pain (mittelschmerz).\",\n        \"Mental/Cognitive Effects: Mood changes may continue, with some users experiencing increased emotional variability.\",\n        \"Biomarkers/Physiological Measurements: Continued elevation of FSH and LH levels. In men, a slight increase in testosterone levels might be observed.\",\n        \"Benefits: Ovulation is likely to occur in women, typically around days 10-14 of the cycle, increasing the chance of conception.\",\n        \"Side Effects: Side effects like hot flashes or abdominal discomfort may persist or peak during this period.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Physical Effects: In women, if conception occurs, early pregnancy symptoms might begin to appear. In men, there may be subtle improvements in energy levels due to increased testosterone.\",\n        \"Mental/Cognitive Effects: Emotional stability might improve as the body adjusts to hormonal changes.\",\n        \"Biomarkers/Physiological Measurements: In men, further increases in testosterone levels might be noted, potentially improving sperm production.\",\n        \"Benefits: For men, improvements in testosterone levels and sperm quality may start to become more noticeable.\",\n        \"Side Effects: Side effects generally stabilize, but some users may continue to experience mild symptoms.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Physical Effects: Women who have not conceived may experience a menstrual period, indicating the end of the cycle. Men may notice improved libido and energy levels.\",\n        \"Mental/Cognitive Effects: Cognitive effects are generally minimal, but mood stabilization continues.\",\n        \"Biomarkers/Physiological Measurements: In women, hormone levels return to baseline if conception has not occurred. In men, sustained testosterone levels may be observed.\",\n        \"Benefits: Continued benefits in men related to testosterone and sperm production.\",\n        \"Side Effects: Side effects typically diminish as the cycle completes, but some users may experience lingering symptoms.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects can vary significantly between individuals due to factors such as dosage, individual hormonal balance, and specific health conditions. The effects described are based on typical responses and may not apply to all users. Additionally, while clomiphene is used off-label in men, the effects and timeline are inferred from its mechanism of action and similar compounds, as there is limited direct research on its use in men.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 708, "total_tokens": 1397, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449d99948190b0a59caba45e187c", "custom_id": "drug8_effects_timeline", "response": {"status_code": 200, "request_id": "2e0ee4ff7f1361fc0ab177fa2861ac62", "body": {"id": "chatcmpl-B9MVDLnZfL4Jt8OZXi5EOIaJtfszH", "object": "chat.completion", "created": 1741571151, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include mild nausea or hot flashes as the body begins to adjust to the medication.\",\n        \"Effect 2: Some users might experience mood swings or mild headaches as the body adapts to changes in hormone levels.\",\n        \"Effect 3: Biomarkers such as estrogen levels may begin to decrease, but significant changes might not be immediately noticeable.\",\n        \"Effect 4: The anti-estrogenic effects on breast tissue may start, but noticeable benefits in terms of cancer treatment or prevention are not expected yet.\",\n        \"Effect 5: Side effects such as fatigue or dizziness might start to appear as the body adjusts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as hot flashes and nausea may continue, but the body might start to adapt, reducing their intensity.\",\n        \"Effect 2: Mental effects could include improved mood stability as the body adjusts, although some individuals may still experience mood swings.\",\n        \"Effect 3: Estrogen levels should show a more noticeable decrease in blood tests, indicating the drug's effectiveness in blocking estrogen receptors.\",\n        \"Effect 4: Benefits in terms of reducing the risk of breast cancer recurrence may begin to be more pronounced, although this is a gradual process.\",\n        \"Effect 5: Side effects like vaginal dryness or changes in menstrual cycle may become more apparent, especially in premenopausal women.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical side effects such as hot flashes may persist but are often less intense as the body becomes accustomed to the drug.\",\n        \"Effect 2: Cognitive effects might stabilize, with many users reporting a return to baseline mental function.\",\n        \"Effect 3: Continued monitoring of biomarkers may show sustained low estrogen levels, and potentially increased testosterone levels in off-label use.\",\n        \"Effect 4: The protective effects against breast cancer are more established, contributing to long-term risk reduction.\",\n        \"Effect 5: Long-term side effects such as changes in bone density or cholesterol levels might begin to manifest, requiring monitoring.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Most physical side effects should be stable, with some users experiencing a reduction in severity.\",\n        \"Effect 2: Mental and cognitive effects are generally stable, with few new changes expected.\",\n        \"Effect 3: Biomarkers should continue to reflect the drug's action, with consistent low estrogen levels and potential increases in testosterone.\",\n        \"Effect 4: The benefits in terms of cancer prevention and treatment are well-established, with ongoing use contributing to sustained protection.\",\n        \"Effect 5: Long-term side effects such as potential impacts on bone density or liver function should be monitored regularly.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for tamoxifen can vary significantly between individuals due to differences in metabolism, dosage, and individual health conditions. The effects described are based on typical use cases and may not apply to all users. Additionally, while some effects are well-documented, others are inferred based on the drug's mechanism of action and similar compounds. Regular medical monitoring is recommended to manage side effects and assess efficacy.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 658, "completion_tokens": 714, "total_tokens": 1372, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449da8508190942afcd960f4a9e3", "custom_id": "drug9_effects_timeline", "response": {"status_code": 200, "request_id": "2e4b1022e677788be4e60ed73e7acc19", "body": {"id": "chatcmpl-B9MVUek2OyyhwfWDPP5YmrGwNJYls", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial appetite suppression may begin to be noticeable as Tesofensine starts to increase levels of dopamine, norepinephrine, and serotonin in the brain.\",\n        \"Effect 2: Some users might experience a slight increase in energy and alertness due to elevated norepinephrine levels.\",\n        \"Effect 3: Mood enhancement could be observed as serotonin levels rise, potentially leading to a more positive outlook.\",\n        \"Effect 4: Side effects such as mild headaches or insomnia might begin to manifest as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued appetite suppression, potentially leading to a reduction in daily caloric intake.\",\n        \"Effect 2: Further improvements in mood and energy levels as neurotransmitter levels stabilize.\",\n        \"Effect 3: Initial weight loss may begin to be noticeable, although this can vary widely among individuals.\",\n        \"Effect 4: Side effects such as dry mouth or slight increases in heart rate might become more apparent.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More consistent weight loss may be observed as appetite suppression continues to encourage reduced food intake.\",\n        \"Effect 2: Enhanced cognitive function and focus might be reported due to sustained neurotransmitter activity.\",\n        \"Effect 3: Improvements in biomarkers such as blood glucose levels could begin to appear, particularly in individuals with obesity-related conditions.\",\n        \"Effect 4: Side effects like insomnia or increased heart rate may peak during this period, requiring monitoring.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant weight loss might be achieved, contributing to improved health outcomes related to obesity.\",\n        \"Effect 2: Sustained mood enhancement and energy levels could support lifestyle changes such as increased physical activity.\",\n        \"Effect 3: Further improvements in physiological measurements, such as reduced blood pressure or improved lipid profiles, may be observed.\",\n        \"Effect 4: Side effects may stabilize or decrease as the body adapts to the compound, though monitoring remains important.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term weight management benefits may become more apparent, with potential reductions in obesity-related health risks.\",\n        \"Effect 2: Continued positive effects on mood and cognitive function could support adherence to healthy lifestyle changes.\",\n        \"Effect 3: Maintenance of improved biomarkers, contributing to overall health improvements.\",\n        \"Effect 4: Any persistent side effects should be evaluated, and dosage adjustments may be considered if necessary.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and inferred effects from similar compounds. Individual responses to Tesofensine can vary significantly, and long-term effects are still under investigation. Monitoring by healthcare professionals is recommended to manage potential side effects and optimize outcomes.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 669, "completion_tokens": 648, "total_tokens": 1317, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449db7e8819090a22e45f7e3da36", "custom_id": "drug10_effects_timeline", "response": {"status_code": 200, "request_id": "d32d5497a1c5a2450d58152ad28d6c57", "body": {"id": "chatcmpl-B9MVERDkTF0MMcIv2dmu8Z44nrpVF", "object": "chat.completion", "created": 1741571152, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial adaptation phase where users might not notice significant physical changes. Some may experience mild increases in energy levels due to metabolic shifts.\",\n        \"Effect 2: Mental effects are likely minimal, but some users might report slight improvements in focus or mood as the body begins to adjust.\",\n        \"Effect 3: Biomarkers such as NNMT activity might begin to show slight reductions, but these changes are typically not noticeable without specific testing.\",\n        \"Effect 4: No significant benefits related to weight management or metabolic enhancement are expected to appear yet.\",\n        \"Effect 5: Side effects, if any, might include mild digestive discomfort or headaches as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice subtle physical changes, such as slight reductions in appetite or minor weight fluctuations.\",\n        \"Effect 2: Cognitive effects could include improved mental clarity or sustained energy levels throughout the day.\",\n        \"Effect 3: Further reductions in NNMT activity might be observed in biomarker tests, potentially leading to early metabolic changes.\",\n        \"Effect 4: Initial signs of metabolic enhancement, such as increased energy expenditure, may begin to manifest.\",\n        \"Effect 5: Side effects, if present, might stabilize or decrease as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable physical changes may occur, including potential weight loss or improved body composition.\",\n        \"Effect 2: Users might experience enhanced cognitive function, such as better concentration and reduced mental fatigue.\",\n        \"Effect 3: Significant changes in biomarkers related to metabolism, such as improved lipid profiles or glucose tolerance, might be observed.\",\n        \"Effect 4: Benefits related to weight management and metabolic enhancement could become more pronounced.\",\n        \"Effect 5: Any side effects are likely to have peaked and may diminish as the body fully adapts.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued physical improvements, with potential stabilization of weight loss and enhanced muscle-to-fat ratio.\",\n        \"Effect 2: Sustained cognitive benefits, including ongoing improvements in mood and mental energy.\",\n        \"Effect 3: Long-term biomarker changes, such as reduced NNMT activity and improved metabolic markers, may be evident.\",\n        \"Effect 4: Full benefits related to energy management and fat storage are likely to be realized.\",\n        \"Effect 5: Side effects, if any, should be minimal or resolved by this stage.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and inferred effects from similar compounds targeting metabolic pathways. Individual responses can vary significantly, and the effects described are speculative until more comprehensive research is conducted. Users should approach this compound with caution and under professional guidance.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 664, "completion_tokens": 638, "total_tokens": 1302, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449dc7e88190a2bd8e42ef2a7a74", "custom_id": "drug11_effects_timeline", "response": {"status_code": 200, "request_id": "4d2c6df256c506bd15fa84be9264ae84", "body": {"id": "chatcmpl-B9MVFIjApqFwboEJyryh6zhWl1Ogk", "object": "chat.completion", "created": 1741571153, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy and motivation during workouts, potentially due to the initial interaction of YK-11 with androgen receptors. This is inferred from the general effects of SARMs.\",\n        \"Effect 2: Some users might experience mild cognitive effects such as increased focus or mental clarity, although this is anecdotal and not well-documented.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected yet, as the compound is just starting to take effect.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice slight improvements in muscle fullness and strength, as the compound begins to enhance protein synthesis and potentially increase follistatin levels.\",\n        \"Effect 2: Increased endurance during workouts may be observed, inferred from the muscle-building properties of similar compounds.\",\n        \"Effect 3: Some users might begin to experience mild side effects such as joint discomfort or mood swings, although these are not well-documented for YK-11 specifically.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable muscle gains and strength improvements are likely to become apparent, as the compound's effects on muscle growth become more pronounced.\",\n        \"Effect 2: Users might experience enhanced recovery times between workouts, inferred from the anabolic effects of YK-11.\",\n        \"Effect 3: Biomarkers such as increased muscle mass or changes in body composition might start to be measurable, although specific data on YK-11 is limited.\",\n        \"Effect 4: Side effects such as potential liver strain or hormonal imbalances might begin to manifest, inferred from the compound's mechanism of action and reports from similar compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and strength gains are expected, with users potentially reaching a plateau in the rate of improvement.\",\n        \"Effect 2: Users might experience increased vascularity and muscle definition, inferred from the reduction of myostatin activity.\",\n        \"Effect 3: Potential side effects such as hair loss, acne, or changes in libido might become more pronounced, inferred from the androgenic activity of YK-11.\",\n        \"Effect 4: Users might observe changes in biomarkers such as lipid profiles or liver enzymes, although specific studies on YK-11 are lacking.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferences from the mechanisms of action of YK-11 and similar compounds. Scientific research on YK-11 is limited, and its long-term effects and safety profile are not well-established. Users should approach this compound with caution, and it is not approved for human use. The effects and side effects can vary significantly between individuals.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 628, "total_tokens": 1319, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449ddf6881908b893191d4c1748b", "custom_id": "drug12_effects_timeline", "response": {"status_code": 200, "request_id": "26bfa7e2b8906bd5dea9e8bae008a74d", "body": {"id": "chatcmpl-B9MVEQZGDM92jUB2e5ONGRtrawPJ4", "object": "chat.completion", "created": 1741571152, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvement in workout performance may be noticed. This is inferred from the mechanism of action of SARMs, which can begin to enhance muscle function early on.\",\n        \"Effect 2: Some users might experience a mild increase in focus and motivation, potentially due to the psychological effects of starting a new regimen.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected yet, as the compound is just beginning to exert its effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Early signs of muscle fullness and slight strength gains might become apparent. This is inferred from anecdotal reports of SARMs users.\",\n        \"Effect 2: Users might notice a slight improvement in recovery times post-exercise, as the compound begins to affect muscle tissue.\",\n        \"Effect 3: Some users might start to experience mild side effects such as changes in vision (e.g., a yellow tint), which have been reported with Andarine use.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable increases in muscle mass and strength are likely to be observed, as the compound's effects on androgen receptors become more pronounced.\",\n        \"Effect 2: Enhanced endurance and stamina during workouts may be reported, contributing to improved athletic performance.\",\n        \"Effect 3: Biomarkers such as testosterone levels might begin to show suppression, a common effect with SARMs, though individual responses can vary.\",\n        \"Effect 4: Side effects such as vision changes might become more pronounced or peak during this period.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and strength gains are expected, with some users reaching a plateau towards the end of this period.\",\n        \"Effect 2: Users might experience increased confidence and well-being due to physical changes and improved performance.\",\n        \"Effect 3: Potential further suppression of natural testosterone production, which could be observed in blood tests.\",\n        \"Effect 4: Long-term side effects, such as hormonal imbalances, might begin to manifest if the compound is used continuously without breaks.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and the known mechanism of action of SARMs like Andarine. Individual experiences can vary significantly, and the safety and efficacy of Andarine have not been fully established. The use of Andarine outside of a controlled research setting is not recommended due to potential health risks and legal issues.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 636, "completion_tokens": 571, "total_tokens": 1207, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449dee408190a11db6f95e65e934", "custom_id": "drug13_effects_timeline", "response": {"status_code": 200, "request_id": "8131674a816faf28a6f660f838416401", "body": {"id": "chatcmpl-B9MVGR5jJdPbKVNVwWOamAIgH3Exf", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial interaction with androgen receptors may begin, but noticeable physical effects such as muscle growth or increased strength are unlikely to be observed yet.\",\n        \"Effect 2: Some users might experience a slight increase in energy or motivation, although this is more anecdotal and not well-documented.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Early signs of muscle fullness or slight increases in strength might begin to appear, although these changes are subtle.\",\n        \"Effect 2: Mental effects such as improved focus or mood could be noticed, but these are inferred based on similar SARMs and not specifically documented for AC-262,536.\",\n        \"Effect 3: Minor changes in biomarkers like testosterone levels might begin, but significant shifts are unlikely.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle mass and strength could start to manifest as the compound continues to interact with androgen receptors.\",\n        \"Effect 2: Enhanced recovery times post-exercise might be observed, inferred from the mechanism of action of SARMs.\",\n        \"Effect 3: Biomarkers such as slight increases in lean body mass or changes in bone density could start to be measurable, although comprehensive studies are lacking.\",\n        \"Effect 4: Potential side effects like mild suppression of natural testosterone production might begin to appear, inferred from similar compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and strength gains are likely to be more pronounced, aligning with the compound's intended effects.\",\n        \"Effect 2: Mental effects such as improved motivation or focus might continue, although these are not well-documented.\",\n        \"Effect 3: Biomarkers such as increased muscle mass and possibly improved bone density could be more evident.\",\n        \"Effect 4: Side effects such as hormonal imbalances or mild liver enzyme changes might become more apparent, inferred from similar SARMs.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and inferences from similar SARMs. AC-262,536 is still under research, and its effects can vary significantly between individuals. The safety and efficacy of this compound have not been fully established, and it is not approved for human use. Researchers should exercise caution and conduct thorough investigations to understand its full range of effects and potential risks.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 563, "total_tokens": 1252, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449dfc9081909e0da6c06d9611bc", "custom_id": "drug14_effects_timeline", "response": {"status_code": 200, "request_id": "1d60ee3b281ead2251651e1d0a717503", "body": {"id": "chatcmpl-B9MVFmPQs0fsN83zTt565i1bVdEbo", "object": "chat.completion", "created": 1741571153, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in skin pigmentation may begin to be noticeable, particularly in individuals with lighter skin tones. This is due to the activation of melanocytes and the start of increased melanin production.\",\n        \"Effect 2: Some users might experience mild nausea or flushing as initial side effects, which are common with compounds that affect hormonal pathways.\",\n        \"Effect 3: No significant mental or cognitive effects are expected, as Melanotanii primarily acts on skin cells.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: More pronounced darkening of the skin as melanin production continues to increase. This effect is more noticeable with continued use.\",\n        \"Effect 2: Any initial side effects such as nausea may begin to subside as the body adjusts to the compound.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are typically observed, aside from skin pigmentation.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Skin pigmentation continues to deepen, reaching a more stable level of increased melanin production.\",\n        \"Effect 2: Users might notice a more even skin tone as melanin distribution becomes more uniform.\",\n        \"Effect 3: Potential side effects such as increased libido have been reported anecdotally, but these are not well-documented and may vary among individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Peak pigmentation effects are typically reached by this time, with the skin appearing significantly darker than baseline.\",\n        \"Effect 2: Any persistent side effects should be monitored closely, and use should be discontinued if adverse effects are severe.\",\n        \"Effect 3: Continued absence of significant mental or cognitive effects, as the compound's action is localized to skin cells.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and anecdotal reports, as Melanotanii is primarily used in research settings. Effects can vary widely among individuals, and the compound is not approved for medical or cosmetic use. The safety profile is not fully understood, and long-term effects are unknown. Users should exercise caution and consult with a healthcare professional before considering any use outside of a research context.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 508, "total_tokens": 1184, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e0d148190a8b89616d0457729", "custom_id": "drug15_effects_timeline", "response": {"status_code": 200, "request_id": "ac853953faff99423be4784e5ff7aed1", "body": {"id": "chatcmpl-B9MVGYlVgUzqvmbwhzb5lG2Fml2h2", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial reduction in estrogen levels may begin, but significant changes in symptoms or biomarkers are unlikely to be noticeable yet.\",\n        \"Effect 2: Some users might experience mild side effects such as hot flashes, nausea, or fatigue as the body begins to adjust to lower estrogen levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in estrogen levels; some users may start to notice a decrease in symptoms related to high estrogen, such as breast tenderness.\",\n        \"Effect 2: Mild cognitive effects such as mood swings or mild depression might begin to appear as the body adjusts to hormonal changes.\",\n        \"Effect 3: Biomarkers such as serum estrogen levels may show a measurable decrease, although this typically requires lab testing to confirm.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as a reduction in breast tissue size in cases of gynecomastia might start to become noticeable.\",\n        \"Effect 2: For breast cancer patients, tumor growth may begin to slow, although this is more effectively monitored through imaging and medical evaluation.\",\n        \"Effect 3: Side effects such as joint pain or stiffness may begin to manifest or intensify as the medication reaches steady-state levels in the body.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant benefits in terms of tumor size reduction or stabilization in breast cancer patients may be observed.\",\n        \"Effect 2: For those using anastrozole for fertility issues, hormone levels may begin to stabilize, potentially improving fertility outcomes.\",\n        \"Effect 3: Side effects such as bone density reduction might begin to be a concern, necessitating monitoring and potential intervention.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained reduction in estrogen levels and continued management of estrogen-dependent conditions are likely to be well-established.\",\n        \"Effect 2: Cognitive effects such as mood changes may stabilize as the body adapts to the new hormonal balance.\",\n        \"Effect 3: Continued monitoring of bone health and cardiovascular markers is recommended due to potential long-term side effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects can vary significantly between individuals based on factors such as dosage, individual health conditions, and concurrent medications. The effects described are based on typical usage patterns and may not apply to all users. Monitoring by healthcare professionals is essential to manage and mitigate potential side effects effectively.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 684, "completion_tokens": 576, "total_tokens": 1260, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e1e348190b818fac8809912dc", "custom_id": "drug16_effects_timeline", "response": {"status_code": 200, "request_id": "038436f45786c385388765fa16fafab1", "body": {"id": "chatcmpl-B9MVFhUtKAjLK9BN9L6LXKvMTQjKD", "object": "chat.completion", "created": 1741571153, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvement in workout performance, inferred from similar compounds like RAD-140.\",\n        \"Effect 2: Possible mild increase in focus and motivation due to androgen receptor activation, although this is more speculative and based on anecdotal reports from similar compounds.\",\n        \"Effect 3: No significant changes in muscle mass or strength are expected this early, as muscle hypertrophy typically requires more time.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Noticeable improvement in endurance and stamina during physical activities, inferred from the compound's mechanism of action.\",\n        \"Effect 2: Potential slight increase in muscle fullness and vascularity as the body begins to respond to enhanced protein synthesis.\",\n        \"Effect 3: Some users might start to experience mild side effects such as headaches or mood swings, inferred from similar compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced gains in muscle mass and strength may begin to appear, as protein synthesis and muscle recovery are enhanced.\",\n        \"Effect 2: Improved recovery times between workouts, allowing for more frequent training sessions.\",\n        \"Effect 3: Possible changes in biomarkers such as increased levels of creatine kinase or alterations in liver enzymes, inferred from similar research chemicals.\",\n        \"Effect 4: Side effects such as mild acne or changes in libido might start to manifest, based on the compound's androgenic activity.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: Continued improvements in muscle mass and definition, with more noticeable changes in body composition.\",\n        \"Effect 2: Enhanced cognitive effects such as improved focus and mental clarity may be reported, although these are less documented and more speculative.\",\n        \"Effect 3: Potential stabilization of any initial side effects, but new side effects such as joint discomfort or increased aggression could appear, inferred from similar compounds.\",\n        \"Effect 4: Benefits such as increased athletic performance and endurance are likely to be at their peak during this period.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is largely speculative and based on the known mechanisms of action of RAD-150 and similar compounds like RAD-140. There is limited direct research on RAD-150, so many effects are inferred from related compounds. It is crucial to note that RAD-150 is still under investigation, and its safety and efficacy are not fully established. Use outside of a controlled research setting is not recommended.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 665, "completion_tokens": 563, "total_tokens": 1228, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e2c7c8190841f87bc3f68e73e", "custom_id": "drug17_effects_timeline", "response": {"status_code": 200, "request_id": "5686a01d21758bbc9e5cb998b0b3b531", "body": {"id": "chatcmpl-B9MVGqTKvSkw0ObVq0tdFFnbwwngT", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial activation of melanocortin receptors may lead to a subtle increase in sexual arousal and interest. Users might notice a mild enhancement in sexual thoughts or fantasies.\",\n        \"Effect 2: Some users might experience slight flushing or warmth due to vasodilation, a common immediate response to melanocortin receptor activation.\",\n        \"Effect 3: Initial side effects such as nausea or headache could begin to manifest as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued activation of melanocortin receptors may lead to more noticeable improvements in sexual desire and arousal. Users might report increased frequency of sexual thoughts and a heightened response to sexual stimuli.\",\n        \"Effect 2: Mental effects could include improved mood or a sense of well-being due to increased sexual satisfaction.\",\n        \"Effect 3: Side effects such as nausea or headache may persist but often decrease in intensity as the body acclimates.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience a stabilization of sexual desire enhancement, with consistent improvements in arousal and responsiveness.\",\n        \"Effect 2: Cognitive effects might include enhanced focus or motivation related to sexual activities, potentially improving relationship satisfaction.\",\n        \"Effect 3: Physiological measurements such as heart rate or blood pressure might show slight variations due to the compound's systemic effects, but these are typically within normal ranges.\",\n        \"Effect 4: Side effects, if present, are likely to have peaked and may begin to diminish as tolerance develops.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained improvements in sexual desire and overall sexual satisfaction are likely to be most pronounced during this period.\",\n        \"Effect 2: Users might notice improved emotional well-being and relationship dynamics as a result of enhanced sexual function.\",\n        \"Effect 3: Any persistent side effects should be monitored, but they are generally expected to be minimal by this stage.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the known mechanism of action of bremenalotide and similar compounds targeting melanocortin receptors. Individual responses can vary significantly, and the effects described are inferred from preliminary studies and related research. Long-term safety and efficacy are still under investigation, and users should be monitored for any adverse reactions.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 641, "completion_tokens": 547, "total_tokens": 1188, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e3b088190892b4a2839ef74e1", "custom_id": "drug18_effects_timeline", "response": {"status_code": 200, "request_id": "9324f29d736dad97473a364369259dea", "body": {"id": "chatcmpl-B9MVOOWGiJN2JLUvC2Aezak3eenCV", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial detoxification processes may begin, with some users noticing a mild increase in energy levels as oxidative stress is reduced.\",\n        \"Effect 2: Some users might experience a slight improvement in mental clarity and focus due to reduced oxidative damage in the brain.\",\n        \"Effect 3: Biomarkers such as reduced oxidative stress markers (e.g., malondialdehyde) may begin to show slight improvements, although significant changes might not be measurable yet.\",\n        \"Effect 4: Users may start to notice subtle improvements in skin health, although significant skin lightening effects are unlikely to be noticeable this early.\",\n        \"Effect 5: Side effects, if any, such as mild gastrointestinal discomfort or skin rashes, might begin to manifest in sensitive individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued detoxification may lead to further increases in energy and vitality as the body adjusts to improved cellular health.\",\n        \"Effect 2: Enhanced immune function might become more noticeable, with users potentially experiencing fewer minor illnesses or quicker recovery from colds.\",\n        \"Effect 3: Biomarkers related to liver function, such as liver enzyme levels, might show improvement, indicating better liver detoxification capacity.\",\n        \"Effect 4: Users interested in skin lightening might start to notice slight changes in skin tone, although this varies greatly among individuals.\",\n        \"Effect 5: Any initial side effects may stabilize or diminish as the body adapts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience a more pronounced sense of well-being and sustained energy levels as glutathione levels stabilize.\",\n        \"Effect 2: Cognitive benefits, such as improved memory and concentration, may become more evident due to ongoing protection against oxidative stress.\",\n        \"Effect 3: Continued improvements in biomarkers related to oxidative stress and liver function might be observed, supporting overall health.\",\n        \"Effect 4: Skin health benefits, including potential lightening effects, may become more noticeable, particularly in individuals using glutathione for this purpose.\",\n        \"Effect 5: Side effects are generally minimal by this stage, but any persistent issues should be evaluated by a healthcare professional.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as enhanced detoxification and immune support are likely to be well-established, contributing to overall health maintenance.\",\n        \"Effect 2: Users may report sustained cognitive benefits, including sharper focus and mental clarity.\",\n        \"Effect 3: Biomarkers indicating reduced oxidative stress and improved liver function may show significant improvements, reflecting the compound's efficacy.\",\n        \"Effect 4: Skin lightening effects, if pursued, may reach their peak, although results vary widely among individuals.\",\n        \"Effect 5: Long-term side effects are rare, but ongoing monitoring is advised to ensure continued safety and efficacy.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for glutathione can vary significantly based on individual factors such as dosage, method of administration (oral, intravenous, etc.), and baseline health status. The effects described are based on typical user experiences and scientific understanding of glutathione's mechanisms. Users should consult healthcare professionals before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 650, "completion_tokens": 725, "total_tokens": 1375, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e49f88190b5052f9dcc435899", "custom_id": "drug19_effects_timeline", "response": {"status_code": 200, "request_id": "5e57212bc50af5bf1c1db82609b26732", "body": {"id": "chatcmpl-B9MVFyZF3lH07qd4jkVajq2WJBw3c", "object": "chat.completion", "created": 1741571153, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in growth hormone levels may be observed, but physical changes are typically not noticeable yet.\",\n        \"Effect 2: Some users might experience mild water retention as the body adjusts to increased growth hormone levels.\",\n        \"Effect 3: No significant cognitive effects are expected at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice slight improvements in energy levels due to increased metabolism.\",\n        \"Effect 2: Initial reduction in abdominal fat may begin, but changes are subtle and not easily measurable.\",\n        \"Effect 3: Some users may experience mild headaches or joint discomfort as a side effect of increased growth hormone.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable reduction in visceral fat may start to appear, particularly around the abdomen.\",\n        \"Effect 2: Improvements in physical appearance and body contouring might become more apparent.\",\n        \"Effect 3: Some users report enhanced mood or slight cognitive improvements, although these effects are not well-documented.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in abdominal fat, with more significant changes in body composition.\",\n        \"Effect 2: Improved metabolic markers, such as reduced triglycerides and improved insulin sensitivity, may be observed.\",\n        \"Effect 3: Side effects such as joint pain or swelling may peak but often stabilize or diminish with continued use.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3-6\",\n      \"effects\": [\n        \"Effect 1: Maximum reduction in visceral fat is typically achieved, with significant improvements in body contour.\",\n        \"Effect 2: Long-term metabolic benefits, such as improved lipid profiles and reduced cardiovascular risk, may become evident.\",\n        \"Effect 3: Cognitive benefits, if any, are likely subtle and not well-quantified in clinical studies.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Tesamorelin is primarily based on its approved use for reducing visceral fat in HIV-associated lipodystrophy. Effects related to cognitive improvements are speculative and not well-supported by clinical evidence. Individual responses can vary, and side effects may differ based on personal health conditions and concurrent medications.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 678, "completion_tokens": 521, "total_tokens": 1199, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e58e08190945f88e43ac8d308", "custom_id": "drug20_effects_timeline", "response": {"status_code": 200, "request_id": "b788e00bc591131509e8979b94e2bead", "body": {"id": "chatcmpl-B9MVGhdh9AANjApDD6i1qqxx88czG", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvements in workout performance may be noticed. These effects are inferred based on the mechanism of action of SARMs, which can enhance muscle activity.\",\n        \"Effect 2: Some users might experience a slight increase in aggression or focus, as seen with other androgenic compounds. This is inferred from similar compounds.\",\n        \"Effect 3: No significant changes in biomarkers such as testosterone levels or liver enzymes are expected this early, but baseline measurements should be taken for comparison.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Noticeable improvements in muscle hardness and slight increases in muscle mass may begin to appear. This is inferred from the anabolic effects of SARMs.\",\n        \"Effect 2: Enhanced endurance and strength during workouts might become more apparent.\",\n        \"Effect 3: Potential suppression of natural testosterone production could begin, as observed with other SARMs, though this is inferred and not documented for S-23 specifically.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Continued increase in muscle mass and strength. Users might start to see visible changes in body composition.\",\n        \"Effect 2: Possible mood changes, such as increased irritability or motivation, may occur due to androgenic activity.\",\n        \"Effect 3: Biomarkers such as testosterone levels might show suppression, and liver enzymes could start to elevate, indicating stress on the liver.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Peak muscle growth and strength gains are likely to be observed, aligning with the compound's intended effects.\",\n        \"Effect 2: Users might experience a plateau in cognitive effects, with no further increases in focus or aggression.\",\n        \"Effect 3: Side effects such as potential hair loss or acne, common with androgenic compounds, might begin to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-6\",\n      \"effects\": [\n        \"Effect 1: Muscle gains and strength improvements may continue but at a slower rate as the body adapts.\",\n        \"Effect 2: Potential for increased fatigue or lethargy as the body adjusts to hormonal changes.\",\n        \"Effect 3: Biomarkers such as testosterone suppression and liver enzyme elevation might peak, necessitating monitoring and potential intervention.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar SARMs and the known mechanism of action of S-23. There is limited specific research on S-23 in humans, so effects and side effects may vary. Users should be aware of the potential for significant hormonal disruption and other health risks.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 598, "total_tokens": 1285, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e67148190b2acbc5d0eb72e61", "custom_id": "drug21_effects_timeline", "response": {"status_code": 200, "request_id": "cdd870f840bd0adde74f4d1f01c289b9", "body": {"id": "chatcmpl-B9MVFonZLc5OYiv6Oub6kzMsykxBu", "object": "chat.completion", "created": 1741571153, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may not notice significant physical changes in the first week as Raloxifene's effects on bone density and cancer risk reduction are gradual.\",\n        \"Effect 2: Some users might experience mild side effects such as hot flashes or leg cramps as the body adjusts to the medication.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected in the first week.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Continued adjustment period with potential mild side effects like hot flashes, leg cramps, or swelling in the hands and feet.\",\n        \"Effect 2: Users might begin to notice a stabilization in mood as the body adjusts to the hormonal modulation, though cognitive effects are generally minimal.\",\n        \"Effect 3: Initial changes in bone turnover markers might begin to be detectable in a research setting, indicating the start of bone density preservation.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users may start to experience a reduction in the frequency and severity of hot flashes as the body becomes accustomed to the medication.\",\n        \"Effect 2: Bone density preservation effects become more pronounced, though these are typically measurable only through clinical tests rather than noticeable physical changes.\",\n        \"Effect 3: Continued monitoring might show further stabilization in bone turnover markers, suggesting ongoing protective effects on bone health.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Users may notice a reduction in the occurrence of leg cramps and other initial side effects as the body fully adjusts to Raloxifene.\",\n        \"Effect 2: The risk reduction for breast cancer becomes more significant, although this is a long-term benefit that is not directly observable by the user.\",\n        \"Effect 3: Clinical tests may show improved bone mineral density, indicating the effectiveness of the medication in preventing osteoporosis.\"\n      ]\n    },\n    {\n      \"period\": \"Month 6-12\",\n      \"effects\": [\n        \"Effect 1: Users should experience the full benefits of Raloxifene in terms of bone density preservation and reduced risk of fractures.\",\n        \"Effect 2: Long-term use continues to support the reduction in breast cancer risk, though this remains a preventive measure rather than a treatment.\",\n        \"Effect 3: Side effects are generally minimal at this stage, with most users having adjusted to the medication.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of Raloxifene are gradual and primarily preventive, focusing on long-term health benefits rather than immediate changes. Side effects are typically mild and decrease over time as the body adjusts. The timeline provided is based on typical use cases and may vary depending on individual health conditions and concurrent medications. Clinical monitoring is essential to assess the effectiveness of the treatment in terms of bone density and cancer risk reduction.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 692, "completion_tokens": 637, "total_tokens": 1329, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e757c81909f9b9be8ffe1e7ec", "custom_id": "drug22_effects_timeline", "response": {"status_code": 200, "request_id": "3feb94c19db873d475c7227f424bd389", "body": {"id": "chatcmpl-B9MVFXv0UZtK6fobMp0r0hB7VXAC6", "object": "chat.completion", "created": 1741571153, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a sense of relaxation and mild sedation. Some users report feeling a reduction in muscle tension.\",\n        \"Effect 2: Mental effects might include a noticeable decrease in anxiety and stress levels, leading to improved mood and sociability.\",\n        \"Effect 3: Users may experience enhanced sleep quality, falling asleep faster and experiencing deeper sleep.\",\n        \"Effect 4: Specific benefits such as reduced anxiety and improved sociability typically begin to appear within a few hours of ingestion.\",\n        \"Effect 5: Side effects such as mild dizziness, nausea, or headache may begin to manifest, especially if taken in higher doses.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to sustained relaxation and reduced anxiety, with users feeling more comfortable in social situations.\",\n        \"Effect 2: Cognitive effects might include slight improvements in focus and concentration due to reduced anxiety.\",\n        \"Effect 3: Physiological changes such as a decrease in heart rate and blood pressure might be observed due to the calming effects.\",\n        \"Effect 4: Users may notice an improvement in overall sleep patterns, with more consistent sleep cycles.\",\n        \"Effect 5: Side effects like tolerance development may begin, requiring higher doses for the same effect, and some users might experience increased fatigue or lethargy.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical effects may plateau, with users experiencing consistent levels of relaxation and reduced anxiety.\",\n        \"Effect 2: Mental effects might include a potential decrease in cognitive sharpness or motivation, especially if doses are increased.\",\n        \"Effect 3: Biomarkers such as liver enzymes could begin to show changes if high doses are used, although this is more speculative.\",\n        \"Effect 4: Benefits like improved sleep and reduced anxiety continue, but the risk of dependence increases.\",\n        \"Effect 5: Side effects such as withdrawal symptoms (e.g., rebound anxiety, insomnia) may begin to appear if usage is abruptly stopped.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Physical effects may diminish as tolerance develops, requiring higher doses for the same effect.\",\n        \"Effect 2: Mental effects might include increased risk of mood swings or depression if the compound is misused.\",\n        \"Effect 3: Long-term use could potentially lead to changes in GABA receptor sensitivity, although specific biomarkers are not well-documented.\",\n        \"Effect 4: Benefits may be overshadowed by the need for higher doses and the risk of dependence.\",\n        \"Effect 5: Side effects such as withdrawal symptoms become more pronounced, and users may experience significant discomfort if the compound is discontinued.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Phenibut is based on anecdotal reports and limited scientific studies. Effects can vary significantly between individuals due to differences in metabolism, dosage, and frequency of use. The potential for dependence and withdrawal is a significant concern, and users should exercise caution. This timeline includes some inferred effects based on the compound's mechanism of action and similarities to other GABAergic substances.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 679, "completion_tokens": 699, "total_tokens": 1378, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e88948190a683b82b17f9eee7", "custom_id": "drug23_effects_timeline", "response": {"status_code": 200, "request_id": "81780bc33284355b900ab1a34c07b45c", "body": {"id": "chatcmpl-B9MVGYszAvbIqzLfxtAOv7kEajoBK", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial reduction in blood pressure may be observed within the first few days, as Telmisartan begins to block the action of angiotensin II, leading to vasodilation.\",\n        \"Effect 2: Some users might experience mild dizziness or lightheadedness, particularly when standing up quickly, due to the initial drop in blood pressure.\",\n        \"Effect 3: No significant mental or cognitive effects are typically expected during this period.\",\n        \"Effect 4: Biomarkers such as blood pressure readings may show a gradual decrease, but significant changes in kidney function or insulin sensitivity are unlikely to be noticeable yet.\",\n        \"Effect 5: Side effects such as fatigue or mild gastrointestinal discomfort might begin to manifest as the body adjusts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in blood pressure, with more stable readings as the body adapts to the medication.\",\n        \"Effect 2: Users may notice an improvement in energy levels as blood pressure stabilizes, although this is not universally reported.\",\n        \"Effect 3: No significant changes in cognitive function are expected.\",\n        \"Effect 4: Initial benefits for heart health might begin to appear, though these are subtle and more pronounced over longer periods.\",\n        \"Effect 5: Side effects such as dizziness may decrease as the body becomes accustomed to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Blood pressure should be consistently lower, with readings approaching target levels set by healthcare providers.\",\n        \"Effect 2: Users with insulin resistance might begin to notice slight improvements in blood sugar control, although this effect is more gradual and varies between individuals.\",\n        \"Effect 3: Kidney function biomarkers might show slight improvements in individuals with diabetic nephropathy, though significant changes are more likely over months.\",\n        \"Effect 4: Cardiovascular benefits, such as reduced strain on the heart, become more apparent, contributing to overall heart health.\",\n        \"Effect 5: Any initial side effects are likely to have diminished, but ongoing monitoring for rare side effects like hyperkalemia (elevated potassium levels) is advised.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Blood pressure control is typically well-established, contributing to reduced risk of cardiovascular events.\",\n        \"Effect 2: Users may experience improved exercise tolerance and reduced symptoms of heart failure, if applicable.\",\n        \"Effect 3: Continued improvements in insulin sensitivity and kidney function may be observed, particularly in those with pre-existing conditions.\",\n        \"Effect 4: Long-term cardiovascular benefits, such as reduced risk of heart attack and stroke, are more pronounced.\",\n        \"Effect 5: Side effects are generally minimal, but ongoing monitoring for any adverse reactions is recommended.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Telmisartan can vary based on individual health conditions, dosage, and adherence to the medication regimen. While some effects, such as blood pressure reduction, can be observed relatively quickly, others, like improvements in insulin sensitivity or kidney function, may take longer to manifest. It is important for users to follow their healthcare provider's guidance and report any unusual side effects. The information provided is based on typical responses and may not apply to all individuals.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 648, "completion_tokens": 729, "total_tokens": 1377, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449e973c8190a9d29c9c552d7039", "custom_id": "drug24_effects_timeline", "response": {"status_code": 200, "request_id": "66005658ad75fa04cab14ca166753210", "body": {"id": "chatcmpl-B9MVGE2hAJhKDlt7UpYqWWJro6Xel", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle increases in energy levels and a slight improvement in sleep quality, as growth hormone can influence sleep patterns.\",\n        \"Effect 2: Initial water retention might occur due to increased growth hormone levels, which can lead to a slight increase in body weight.\",\n        \"Effect 3: No significant changes in muscle mass or fat reduction are typically observed at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Some users may start to experience improved recovery times after workouts, as growth hormone aids in tissue repair.\",\n        \"Effect 2: A slight increase in appetite might be noticed, potentially due to metabolic changes.\",\n        \"Effect 3: Biomarkers such as IGF-1 (Insulin-like Growth Factor 1) levels might begin to rise, indicating increased growth hormone activity.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may begin to see modest improvements in muscle tone and a reduction in body fat, although these changes are typically subtle.\",\n        \"Effect 2: Enhanced cognitive function, such as improved focus and mental clarity, might be reported by some users.\",\n        \"Effect 3: Side effects such as mild joint pain or tingling in extremities could begin to manifest as a result of increased growth hormone levels.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: More noticeable increases in muscle mass and strength may be observed, particularly if combined with resistance training.\",\n        \"Effect 2: Continued improvements in recovery times and overall physical performance.\",\n        \"Effect 3: Potential side effects, such as increased water retention or carpal tunnel syndrome, might peak during this period.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Users might experience more significant changes in body composition, with increased lean muscle mass and reduced body fat.\",\n        \"Effect 2: Long-term cognitive benefits, such as sustained improvements in memory and learning, could become more apparent.\",\n        \"Effect 3: Monitoring of biomarkers like IGF-1 and glucose levels is recommended, as prolonged use can affect insulin sensitivity.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for CJC-1295 is based on anecdotal reports and inferred from its mechanism of action, as comprehensive clinical studies are limited. Individual responses can vary significantly, and long-term safety is not well-documented. Users should be cautious of potential side effects and consult with a healthcare professional before considering use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 586, "total_tokens": 1277, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449ea7908190be60a70accd35d1b", "custom_id": "drug25_effects_timeline", "response": {"status_code": 200, "request_id": "e123a4ddfce73fdef7559c214512040a", "body": {"id": "chatcmpl-B9MVNEKk6Da20lJNpMYWhHskxsNEF", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial onset of increased energy levels and reduced fatigue may be noticeable. Users might feel more alert and less tired during the day.\",\n        \"Effect 2: Some users may experience a mild improvement in mood and motivation due to the modulation of dopamine and serotonin levels.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\",\n        \"Effect 4: Initial cognitive enhancements, such as improved concentration and focus, might begin to appear.\",\n        \"Effect 5: Side effects, if any, such as mild headaches or slight insomnia, might start to manifest but are generally not severe.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Enhanced physical endurance and reduced perception of stress may become more pronounced, allowing for better performance in physically demanding tasks.\",\n        \"Effect 2: Cognitive benefits, including improved memory retention and mental clarity, are likely to become more noticeable.\",\n        \"Effect 3: Users might observe a slight increase in heart rate or blood pressure, although these changes are typically within normal ranges.\",\n        \"Effect 4: The benefits of reduced anxiety and improved stress management are likely to be more evident, particularly in high-pressure situations.\",\n        \"Effect 5: Side effects such as mild gastrointestinal discomfort or restlessness might peak but are generally manageable.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in energy levels and physical performance are expected, with users feeling less fatigued even after exertion.\",\n        \"Effect 2: Continued enhancement of cognitive functions, including faster information processing and better decision-making abilities.\",\n        \"Effect 3: Potential stabilization of biomarkers related to stress, such as cortisol levels, although individual responses may vary.\",\n        \"Effect 4: The full spectrum of benefits, including enhanced mental and physical resilience, is likely to be fully realized by this period.\",\n        \"Effect 5: Any initial side effects are expected to diminish as the body adjusts, but long-term use should be monitored for tolerance development.\"\n      ]\n    },\n    {\n      \"period\": \"Month 1-2\",\n      \"effects\": [\n        \"Effect 1: Users may experience a plateau in the enhancement effects as the body adapts to the compound.\",\n        \"Effect 2: Cognitive and mood benefits are maintained, with users reporting sustained improvements in motivation and overall well-being.\",\n        \"Effect 3: Regular monitoring of physiological parameters is advised to ensure no adverse changes occur over extended use.\",\n        \"Effect 4: The actoprotector effects, such as improved stress management without increased oxygen demand, continue to support high performance.\",\n        \"Effect 5: Long-term side effects are not well-documented, but users should be cautious of potential dependency or withdrawal symptoms upon cessation.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline is based on limited available data and inferred effects from similar compounds. Individual responses to Bromantane can vary significantly, and long-term safety data is lacking. Users should approach with caution and under professional guidance.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 638, "completion_tokens": 671, "total_tokens": 1309, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449eb5f8819088a71fcf58899410", "custom_id": "drug26_effects_timeline", "response": {"status_code": 200, "request_id": "b96ee2cb692d228ef8e3f1f3025658f0", "body": {"id": "chatcmpl-B9MVGsBW8NNfGgTH1p03SUNCFSqhq", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial interaction with Rev-erb may begin, potentially leading to subtle changes in circadian rhythm regulation. Users might notice slight alterations in sleep patterns or energy levels, although these effects are primarily inferred from animal studies.\",\n        \"Effect 2: Early metabolic changes could start to manifest, such as a mild increase in energy expenditure. This is based on the compound's mechanism of action but not yet documented in human studies.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected this early, as the compound's effects are likely to be gradual.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might begin to experience enhanced physical endurance during exercise, as suggested by animal studies. This is inferred from the compound's potential impact on energy metabolism.\",\n        \"Effect 2: Some users may notice a slight improvement in mood or cognitive function due to better-regulated sleep-wake cycles, although this is speculative and based on the compound's interaction with circadian rhythms.\",\n        \"Effect 3: Minor changes in biomarkers related to metabolism, such as glucose levels or lipid profiles, might start to appear, but significant changes are unlikely at this stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable effects on body composition may begin to emerge, such as a reduction in body fat percentage or changes in muscle mass, inferred from animal studies on fat storage and utilization.\",\n        \"Effect 2: Continued improvements in physical endurance and energy levels might be observed, aligning with the compound's proposed benefits.\",\n        \"Effect 3: Potential side effects, such as disruptions in sleep patterns or mild gastrointestinal discomfort, could start to manifest as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Users might experience more pronounced benefits in weight management and metabolic health, including improved lipid profiles and glucose metabolism, based on the compound's mechanism of action.\",\n        \"Effect 2: Enhanced cognitive function and mood stabilization could be more evident, inferred from the compound's impact on circadian regulation.\",\n        \"Effect 3: Side effects, if any, might peak during this period, potentially including sleep disturbances or metabolic imbalances, although these are speculative and based on similar compounds.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is largely speculative and based on animal studies and the known mechanism of action of SR-9011. Human studies are limited, and effects can vary significantly between individuals. Researchers should exercise caution and consider these effects as potential outcomes rather than guaranteed results.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 681, "completion_tokens": 585, "total_tokens": 1266, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449ed2588190972b39098581cfd1", "custom_id": "drug27_effects_timeline", "response": {"status_code": 200, "request_id": "8c95aaaa3a3afb2e99c0dd936958ddbf", "body": {"id": "chatcmpl-B9MVN4HfSGOpNRZrQr7lWtIIEadMN", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels may be noticed as the body begins to respond to increased growth hormone production. This effect is inferred from the mechanism of action.\",\n        \"Effect 2: Some users might experience improved sleep quality due to the role of growth hormone in sleep regulation. This is an inferred effect based on similar compounds.\",\n        \"Effect 3: Minor changes in mood or cognitive clarity might be observed, although these are not well-documented and are more anecdotal.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued increase in energy and potential improvement in recovery times from physical activity, as the body adjusts to higher growth hormone levels.\",\n        \"Effect 2: Initial changes in body composition might begin, such as slight increases in lean muscle mass or reductions in body fat, though these changes are subtle and inferred.\",\n        \"Effect 3: Some users might start to notice improved skin texture, as growth hormone can influence collagen production. This is an inferred effect.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle tone and strength may begin to manifest, particularly if combined with exercise. This is inferred from the role of growth hormone in muscle development.\",\n        \"Effect 2: Enhanced recovery from workouts and reduced muscle soreness might be observed.\",\n        \"Effect 3: Biomarkers such as IGF-1 (Insulin-like Growth Factor 1) levels may show measurable increases, indicating enhanced growth hormone activity.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: More significant changes in body composition, such as increased muscle mass and reduced fat mass, may become apparent.\",\n        \"Effect 2: Improvements in skin elasticity and reduction in fine lines could be observed, inferred from growth hormone's effects on collagen.\",\n        \"Effect 3: Potential stabilization of mood and cognitive benefits, although these effects are less documented and more anecdotal.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in physical performance and recovery, with potential peak benefits in muscle growth and fat loss.\",\n        \"Effect 2: Long-term users might notice enhanced overall vitality and well-being, although these effects are subjective and vary widely.\",\n        \"Effect 3: Side effects such as joint pain, edema, or insulin resistance might begin to manifest or peak, as these are associated with prolonged growth hormone elevation.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for sermorelin is largely inferred from its mechanism of action and the effects of growth hormone. Individual responses can vary significantly, and the safety and efficacy of sermorelin for off-label uses are not well-established. Users should be cautious of potential side effects and consult healthcare professionals before use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 638, "total_tokens": 1323, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449ee04081908d20b64aace0f962", "custom_id": "drug28_effects_timeline", "response": {"status_code": 200, "request_id": "09026bb13bf03bc6676bcddb5e123746", "body": {"id": "chatcmpl-B9MVU2SnoZ0njJ8hYKxfBFcuId1QM", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial hormonal changes begin as hMG introduces FSH and LH into the body, potentially leading to mild ovarian stimulation in women or testicular stimulation in men.\",\n        \"Effect 2: Some users may experience slight mood changes or emotional sensitivity due to hormonal fluctuations, although this is more commonly reported in women.\",\n        \"Effect 3: Biomarkers such as FSH and LH levels in the blood may start to rise, indicating the onset of the drug's action.\",\n        \"Effect 4: Side effects such as mild bloating, breast tenderness, or headaches might begin to appear as the body adjusts to the hormonal changes.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: In women, more noticeable ovarian stimulation may occur, potentially leading to the development of multiple follicles as the ovaries respond to increased FSH and LH levels.\",\n        \"Effect 2: Men may start to experience an increase in testosterone levels, which could lead to improved mood and energy levels.\",\n        \"Effect 3: Biomarkers such as estradiol levels in women may increase, reflecting follicular development.\",\n        \"Effect 4: Side effects such as abdominal discomfort or mood swings may become more pronounced as hormonal activity intensifies.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Women may experience ovulation, especially if hCG (human chorionic gonadotropin) is administered to trigger it, marking a key benefit of hMG therapy.\",\n        \"Effect 2: Men might notice an improvement in sperm production, although significant changes in sperm count or quality may take longer to manifest.\",\n        \"Effect 3: Continued monitoring of biomarkers like estradiol and testosterone levels can confirm the drug's effectiveness.\",\n        \"Effect 4: Side effects such as ovarian hyperstimulation syndrome (OHSS) in women could occur, especially if multiple follicles mature simultaneously.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: For women, the potential for conception increases if ovulation has been successfully induced and timed with intercourse or insemination.\",\n        \"Effect 2: Men may continue to see gradual improvements in sperm parameters, although full effects might take several months.\",\n        \"Effect 3: Hormonal levels may stabilize as the body adjusts to the treatment, reducing some side effects.\",\n        \"Effect 4: Any severe side effects should be monitored closely, and adjustments to dosage or treatment may be necessary.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for hMG can vary significantly between individuals based on factors such as dosage, individual hormonal baseline, and concurrent use of other fertility treatments. The effects described are based on typical responses observed in clinical settings, but individual experiences may differ. Inferred effects are noted where direct documentation is limited, particularly regarding male use, which is less commonly studied.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 668, "completion_tokens": 639, "total_tokens": 1307, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce449ef0e08190869d918065df78dd", "custom_id": "drug29_effects_timeline", "response": {"status_code": 200, "request_id": "caafab4020d924ced1ecf487b4b28a07", "body": {"id": "chatcmpl-B9MVGIAkbEJa6b5nGjERjwar0XGlV", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight increase in energy levels as the body starts to respond to the synthetic T3. This is due to the initial increase in basal metabolic rate.\",\n        \"Effect 2: Some individuals might experience improved mood and reduced feelings of fatigue, although these effects can vary depending on the severity of hypothyroidism and individual response.\",\n        \"Effect 3: Initial changes in biomarkers such as increased heart rate and body temperature might be observed as metabolism begins to ramp up.\",\n        \"Effect 4: Side effects such as mild headaches, nervousness, or slight insomnia might begin to manifest as the body adjusts to the hormone.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels and mood is likely as the body becomes more accustomed to the increased thyroid hormone levels.\",\n        \"Effect 2: Cognitive effects such as enhanced mental clarity and focus may start to become more noticeable.\",\n        \"Effect 3: Weight loss might begin to occur, particularly if the user had significant hypothyroid-related weight gain, as metabolism continues to increase.\",\n        \"Effect 4: Side effects such as palpitations or increased sweating may peak during this period as the body adjusts to the hormone levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Most users will experience a stabilization of energy levels, mood, and cognitive functions as the body reaches a new equilibrium with the hormone.\",\n        \"Effect 2: Biomarkers such as TSH (Thyroid Stimulating Hormone) levels may show normalization, indicating effective treatment of hypothyroidism.\",\n        \"Effect 3: Continued weight loss and improved metabolic function are likely, especially if accompanied by dietary and lifestyle changes.\",\n        \"Effect 4: Side effects should begin to diminish as the body fully adapts to the hormone supplementation.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained energy levels, stable mood, and improved metabolic health are typically well-established by this period.\",\n        \"Effect 2: Cognitive improvements, including better concentration and memory, are likely to be maintained.\",\n        \"Effect 3: Regular monitoring may show stable thyroid hormone levels, confirming effective management of hypothyroidism.\",\n        \"Effect 4: Any persistent side effects should be evaluated by a healthcare provider, as they might indicate the need for dosage adjustment.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects can vary significantly between individuals based on factors such as the severity of hypothyroidism, individual metabolic rate, and overall health. It is crucial for users to be under medical supervision when using Liothyronine to ensure proper dosage and to monitor for adverse effects. The timeline provided is based on typical responses observed in clinical settings, but individual experiences may differ.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 681, "completion_tokens": 637, "total_tokens": 1318, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449efef081909773d071467df6bc", "custom_id": "drug30_effects_timeline", "response": {"status_code": 200, "request_id": "8996565b15fec9075ba0eab503e70374", "body": {"id": "chatcmpl-B9MVG4ZVW3gigZhBhNJUgqZVBAPA7", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial subtle cognitive improvements may be noticed, such as slight enhancements in focus and mental clarity. These effects are inferred from the compound's mechanism of action and early-stage animal studies.\",\n        \"Effect 2: Users might experience mild physical sensations such as increased energy levels or slight changes in sleep patterns, although these are not well-documented in human studies.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage, as the compound's effects are primarily cognitive and may take time to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued cognitive improvements, potentially including better memory recall and faster information processing, inferred from the compound's interaction with HGF and c-Met.\",\n        \"Effect 2: Users might start noticing a slight improvement in mood or reduction in mental fatigue, although this is speculative based on similar neurotrophic compounds.\",\n        \"Effect 3: No major side effects are expected to manifest at this stage, but users should monitor for any unusual symptoms.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced cognitive benefits may become apparent, such as enhanced learning capabilities and improved problem-solving skills, based on the compound's proposed neuroprotective effects.\",\n        \"Effect 2: Users might observe a stabilization in mood and a more consistent level of mental energy throughout the day.\",\n        \"Effect 3: Potential changes in biomarkers related to neuroplasticity could begin to appear, such as increased levels of brain-derived neurotrophic factor (BDNF), although this is speculative and would require specific testing.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained cognitive improvements with possible peak effects in memory enhancement and learning efficiency, inferred from ongoing neurogenesis and synaptic repair.\",\n        \"Effect 2: Users might experience a plateau in cognitive benefits, maintaining the improvements achieved in previous weeks.\",\n        \"Effect 3: Any side effects, if present, might become more noticeable, such as headaches or gastrointestinal discomfort, although these are not well-documented and would vary by individual.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Long-term users might experience continued maintenance of cognitive benefits, with potential for further improvements in brain resilience against age-related decline.\",\n        \"Effect 2: Users should monitor for any diminishing returns or tolerance development, although this is speculative and would depend on individual response.\",\n        \"Effect 3: Long-term safety and side effects remain largely unknown, emphasizing the need for caution and regular health monitoring.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is largely speculative and based on limited animal studies and theoretical mechanisms of action. Human data is sparse, and effects can vary significantly between individuals. Researchers should approach Dihexa with caution, considering the lack of comprehensive safety and efficacy data.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 650, "completion_tokens": 660, "total_tokens": 1310, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449f0cc8819099b80112f625e38a", "custom_id": "drug31_effects_timeline", "response": {"status_code": 200, "request_id": "51cd60a913ece3b18e7f8e6d7b3b4f2b", "body": {"id": "chatcmpl-B9MVOPsBOLterMtc1UILiAMcXS01d", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial reduction in blood pressure may be observed within the first few days of starting Nebivolol. This is due to its action on beta-1 adrenergic receptors, leading to a decrease in heart rate and cardiac output.\",\n        \"Effect 2: Some users might experience mild dizziness or fatigue as the body adjusts to the lowered blood pressure. These effects are common as the cardiovascular system adapts.\",\n        \"Effect 3: Mental clarity might improve slightly due to better blood flow and oxygenation, although this effect can be subtle and varies among individuals.\",\n        \"Effect 4: Biomarkers such as heart rate and blood pressure readings should show a downward trend, indicating the medication's effectiveness.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued stabilization of blood pressure, with more consistent readings as the body adjusts to the medication.\",\n        \"Effect 2: Users might notice a reduction in symptoms related to high blood pressure, such as headaches or shortness of breath.\",\n        \"Effect 3: Side effects like dizziness or fatigue may persist but often begin to diminish as the body acclimates to the medication.\",\n        \"Effect 4: Enhanced production of nitric oxide may start to contribute to improved vascular health, although this is a gradual process.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Blood pressure should be more consistently within target ranges, reflecting the full therapeutic effect of Nebivolol.\",\n        \"Effect 2: Improvement in heart function might be observed, particularly in patients with heart failure, as the heart's workload is reduced.\",\n        \"Effect 3: Cognitive effects such as improved focus or reduced anxiety may be noted due to better cardiovascular health, although these are secondary effects.\",\n        \"Effect 4: Any initial side effects should be significantly reduced by this time, with most users experiencing minimal adverse effects.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term cardiovascular benefits become more pronounced, with sustained blood pressure control and improved heart health.\",\n        \"Effect 2: Users with heart failure may notice a significant improvement in symptoms such as fatigue and shortness of breath.\",\n        \"Effect 3: Biomarkers such as cholesterol levels and arterial health may show improvement due to the enhanced nitric oxide production and better blood flow.\",\n        \"Effect 4: Side effects are generally minimal, but ongoing monitoring is important to ensure continued efficacy and safety.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Nebivolol can vary based on individual factors such as dosage, adherence to medication, and overall health status. The effects described are based on typical responses observed in clinical settings. Some effects are inferred based on the mechanism of action and similar compounds, particularly regarding cognitive and long-term cardiovascular benefits.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 683, "completion_tokens": 632, "total_tokens": 1315, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce449f1cc08190aa26e8bd11ebdee2", "custom_id": "drug32_effects_timeline", "response": {"status_code": 200, "request_id": "e72d7f3908549a891df35006b3edf53c", "body": {"id": "chatcmpl-B9MVGurpwreJcxQuN3U6Qev7cob8D", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle improvements in mental clarity and focus. These effects are often mild and may not be immediately apparent.\",\n        \"Effect 2: Some individuals report a slight increase in energy levels and alertness, potentially due to enhanced neural communication.\",\n        \"Effect 3: Initial side effects, if any, such as headaches or gastrointestinal discomfort, might start to appear as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Cognitive enhancements, such as improved memory recall and faster information processing, may become more noticeable.\",\n        \"Effect 2: Users might experience a more pronounced sense of mental sharpness and an ability to concentrate for longer periods.\",\n        \"Effect 3: Any initial side effects may begin to subside as the body becomes accustomed to piracetam.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in cognitive functions, with potential benefits in verbal fluency and problem-solving skills.\",\n        \"Effect 2: Users may notice a stabilization of mood and a reduction in anxiety levels, although this effect is more anecdotal and less documented.\",\n        \"Effect 3: Biomarkers such as increased cerebral blood flow might be observed in clinical settings, although this is not typically measured outside of research environments.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained cognitive benefits, with users often reporting consistent improvements in memory and learning capabilities.\",\n        \"Effect 2: Long-term users might experience enhanced neuroplasticity, contributing to better adaptation to new learning tasks.\",\n        \"Effect 3: Any side effects are generally minimal at this stage, but long-term safety data is limited, so monitoring for adverse effects is recommended.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for piracetam can vary significantly between individuals due to differences in metabolism, dosage, and baseline cognitive function. While some effects are documented, others are inferred based on user reports and similar compounds. It's important to note that piracetam is not approved for cognitive enhancement in many countries, and its use should be approached with caution. Clinical studies are limited, and more research is needed to fully understand its long-term effects and efficacy.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 671, "completion_tokens": 517, "total_tokens": 1188, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449f2e1081909a1b848361c59cdf", "custom_id": "drug33_effects_timeline", "response": {"status_code": 200, "request_id": "4501b8de31b78b1a6ee4b68defdea0bd", "body": {"id": "chatcmpl-B9MVGdZhoCVgD9FIVrtWNJHpMQVDg", "object": "chat.completion", "created": 1741571154, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a reduction in tremors and stiffness for Parkinson's disease patients, as pramipexole begins to activate dopamine receptors.\",\n        \"Effect 2: For those with restless legs syndrome (RLS), some reduction in leg discomfort and the urge to move may be noticed, particularly at night.\",\n        \"Effect 3: Mental effects might include slight improvements in mood and focus, although these may not be pronounced yet.\",\n        \"Effect 4: Side effects such as nausea, dizziness, or drowsiness may begin to manifest as the body adjusts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in motor symptoms for Parkinson's disease patients, with further reduction in tremors and improved movement.\",\n        \"Effect 2: RLS symptoms may continue to decrease, leading to better sleep quality.\",\n        \"Effect 3: Cognitive effects such as enhanced focus and mood stabilization might become more noticeable, particularly in off-label use for depression or ADHD.\",\n        \"Effect 4: Side effects like nausea and dizziness may persist but could start to diminish as tolerance develops.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Maximum therapeutic benefits for Parkinson's disease and RLS are typically reached, with significant alleviation of symptoms.\",\n        \"Effect 2: Mental health benefits, if used off-label, may become more pronounced, with improved mood and cognitive function.\",\n        \"Effect 3: Biomarkers such as improved sleep patterns (for RLS) and motor function tests (for Parkinson's) may show positive changes.\",\n        \"Effect 4: Side effects like sleep disturbances or compulsive behaviors (e.g., gambling, eating) might emerge or peak, requiring monitoring.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained symptom control for both Parkinson's disease and RLS, with stable improvements in quality of life.\",\n        \"Effect 2: Continued cognitive and mood benefits, particularly for those using pramipexole off-label.\",\n        \"Effect 3: Physiological measurements such as blood pressure and heart rate should be monitored, as pramipexole can affect these parameters.\",\n        \"Effect 4: Long-term side effects, such as impulse control disorders, may become more apparent and require intervention.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for pramipexole can vary based on individual response, dosage, and specific condition being treated. Close monitoring by healthcare professionals is recommended to manage side effects and adjust dosing as necessary. The effects described are based on documented clinical observations and inferred from the compound's mechanism of action.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 609, "total_tokens": 1300, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449f3c7c8190b8ff0ceb93780adb", "custom_id": "drug34_effects_timeline", "response": {"status_code": 200, "request_id": "13d613282ce9b63715804f4669fdbb85", "body": {"id": "chatcmpl-B9MVNOLrgTzmZzAjAA6vyQ641I4DQ", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users might notice a subtle increase in mental clarity and focus, potentially due to initial modulation of dopamine and serotonin systems.\",\n        \"Effect 2: Some individuals may experience a mild improvement in mood, as Semax begins to influence neurotransmitter levels.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected this early.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Enhanced cognitive function, including improved memory recall and learning ability, may become more noticeable as BDNF levels start to increase.\",\n        \"Effect 2: Users might experience a sustained improvement in mood and motivation, potentially linked to dopamine system modulation.\",\n        \"Effect 3: Some users may report a slight increase in energy levels, although this is more anecdotal and not well-documented.\",\n        \"Effect 4: Side effects, if any, such as mild headaches or irritability, might begin to manifest but are generally considered rare.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued enhancement of cognitive abilities, with more pronounced improvements in focus and mental clarity.\",\n        \"Effect 2: Users may observe a more stable mood and reduced feelings of mental fatigue.\",\n        \"Effect 3: Potential further increase in BDNF levels, supporting neuroplasticity and cognitive resilience.\",\n        \"Effect 4: Any initial side effects are likely to stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Peak cognitive benefits, including enhanced memory retention and learning capacity, are likely to be experienced.\",\n        \"Effect 2: Users may notice improved stress resilience and emotional stability, possibly due to long-term modulation of neurotransmitter systems.\",\n        \"Effect 3: Biomarkers related to cognitive health, such as BDNF, might show measurable increases, although this would require specific testing.\",\n        \"Effect 4: Side effects, if present, are typically minimal and manageable at this stage.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained cognitive benefits, with users reporting consistent improvements in mental performance and brain health.\",\n        \"Effect 2: Long-term users might experience enhanced neuroprotection, potentially reducing the risk of cognitive decline.\",\n        \"Effect 3: Continued modulation of neurotransmitter systems may contribute to ongoing mood stability and motivation.\",\n        \"Effect 4: Any side effects are generally well-tolerated, with most users experiencing minimal adverse reactions.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Semax is based on limited clinical data and anecdotal reports. The compound's effects can vary significantly between individuals, and not all users will experience the same benefits or side effects. The information provided is inferred from the known mechanisms of action of Semax and similar compounds. Users should consult with a healthcare professional before starting any new research chemical.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 638, "completion_tokens": 666, "total_tokens": 1304, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce449f4b1c8190bb6ead0b3b15fa48", "custom_id": "drug35_effects_timeline", "response": {"status_code": 200, "request_id": "b6f65130ac701f4e127a49cb44a94a52", "body": {"id": "chatcmpl-B9MVItuDVxgxzrHlk7rgiXItAYU7x", "object": "chat.completion", "created": 1741571156, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial exposure to 9-methyl-\u03b2-carboline may not produce noticeable physical effects, as the compound is primarily studied for cognitive enhancement rather than physical changes.\",\n        \"Effect 2: Users might begin to notice subtle improvements in cognitive functions such as increased alertness or slight improvements in focus. These effects are inferred based on the compound's proposed mechanism of action on neurotransmitter systems.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected during the first week, as the compound's effects on the body are primarily cognitive and may take time to manifest.\",\n        \"Effect 4: Specific cognitive benefits, such as improved memory or learning abilities, are unlikely to be noticeable within the first week, as these effects typically require sustained exposure.\",\n        \"Effect 5: Side effects, if any, might include mild headaches or nausea, inferred from similar compounds affecting neurotransmitter systems, but these are not well-documented for 9-methyl-\u03b2-carboline.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to more noticeable cognitive enhancements, such as improved memory recall or faster information processing, although these effects are still largely hypothetical.\",\n        \"Effect 2: Users might experience a slight increase in motivation or mental energy, inferred from the compound's potential impact on neurotransmitter activity.\",\n        \"Effect 3: Biomarker changes, such as alterations in neurotransmitter levels, might begin to be detectable in research settings, though specific data on 9-methyl-\u03b2-carboline is limited.\",\n        \"Effect 4: Cognitive benefits related to learning and memory might start to become more apparent, particularly in tasks requiring sustained attention or complex problem-solving.\",\n        \"Effect 5: Side effects, if present, could include mild anxiety or restlessness, inferred from similar cognitive enhancers, but these are speculative for this compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might experience more consistent cognitive improvements, such as enhanced learning capacity and better memory retention, as the compound's effects accumulate.\",\n        \"Effect 2: Mental clarity and focus could be more pronounced, potentially aiding in tasks that require prolonged concentration.\",\n        \"Effect 3: Physiological measurements might show more consistent changes in neurotransmitter activity, though specific biomarkers for 9-methyl-\u03b2-carboline are not well-documented.\",\n        \"Effect 4: The compound's potential benefits on cognitive functions are likely to be more noticeable, particularly in research settings focused on memory and learning.\",\n        \"Effect 5: Side effects might stabilize or decrease as the body adjusts, but any persistent adverse effects should be monitored closely.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is largely speculative due to the limited research available on 9-methyl-\u03b2-carboline. Most effects are inferred from the compound's proposed mechanism of action and comparisons to similar cognitive enhancers. Further research is needed to confirm these effects and establish a more precise timeline.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 660, "completion_tokens": 664, "total_tokens": 1324, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449f5998819081e09ee1900e704b", "custom_id": "drug36_effects_timeline", "response": {"status_code": 200, "request_id": "a83c456c5cea559d4b26536f2d8de074", "body": {"id": "chatcmpl-B9MVPLhVSEh5u1bChUslFKvA2h4Qp", "object": "chat.completion", "created": 1741571163, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial onset of anxiolytic effects may be observed, with a slight reduction in anxiety levels. This is inferred from Selank's modulation of serotonin and stabilization of enkephalins.\",\n        \"Effect 2: Some users might notice a subtle improvement in mood and a sense of calmness, although these effects can vary widely among individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in anxiety symptoms is likely, with users potentially experiencing a more noticeable sense of relaxation and decreased stress.\",\n        \"Effect 2: Cognitive improvements, such as enhanced mental clarity and focus, might begin to manifest, although these effects are more anecdotal and require further research.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this stage, as Selank primarily affects neurotransmitter levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Anxiolytic effects may become more pronounced, with users experiencing a more stable mood and reduced frequency of anxiety episodes.\",\n        \"Effect 2: Cognitive benefits, such as improved memory retention and sharper focus, might be more evident, although these are still largely anecdotal.\",\n        \"Effect 3: Some users might report a general improvement in overall well-being and stress resilience.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The full anxiolytic potential of Selank might be realized, with users experiencing significant relief from anxiety symptoms.\",\n        \"Effect 2: Cognitive enhancements, if present, are likely to stabilize, providing consistent improvements in mental performance.\",\n        \"Effect 3: Potential side effects, such as mild headaches or fatigue, might begin to manifest, although these are generally considered rare and mild.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term users may experience sustained anxiolytic and cognitive benefits, with a stable improvement in mood and mental clarity.\",\n        \"Effect 2: Any initial side effects are likely to have peaked and may diminish as the body adjusts to the compound.\",\n        \"Effect 3: No significant long-term changes in physiological measurements are expected, but ongoing monitoring is recommended.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available research and anecdotal reports. Selank's effects can vary significantly among individuals, and more clinical studies are needed to confirm these observations. Users should approach Selank with caution, as it is not approved for medical use outside of research settings. Additionally, the effects described are inferred from Selank's mechanism of action and similar compounds, and individual experiences may differ.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 632, "completion_tokens": 609, "total_tokens": 1241, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449f69308190a119cd41b1c1747a", "custom_id": "drug37_effects_timeline", "response": {"status_code": 200, "request_id": "d5d2818e44f2c9e6a7d64ddb9563e9bb", "body": {"id": "chatcmpl-B9MVI1eHFA5lKPRQr5GAEy2XTI6ia", "object": "chat.completion", "created": 1741571156, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users might notice a slight increase in mental clarity and focus, although these effects can be subtle initially.\",\n        \"Effect 2: Some individuals may experience a mild reduction in anxiety, potentially leading to a calmer mental state.\",\n        \"Effect 3: Physical effects are generally minimal at this stage, but some users report a slight increase in energy levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Cognitive enhancements such as improved memory recall and faster information processing may become more noticeable.\",\n        \"Effect 2: Users might experience an uplift in mood, which could be attributed to the compound's potential anxiolytic effects.\",\n        \"Effect 3: There might be an increase in motivation and productivity, particularly in tasks requiring sustained mental effort.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced learning ability and retention of new information may become more pronounced.\",\n        \"Effect 2: Users could observe a more consistent improvement in focus and concentration during cognitive tasks.\",\n        \"Effect 3: Some individuals might start noticing a stabilization of mood and a reduction in stress levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The cognitive benefits, such as improved memory and mental agility, are likely to be at their peak.\",\n        \"Effect 2: Users might experience a sustained improvement in overall mental clarity and cognitive performance.\",\n        \"Effect 3: Potential side effects, such as headaches or irritability, may begin to manifest or peak, especially if the dosage is not well-tolerated.\"\n      ]\n    },\n    {\n      \"period\": \"Month 1-2\",\n      \"effects\": [\n        \"Effect 1: Long-term users may report continued cognitive benefits, although the initial intensity of effects might plateau.\",\n        \"Effect 2: Some users might observe improvements in brain health markers, such as increased BDNF levels, although these are not typically measured outside of a clinical setting.\",\n        \"Effect 3: Any side effects experienced earlier may diminish as the body adjusts, but persistent issues should be evaluated.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Noopept is based on anecdotal reports and limited studies, as comprehensive clinical data is lacking. Individual responses can vary significantly, and effects are inferred from similar nootropic compounds. Users should be cautious of potential side effects and consult with a healthcare professional before use. The compound is not approved for cognitive enhancement, and its long-term safety profile is not well-established.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 639, "completion_tokens": 577, "total_tokens": 1216, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449f7980819086f1243112151e92", "custom_id": "drug39_effects_timeline", "response": {"status_code": 200, "request_id": "4519fa977695358be8fb191a8ee546ab", "body": {"id": "chatcmpl-B9MVHkiLpTqQewiKROfO1XI8ETet7", "object": "chat.completion", "created": 1741571155, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial binding to IGF-1 receptors may begin, but noticeable physical effects are unlikely to be observed immediately.\",\n        \"Effect 2: Some users might experience a slight increase in energy or alertness, although this is more anecdotal and not well-documented.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Early signs of increased muscle pump during workouts might be noticed due to enhanced nutrient uptake and blood flow.\",\n        \"Effect 2: No significant cognitive effects are expected at this stage.\",\n        \"Effect 3: Biomarkers such as IGF-1 levels in blood might start to show slight elevation, but this would require specific testing to confirm.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Some users might begin to notice slight improvements in muscle recovery times post-exercise.\",\n        \"Effect 2: Enhanced muscle fullness and slight increases in strength could start to appear, although these effects are more pronounced in anecdotal reports rather than scientific studies.\",\n        \"Effect 3: No significant mental or cognitive changes expected.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle recovery and potential slight increases in muscle mass may be observed.\",\n        \"Effect 2: Users might report feeling more energetic or motivated, although this is largely anecdotal.\",\n        \"Effect 3: Biomarkers such as increased protein synthesis rates might be detectable in a research setting.\",\n        \"Effect 4: Potential side effects such as joint pain or swelling could begin to manifest, particularly if dosages are high.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and improved recovery are likely to be more pronounced.\",\n        \"Effect 2: Some users might experience increased endurance or stamina during physical activities.\",\n        \"Effect 3: Side effects such as insulin resistance or hypoglycemia could become more apparent, especially if not monitored properly.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited scientific data and anecdotal reports. IGF-1 DES is primarily used in research settings, and effects can vary widely based on individual factors such as dosage, frequency of use, and personal physiology. The potential for side effects underscores the importance of using this compound strictly within a research context. The effects described are inferred from the known mechanisms of IGF-1 and similar compounds, as specific studies on IGF-1 DES are limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 578, "total_tokens": 1269, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449f88d881909252ab78feb52cb3", "custom_id": "drug40_effects_timeline", "response": {"status_code": 200, "request_id": "0614bea1029a91827f1b20e8634b486c", "body": {"id": "chatcmpl-B9MVI5FBzo3n9QX3MAhCXpC87NrI6", "object": "chat.completion", "created": 1741571156, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels may be noticed as mitochondrial function begins to improve. This is inferred from the compound's mechanism of action on mitochondria.\",\n        \"Effect 2: Some users might experience a slight improvement in mood or cognitive clarity due to enhanced energy metabolism, although this is more anecdotal and inferred from similar compounds.\",\n        \"Effect 3: Biomarkers such as blood glucose levels might start to show slight improvements, particularly in individuals with insulin sensitivity issues, but significant changes are unlikely this early.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels and possibly endurance, as the body becomes more efficient in glucose utilization.\",\n        \"Effect 2: Users might notice a more consistent mood and mental clarity, potentially due to stabilized blood sugar levels.\",\n        \"Effect 3: More noticeable changes in biomarkers such as fasting blood glucose and insulin sensitivity could begin to appear, particularly in those with pre-existing metabolic issues.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Enhanced physical performance and stamina might be observed, as mitochondrial efficiency continues to improve.\",\n        \"Effect 2: Cognitive benefits, such as improved focus and reduced mental fatigue, could become more pronounced.\",\n        \"Effect 3: Significant improvements in metabolic biomarkers, including insulin sensitivity and possibly lipid profiles, might be measurable.\",\n        \"Effect 4: Potential side effects, such as mild gastrointestinal discomfort or headaches, could manifest as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in energy levels and metabolic efficiency, with possible reductions in body fat percentage due to improved glucose metabolism.\",\n        \"Effect 2: Long-term cognitive benefits, such as sustained attention and memory improvements, might be more evident.\",\n        \"Effect 3: Continued positive changes in biomarkers, with potential reductions in HbA1c levels for those with insulin resistance.\",\n        \"Effect 4: Any side effects are likely to stabilize or diminish as the body adapts to the compound.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available research and inferred effects from similar compounds. MOTS-c is still under investigation, and individual responses can vary significantly. The effects and side effects mentioned are hypothetical and should be interpreted with caution. Further clinical studies are needed to confirm these potential outcomes.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 686, "completion_tokens": 547, "total_tokens": 1233, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449f96a881908533439bd01f8163", "custom_id": "drug41_effects_timeline", "response": {"status_code": 200, "request_id": "f5fcdb08615f0274f7667e1aebe7f421", "body": {"id": "chatcmpl-B9MVJbRHn4bwOEi2JIUxwLl23KG0o", "object": "chat.completion", "created": 1741571157, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial mild improvement in sleep quality may be noticed, with some users experiencing deeper sleep cycles.\",\n        \"Effect 2: Slight reduction in perceived stress levels due to initial interaction with neurotransmitter systems.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\",\n        \"Effect 4: Some users might experience mild relaxation effects, but these are subtle and not pronounced.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Noticeable improvement in sleep quality, with more consistent deep sleep phases and fewer awakenings during the night.\",\n        \"Effect 2: Enhanced mood and cognitive clarity during the day due to better sleep, though this varies by individual.\",\n        \"Effect 3: Initial changes in stress-related biomarkers, such as cortisol levels, may begin to be observed, though these are not yet significant.\",\n        \"Effect 4: Some users may start to experience mild pain relief, particularly if sleep quality has improved significantly.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in sleep quality, with users reporting feeling more rested and energetic upon waking.\",\n        \"Effect 2: Further reduction in stress perception and potential improvement in mood stability.\",\n        \"Effect 3: More noticeable changes in biomarkers related to stress and sleep, such as reduced cortisol levels and improved heart rate variability.\",\n        \"Effect 4: Potential onset of hormonal regulation effects, though these are still under investigation and not well-documented.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Stabilization of sleep patterns, with consistent deep sleep and improved overall sleep architecture.\",\n        \"Effect 2: Enhanced cognitive function and mental clarity, likely due to sustained improvements in sleep quality.\",\n        \"Effect 3: Continued positive changes in physiological measurements, such as improved immune function markers.\",\n        \"Effect 4: Potential for mild side effects such as grogginess or vivid dreams, though these are not commonly reported.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits in sleep quality and stress reduction become more pronounced and stable.\",\n        \"Effect 2: Possible improvements in chronic pain management due to sustained better sleep and reduced stress.\",\n        \"Effect 3: Hormonal balance effects might become more evident, though these are still speculative and require more research.\",\n        \"Effect 4: Any side effects are likely to have stabilized, with most users not experiencing significant adverse effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of DSIP are still under investigation, and individual responses can vary significantly. The timeline provided is based on preliminary research and inferred effects from similar compounds. Long-term effects and safety profiles are not fully established, and ongoing research is needed to confirm these findings.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 645, "total_tokens": 1336, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449fa4048190ae20524686008c74", "custom_id": "drug42_effects_timeline", "response": {"status_code": 200, "request_id": "b2d9bb114760fe10ded004374815567e", "body": {"id": "chatcmpl-B9MVT2qKCPNMPaecvYOFYkidZGGpr", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial reduction in estrogen levels may begin, but significant changes in physical symptoms might not be noticeable yet.\",\n        \"Effect 2: Some users might experience mild headaches or fatigue as the body adjusts to hormonal changes.\",\n        \"Effect 3: Biomarkers such as serum estrogen levels may start to decrease, though this might not be clinically significant yet.\",\n        \"Effect 4: For fertility purposes, there might be an increase in follicle-stimulating hormone (FSH) as the body compensates for lower estrogen levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: More noticeable reduction in estrogen-related symptoms such as water retention and breast tenderness in bodybuilders.\",\n        \"Effect 2: Some users might start to experience mood changes, such as mild depression or anxiety, due to hormonal shifts.\",\n        \"Effect 3: Continued decrease in estrogen levels, potentially observable in blood tests.\",\n        \"Effect 4: For fertility, ovulation may be stimulated, increasing the likelihood of conception.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: For breast cancer patients, potential slowing of cancer progression as estrogen levels remain suppressed.\",\n        \"Effect 2: Bodybuilders might notice a reduction in estrogen-related side effects like gynecomastia.\",\n        \"Effect 3: Some users may experience joint pain or stiffness as a side effect of reduced estrogen.\",\n        \"Effect 4: Cognitive effects such as difficulty concentrating might be reported by some users.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Continued suppression of estrogen levels, with potential stabilization of symptoms.\",\n        \"Effect 2: For fertility, users might confirm pregnancy if conception occurred.\",\n        \"Effect 3: Side effects such as hot flashes or night sweats might become more pronounced.\",\n        \"Effect 4: Long-term users might start to notice bone density changes due to prolonged low estrogen levels.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained reduction in estrogen levels, with ongoing management of breast cancer or estrogen-related symptoms.\",\n        \"Effect 2: Potential peak in side effects such as bone density reduction or increased cholesterol levels.\",\n        \"Effect 3: For bodybuilders, continued control over estrogen-related side effects.\",\n        \"Effect 4: For fertility, if conception has not occurred, users might reassess treatment options.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects can vary significantly based on individual factors such as dosage, duration of use, and individual hormonal baseline. The effects described are based on typical usage patterns and may not apply to all users. Additionally, some effects are inferred based on the mechanism of action and similar compounds, particularly regarding cognitive and long-term physiological changes.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 634, "total_tokens": 1310, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce449fb1b48190bb81024e8ab3c863", "custom_id": "drug43_effects_timeline", "response": {"status_code": 200, "request_id": "ff838d7010056785862b5292100e999b", "body": {"id": "chatcmpl-B9MVIIg4E2BQVj4MzbjGeKzASD0ia", "object": "chat.completion", "created": 1741571156, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a slight increase in energy levels, particularly noticeable during physical activity, as the body begins to utilize fatty acids more efficiently for energy production.\",\n        \"Effect 2: Some users might experience mild gastrointestinal discomfort as the body adjusts to the supplement, which is a common initial side effect.\",\n        \"Effect 3: Mental effects are likely minimal at this stage, but some users report a slight improvement in focus and alertness due to increased energy availability.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in exercise performance might be observed, with users potentially noticing enhanced endurance and reduced fatigue during workouts.\",\n        \"Effect 2: Cognitive effects may start to become more noticeable, with some users experiencing improved mental clarity and focus.\",\n        \"Effect 3: Biomarkers such as blood lipid profiles might begin to show slight improvements, although significant changes are unlikely this early.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice more pronounced weight loss effects, particularly if combined with a proper diet and exercise regimen, as fat metabolism becomes more efficient.\",\n        \"Effect 2: Enhanced recovery times post-exercise could be observed, potentially due to improved energy utilization and reduced muscle damage.\",\n        \"Effect 3: Cognitive benefits such as improved memory and cognitive performance might become more apparent, although these effects can vary widely among individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term users may experience sustained improvements in exercise performance and endurance, with some reporting increased muscle mass and reduced body fat percentage.\",\n        \"Effect 2: Potential improvements in cardiovascular health markers, such as reduced triglyceride levels and improved blood flow, might be observed.\",\n        \"Effect 3: Any initial side effects, such as gastrointestinal discomfort, are likely to have subsided by this point.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Users might experience continued benefits in terms of energy levels, exercise performance, and body composition, provided they maintain a consistent supplementation routine.\",\n        \"Effect 2: Long-term cognitive benefits, such as sustained mental clarity and focus, may be experienced, although individual responses can vary.\",\n        \"Effect 3: Regular monitoring of biomarkers could show continued improvements in lipid profiles and other cardiovascular health indicators.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for L-carnitine can vary significantly between individuals due to factors such as baseline L-carnitine levels, diet, exercise habits, and overall health. While some effects are documented, others are inferred based on the compound's mechanism of action and user reports. It is important to note that while L-carnitine is generally considered safe, individuals should consult with a healthcare provider before starting supplementation, especially if they have pre-existing health conditions or are taking other medications.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 661, "total_tokens": 1352, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449fc2188190afd72e5fe8fc7de5", "custom_id": "drug44_effects_timeline", "response": {"status_code": 200, "request_id": "d67bbe5b3a36be4058ae128ffd545311", "body": {"id": "chatcmpl-B9MVIuh3PXwQvBqXYcDTaFgo7ddCy", "object": "chat.completion", "created": 1741571156, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial increase in appetite due to ghrelin mimetic activity, which may be noticeable within the first few days.\",\n        \"Effect 2: Some users might experience mild water retention as the body adjusts to increased growth hormone levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Slight improvement in sleep quality, as growth hormone can influence sleep patterns.\",\n        \"Effect 2: Early signs of increased energy levels and slight improvements in recovery time post-exercise.\",\n        \"Effect 3: Initial changes in biomarkers such as a slight increase in IGF-1 (Insulin-like Growth Factor 1) levels, which can be measured through blood tests.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Noticeable reduction in muscle soreness and faster recovery from workouts, as the body adapts to higher growth hormone levels.\",\n        \"Effect 2: Potential for slight improvements in skin elasticity and texture due to enhanced cell repair processes.\",\n        \"Effect 3: Some users might begin to notice mild joint discomfort as a side effect, which could peak around this time.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced muscle growth and strength gains may start to become apparent, particularly if combined with resistance training.\",\n        \"Effect 2: Continued improvements in body composition, with potential reductions in body fat percentage.\",\n        \"Effect 3: Mental clarity and cognitive function might improve slightly, although this is more anecdotal and less documented.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained muscle growth and enhanced physical performance, with more significant changes in body composition.\",\n        \"Effect 2: Possible stabilization of appetite increases as the body adjusts to the compound.\",\n        \"Effect 3: Long-term side effects such as insulin resistance or carpal tunnel syndrome could begin to manifest if usage is prolonged.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for GHRP-6 can vary significantly between individuals due to factors such as dosage, frequency of administration, and individual physiological differences. The effects listed are based on both documented research and educated inferences from similar compounds. It is important to note that GHRP-6 is not approved for human use outside of research settings, and any use should be conducted under strict ethical and legal guidelines.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 556, "total_tokens": 1247, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449fd018819090b88b1bfb7d6412", "custom_id": "drug45_effects_timeline", "response": {"status_code": 200, "request_id": "0fecd0c21538c5690652b7f14a1ef572", "body": {"id": "chatcmpl-B9MVIC3q6nlgLRsnnA3O9hhRdcuYW", "object": "chat.completion", "created": 1741571156, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects might be minimal, with some users potentially experiencing mild headaches or slight nausea as the body adjusts to the compound. These effects are inferred based on similar cognitive enhancers.\",\n        \"Effect 2: Users may begin to notice subtle improvements in mental clarity and focus, although significant cognitive enhancements are unlikely to be prominent at this early stage.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected during the first week, as the compound's effects are primarily cognitive.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical side effects, if any, may start to diminish as the body acclimates to SLU-PP-332.\",\n        \"Effect 2: Cognitive effects such as improved memory retention and problem-solving skills might become more noticeable. Users may report feeling more mentally sharp and efficient in processing information.\",\n        \"Effect 3: Researchers might observe initial changes in neurotransmitter activity through biomarkers, although these changes are likely subtle and require specific testing to detect.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might experience a plateau in physical side effects, with most adverse effects subsiding. However, individual responses can vary.\",\n        \"Effect 2: Enhanced cognitive abilities, such as better memory recall and quicker problem-solving, are expected to be more pronounced. This period may mark the onset of the compound's peak cognitive benefits.\",\n        \"Effect 3: Continued monitoring of biomarkers may show more defined changes in neurotransmitter levels, supporting the cognitive improvements observed.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term physical effects are not well-documented, but users should be monitored for any emerging side effects.\",\n        \"Effect 2: Cognitive benefits are likely to stabilize, with users experiencing sustained improvements in mental clarity and cognitive function.\",\n        \"Effect 3: Biomarker analysis might reveal more consistent alterations in neurotransmitter activity, indicating a sustained impact on brain chemistry.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar cognitive-enhancing compounds, as specific data on SLU-PP-332 is limited. Individual responses can vary significantly, and long-term safety and efficacy are not yet established. Continuous monitoring and further research are essential to fully understand the compound's impact.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 655, "completion_tokens": 536, "total_tokens": 1191, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449fdfe081908870628848eece24", "custom_id": "drug46_effects_timeline", "response": {"status_code": 200, "request_id": "a4a636f11b8f09381e85fc4017973ed7", "body": {"id": "chatcmpl-B9MVJwTLdIAv3EZLzoKq36dyovzrV", "object": "chat.completion", "created": 1741571157, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial administration of follistatin-344 may not result in noticeable physical changes immediately. Users might not observe significant muscle growth or strength gains during the first week.\",\n        \"Effect 2: Some users might experience mild muscle soreness as the body begins to adapt to potential changes in muscle protein synthesis.\",\n        \"Effect 3: No significant mental or cognitive effects are expected during this period.\",\n        \"Effect 4: Biomarkers related to muscle growth, such as creatine kinase levels, might begin to show slight changes, although these are likely minimal and not easily detectable without specific testing.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice subtle increases in muscle fullness or slight improvements in muscle tone as follistatin-344 begins to exert its effects on myostatin inhibition.\",\n        \"Effect 2: Energy levels might slightly improve due to increased muscle activity, although this is more speculative.\",\n        \"Effect 3: There might be a slight increase in muscle protein synthesis markers, but significant changes in biomarkers are still unlikely to be prominent.\",\n        \"Effect 4: No major side effects are typically expected to manifest at this stage, but users should monitor for any unusual symptoms.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable muscle growth and strength gains may begin to appear as the inhibition of myostatin becomes more pronounced.\",\n        \"Effect 2: Users might experience improved recovery times between workouts due to enhanced muscle repair processes.\",\n        \"Effect 3: Some users might report a slight increase in overall well-being or motivation, although this is anecdotal and not well-documented.\",\n        \"Effect 4: Biomarkers such as increased muscle mass or changes in body composition might become more apparent with advanced testing methods.\",\n        \"Effect 5: Potential side effects, such as joint discomfort or muscle tightness, could begin to manifest as muscle growth accelerates.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in muscle size and strength are likely to be observed, assuming consistent use and adequate training stimulus.\",\n        \"Effect 2: Users might experience enhanced endurance and performance in physical activities.\",\n        \"Effect 3: Continued monitoring of biomarkers might show sustained increases in muscle mass and possible changes in hormone levels related to muscle growth.\",\n        \"Effect 4: Side effects, if any, might peak during this period, with potential issues such as muscle imbalances or overuse injuries becoming more prominent.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Muscle growth and strength gains may plateau as the body adapts to the presence of follistatin-344.\",\n        \"Effect 2: Long-term effects on muscle maintenance and recovery might become more stable, with users needing to adjust training and nutrition to sustain gains.\",\n        \"Effect 3: Long-term safety and efficacy remain uncertain, and users should be cautious of potential unknown side effects or health risks.\",\n        \"Effect 4: Regular monitoring of health markers is advised to detect any adverse effects early.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and inferred effects from similar compounds that inhibit myostatin. Follistatin-344 is not approved for human use, and its long-term safety and efficacy are not well understood. Researchers should exercise caution and prioritize safety in any studies involving this compound.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 692, "completion_tokens": 773, "total_tokens": 1465, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449ff0148190bf7cfc9c092d1a0b", "custom_id": "drug47_effects_timeline", "response": {"status_code": 200, "request_id": "ee2e39f35d6ef3efbf0f0381a7504178", "body": {"id": "chatcmpl-B9MVKJEkd58kZ7Ywe2xOL93F9hOq4", "object": "chat.completion", "created": 1741571158, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial adaptation phase where users might not notice significant physical changes. Some individuals may experience mild headaches or dizziness as the body adjusts to the compound.\",\n        \"Effect 2: Subtle mental effects may begin to emerge, such as slight improvements in mood or a reduction in anxiety, although these are often not pronounced at this early stage.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected during the first week.\",\n        \"Effect 4: Any potential benefits related to neurogenesis or cognitive enhancement are unlikely to be noticeable yet.\",\n        \"Effect 5: Side effects, if any, are typically mild and may include transient headaches or sleep disturbances.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice slight improvements in energy levels and overall well-being.\",\n        \"Effect 2: Cognitive effects such as enhanced focus or clarity may begin to be more noticeable, although still subtle.\",\n        \"Effect 3: No significant changes in biomarkers are expected, but some users might report subjective improvements in mood.\",\n        \"Effect 4: Early signs of mood stabilization could start to appear, although this varies widely among individuals.\",\n        \"Effect 5: Side effects, if present, may continue at a mild level, with some users experiencing gastrointestinal discomfort or sleep pattern changes.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as improved energy and reduced fatigue may become more consistent.\",\n        \"Effect 2: Cognitive enhancements, including better memory recall and mental clarity, are more likely to be noticeable.\",\n        \"Effect 3: Some users might observe changes in mood-related biomarkers, such as reduced cortisol levels, although this is not well-documented.\",\n        \"Effect 4: Benefits related to mood improvement and cognitive function are more likely to be apparent, with some users reporting significant improvements in depressive symptoms.\",\n        \"Effect 5: Side effects may stabilize or diminish as the body adjusts, but some users might still experience mild headaches or sleep disturbances.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical improvements such as increased energy and vitality are often well-established by this period.\",\n        \"Effect 2: Cognitive benefits, including enhanced memory and learning capabilities, are typically more pronounced.\",\n        \"Effect 3: Users might observe more consistent mood stabilization and reduced symptoms of depression.\",\n        \"Effect 4: The full potential benefits of NSI-189, such as improved mood and cognitive function, are more likely to be realized.\",\n        \"Effect 5: Side effects, if any, are generally mild and may continue to decrease in frequency and intensity.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for NSI-189 is based on limited clinical data and anecdotal reports. The compound's effects can vary significantly among individuals, and the timeline provided is an approximation. More research is needed to fully understand the long-term effects and safety profile of NSI-189. The effects described are inferred from the compound's proposed mechanism of action and comparisons with similar compounds.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 659, "completion_tokens": 692, "total_tokens": 1351, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce449ffe5881909732713fbd3d9d72", "custom_id": "drug48_effects_timeline", "response": {"status_code": 200, "request_id": "7b777ec1e7ee3b5903925a7810ec7a84", "body": {"id": "chatcmpl-B9MVIln9tXmCIApKB0Zq8xr2MOD4u", "object": "chat.completion", "created": 1741571156, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a mild increase in mental clarity and focus within the first few days of supplementation. This is due to the initial increase in acetylcholine levels in the brain.\",\n        \"Effect 2: Some individuals might experience slight improvements in memory recall and learning ability as the brain starts to utilize the increased choline supply.\",\n        \"Effect 3: Initial physical effects are generally minimal, but some users report a subtle increase in energy levels and motivation.\",\n        \"Effect 4: Side effects, if any, such as headaches or gastrointestinal discomfort, may begin to manifest as the body adjusts to the supplement.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Cognitive enhancements, such as improved memory and concentration, may become more noticeable as acetylcholine levels stabilize.\",\n        \"Effect 2: Users might observe a slight improvement in mood and mental stamina, potentially due to better neurotransmitter balance.\",\n        \"Effect 3: Physical effects, such as enhanced muscle strength or endurance, are still unlikely to be significant, as these benefits are less documented and require more research.\",\n        \"Effect 4: Any initial side effects may begin to subside as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued cognitive benefits, with some users experiencing enhanced problem-solving skills and quicker information processing.\",\n        \"Effect 2: Potential improvements in athletic performance might start to appear, although these effects are more anecdotal and require further scientific validation.\",\n        \"Effect 3: Biomarkers such as choline levels in the blood may show an increase, reflecting the supplementation.\",\n        \"Effect 4: Side effects, if present, are likely to have stabilized or diminished, but users should monitor for any new symptoms.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users may experience sustained cognitive improvements, with consistent benefits in memory, learning, and focus.\",\n        \"Effect 2: Any potential physical performance enhancements would likely be more noticeable by this time, although individual responses can vary widely.\",\n        \"Effect 3: Long-term use might lead to a more pronounced increase in acetylcholine receptor sensitivity, though this is speculative and requires more research.\",\n        \"Effect 4: Long-term side effects are not well-documented, but users should be cautious of any persistent adverse effects and consult a healthcare professional if necessary.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on available research and anecdotal reports. Individual responses to Alpha-GPC can vary significantly, and more research is needed to fully understand its long-term effects and efficacy. Users should consult with a healthcare professional before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 655, "completion_tokens": 616, "total_tokens": 1271, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a00d3881908a43305f17d96ac1", "custom_id": "drug49_effects_timeline", "response": {"status_code": 200, "request_id": "a15ebd830c6f94f62ce3a25c8c7c3a1a", "body": {"id": "chatcmpl-B9MVLPuS8sh9qXcxwIBgH6hQey0O7", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Some users may begin to notice a mild increase in mental clarity and focus within the first few days. This is often described as a subtle enhancement in the ability to concentrate on tasks.\",\n        \"Effect 2: Initial physical effects are typically minimal, but some individuals might experience a slight increase in energy levels, possibly due to enhanced glucose and oxygen utilization in the brain.\",\n        \"Effect 3: There are generally no significant changes in biomarkers or physiological measurements at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Cognitive effects such as improved memory recall and faster information processing may start to become more noticeable. Users often report feeling more efficient in learning and retaining new information.\",\n        \"Effect 2: Physical effects remain subtle, with some users experiencing a slight improvement in overall mental stamina.\",\n        \"Effect 3: Side effects, if any, might begin to manifest, such as mild headaches or insomnia, which are commonly reported with racetams. These effects are usually transient and may subside with continued use.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced cognitive functions, particularly in memory and learning, are often more pronounced. Users may find it easier to engage in complex cognitive tasks and experience improved problem-solving abilities.\",\n        \"Effect 2: Some individuals might notice a more consistent level of mental energy throughout the day, potentially reducing mental fatigue during prolonged periods of concentration.\",\n        \"Effect 3: Continued use may lead to a stabilization of any initial side effects. However, if side effects persist or worsen, users should consider adjusting the dosage or discontinuing use.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The cognitive benefits of oxiracetam, such as enhanced memory retention and learning capabilities, are typically well-established by this period. Users often report sustained improvements in cognitive performance.\",\n        \"Effect 2: Physical effects remain consistent, with some users experiencing a slight increase in motivation and drive, potentially due to improved cognitive function.\",\n        \"Effect 3: No significant changes in biomarkers are expected, but users should monitor for any persistent side effects. Long-term use should be evaluated for safety and efficacy.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of oxiracetam can vary significantly between individuals due to differences in brain chemistry, dosage, and frequency of use. The timeline provided is based on anecdotal reports and inferred from the general properties of racetams. It is important to note that oxiracetam is not approved for medical use, and its long-term effects are not well-documented. Users should approach its use with caution and consult with a healthcare professional if any adverse effects occur.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 681, "completion_tokens": 611, "total_tokens": 1292, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a01b708190822a323693a53e1a", "custom_id": "drug51_effects_timeline", "response": {"status_code": 200, "request_id": "52b7742c6e0462e9a4911e986e5ff246", "body": {"id": "chatcmpl-B9MVS7MQRYi5hyZYocqM2ckrGHPLy", "object": "chat.completion", "created": 1741571166, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle improvements in focus and concentration, although these effects can vary widely among individuals. This is inferred from the compound's mechanism of increasing choline uptake.\",\n        \"Effect 2: Some users may experience a mild increase in mental clarity and alertness, potentially due to enhanced acetylcholine production. This is an inferred effect based on similar nootropic compounds.\",\n        \"Effect 3: Initial side effects such as headaches might occur, particularly if the user has a low choline intake. This is a common side effect associated with increased acetylcholine activity.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Cognitive benefits such as improved memory retention and recall might become more noticeable. This is based on anecdotal reports and the compound's proposed mechanism of action.\",\n        \"Effect 2: Users may experience enhanced learning capabilities, potentially due to increased neuronal communication. This is inferred from the compound's effects on brain cell membranes.\",\n        \"Effect 3: Some users might observe a slight increase in motivation and mental energy, although this is more anecdotal and less documented.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in cognitive functions such as problem-solving and logical reasoning may be observed. This is inferred from ongoing use and accumulation of effects.\",\n        \"Effect 2: Users might notice a stabilization of mood and reduction in mental fatigue, possibly due to improved brain oxygenation and nutrient delivery.\",\n        \"Effect 3: Side effects such as headaches may decrease as the body adjusts, especially if choline supplementation is used to mitigate this.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Peak cognitive enhancement effects might be reached, with users experiencing optimal memory and learning improvements. This is inferred from the typical timeline of nootropic effects.\",\n        \"Effect 2: Some users may report enhanced sensory perception and quicker reaction times, although these effects are more anecdotal.\",\n        \"Effect 3: Any persistent side effects should be monitored, and users might consider adjusting dosage or discontinuing use if adverse effects outweigh benefits.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of pramiracetam can vary significantly between individuals due to differences in brain chemistry, dosage, and concurrent use of other supplements or medications. The timeline provided is based on anecdotal reports and inferred from the compound's mechanism of action, as there is limited clinical research specifically detailing the week-by-week effects of pramiracetam. Users should approach the use of pramiracetam with caution and consult with a healthcare professional before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 670, "completion_tokens": 588, "total_tokens": 1258, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a028b88190a933fdd2dfede7ab", "custom_id": "drug52_effects_timeline", "response": {"status_code": 200, "request_id": "d3ab0c0f9f91943c28ecb77b5d5c1602", "body": {"id": "chatcmpl-B9MVY3CFodG62Bpaj78G5Vy17s7YE", "object": "chat.completion", "created": 1741571172, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may be subtle. Some users might notice a slight increase in energy levels and a reduction in fatigue as the body begins to adjust to the medication.\",\n        \"Effect 2: Mental clarity might start to improve slightly, with some users experiencing a mild enhancement in focus and cognitive function.\",\n        \"Effect 3: Biomarkers such as TSH (Thyroid Stimulating Hormone) levels may begin to decrease, indicating the body is responding to the hormone replacement.\",\n        \"Effect 4: Side effects such as minor headaches or slight nervousness might occur as the body adjusts to the new hormone levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical effects become more noticeable. Users often report improved energy levels and a decrease in symptoms of hypothyroidism such as cold intolerance.\",\n        \"Effect 2: Mental effects continue to improve, with enhanced mood and cognitive function becoming more apparent.\",\n        \"Effect 3: Continued normalization of TSH levels, with potential improvements in other thyroid-related biomarkers such as free T4 and T3 levels.\",\n        \"Effect 4: Some users may begin to notice weight stabilization or slight weight loss if previously affected by hypothyroidism-related weight gain.\",\n        \"Effect 5: Side effects, if present, may include increased heart rate or palpitations, especially if the dose is too high.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: Most users experience significant relief from hypothyroid symptoms, with energy levels and metabolic rate approaching normal.\",\n        \"Effect 2: Cognitive and mood improvements are typically well-established, with users reporting better mental clarity and reduced depressive symptoms.\",\n        \"Effect 3: Biomarkers such as TSH, free T4, and T3 should be within normal ranges if the dosage is appropriate.\",\n        \"Effect 4: Benefits related to weight management and metabolic health are more pronounced, particularly if combined with lifestyle changes.\",\n        \"Effect 5: Side effects should stabilize; however, if symptoms like anxiety, insomnia, or heart palpitations persist, dosage adjustments may be necessary.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical and mental effects are fully realized, with most users achieving optimal thyroid hormone levels and symptom relief.\",\n        \"Effect 2: Long-term benefits such as improved metabolic health and weight management continue to develop.\",\n        \"Effect 3: Regular monitoring of thyroid function tests is essential to ensure ongoing efficacy and safety.\",\n        \"Effect 4: Side effects are generally minimal if the dosage is correctly adjusted, but ongoing monitoring is important to prevent over-replacement.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for levothyroxine can vary significantly between individuals based on factors such as the severity of hypothyroidism, individual metabolism, and adherence to the medication regimen. Regular monitoring by a healthcare provider is crucial to ensure the correct dosage and to minimize potential side effects. Adjustments to dosage may be necessary based on periodic thyroid function tests.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 648, "completion_tokens": 683, "total_tokens": 1331, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a0379881909bae92a75db49978", "custom_id": "drug53_effects_timeline", "response": {"status_code": 200, "request_id": "1358d0ed54f1321b354e87b41be75287", "body": {"id": "chatcmpl-B9MVgpOClNXcG0bSDQTTZv6v0eo4R", "object": "chat.completion", "created": 1741571180, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may notice a mild increase in energy levels and alertness due to the stimulant properties of synephrine. This is similar to the initial effects of caffeine.\",\n        \"Effect 2: Some individuals might experience a slight increase in heart rate and blood pressure as synephrine activates receptors in the sympathetic nervous system.\",\n        \"Effect 3: Initial thermogenic effects might begin, leading to a slight increase in body temperature and calorie expenditure.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued mild increase in energy and alertness, potentially leading to improved exercise performance and endurance.\",\n        \"Effect 2: Users might start to notice a slight decrease in appetite, although this effect can vary significantly among individuals.\",\n        \"Effect 3: Biomarkers such as heart rate and blood pressure may remain slightly elevated, especially in those sensitive to stimulants.\",\n        \"Effect 4: Initial weight loss effects might be observed, primarily due to increased energy expenditure and potential appetite suppression.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced energy levels and endurance during physical activities may continue, potentially leading to improved workout performance.\",\n        \"Effect 2: Users might experience a stabilization of appetite suppression effects, contributing to potential weight loss.\",\n        \"Effect 3: Some users may begin to notice a plateau in the initial weight loss effects as the body adjusts to the compound.\",\n        \"Effect 4: Side effects such as jitteriness, increased heart rate, or mild headaches might manifest or peak, particularly in sensitive individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Sustained energy and alertness levels, with potential improvements in mood and cognitive function due to increased norepinephrine activity.\",\n        \"Effect 2: Continued support for weight management, although the rate of weight loss may slow as the body adapts.\",\n        \"Effect 3: Physiological measurements such as heart rate and blood pressure should be monitored, as prolonged use might exacerbate these effects.\",\n        \"Effect 4: Users may experience a reduction in side effects as the body becomes accustomed to synephrine, though this varies by individual.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of synephrine can vary widely among individuals due to differences in sensitivity to stimulants and metabolic rates. The timeline provided is based on general observations and may not apply to everyone. Additionally, the long-term safety and efficacy of synephrine for weight loss and performance enhancement have not been conclusively established, and users should approach its use with caution. Monitoring by a healthcare professional is recommended, especially for individuals with cardiovascular conditions or those taking other medications.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 607, "total_tokens": 1252, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a046248190b3afb79eaf08bca8", "custom_id": "drug54_effects_timeline", "response": {"status_code": 200, "request_id": "88d7c1b8e92058ef0c459b51d8e4a7b7", "body": {"id": "chatcmpl-B9MVJbg1sITfnx48piv9j2Tq8ux7r", "object": "chat.completion", "created": 1741571157, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might notice a slight increase in energy levels as NAD+ begins to support cellular energy production. This is due to its role in ATP synthesis.\",\n        \"Effect 2: Some users may experience improved mental clarity and focus, as NAD+ supports brain function through enhanced cellular metabolism.\",\n        \"Effect 3: Initial changes in biomarkers such as increased NAD+ levels in the blood may be observed, although significant physiological changes might not yet be apparent.\",\n        \"Effect 4: Mild side effects such as headaches or fatigue could occur as the body adjusts to increased NAD+ levels, but these are generally transient.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels and endurance, potentially noticeable during physical activities.\",\n        \"Effect 2: Enhanced cognitive function, including better memory retention and quicker information processing, may become more pronounced.\",\n        \"Effect 3: Biomarkers such as improved mitochondrial function and reduced oxidative stress might begin to show measurable changes.\",\n        \"Effect 4: Any initial side effects are likely to diminish as the body acclimates to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience more consistent energy levels throughout the day, with reduced feelings of fatigue.\",\n        \"Effect 2: Cognitive benefits such as improved mood and reduced mental fatigue may become more stable.\",\n        \"Effect 3: Potential improvements in biomarkers related to inflammation and cellular repair processes could be observed.\",\n        \"Effect 4: The anti-aging benefits, such as improved skin elasticity or reduced signs of aging, might begin to appear, although these effects are subtle and gradual.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained energy and cognitive benefits are likely to be well-established, with users reporting enhanced overall well-being.\",\n        \"Effect 2: Long-term improvements in biomarkers such as cholesterol levels, blood pressure, and insulin sensitivity might be noted.\",\n        \"Effect 3: More noticeable anti-aging effects, such as improved skin appearance and joint health, could become apparent.\",\n        \"Effect 4: Any side effects are expected to be minimal, with most users experiencing no adverse reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Users may report significant improvements in physical performance and recovery times, particularly in endurance activities.\",\n        \"Effect 2: Cognitive enhancements, including sustained attention and memory, are likely to be maintained.\",\n        \"Effect 3: Continued positive changes in biomarkers related to metabolic health and cellular repair are expected.\",\n        \"Effect 4: The potential for long-term benefits in longevity and overall health becomes more plausible, although these effects are still under investigation.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of NAD+ supplementation can vary significantly between individuals due to factors such as age, baseline health status, and lifestyle. The timeline provided is based on current research and anecdotal reports, but individual experiences may differ. Additionally, while NAD+ is being studied for its potential anti-aging benefits, these effects are not yet fully understood or clinically validated. Users should consult with a healthcare professional before starting any new supplementation regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 679, "completion_tokens": 718, "total_tokens": 1397, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a055948190907e1b9db5a82d1f", "custom_id": "drug55_effects_timeline", "response": {"status_code": 200, "request_id": "645eeaabdc158b4ba7a63921804fbb46", "body": {"id": "chatcmpl-B9MVL96Xy7tdHhGnEwF3C4RGGO5nL", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in physical endurance and a reduction in perceived fatigue during physical activities. This is due to the initial enhancement of mitochondrial function and energy production.\",\n        \"Effect 2: Mentally, users may experience a mild improvement in focus and cognitive clarity as the compound starts to optimize RNA production and cellular energy utilization.\",\n        \"Effect 3: Biomarkers such as ATP levels might show a slight increase, indicating improved energy metabolism at the cellular level.\",\n        \"Effect 4: Initial benefits related to reduced tiredness and sustained performance may start to appear, although they are likely subtle at this stage.\",\n        \"Effect 5: Side effects, if any, might include mild gastrointestinal discomfort or headaches as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical endurance and recovery times may continue to improve, with users noticing more significant reductions in fatigue during and after exertion.\",\n        \"Effect 2: Cognitive effects might become more pronounced, with enhanced mental stamina and quicker recovery from mental fatigue.\",\n        \"Effect 3: Continued support for mitochondrial function could lead to further improvements in biomarkers related to energy metabolism, such as increased ATP production.\",\n        \"Effect 4: The benefits of enhanced performance and endurance in challenging environments are likely to become more noticeable.\",\n        \"Effect 5: Side effects, if present, might stabilize or diminish as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might experience peak physical performance benefits, with significant improvements in endurance and stamina during prolonged activities.\",\n        \"Effect 2: Mental clarity and cognitive resilience are likely to be at their highest, with users reporting sustained focus and reduced mental fatigue.\",\n        \"Effect 3: Biomarkers related to oxidative stress might show improvements, indicating enhanced cellular resilience.\",\n        \"Effect 4: The full spectrum of benefits related to performance enhancement and fatigue reduction should be evident by this period.\",\n        \"Effect 5: Any side effects are likely to have peaked and should be minimal if the compound is well-tolerated.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical and mental performance benefits are maintained, with users experiencing consistent improvements in endurance and cognitive function.\",\n        \"Effect 2: Long-term use might lead to further optimization of energy metabolism, with sustained improvements in biomarkers such as ATP levels and mitochondrial efficiency.\",\n        \"Effect 3: Users might notice an overall enhancement in their ability to handle stress and recover from both physical and mental exertion.\",\n        \"Effect 4: Side effects, if any, should be minimal and manageable, assuming proper dosing and individual tolerance.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for bemethyl is inferred based on its mechanism of action and similarities to other compounds that enhance mitochondrial function and energy metabolism. Individual responses may vary, and the compound's effects have not been extensively documented in clinical settings for these specific uses. Researchers should monitor subjects closely for any adverse reactions and adjust dosages accordingly.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 614, "completion_tokens": 690, "total_tokens": 1304, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a063cc8190a40724d70c902bbc", "custom_id": "drug56_effects_timeline", "response": {"status_code": 200, "request_id": "f8915c9d4453c19f6cee28c88c21c7f9", "body": {"id": "chatcmpl-B9MVU2JIboOOxZusniZfpykyqauzZ", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle improvements in mental clarity and focus, as fasoracetam starts to modulate neurotransmitter activity, particularly acetylcholine. These effects are inferred from its mechanism of action.\",\n        \"Effect 2: Some users may experience a mild reduction in anxiety due to the modulation of GABA receptors, which could lead to a calmer mental state.\",\n        \"Effect 3: Initial side effects such as headaches or fatigue might occur as the body adjusts to the compound. These are common with nootropics and are inferred from user reports.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Cognitive enhancements, such as improved memory recall and learning ability, may become more noticeable as fasoracetam continues to influence acetylcholine and glutamate pathways.\",\n        \"Effect 2: Users might experience a more pronounced reduction in anxiety and stress levels, attributed to ongoing GABA modulation.\",\n        \"Effect 3: Any initial side effects may begin to subside as the body acclimates to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Enhanced cognitive functions, including sustained attention and mental stamina, are likely to be more evident. These effects are based on the compound's potential impact on neurotransmitter systems.\",\n        \"Effect 2: Users with ADHD might start noticing improvements in attention and focus, although this is still under research and not conclusively documented.\",\n        \"Effect 3: Side effects, if any, should be minimal by this stage, but some users might still experience mild headaches or digestive issues.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term cognitive benefits, such as enhanced learning capacity and memory retention, may become more stable and consistent.\",\n        \"Effect 2: For individuals with cognitive impairments or ADHD, more significant improvements might be observed, although this is speculative and based on ongoing research.\",\n        \"Effect 3: Physiological measurements, such as improved sleep patterns or reduced stress markers, might be observed, although specific biomarker changes are not well-documented.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available research and anecdotal reports from users. Fasoracetam is still under investigation, and its effects can vary significantly between individuals. The effects described are inferred from its known mechanisms of action and comparisons with similar nootropic compounds. Users should exercise caution and consult with a healthcare professional before using fasoracetam for research purposes.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 674, "completion_tokens": 568, "total_tokens": 1242, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a071048190b4d46cf44154dff6", "custom_id": "drug57_effects_timeline", "response": {"status_code": 200, "request_id": "503d51cfcf3fb7285db80503a254accc", "body": {"id": "chatcmpl-B9MVJkmsiKi8HjmSfaqMBybJvrPq1", "object": "chat.completion", "created": 1741571157, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a mild calming effect within 30 to 60 minutes of ingestion, as L-theanine is rapidly absorbed and crosses the blood-brain barrier.\",\n        \"Effect 2: Initial improvements in mental clarity and focus might be observed, particularly in situations that typically induce stress or anxiety.\",\n        \"Effect 3: Some users might experience a subtle increase in alpha brain wave activity, contributing to a state of relaxed alertness.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Consistent use may lead to more noticeable reductions in stress and anxiety levels, with users reporting a greater sense of calmness throughout the day.\",\n        \"Effect 2: Enhanced cognitive performance, particularly in tasks requiring sustained attention, may become more apparent.\",\n        \"Effect 3: Users might observe improved sleep quality, with easier transitions into restful states, although this effect can vary.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Continued use may solidify the calming effects, with users experiencing a more stable mood and reduced anxiety in stressful situations.\",\n        \"Effect 2: Cognitive benefits, such as improved focus and mental clarity, may become more pronounced and consistent.\",\n        \"Effect 3: Some users might notice a slight improvement in overall well-being and mood, potentially due to increased serotonin and dopamine activity.\",\n        \"Effect 4: Any initial side effects, such as mild headaches or gastrointestinal discomfort, are likely to diminish as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Month 1-3\",\n      \"effects\": [\n        \"Effect 1: Long-term use may lead to sustained improvements in stress management and cognitive performance.\",\n        \"Effect 2: Users might report a more balanced emotional state and enhanced resilience to daily stressors.\",\n        \"Effect 3: Potential changes in biomarkers, such as reduced cortisol levels, could be observed, although this would require specific testing.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for L-theanine can vary significantly between individuals due to factors such as dosage, frequency of use, and individual biochemistry. Most effects are subtle and may not be easily quantifiable without subjective reporting or specific cognitive tests. While L-theanine is generally well-tolerated, any adverse effects are typically mild and transient. The information provided is based on user reports and limited studies; more research is needed to fully understand the long-term effects and mechanisms of L-theanine.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 557, "total_tokens": 1244, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a08078819086e70c571692d762", "custom_id": "drug58_effects_timeline", "response": {"status_code": 200, "request_id": "84180a756171537c81a5ac044f78a149", "body": {"id": "chatcmpl-B9MVJ7vnBF65lVVD6C7nmOySQQhc2", "object": "chat.completion", "created": 1741571157, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a mild improvement in digestive comfort, as TUDCA can help with bile flow, potentially reducing bloating or discomfort.\",\n        \"Effect 2: Initial stabilization of liver enzymes might be observed in blood tests, although significant changes are more likely to be seen over a longer period.\",\n        \"Effect 3: No significant mental or cognitive effects are expected at this stage, as TUDCA primarily targets liver health.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued support for liver function may lead to a slight improvement in energy levels, as the liver plays a crucial role in metabolism.\",\n        \"Effect 2: Users might notice a reduction in symptoms associated with liver stress, such as fatigue or mild jaundice, if present.\",\n        \"Effect 3: Biomarkers such as ALT and AST levels might begin to show improvement, indicating reduced liver stress.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in liver function tests could be observed, with a further reduction in liver enzyme levels.\",\n        \"Effect 2: Users might experience enhanced overall well-being due to improved liver function, although this is subjective and varies by individual.\",\n        \"Effect 3: Any initial side effects, such as mild gastrointestinal discomfort, would likely have subsided by this point.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-12\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained liver health and function are more likely to be evident, particularly in individuals with pre-existing liver conditions.\",\n        \"Effect 2: Continued improvements in biomarkers like bilirubin levels, indicating better liver detoxification processes.\",\n        \"Effect 3: No significant cognitive effects are expected, as TUDCA's primary action is on liver cells.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on general observations and the known mechanisms of TUDCA. Individual responses can vary significantly based on factors such as dosage, baseline liver health, and overall health status. Most effects are inferred from the compound's known actions and similar compounds, as specific detailed timelines for TUDCA are not extensively documented in the literature. Users should consult healthcare professionals before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 671, "completion_tokens": 519, "total_tokens": 1190, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a08fc88190a46b26398706c457", "custom_id": "drug59_effects_timeline", "response": {"status_code": 200, "request_id": "8dcef22a0efb2c24432d2b80619bf6f4", "body": {"id": "chatcmpl-B9MVKF6C0nmAgz2ky7O39LOpi4U0T", "object": "chat.completion", "created": 1741571158, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might not notice significant physical changes in hair density or growth during the first week. Initial application may cause mild scalp irritation or redness as the skin adjusts to the compound.\",\n        \"Effect 2: No significant mental or cognitive effects are expected, as RU58841 is applied topically and is designed to act locally.\",\n        \"Effect 3: Biomarkers such as scalp DHT levels might begin to decrease slightly, but this would not be noticeable without specific testing.\",\n        \"Effect 4: No specific benefits in terms of hair preservation or growth are likely to be observed yet.\",\n        \"Effect 5: Initial side effects, if any, such as mild itching or dryness, might begin to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Some users might start to notice a reduction in hair shedding, although this can vary widely among individuals.\",\n        \"Effect 2: Continued absence of mental or cognitive effects is expected.\",\n        \"Effect 3: Further reduction in scalp DHT levels might occur, but still not noticeable without testing.\",\n        \"Effect 4: Early signs of reduced hair loss might begin to appear, particularly in areas that were thinning.\",\n        \"Effect 5: Side effects such as scalp irritation might persist but are generally mild and manageable.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice visible improvements in hair density and thickness, particularly in areas previously affected by thinning.\",\n        \"Effect 2: No mental or cognitive effects should be expected.\",\n        \"Effect 3: Continued stabilization or reduction in scalp DHT levels, contributing to the preservation of hair follicles.\",\n        \"Effect 4: Benefits such as healthier hair growth and reduced hair loss are likely to become more apparent.\",\n        \"Effect 5: Side effects, if present, might stabilize or diminish as the scalp adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in hair density and overall scalp health might be observed by this period.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: Biomarkers related to hair health, such as hair shaft thickness, might show improvement.\",\n        \"Effect 4: Users are likely to experience the full benefits of RU58841, with noticeable preservation of hair density and reduced hair loss.\",\n        \"Effect 5: Long-term side effects are not well-documented, but continued monitoring for any adverse reactions is advised.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available research and anecdotal reports, as RU58841 is still an experimental compound. Effects can vary significantly between individuals. The compound's long-term safety and efficacy have not been fully established, and it should be used with caution in research settings. Inferences are made based on the compound's mechanism of action and comparisons to similar anti-androgen treatments.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 664, "total_tokens": 1351, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a09e0081908958e0c23c682ea0", "custom_id": "drug60_effects_timeline", "response": {"status_code": 200, "request_id": "5adc7db7ab6795fc6c72ead10eea3191", "body": {"id": "chatcmpl-B9MVK4deU1XPmmzkIZYsgDKqlAuIC", "object": "chat.completion", "created": 1741571158, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle changes in mood and energy levels. These changes are often mild and can vary greatly between individuals.\",\n        \"Effect 2: Some users may experience initial improvements in cognitive clarity or focus, although these effects are not well-documented and could be placebo-driven.\",\n        \"Effect 3: There may be no significant changes in biomarkers or physiological measurements at this early stage.\",\n        \"Effect 4: Initial side effects, if any, might include mild headaches or gastrointestinal discomfort as the body adjusts to the supplement.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued subtle improvements in mood and energy might be observed, potentially becoming more noticeable.\",\n        \"Effect 2: Cognitive effects such as enhanced memory or focus could become more apparent, though evidence is largely anecdotal.\",\n        \"Effect 3: Hormonal changes might begin to manifest, but these are typically not measurable without specific tests.\",\n        \"Effect 4: Some users might start to notice improvements in skin health, although this is speculative and not well-supported by research.\",\n        \"Effect 5: Side effects, if present, might stabilize or diminish as the body acclimates to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might report more consistent improvements in mood and stress resilience, potentially linked to pregnenolone's role in hormone synthesis.\",\n        \"Effect 2: Cognitive benefits, such as improved memory retention or mental clarity, may become more consistent, though individual responses vary.\",\n        \"Effect 3: Some users might observe changes in sleep patterns, potentially experiencing more restful sleep.\",\n        \"Effect 4: Any skin health benefits might become more noticeable, though this remains speculative.\",\n        \"Effect 5: Side effects are generally mild but could include hormonal imbalances if the supplement affects hormone levels significantly.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users might experience sustained improvements in mood and cognitive function, with potential benefits in stress management becoming more pronounced.\",\n        \"Effect 2: Hormonal balance might be more evident, potentially affecting reproductive health or libido, though this is highly individual.\",\n        \"Effect 3: Biomarkers related to hormone levels could show changes, but this would require specific testing to confirm.\",\n        \"Effect 4: Long-term skin health benefits might be observed, although evidence is largely anecdotal.\",\n        \"Effect 5: Long-term side effects could include hormonal imbalances, particularly if used in high doses or without medical supervision.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of pregnenolone supplementation can vary widely among individuals due to differences in baseline hormone levels, genetic factors, and overall health. Most of the potential benefits and side effects are based on anecdotal evidence and theoretical mechanisms, as robust clinical research on pregnenolone supplementation is limited. Users should approach supplementation cautiously and consider consulting with a healthcare professional, especially if they have underlying health conditions or are taking other medications.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 672, "total_tokens": 1348, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a0ab60819088b424e7d5212290", "custom_id": "drug61_effects_timeline", "response": {"status_code": 200, "request_id": "55ba95868ef6289ed77673bfbc238dfa", "body": {"id": "chatcmpl-B9MVSnpopxQN202ovGvYYRZH7Le7d", "object": "chat.completion", "created": 1741571166, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of GHK-Cu may lead to a slight improvement in skin hydration and texture, as the compound begins to bind with copper ions and initiate cellular processes.\",\n        \"Effect 2: Users might notice a mild reduction in skin redness or irritation due to the anti-inflammatory properties of GHK-Cu.\",\n        \"Effect 3: No significant mental or cognitive effects are expected at this stage, as GHK-Cu primarily acts on skin and tissue.\",\n        \"Effect 4: Biomarkers such as skin elasticity and firmness are unlikely to show measurable changes yet, but cellular activity related to collagen production is beginning.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to noticeable improvements in skin smoothness and a slight reduction in fine lines as collagen synthesis is enhanced.\",\n        \"Effect 2: Users might observe faster healing of minor skin injuries or blemishes, reflecting GHK-Cu's role in tissue repair.\",\n        \"Effect 3: No significant changes in mental or cognitive functions are expected.\",\n        \"Effect 4: Biomarkers related to skin health, such as moisture retention, may begin to show improvement.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced reduction in the appearance of fine lines and wrinkles as collagen production continues to increase.\",\n        \"Effect 2: Enhanced skin firmness and elasticity become more noticeable, contributing to a more youthful appearance.\",\n        \"Effect 3: Users might experience a further reduction in skin inflammation and redness.\",\n        \"Effect 4: Biomarkers such as skin thickness and elasticity might show measurable improvements.\",\n        \"Effect 5: Side effects, if any, such as skin irritation or allergic reactions, might become apparent, although these are generally rare.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in overall skin tone and texture, with a marked reduction in visible signs of aging.\",\n        \"Effect 2: Continued enhancement in wound healing capabilities, with faster recovery from skin injuries.\",\n        \"Effect 3: Some users might notice improvements in hair health or growth, although this is less documented.\",\n        \"Effect 4: Biomarkers related to oxidative stress might show reductions, indicating healthier skin at a cellular level.\",\n        \"Effect 5: Any side effects are likely to have stabilized; ongoing monitoring for skin reactions is advised.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical use cases and available research on GHK-Cu. Individual responses may vary, and effects can be influenced by factors such as dosage, application method, and individual skin type. While GHK-Cu is generally well-tolerated, users should monitor for any adverse reactions and consult with a healthcare professional if needed. The effects on hair growth are inferred based on anecdotal evidence and require further research for confirmation.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 688, "completion_tokens": 647, "total_tokens": 1335, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a0bb288190aaf335c339a878ad", "custom_id": "drug62_effects_timeline", "response": {"status_code": 200, "request_id": "e3758450503cb9675448812ff272fa29", "body": {"id": "chatcmpl-B9MVbrmaTBWjwHXlBEY96SecCRSla", "object": "chat.completion", "created": 1741571175, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may notice an initial increase in energy and alertness shortly after taking DMHA, similar to the effects of caffeine. This is due to the stimulation of the central nervous system.\",\n        \"Effect 2: Some users might experience heightened mental focus and concentration, potentially improving cognitive tasks and workout performance.\",\n        \"Effect 3: Initial side effects such as jitteriness, increased heart rate, or mild headaches might occur as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as increased stamina and endurance during workouts may become more noticeable as users continue to take DMHA.\",\n        \"Effect 2: Mental effects like improved motivation and reduced fatigue could be more pronounced, aiding in longer and more intense exercise sessions.\",\n        \"Effect 3: Users might observe changes in biomarkers such as elevated blood pressure or heart rate, which should be monitored closely.\",\n        \"Effect 4: Side effects like insomnia or anxiety might begin to manifest, especially if taken in high doses or late in the day.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: The benefits of increased energy and focus might stabilize, with users experiencing consistent performance enhancements during physical activities.\",\n        \"Effect 2: Some users may report a plateau in effects, as the body potentially develops a tolerance to DMHA.\",\n        \"Effect 3: Continued monitoring of physiological measurements is advised, as prolonged use could exacerbate cardiovascular side effects.\",\n        \"Effect 4: Side effects such as irritability or digestive issues might peak, prompting some users to adjust their dosage or discontinue use.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users who continue to experience benefits may find them to be more subtle, with less pronounced energy boosts compared to the initial weeks.\",\n        \"Effect 2: Cognitive enhancements might persist, but the risk of tolerance remains, potentially requiring cycling off the compound to maintain effectiveness.\",\n        \"Effect 3: Long-term side effects, such as increased blood pressure or potential cardiovascular strain, should be closely monitored.\",\n        \"Effect 4: Users might experience withdrawal symptoms, such as fatigue or mood swings, if they decide to stop using DMHA abruptly.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred effects from similar compounds, as there is limited scientific research specifically on DMHA. Users should approach DMHA with caution, considering the lack of regulatory oversight and comprehensive studies on its long-term safety and efficacy. It is advisable to consult with a healthcare professional before starting or discontinuing use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 595, "total_tokens": 1280, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a0c9a88190aed6159028130835", "custom_id": "drug63_effects_timeline", "response": {"status_code": 200, "request_id": "80b891255d7a284831de22de093e3e71", "body": {"id": "chatcmpl-B9MVJ4CkIrxfmhJH1py7WwjnT88On", "object": "chat.completion", "created": 1741571157, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle cognitive enhancements, such as improved focus and slight increases in memory recall, particularly for short-term memory tasks. These effects are based on anecdotal reports and may vary between individuals.\",\n        \"Effect 2: Some users might experience a mild increase in motivation and mental clarity, potentially due to interactions with dopamine pathways. This is inferred from the compound's proposed mechanism of action.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Cognitive effects such as enhanced memory recall and learning efficiency may become more pronounced. Users might find it easier to remember lists or details from recent events.\",\n        \"Effect 2: Physical effects are generally minimal, but some users might report a slight increase in energy levels or alertness.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this stage, as PRL-8-53 is primarily noted for its cognitive effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued cognitive improvements might be observed, with users experiencing more consistent memory enhancement and possibly faster learning speeds.\",\n        \"Effect 2: Some users could report a plateau in effects, where the initial boost in cognitive function stabilizes.\",\n        \"Effect 3: Potential side effects, such as mild headaches or restlessness, might begin to manifest, although these are not well-documented and are based on anecdotal evidence.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience sustained cognitive benefits, with ongoing improvements in memory and learning tasks. These effects are likely to be most noticeable in tasks requiring short-term memory recall.\",\n        \"Effect 2: Any side effects, if present, might peak during this period. Users should monitor for any adverse reactions and adjust usage accordingly.\",\n        \"Effect 3: As with earlier periods, no significant changes in physiological measurements are expected, given the compound's primary cognitive focus.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and anecdotal reports, as PRL-8-53 has not been extensively studied in clinical settings. Effects can vary significantly between individuals, and long-term safety and efficacy remain uncertain. Users should approach this compound with caution and prioritize safety in experimental settings.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 683, "completion_tokens": 528, "total_tokens": 1211, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a0d7e48190a0f55ee4713eb6a8", "custom_id": "drug64_effects_timeline", "response": {"status_code": 200, "request_id": "8c0359f6a17a7a0a728d53e7c6568c47", "body": {"id": "chatcmpl-B9MVJBKDzJUbkj2t7IL85EiICY4J5", "object": "chat.completion", "created": 1741571157, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users might notice a slight increase in alertness and focus, as Sunifiram is thought to enhance AMPA receptor activity, which could lead to improved communication between brain cells.\",\n        \"Effect 2: Some users report a mild boost in mood, although this is anecdotal and not scientifically verified.\",\n        \"Effect 3: Initial physical effects might include a slight increase in energy levels, but this is not well-documented.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Cognitive effects such as improved memory recall and learning ability may start to become more noticeable, as the compound continues to influence neurotransmitter activity.\",\n        \"Effect 2: Users might experience enhanced concentration and mental clarity, potentially aiding in tasks that require sustained attention.\",\n        \"Effect 3: Some users might begin to notice side effects such as headaches or nausea, which are common with nootropic compounds, although specific data on Sunifiram is limited.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use might lead to more pronounced cognitive benefits, with users reporting sharper memory and quicker information processing.\",\n        \"Effect 2: Mood enhancement effects, if present, might stabilize, providing a consistent feeling of well-being.\",\n        \"Effect 3: Physiological changes such as slight alterations in sleep patterns could occur, as the brain adapts to the compound's effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Cognitive enhancements may reach a peak, with users experiencing optimal memory and learning improvements.\",\n        \"Effect 2: Some users might experience a plateau in effects, where no further cognitive improvements are noticed.\",\n        \"Effect 3: Side effects, if any, might also stabilize or become more noticeable, including potential irritability or anxiety.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term users might report sustained cognitive benefits, although the risk of tolerance developing is possible, leading to diminished effects.\",\n        \"Effect 2: Any mood-enhancing effects might persist, but the potential for psychological dependence should be considered.\",\n        \"Effect 3: Users might observe changes in biomarkers such as neurotransmitter levels, although specific data on Sunifiram is lacking.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred effects from similar compounds, as there is limited scientific research specifically on Sunifiram. Users should exercise caution due to the lack of comprehensive safety and efficacy data. Individual responses can vary significantly, and long-term effects are not well understood.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 637, "completion_tokens": 599, "total_tokens": 1236, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a0e6c88190973fdf3a5fb5b609", "custom_id": "drug65_effects_timeline", "response": {"status_code": 200, "request_id": "cd22d4c27bbfcae2b37dff3e586960b9", "body": {"id": "chatcmpl-B9MVMiKAAgWcNw1py7gTkFpfMx91Y", "object": "chat.completion", "created": 1741571160, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "\n{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial activation of the hypothalamic-pituitary-gonadal (HPG) axis, leading to a potential increase in GnRH release. This may not be immediately noticeable physically but is a crucial initial step.\",\n        \"Effect 2: No significant mental or cognitive effects are expected at this early stage.\",\n        \"Effect 3: Biomarkers such as GnRH, LH, and FSH levels may begin to show slight increases, measurable through blood tests.\",\n        \"Effect 4: No specific reproductive benefits are expected to appear yet.\",\n        \"Effect 5: Side effects are unlikely to manifest this early, but some users might experience mild headaches or nausea as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might start noticing subtle changes in reproductive hormone levels, potentially affecting menstrual cycle regularity or sperm production.\",\n        \"Effect 2: Mental effects remain minimal, though some users might report slight mood changes due to hormonal fluctuations.\",\n        \"Effect 3: Continued increase in LH and FSH levels, which can be confirmed through blood tests.\",\n        \"Effect 4: Early signs of improved reproductive health might begin to appear, such as more regular menstrual cycles or improved sperm parameters, but these are typically not pronounced yet.\",\n        \"Effect 5: Mild side effects like headaches or nausea might persist but are not expected to peak.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: More noticeable physical changes related to reproductive health, such as improved menstrual cycle regularity or increased libido.\",\n        \"Effect 2: Users might experience improved mood or energy levels due to hormonal balance.\",\n        \"Effect 3: Significant increases in LH and FSH levels, with potential normalization of testosterone or estrogen levels.\",\n        \"Effect 4: Benefits such as enhanced fertility or improved reproductive health are more likely to become apparent.\",\n        \"Effect 5: Side effects, if any, are expected to stabilize. Users might experience mild fatigue or mood swings as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in reproductive health markers, with potential benefits in fertility treatments becoming more evident.\",\n        \"Effect 2: Mental clarity and mood stabilization as hormonal levels reach a new equilibrium.\",\n        \"Effect 3: Sustained increases in reproductive hormone levels, with potential improvements in biomarkers related to fertility.\",\n        \"Effect 4: Significant benefits in reproductive health and fertility are likely to be observed, especially in research settings focusing on these outcomes.\",\n        \"Effect 5: Side effects should be minimal, with most users experiencing stabilization of any initial discomfort.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the typical pharmacodynamics of Kisspeptin-10 and similar compounds. Individual responses can vary significantly based on factors such as dosage, administration method, and individual physiology. Most effects are inferred from the known mechanism of action and studies on similar peptides, as specific long-term studies on Kisspeptin-10 are limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 685, "total_tokens": 1376, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a0f5ec8190b25bd808ad98c884", "custom_id": "drug66_effects_timeline", "response": {"status_code": 200, "request_id": "3cb2cb67891953c9a39b426964bc280c", "body": {"id": "chatcmpl-B9MVJ07s5Dxj0IIRFwXOEHFgkrS1Z", "object": "chat.completion", "created": 1741571157, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle improvements in mental clarity and focus, as Coluracetam starts to enhance choline uptake, potentially leading to increased acetylcholine levels. These effects are inferred based on the compound's mechanism of action.\",\n        \"Effect 2: Some users may experience mild physical effects such as increased energy levels or slight changes in sleep patterns, although these are not well-documented and may vary individually.\",\n        \"Effect 3: Initial changes in biomarkers, such as slight increases in acetylcholine levels, could be observed in a research setting, though these are not typically noticeable without specific testing.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Cognitive benefits such as improved memory retention and learning ability might become more noticeable as the compound continues to support acetylcholine production. These effects are inferred from similar compounds in the racetam family.\",\n        \"Effect 2: Users might report a reduction in anxiety levels, potentially due to enhanced neurotransmitter balance, although this is based on anecdotal evidence rather than clinical studies.\",\n        \"Effect 3: Side effects such as headaches or gastrointestinal discomfort might begin to manifest in some users, particularly if the dosage is not well-tolerated.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued cognitive enhancement, with users potentially experiencing sharper thinking and better problem-solving abilities. These effects are inferred from the compound's proposed mechanism.\",\n        \"Effect 2: Physical effects might stabilize, with users adapting to any initial changes in energy levels or sleep patterns.\",\n        \"Effect 3: If side effects were present, they might peak during this period, especially if the dosage is not adjusted. Users should monitor for any persistent adverse effects.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users might experience sustained cognitive benefits, with ongoing improvements in memory and learning, assuming consistent use and proper dosing.\",\n        \"Effect 2: Long-term changes in biomarkers, such as more stable acetylcholine levels, could be observed in a research context, though these would require specific testing to confirm.\",\n        \"Effect 3: Any side effects should be evaluated, and users may need to adjust dosage or discontinue use if adverse effects persist.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Coluracetam is largely inferred from its mechanism of action and anecdotal reports, as there is limited clinical research specifically detailing the compound's effects over time. Users should approach its use cautiously and consult with a healthcare professional before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 623, "completion_tokens": 583, "total_tokens": 1206, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a1045081908b196ae9a4465dc6", "custom_id": "drug67_effects_timeline", "response": {"status_code": 200, "request_id": "157f087e5685ecd177e7f19dbe933750", "body": {"id": "chatcmpl-B9MVQE2sT9Pcch1TjITIYZw44lOZX", "object": "chat.completion", "created": 1741571164, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in muscle recovery rate may be observed, as MGF begins to activate muscle stem cells. This is inferred from its role in muscle repair.\",\n        \"Effect 2: Some users might notice slight improvements in muscle soreness reduction post-exercise, although significant changes are more likely to develop over time.\",\n        \"Effect 3: No significant mental or cognitive effects are expected at this stage, as MGF primarily targets muscle tissue.\",\n        \"Effect 4: Biomarkers such as creatine kinase levels might start to decrease slightly, indicating reduced muscle damage, but this is speculative based on MGF's proposed mechanism.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in muscle recovery and slight increases in muscle strength may become more noticeable.\",\n        \"Effect 2: Users might start to experience a subtle increase in muscle mass, although this is more likely to be observed in subsequent weeks.\",\n        \"Effect 3: No significant changes in cognitive function are expected, as MGF does not directly influence brain activity.\",\n        \"Effect 4: Biomarkers related to muscle growth, such as IGF-1 levels, might show slight increases, although this is inferred from MGF's relationship with IGF-1.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced improvements in muscle strength and mass could be observed, as MGF's effects on muscle stem cells accumulate.\",\n        \"Effect 2: Enhanced muscle recovery and reduced fatigue during workouts might be more evident.\",\n        \"Effect 3: Users may notice a more significant reduction in muscle soreness post-exercise.\",\n        \"Effect 4: Potential side effects, such as localized irritation at injection sites, might begin to manifest if MGF is administered via injection.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in muscle mass and strength are likely, with users potentially reaching a plateau in gains.\",\n        \"Effect 2: Continued enhancement in muscle recovery and reduced injury risk due to stronger muscle tissue.\",\n        \"Effect 3: No significant mental or cognitive effects are expected throughout the usage period.\",\n        \"Effect 4: Any side effects, such as injection site reactions, should be monitored, but systemic side effects are not well-documented.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects described are largely inferred from MGF's proposed mechanism of action and its relationship to IGF-1. There is limited direct research on MGF's timeline of effects in humans, and most information is extrapolated from animal studies and theoretical models. Users should be cautious and consult with a healthcare professional before considering the use of research chemicals.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 675, "completion_tokens": 610, "total_tokens": 1285, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a111dc81908203818a0c34788b", "custom_id": "drug68_effects_timeline", "response": {"status_code": 200, "request_id": "62852066e7fa8c7d49f8606f4d7d2dd8", "body": {"id": "chatcmpl-B9MVXt76uSGsJMF5KKItCkPlnbt8t", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels as mitochondrial efficiency starts to improve. This is an inferred effect based on the compound's mechanism of action.\",\n        \"Effect 2: Some users may experience mild improvements in mental clarity and focus, although significant cognitive changes are unlikely to be noticeable this early.\",\n        \"Effect 3: Initial antioxidant effects might start to reduce oxidative stress, but changes in biomarkers such as oxidative stress markers would likely be subtle and not easily measurable in this short period.\",\n        \"Effect 4: Side effects, if any, such as mild gastrointestinal discomfort, might begin to manifest as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels as mitochondrial biogenesis progresses. Users might feel less fatigued during daily activities.\",\n        \"Effect 2: Cognitive effects such as improved memory recall and sharper focus may become more noticeable, although these are inferred effects and can vary widely among individuals.\",\n        \"Effect 3: Biomarkers related to mitochondrial function, such as ATP production, might show slight improvements, but these would typically require laboratory testing to confirm.\",\n        \"Effect 4: Any initial side effects might begin to subside as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might experience more pronounced improvements in overall energy and endurance, particularly during physical activities.\",\n        \"Effect 2: Cognitive benefits, such as enhanced memory and concentration, could become more consistent and noticeable.\",\n        \"Effect 3: Potential reductions in biomarkers of oxidative stress might be more measurable, indicating the antioxidant effects of PQQ disodium.\",\n        \"Effect 4: If side effects were present, they are likely to have diminished by this point, assuming typical dosing.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in energy levels and physical performance due to enhanced mitochondrial function.\",\n        \"Effect 2: Long-term cognitive benefits, such as improved memory retention and mental acuity, may be more evident, although these effects are still largely inferred.\",\n        \"Effect 3: Continued positive changes in biomarkers related to mitochondrial health and oxidative stress could be observed in a research setting.\",\n        \"Effect 4: Long-term side effects are not well-documented, but users should monitor for any unusual symptoms and consult with a healthcare professional if needed.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from the known mechanisms of PQQ disodium and similar compounds. Individual experiences may vary, and more research is needed to fully understand the compound's effects and potential side effects. Users should consult with a healthcare professional before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 623, "total_tokens": 1312, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a1210c81909bedf118dc0f4008", "custom_id": "drug69_effects_timeline", "response": {"status_code": 200, "request_id": "2d5640bbf9965a31982afa898419e20b", "body": {"id": "chatcmpl-B9MVK3BYLGm5pR10WhbVTQovLLJhq", "object": "chat.completion", "created": 1741571158, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial modulation of the immune response may begin, but noticeable physical effects are unlikely at this early stage.\",\n        \"Effect 2: No significant mental or cognitive effects are expected immediately.\",\n        \"Effect 3: Biomarkers related to inflammation, such as CRP (C-reactive protein), may start to show slight changes, but these are typically not measurable this early.\",\n        \"Effect 4: No specific benefits related to inflammation reduction or infection control are expected to be noticeable yet.\",\n        \"Effect 5: Side effects, if any, are likely to be minimal and may include mild irritation at the site of administration if applicable.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Some users might begin to notice a reduction in localized inflammation, particularly in skin conditions, though this is not guaranteed.\",\n        \"Effect 2: Mental effects remain minimal; however, a slight improvement in mood could occur due to reduced physical discomfort.\",\n        \"Effect 3: Inflammatory biomarkers might show a modest decrease, indicating the beginning of an anti-inflammatory response.\",\n        \"Effect 4: Initial benefits for skin conditions or mild inflammatory symptoms might start to appear, but significant improvements are unlikely.\",\n        \"Effect 5: Side effects, if present, may include mild gastrointestinal discomfort or skin irritation, but these are generally not severe.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: More noticeable reduction in inflammation-related symptoms, such as decreased swelling and pain in affected areas.\",\n        \"Effect 2: Potential improvement in cognitive function or mental clarity due to reduced systemic inflammation.\",\n        \"Effect 3: Continued decrease in inflammatory biomarkers, with more measurable changes in CRP or other markers.\",\n        \"Effect 4: Benefits for conditions like inflammatory bowel disease or skin disorders may become more apparent, with reduced symptoms and improved quality of life.\",\n        \"Effect 5: Side effects, if any, might stabilize or decrease as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: Sustained reduction in inflammation and further improvement in symptoms of inflammatory conditions.\",\n        \"Effect 2: Enhanced mental well-being and cognitive function due to ongoing reduction in inflammation.\",\n        \"Effect 3: Significant changes in biomarkers, with potential normalization of inflammatory markers in some users.\",\n        \"Effect 4: Long-term benefits for chronic inflammatory conditions may be evident, with improved management of symptoms.\",\n        \"Effect 5: Side effects are generally minimal at this stage, but long-term safety data is limited.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on preliminary research and inferred effects from similar compounds. Individual responses to KPV can vary significantly, and more clinical data is needed to establish a definitive timeline of effects. Researchers should monitor subjects closely for any adverse reactions and adjust dosages accordingly. The compound is still under investigation and not approved for medical use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 647, "completion_tokens": 661, "total_tokens": 1308, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a12edc8190ba95512fd5e5a729", "custom_id": "drug70_effects_timeline", "response": {"status_code": 200, "request_id": "4f4d08ac18b2039bbbbf0c4192df9633", "body": {"id": "chatcmpl-B9MVLpSWriwlcnZwOuvJ5Hoywcs1L", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial activation of TrkB receptors may lead to subtle improvements in mood and cognitive clarity, although these effects might be mild and not immediately noticeable.\",\n        \"Effect 2: Some users might experience a slight increase in energy levels or motivation due to enhanced neuronal signaling, but this is largely anecdotal and not well-documented.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued activation of TrkB receptors could lead to more noticeable improvements in mood and cognitive function, such as better focus and memory retention.\",\n        \"Effect 2: Users might start to feel a reduction in anxiety or depressive symptoms, although this is inferred from the compound's mechanism and not extensively documented.\",\n        \"Effect 3: Minor changes in biomarkers related to neuroplasticity might begin to appear, such as increased levels of BDNF in the brain, but these would typically require laboratory testing to confirm.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Cognitive benefits, such as enhanced learning and memory, may become more pronounced as neuroplasticity continues to improve.\",\n        \"Effect 2: Users might experience a stabilization of mood with reduced fluctuations, potentially aiding in the management of mood disorders.\",\n        \"Effect 3: Physiological measurements might show improved synaptic plasticity, although this would be more evident in a controlled research setting rather than through subjective observation.\",\n        \"Effect 4: Any potential side effects, such as headaches or mild gastrointestinal discomfort, might begin to manifest or peak during this period, but these are generally considered rare.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits for brain health, such as sustained cognitive improvements and neuroprotection, are more likely to be observed.\",\n        \"Effect 2: Users might notice a significant reduction in symptoms related to neurodegenerative conditions, inferred from animal studies and preliminary human research.\",\n        \"Effect 3: Biomarkers indicating enhanced brain health, such as increased BDNF levels, may be more consistently elevated, though this requires specific testing to confirm.\",\n        \"Effect 4: Side effects, if any, are likely to stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited human studies and extrapolation from animal research. Individual responses to 7,8-dihydroxyflavone can vary significantly, and the effects mentioned are inferred from its mechanism of action and similar compounds. Further research is needed to establish a definitive timeline of effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 704, "completion_tokens": 605, "total_tokens": 1309, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a13c7081909954caa44cb85bcc", "custom_id": "drug71_effects_timeline", "response": {"status_code": 200, "request_id": "eaf60e87c21d10ec3c16aaf87ca05184", "body": {"id": "chatcmpl-B9MVTAzhnSa2BQZc8OkKzUbvEYYPx", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial administration of myostatin inhibitors might not produce noticeable physical changes in muscle mass or strength. Users may not observe any immediate physical effects.\",\n        \"Effect 2: Mental or cognitive effects are unlikely to be noticeable at this stage, as myostatin primarily affects muscle tissue.\",\n        \"Effect 3: Biomarkers such as serum myostatin levels might begin to decrease, indicating the compound's activity, but these changes may not be significant enough to detect without sensitive assays.\",\n        \"Effect 4: No specific benefits related to increased muscle mass or strength are expected to appear yet.\",\n        \"Effect 5: Side effects, if any, are likely minimal at this stage, as the body is just beginning to respond to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice subtle changes in muscle tone or slight increases in muscle mass, although these changes are likely to be minimal.\",\n        \"Effect 2: There may be a slight increase in energy levels or motivation due to the anticipation of results, but this is more psychological than physiological.\",\n        \"Effect 3: Continued monitoring might show further decreases in myostatin levels, and possibly slight increases in muscle-related biomarkers like creatine kinase or IGF-1.\",\n        \"Effect 4: Initial benefits such as improved muscle recovery times might begin to manifest, although significant muscle growth is still unlikely.\",\n        \"Effect 5: Mild side effects such as muscle cramps or joint discomfort could begin to appear as the body adjusts to changes in muscle dynamics.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: More noticeable increases in muscle mass and strength may begin to appear, particularly in individuals who are also engaging in resistance training.\",\n        \"Effect 2: Users might experience improved mood or confidence due to visible physical changes, although these effects are secondary to the compound's action.\",\n        \"Effect 3: Biomarkers such as muscle protein synthesis rates might show significant increases, reflecting enhanced muscle growth.\",\n        \"Effect 4: Benefits such as increased muscle mass and improved physical performance are likely to become more apparent.\",\n        \"Effect 5: Side effects might peak during this period, with potential issues such as joint pain or muscle tightness becoming more pronounced.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-12\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and strength gains are expected, with users potentially reaching a plateau depending on individual response and training regimen.\",\n        \"Effect 2: Sustained improvements in mental well-being and self-esteem may occur as physical changes stabilize.\",\n        \"Effect 3: Long-term changes in biomarkers, such as reduced myostatin levels and increased anabolic markers, might be consistently observed.\",\n        \"Effect 4: The full benefits of muscle mass increase and enhanced physical performance are likely to be realized by this stage.\",\n        \"Effect 5: Side effects should stabilize, but long-term use could lead to issues such as tendon stress or imbalances in muscle groups.\"\n      ]\n    }\n  ],\n  \"notes\": \"This timeline is based on the hypothetical use of myostatin inhibitors, as direct use of myostatin itself is not typical. Effects are inferred from studies on myostatin inhibition and similar mechanisms. Individual responses can vary significantly, and the use of myostatin inhibitors is not approved for human use outside of research settings. Long-term safety and efficacy are not well-established.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 664, "completion_tokens": 761, "total_tokens": 1425, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a149f88190bb1eafad579f5673", "custom_id": "drug72_effects_timeline", "response": {"status_code": 200, "request_id": "a4f4c3d97e066127bd7e9f43ef8b3649", "body": {"id": "chatcmpl-B9MVbajIezAvyCYoq1Pfqb4SujUe4", "object": "chat.completion", "created": 1741571175, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in muscle fullness and slight improvement in muscle tone may be observed due to fluid retention and early anabolic signaling.\",\n        \"Effect 2: Users might experience a slight increase in energy levels and motivation, although this is more anecdotal and not well-documented.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected yet, as the compound's effects are just beginning to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Noticeable increase in muscle mass and strength might begin to appear as the compound continues to inhibit myostatin, allowing for enhanced muscle growth.\",\n        \"Effect 2: Some users might report improved recovery times between workouts, attributed to increased protein synthesis and muscle repair.\",\n        \"Effect 3: Potential changes in biomarkers such as increased creatine kinase levels could indicate enhanced muscle activity, though this is speculative.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and strength gains are likely to be more pronounced, with users potentially observing significant changes in physique.\",\n        \"Effect 2: Some users might experience mood elevation or increased focus due to improved physical performance, though this is not well-documented.\",\n        \"Effect 3: Side effects such as joint pain or fluid retention might begin to manifest as the body adjusts to increased muscle mass.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Muscle hypertrophy and strength gains may peak, with users achieving substantial improvements in muscle size and performance.\",\n        \"Effect 2: Potential mental effects could include increased confidence due to physical changes, although this is anecdotal.\",\n        \"Effect 3: Biomarkers such as liver enzymes or lipid profiles might show alterations due to the body's adaptation to increased muscle mass and metabolic demands.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3\",\n      \"effects\": [\n        \"Effect 1: Muscle growth may plateau as the body reaches a new equilibrium, with maintenance of gained muscle mass being the primary focus.\",\n        \"Effect 2: Users might experience fatigue or decreased motivation if the compound's effects begin to wane or if side effects become more pronounced.\",\n        \"Effect 3: Long-term side effects such as potential cardiovascular strain or metabolic imbalances might become more apparent, though these are speculative.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and inferences from similar compounds that inhibit myostatin. Ace-031 is still under investigation, and its effects in humans are not fully understood. The use of Ace-031 outside of controlled research settings is not recommended due to potential unknown risks and side effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 684, "completion_tokens": 608, "total_tokens": 1292, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a159248190accd83801b5df175", "custom_id": "drug73_effects_timeline", "response": {"status_code": 200, "request_id": "d29f0d87e2456cb2551a6dd862d9224c", "body": {"id": "chatcmpl-B9MVL7uu5TKIAd0pYvU2fY7PxUoSj", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial antioxidant effects may begin to manifest, potentially leading to a slight improvement in overall energy levels as oxidative stress is reduced. This is inferred from the general action of antioxidants.\",\n        \"Effect 2: Some users might notice a mild reduction in inflammation-related symptoms, such as joint discomfort or minor swelling, as amentoflavone starts to inhibit inflammatory enzymes. This is based on its proposed mechanism of action.\",\n        \"Effect 3: Cognitive effects are likely minimal at this stage, but some users might experience a subtle improvement in mental clarity or focus due to initial interactions with brain receptors. This is inferred from similar compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued antioxidant activity might lead to more noticeable improvements in skin health or recovery from physical exertion, as cellular protection is enhanced.\",\n        \"Effect 2: Further reduction in inflammation might be observed, potentially leading to decreased frequency or severity of headaches or muscle soreness.\",\n        \"Effect 3: Early signs of mood stabilization could appear, with users reporting a slight improvement in stress management or mood swings. This is inferred from its interaction with brain receptors.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Antiviral properties might begin to manifest, potentially contributing to a reduced incidence of common viral infections, though this effect is speculative and based on preliminary research.\",\n        \"Effect 2: Cognitive enhancements, such as improved memory retention or quicker information processing, might become more apparent as brain receptor interactions continue.\",\n        \"Effect 3: Biomarkers such as C-reactive protein (CRP) levels might show a decrease, indicating reduced systemic inflammation. This is inferred from its anti-inflammatory properties.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Users might experience sustained improvements in mood and cognitive function, with more consistent mental clarity and emotional balance.\",\n        \"Effect 2: Long-term antioxidant effects could contribute to improved cardiovascular health markers, such as reduced LDL cholesterol levels, though this is speculative and based on general antioxidant benefits.\",\n        \"Effect 3: Any side effects, such as gastrointestinal discomfort or mild headaches, might peak during this period as the body adjusts to the compound. These are inferred from general flavonoid supplementation experiences.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of amentoflavone are largely inferred from its proposed mechanisms and similar compounds, as direct human studies are limited. Individual responses can vary significantly, and the timeline is speculative based on available data. Further research is needed to confirm these effects and their onset.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 585, "total_tokens": 1276, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a1672881909fe909345a48598a", "custom_id": "drug74_effects_timeline", "response": {"status_code": 200, "request_id": "a390e895bb6e2dda8032cfec599ca07f", "body": {"id": "chatcmpl-B9MVLwhgoZmccvJWGlkOhWEUccaC3", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users might notice a reduction in the sedative effects of alcohol, feeling less intoxicated than usual after consuming alcohol. This is due to dihydromyricetin's interaction with GABA-A receptors.\",\n        \"Effect 2: Some users may experience a mild improvement in cognitive clarity and alertness after alcohol consumption, as the compound may help counteract alcohol-induced cognitive impairment.\",\n        \"Effect 3: Initial antioxidant effects might begin, potentially reducing oxidative stress markers, although these changes may not be immediately measurable.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in alcohol intoxication effects, with users potentially experiencing quicker recovery from hangovers.\",\n        \"Effect 2: Users might start noticing a slight improvement in mood and mental clarity, especially after alcohol consumption.\",\n        \"Effect 3: Early signs of liver protection could begin, with potential reductions in liver enzyme levels, though significant changes might not be measurable yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Enhanced liver protection effects might become more noticeable, with possible improvements in liver function tests for some users.\",\n        \"Effect 2: Users may experience a more pronounced reduction in alcohol withdrawal symptoms, aiding those trying to reduce or quit alcohol.\",\n        \"Effect 3: Antioxidant effects might lead to a reduction in oxidative stress markers, contributing to overall cellular health.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Users might observe sustained improvements in alcohol tolerance and recovery, with less severe hangovers.\",\n        \"Effect 2: Continued cognitive benefits, with improved focus and mental clarity, especially in contexts involving alcohol.\",\n        \"Effect 3: Potential stabilization of liver enzyme levels, indicating ongoing liver protection.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term liver health benefits might become more evident, with users potentially observing improved liver function over time.\",\n        \"Effect 2: Sustained reduction in alcohol-related cognitive impairments and withdrawal symptoms.\",\n        \"Effect 3: Continued antioxidant benefits, potentially contributing to overall health and well-being.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available research and anecdotal reports. Most effects are inferred from the compound's mechanism of action and studies on similar compounds. Individual responses may vary, and more research is needed to confirm these effects and their timelines. Users should be cautious of potential side effects, such as gastrointestinal discomfort or allergic reactions, which might occur early in the usage period.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 692, "completion_tokens": 590, "total_tokens": 1282, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a1754c8190b0ac9c3747589c52", "custom_id": "drug75_effects_timeline", "response": {"status_code": 200, "request_id": "01e9a0932de8068a4f4c6faeda54401f", "body": {"id": "chatcmpl-B9MVTm8LlydtbMmU28CvPhgbiMkF9", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial immune modulation begins, with T-cell activity starting to increase. Users might not notice significant physical changes yet.\",\n        \"Effect 2: Some users may experience mild flu-like symptoms as the immune system begins to activate, including slight fatigue or mild headache.\",\n        \"Effect 3: Biomarkers such as T-cell count may start to show slight increases, although this might not be significant enough to detect without specific tests.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced immune response becomes more noticeable. Users might experience quicker recovery from minor infections or colds.\",\n        \"Effect 2: Some users may report improved energy levels as the immune system stabilizes.\",\n        \"Effect 3: Continued increase in T-cell activity and possibly other immune markers like cytokine levels, which can be measured in a clinical setting.\",\n        \"Effect 4: Initial benefits for chronic conditions like hepatitis B or C might start to appear, though this varies depending on individual health status.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may notice a more robust immune response, with fewer incidences of minor illnesses.\",\n        \"Effect 2: Mental clarity and cognitive function might improve as overall health stabilizes, although this is more anecdotal.\",\n        \"Effect 3: Biomarkers such as viral load in hepatitis patients may begin to show improvement, indicating the compound's effectiveness.\",\n        \"Effect 4: Side effects, if any, such as injection site reactions, might become apparent but typically remain mild.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained immune enhancement, with significant improvements in managing chronic infections like hepatitis B or C.\",\n        \"Effect 2: Users may report sustained energy levels and overall well-being.\",\n        \"Effect 3: Clinical markers such as liver function tests in hepatitis patients may show improvement.\",\n        \"Effect 4: Long-term side effects are rare but could include continued mild flu-like symptoms in some users.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Continued immune support, with potential benefits in autoimmune conditions or during cancer treatment becoming more evident.\",\n        \"Effect 2: Users might experience a plateau in physical and cognitive benefits as the body adapts to the compound.\",\n        \"Effect 3: Long-term biomarkers such as sustained T-cell levels and improved liver function tests in hepatitis patients.\",\n        \"Effect 4: Side effects are generally minimal, with most users tolerating the compound well over extended periods.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Thymosin alpha-1 can vary significantly based on individual health conditions, dosage, and treatment duration. The effects described are based on documented uses and inferred from similar immune-modulating compounds. Clinical monitoring is recommended to assess the compound's impact accurately.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 693, "completion_tokens": 656, "total_tokens": 1349, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a182f08190b8a3cb1c18d7231e", "custom_id": "drug76_effects_timeline", "response": {"status_code": 200, "request_id": "77af2eeb118918684d32c31da0da1640", "body": {"id": "chatcmpl-B9MVbsqkplwXdP6WH9zeoJdtjoese", "object": "chat.completion", "created": 1741571175, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial antioxidant effects may begin, potentially leading to a slight reduction in oxidative stress markers, although these changes might not be immediately noticeable.\",\n        \"Effect 2: Some users might experience mild improvements in allergy symptoms, such as reduced sneezing or itching, due to quercetin's mast cell stabilization properties.\",\n        \"Effect 3: No significant mental or cognitive effects are typically expected this early, as quercetin's primary actions are physical.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in oxidative stress may lead to slight improvements in inflammation-related symptoms, such as minor joint pain relief.\",\n        \"Effect 2: Some users might notice a modest improvement in circulation, potentially leading to slightly lower blood pressure readings.\",\n        \"Effect 3: Enhanced immune response might begin to manifest, potentially reducing the frequency or severity of minor colds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in allergy symptoms may occur, with users experiencing less frequent or severe allergic reactions.\",\n        \"Effect 2: Sustained antioxidant activity could lead to further reductions in oxidative stress biomarkers, such as lower levels of C-reactive protein.\",\n        \"Effect 3: Users might start to feel a general sense of improved well-being due to reduced inflammation and oxidative stress.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Potential cardiovascular benefits, such as improved endothelial function and further reductions in blood pressure, may become more apparent.\",\n        \"Effect 2: Long-term immune support might lead to a noticeable decrease in the frequency of common illnesses.\",\n        \"Effect 3: Any side effects, such as mild gastrointestinal discomfort, might peak during this period but are generally uncommon and mild.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Users may experience sustained benefits in heart health and allergy symptom management.\",\n        \"Effect 2: Long-term use might contribute to overall health maintenance, with continued antioxidant and anti-inflammatory effects.\",\n        \"Effect 3: Any side effects are likely to stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for quercetin can vary significantly among individuals due to differences in metabolism, dosage, and overall health. While some effects are documented, others are inferred based on quercetin's mechanisms of action and similar compounds. Users should consult with a healthcare professional before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 580, "total_tokens": 1267, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a199cc8190922432c84e556b3f", "custom_id": "drug77_effects_timeline", "response": {"status_code": 200, "request_id": "b43e57b339b5f4c15152d02da38fec0a", "body": {"id": "chatcmpl-B9MViaOtI8pto9D1NLDj7h2iLyte4", "object": "chat.completion", "created": 1741571182, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial reduction in appetite may be noticed as OEA begins to interact with PPAR-\u03b1 receptors, signaling satiety to the brain. This effect is inferred from its mechanism of action.\",\n        \"Effect 2: Some users might experience a slight increase in energy expenditure as the body starts to break down fats more efficiently. This is an inferred effect based on OEA's role in energy management.\",\n        \"Effect 3: No significant changes in biomarkers such as body weight or fat percentage are expected yet, as these typically require more time to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued appetite suppression might become more noticeable, potentially leading to reduced caloric intake.\",\n        \"Effect 2: Users may begin to observe slight changes in body composition, such as a small reduction in body weight, as fat metabolism is influenced.\",\n        \"Effect 3: Mental effects such as improved mood or focus could be experienced due to better energy regulation, although this is more speculative and not well-documented.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced weight loss effects might start to appear as the cumulative impact of reduced appetite and increased fat breakdown takes effect.\",\n        \"Effect 2: Users might notice improvements in metabolic biomarkers, such as a slight decrease in triglyceride levels, inferred from OEA's role in lipid metabolism.\",\n        \"Effect 3: Any side effects, such as mild gastrointestinal discomfort, could manifest during this period, although these are not commonly reported.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained weight loss and improved body composition may be observed, with more significant reductions in body fat percentage.\",\n        \"Effect 2: Continued improvements in metabolic health markers, such as cholesterol levels, might be noted.\",\n        \"Effect 3: Long-term appetite regulation could lead to more stable eating patterns and potentially improved mental well-being, although this is speculative.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of Oleoylethanolamide (OEA) are primarily inferred from its mechanism of action and limited human studies. Individual responses may vary, and the compound's effects are not well-documented in large-scale clinical trials. As such, the timeline provided is based on educated inferences and should be interpreted with caution. OEA is not approved for medical use, and its use should be limited to research purposes.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 557, "total_tokens": 1199, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a1a7008190a6f4662b715aa533", "custom_id": "drug78_effects_timeline", "response": {"status_code": 200, "request_id": "82494ca6d0bf91546f90b9f6a7fb718d", "body": {"id": "chatcmpl-B9MVn1jAZopvTpF3TVf8pp3hPqUOs", "object": "chat.completion", "created": 1741571187, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physiological changes may include improved blood flow to tissues, potentially leading to a slight increase in energy levels and reduced fatigue, especially in individuals with anemia or ischemic conditions.\",\n        \"Effect 2: Some users might notice a mild improvement in cognitive function due to enhanced oxygen delivery to the brain, although this is more speculative and based on the compound's mechanism of action.\",\n        \"Effect 3: Biomarker changes could include slight alterations in blood oxygen levels, but significant changes in red blood cell count are not expected due to cibinitide's unique action compared to traditional EPO.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in tissue oxygenation may lead to noticeable reductions in symptoms related to poor blood flow, such as cold extremities or muscle cramps.\",\n        \"Effect 2: Cognitive effects might become more pronounced, with users experiencing better focus and mental clarity, inferred from improved cerebral oxygenation.\",\n        \"Effect 3: Biomarkers such as lactate levels might decrease, indicating improved metabolic efficiency and reduced anaerobic metabolism in tissues.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Potential nerve protection effects could begin to manifest, with users experiencing reduced neuropathic pain or tingling sensations, although this is still under investigation.\",\n        \"Effect 2: Enhanced physical performance might be observed, particularly in endurance activities, due to better oxygen delivery and utilization.\",\n        \"Effect 3: Side effects, if any, might start to appear, such as mild headaches or dizziness, as the body adjusts to altered blood flow dynamics.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained improvements in anemia-related symptoms and overall quality of life may become more evident.\",\n        \"Effect 2: Cognitive benefits, if present, could stabilize, providing consistent mental clarity and reduced cognitive fatigue.\",\n        \"Effect 3: Monitoring of biomarkers like hemoglobin levels and oxygen saturation might show stable improvements, reflecting the compound's efficacy in enhancing oxygen delivery without excessive erythropoiesis.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline is based on inferred effects from cibinitide's mechanism of action and similar compounds, as detailed clinical data on cibinitide's effects over time is limited. The onset and magnitude of effects can vary significantly between individuals, and the compound is still under investigation, with its safety and efficacy not yet fully established.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 679, "completion_tokens": 561, "total_tokens": 1240, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a1b5cc8190944523cb9416c707", "custom_id": "drug79_effects_timeline", "response": {"status_code": 200, "request_id": "8053f31f90d324d1f1daba263ae72d18", "body": {"id": "chatcmpl-B9MVLudKyAAOFbBJfkDgIzRbT2Teg", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial reduction in appetite may be noticed as Cagrilintide begins to mimic amylin, leading to a decreased desire to eat.\",\n        \"Effect 2: Some users might experience mild gastrointestinal discomfort as the body adjusts to the compound, such as nausea or bloating.\",\n        \"Effect 3: No significant changes in weight are expected yet, but users might feel fuller after meals.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued appetite suppression with potentially more noticeable effects on meal sizes and frequency.\",\n        \"Effect 2: Users might start to experience a slight reduction in weight as caloric intake decreases.\",\n        \"Effect 3: Mild cognitive effects such as increased focus on satiety cues might be observed, helping users recognize fullness more effectively.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced weight loss may begin to manifest as the cumulative effect of reduced calorie intake takes hold.\",\n        \"Effect 2: Users might report improved mood and energy levels due to better regulation of blood sugar and reduced hunger-related stress.\",\n        \"Effect 3: Biomarkers such as blood glucose levels might show improvement, reflecting better metabolic control.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained weight loss and maintenance of reduced appetite are likely, with users potentially reaching a plateau as the body adjusts.\",\n        \"Effect 2: Enhanced feelings of satiety and satisfaction after meals continue, supporting long-term dietary changes.\",\n        \"Effect 3: Any initial side effects like nausea are likely to diminish as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as significant weight loss and improved metabolic markers (e.g., cholesterol, insulin sensitivity) may be observed.\",\n        \"Effect 2: Users might experience a stabilization in weight as the body adapts to the new energy balance.\",\n        \"Effect 3: Psychological benefits such as increased confidence and motivation due to successful weight management might be reported.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the expected pharmacological action of Cagrilintide as an amylin analog and its effects on appetite regulation. As Cagrilintide is still under investigation, specific effects and timelines are inferred from similar compounds and mechanisms. Individual responses may vary, and long-term effects are still being studied. Users should be monitored for any adverse effects, particularly gastrointestinal issues, which are common with appetite-regulating compounds.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 688, "completion_tokens": 594, "total_tokens": 1282, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a1c978819096952c9b0c3ee1bd", "custom_id": "drug81_effects_timeline", "response": {"status_code": 200, "request_id": "6efb76ff96bcc5ca8e36db5a9990fb8b", "body": {"id": "chatcmpl-B9MVOZRyZ0LCLzpJVfhKjJtyniBhO", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in appetite due to GHRP-2's interaction with the ghrelin receptor, which may lead to increased food intake.\",\n        \"Effect 2: Some users might notice slight improvements in sleep quality as growth hormone can influence sleep patterns.\",\n        \"Effect 3: No significant changes in muscle mass or body composition are expected this early, as these effects typically require more time.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice slight increases in energy levels and recovery times post-exercise, as growth hormone levels start to rise.\",\n        \"Effect 2: Some may experience mild water retention, a common early effect of increased growth hormone levels.\",\n        \"Effect 3: No significant cognitive effects are typically reported at this stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle recovery and slight increases in muscle mass may begin to appear.\",\n        \"Effect 2: Users might observe a reduction in body fat percentage, although this can vary based on diet and exercise.\",\n        \"Effect 3: Some individuals may experience joint discomfort or tingling sensations, which are potential side effects of increased growth hormone.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued improvements in muscle growth and fat loss are likely, with more pronounced changes in body composition.\",\n        \"Effect 2: Enhanced recovery and endurance during workouts may be more evident.\",\n        \"Effect 3: Biomarkers such as IGF-1 levels may show significant increases, reflecting elevated growth hormone activity.\",\n        \"Effect 4: Potential side effects like insulin resistance or increased blood sugar levels might start to manifest, requiring monitoring.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Peak benefits in terms of muscle mass increase and fat reduction are typically observed during this period.\",\n        \"Effect 2: Users might experience stabilization of energy levels and overall physical performance.\",\n        \"Effect 3: Long-term side effects, such as carpal tunnel syndrome or other joint-related issues, could become more pronounced if they occur.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred effects from similar growth hormone-releasing peptides. Individual responses can vary significantly, and the safety and efficacy of GHRP-2 for these purposes are not well-established. Monitoring by a healthcare professional is recommended if used in a research setting.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 663, "completion_tokens": 578, "total_tokens": 1241, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a1d854819086a08335e8aa5281", "custom_id": "drug82_effects_timeline", "response": {"status_code": 200, "request_id": "4097cd0a8582bc57c3c42e3456d82deb", "body": {"id": "chatcmpl-B9MVLXLowE0QIR9yQjA71IMrhzC1I", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvement in workout performance due to enhanced nutrient uptake and cellular activity.\",\n        \"Effect 2: Some users may notice slight improvements in recovery times post-exercise, although significant changes are not yet prominent.\",\n        \"Effect 3: No significant changes in biomarkers are typically observed this early, but some users might experience slight fluctuations in blood glucose levels due to IGF-1's insulin-like effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle recovery and reduced muscle soreness, allowing for more frequent or intense workouts.\",\n        \"Effect 2: Some users might experience a mild increase in appetite, which can be attributed to the compound's anabolic effects.\",\n        \"Effect 3: Initial signs of muscle fullness or slight increases in muscle size may begin to appear, although these changes are subtle.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Enhanced muscle growth becomes more apparent, with users potentially noticing increased muscle size and strength.\",\n        \"Effect 2: Improved cognitive focus and motivation during workouts, possibly due to increased energy levels and better recovery.\",\n        \"Effect 3: Biomarkers such as IGF-1 levels in the blood may show an increase, reflecting the compound's activity.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and strength gains, with some users reporting significant improvements in physical performance.\",\n        \"Effect 2: Enhanced recovery times and reduced fatigue, allowing for sustained high-intensity training sessions.\",\n        \"Effect 3: Potential side effects such as joint pain or swelling might begin to manifest, as IGF-1 can affect connective tissues.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-6\",\n      \"effects\": [\n        \"Effect 1: Peak muscle growth and performance benefits are typically observed during this period, with users experiencing optimal results.\",\n        \"Effect 2: Some users might notice increased vascularity and muscle definition due to reduced body fat and increased muscle mass.\",\n        \"Effect 3: Side effects such as hypoglycemia (low blood sugar) might peak, requiring careful monitoring of blood glucose levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-8\",\n      \"effects\": [\n        \"Effect 1: Sustained muscle growth and performance improvements, although the rate of gains may plateau as the body adapts.\",\n        \"Effect 2: Users might experience a stabilization of appetite and energy levels as the body adjusts to the compound.\",\n        \"Effect 3: Long-term side effects, such as potential insulin resistance, should be monitored, especially if usage is extended beyond this period.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects and timeline described are based on anecdotal reports and inferred from the known mechanisms of IGF-1 LR3 and similar compounds. Individual responses can vary significantly, and the use of IGF-1 LR3 is not approved for human use outside of research settings. Users should be aware of the potential for serious side effects and the lack of long-term safety data.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 693, "completion_tokens": 698, "total_tokens": 1391, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a1e8ac8190b660c7452e8136b1", "custom_id": "drug83_effects_timeline", "response": {"status_code": 200, "request_id": "92916f0f58b0e43f04a41087d1771472", "body": {"id": "chatcmpl-B9MVM67Rny3kTzdPtQgrzW2wseuAo", "object": "chat.completion", "created": 1741571160, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvement in sleep quality may be observed as the body begins to respond to increased growth hormone levels. These effects are inferred from the mechanism of action of growth hormone secretagogues.\",\n        \"Effect 2: Some users might notice a slight increase in appetite due to the ghrelin-mimicking action of ipamorelin, although this is more commonly associated with ghrelin itself.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice subtle changes in muscle tone and recovery times post-exercise, as increased growth hormone levels can aid in muscle repair and growth. This is inferred from the known effects of growth hormone.\",\n        \"Effect 2: Improved mood and cognitive function could begin to manifest, as growth hormone can have positive effects on brain function and overall well-being.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle mass and strength may start to appear, especially if combined with resistance training. This is based on anecdotal reports and the role of growth hormone in muscle development.\",\n        \"Effect 2: Reduction in body fat might become more apparent, as growth hormone can promote lipolysis (fat breakdown).\",\n        \"Effect 3: Biomarkers such as IGF-1 (Insulin-like Growth Factor 1) levels might show an increase, reflecting the body's response to elevated growth hormone.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued improvements in muscle mass, strength, and body composition are likely, with more pronounced effects in individuals who maintain a consistent exercise regimen.\",\n        \"Effect 2: Enhanced recovery from physical exertion and potentially faster healing from minor injuries could be observed.\",\n        \"Effect 3: Side effects such as water retention or joint pain might begin to manifest or peak, as these are common with increased growth hormone levels.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Long-term users might experience stabilization of benefits, with sustained improvements in muscle mass and body composition.\",\n        \"Effect 2: Potential for more pronounced side effects, including insulin resistance or carpal tunnel syndrome, especially if dosages are not carefully managed.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline and effects described are based on the general mechanism of action of growth hormone secretagogues and anecdotal reports, as specific clinical data on ipamorelin is limited. Individual responses can vary significantly, and the safety and efficacy of ipamorelin for any non-research use have not been established.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 606, "total_tokens": 1295, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a1f6ac8190989f8f4bcdecd775", "custom_id": "drug85_effects_timeline", "response": {"status_code": 200, "request_id": "aef60f157fa0a1217906a599bbd86993", "body": {"id": "chatcmpl-B9MVLzcedwAcwxEeAS4jLMERFToss", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice an increase in sexual desire and arousal within a few hours after administration, as PT-141 acts quickly by targeting melanocortin receptors in the brain.\",\n        \"Effect 2: Some users might experience mild side effects such as nausea or flushing, which are common with initial doses.\"\n      ]\n    },\n    {\n      \"period\": \"Day 4-7\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to more consistent improvements in sexual desire, with effects becoming more predictable as the body adjusts to the compound.\",\n        \"Effect 2: Mental effects such as increased motivation or mood enhancement related to sexual activity might be observed, although these are secondary to the primary effects on sexual desire.\",\n        \"Effect 3: Side effects like nausea may diminish as the body acclimates, but some users might still experience them intermittently.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users may experience a stabilization of effects, with a reliable increase in sexual desire and arousal during this period.\",\n        \"Effect 2: Cognitive effects related to sexual motivation might become more pronounced, potentially improving interpersonal relationships or reducing distress related to HSDD.\",\n        \"Effect 3: Biomarkers such as heart rate or blood pressure might show slight variations due to the compound's systemic effects, but these are generally not significant.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The benefits of PT-141, such as enhanced sexual desire, are likely to be well-established by this time, with users experiencing consistent improvements.\",\n        \"Effect 2: Side effects, if present, are expected to be mild and manageable, with most users having adapted to the compound.\",\n        \"Effect 3: Any initial physiological changes should have stabilized, with no significant long-term alterations expected in biomarkers.\"\n      ]\n    }\n  ],\n  \"notes\": \"PT-141 is known for its rapid onset of action, with effects on sexual desire typically appearing within hours of administration. The timeline provided is based on typical use patterns and may vary depending on individual response and dosage. While the compound is primarily studied in women with HSDD, off-label use in men for erectile dysfunction may follow a similar timeline, though this is less documented. Users should be aware of potential side effects and consult healthcare professionals for personalized advice.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 670, "completion_tokens": 536, "total_tokens": 1206, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a205c88190a87430f96d5da2c4", "custom_id": "drug86_effects_timeline", "response": {"status_code": 200, "request_id": "e666e77912597d763be909d90d561357", "body": {"id": "chatcmpl-B9MVLmDqixm5zaehQbaNhFfkFE1Gl", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial activation of GLP-1, GIP, and glucagon receptors may lead to a slight decrease in appetite, as the body begins to adjust to the compound's presence.\",\n        \"Effect 2: Some users might experience mild gastrointestinal discomfort, such as nausea, as the body adapts to the compound's effects on appetite regulation.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected yet, as the compound's effects are just beginning to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in appetite may become more noticeable, potentially leading to a slight decrease in food intake.\",\n        \"Effect 2: Users might start to experience a mild increase in energy expenditure, although this may not be immediately perceptible.\",\n        \"Effect 3: Initial stabilization of blood sugar levels could begin, particularly in individuals with type 2 diabetes, but significant changes are not yet expected.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced appetite suppression and potential weight loss may start to become evident as the compound's effects accumulate.\",\n        \"Effect 2: Users might notice improved mental clarity and focus due to more stable blood sugar levels, although this is an inferred effect based on similar compounds.\",\n        \"Effect 3: Biomarkers such as fasting glucose levels may show initial improvements, particularly in diabetic subjects.\",\n        \"Effect 4: Gastrointestinal side effects, if present, might begin to subside as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant weight loss could be observed, with users potentially noticing changes in body composition.\",\n        \"Effect 2: Sustained improvements in energy levels and metabolic rate may become more apparent.\",\n        \"Effect 3: Continued stabilization of blood sugar levels, with potential reductions in HbA1c in diabetic individuals.\",\n        \"Effect 4: Any initial side effects are likely to have diminished, but ongoing monitoring for new side effects is recommended.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained weight loss and improved metabolic health are likely to be more pronounced.\",\n        \"Effect 2: Users may experience enhanced overall well-being and quality of life due to better weight management and metabolic control.\",\n        \"Effect 3: Significant improvements in biomarkers related to metabolic health, such as cholesterol levels and insulin sensitivity, may be observed.\",\n        \"Effect 4: Long-term side effects, if any, should be monitored closely, although specific long-term data on retatrutide is limited.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the mechanism of action of retatrutide and similar compounds, such as GLP-1 receptor agonists. As retatrutide is still in the research phase, specific effects and timelines may vary among individuals. Clinical trials and further research are necessary to confirm these effects and establish a comprehensive safety profile.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 685, "total_tokens": 1374, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a2159081908f7776be49c5d8a2", "custom_id": "drug87_effects_timeline", "response": {"status_code": 200, "request_id": "1fdbc5f07fca930fab37ce0682f7ce09", "body": {"id": "chatcmpl-B9MVTJjoyeykTmQqQcMYSIRSMpevN", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Physical Effects: Initial gastrointestinal side effects such as nausea, vomiting, or diarrhea may begin to appear as the body adjusts to the medication.\",\n        \"Mental/Cognitive Effects: Some users might experience mild headaches or fatigue as their body adapts.\",\n        \"Biomarkers/Physiological Measurements: There may be a slight reduction in blood glucose levels, but significant changes are not typically observed this early.\",\n        \"Benefits: Users may start to notice a slight decrease in appetite, although significant weight loss is not expected yet.\",\n        \"Side Effects: Gastrointestinal side effects are most common during this period and may peak towards the end of the week.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Physical Effects: Continued adjustment to the medication with possible persistence of gastrointestinal side effects, though they may begin to subside.\",\n        \"Mental/Cognitive Effects: Users might experience improved mental clarity as blood sugar levels begin to stabilize.\",\n        \"Biomarkers/Physiological Measurements: More noticeable reductions in blood glucose levels may be observed.\",\n        \"Benefits: Appetite suppression becomes more noticeable, potentially leading to reduced caloric intake.\",\n        \"Side Effects: Gastrointestinal side effects may continue but are often less severe as the body adapts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Physical Effects: Users may start to notice initial weight loss, particularly if they are adhering to dietary recommendations.\",\n        \"Mental/Cognitive Effects: Improved mood and energy levels as a result of better blood sugar control.\",\n        \"Biomarkers/Physiological Measurements: Continued improvement in blood glucose levels, with potential reductions in HbA1c beginning to manifest.\",\n        \"Benefits: Significant appetite suppression and potential weight loss become more evident.\",\n        \"Side Effects: Gastrointestinal side effects typically continue to diminish, but some users may still experience them.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Physical Effects: Noticeable weight loss for many users, especially those adhering to lifestyle changes.\",\n        \"Mental/Cognitive Effects: Enhanced cognitive function and mood stability due to consistent blood sugar levels.\",\n        \"Biomarkers/Physiological Measurements: Significant reductions in HbA1c and fasting blood glucose levels are often observed.\",\n        \"Benefits: Both blood sugar control and weight loss benefits are well-established by this period.\",\n        \"Side Effects: Most initial side effects have subsided, but some users may experience ongoing mild gastrointestinal discomfort.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Physical Effects: Continued weight loss and stabilization of blood sugar levels.\",\n        \"Mental/Cognitive Effects: Sustained improvements in mood and cognitive function.\",\n        \"Biomarkers/Physiological Measurements: Further reductions in HbA1c and stabilization of blood glucose levels.\",\n        \"Benefits: Long-term benefits in both weight management and diabetes control are solidified.\",\n        \"Side Effects: Minimal side effects for most users, though some may experience persistent mild gastrointestinal issues.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects can vary based on individual factors such as dosage, adherence to dietary recommendations, and individual metabolic response. The gastrointestinal side effects are the most commonly reported and tend to decrease over time as the body adjusts to the medication. The timeline provided is based on documented effects and typical user experiences, but individual results may vary.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 742, "total_tokens": 1431, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a2238c8190a5d795b74aae9ecc", "custom_id": "drug88_effects_timeline", "response": {"status_code": 200, "request_id": "6d9e63e49edddded706b2f89a97b55b9", "body": {"id": "chatcmpl-B9MVLpCDEi2Gvyp0ZVySV5oJynEBa", "object": "chat.completion", "created": 1741571159, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight reduction in inflammation and minor improvements in flexibility, particularly if they are recovering from a recent injury. This is due to TB-500's anti-inflammatory properties.\",\n        \"Effect 2: Some users may experience a placebo effect, feeling more optimistic about recovery due to starting a new treatment regimen.\",\n        \"Effect 3: Initial changes in biomarkers such as a slight decrease in inflammatory markers could be observed, although this might not be significant yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle recovery and reduced soreness after physical activity might be observed. This is when TB-500's effects on actin and cell movement start to become more apparent.\",\n        \"Effect 2: Users might experience a slight increase in energy levels and motivation due to reduced pain and improved recovery.\",\n        \"Effect 3: Continued reduction in inflammation markers could be measured, with potential improvements in blood flow to affected areas.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Enhanced healing of minor injuries, with users reporting faster recovery times for muscle strains or minor tendon injuries.\",\n        \"Effect 2: Improved flexibility and range of motion may become more noticeable, aiding in physical performance.\",\n        \"Effect 3: Biomarkers related to tissue repair, such as increased levels of actin, might be detectable in blood tests.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Users might experience significant improvements in chronic injury recovery, with reduced pain and increased mobility.\",\n        \"Effect 2: Mental effects such as improved mood and reduced stress levels due to decreased physical discomfort and enhanced recovery.\",\n        \"Effect 3: Peak benefits in terms of muscle recovery and inflammation reduction are likely to be observed around this time.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in muscle and tendon recovery, with users potentially experiencing enhanced physical performance.\",\n        \"Effect 2: Continued positive mental effects, including increased confidence in physical capabilities.\",\n        \"Effect 3: Long-term changes in biomarkers, such as consistently lower levels of inflammation and improved tissue health, might be evident.\",\n        \"Effect 4: Any side effects, such as potential fatigue or headache, might begin to manifest or peak, although these are generally considered mild and infrequent.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and limited studies on TB-500. Effects can vary significantly between individuals due to factors such as dosage, frequency of use, and individual health conditions. The compound is not approved for medical use, and its safety and efficacy have not been fully established. Users should exercise caution and consult with a healthcare professional before considering use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 675, "completion_tokens": 635, "total_tokens": 1310, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a232e881908a0c34a62d9732c8", "custom_id": "drug89_effects_timeline", "response": {"status_code": 200, "request_id": "bb580c81f329d033db151a5cf549f1dd", "body": {"id": "chatcmpl-B9MVMBcCfTi944lUHpcMHQTLiKWtb", "object": "chat.completion", "created": 1741571160, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial reduction in blood glucose levels may be observed as tirzepatide begins to enhance insulin secretion. This effect can vary based on individual response and baseline glucose levels.\",\n        \"Effect 2: Some users might experience mild gastrointestinal side effects such as nausea or diarrhea as the body adjusts to the medication. These are common with GLP-1 receptor agonists and may peak during the first few weeks.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in blood glucose control is likely, with more stable blood sugar levels throughout the day.\",\n        \"Effect 2: Users may start to notice a slight decrease in appetite, which is a potential side effect of GLP-1 receptor agonists and could contribute to weight loss over time.\",\n        \"Effect 3: Gastrointestinal side effects may persist but often begin to subside as the body acclimates to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Blood glucose levels should show more consistent improvement, with potential reductions in HbA1c becoming measurable, although significant changes in HbA1c typically require a longer duration.\",\n        \"Effect 2: Some users might experience increased satiety and reduced food intake, contributing to gradual weight loss.\",\n        \"Effect 3: Any initial side effects such as nausea or diarrhea are likely to decrease in intensity as tolerance develops.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in HbA1c levels may become apparent, reflecting better long-term blood sugar control.\",\n        \"Effect 2: Weight loss effects might become more noticeable, with some users experiencing a reduction in body weight due to decreased appetite and caloric intake.\",\n        \"Effect 3: Users may report improved energy levels and mood as a result of better blood sugar management and potential weight loss.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Continued stabilization of blood glucose levels and further reductions in HbA1c are expected, indicating sustained efficacy of the medication.\",\n        \"Effect 2: Weight loss may continue, although the rate of loss might slow as the body reaches a new equilibrium.\",\n        \"Effect 3: Long-term side effects, if any, should be monitored, but most users will have adjusted to the medication by this point.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed in clinical trials and may vary between individuals. The effects on weight loss are inferred from the mechanism of action and preliminary studies, as tirzepatide is not yet officially approved for weight management. Users should be monitored for any adverse effects, especially gastrointestinal symptoms, which are common with GLP-1 receptor agonists. Regular follow-up with healthcare providers is recommended to adjust dosages and manage any side effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 677, "completion_tokens": 651, "total_tokens": 1328, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a2410c8190ba73a0a00d2d6723", "custom_id": "drug90_effects_timeline", "response": {"status_code": 200, "request_id": "0ce6734ef500592c0923674fd9e4b7b9", "body": {"id": "chatcmpl-B9MVNOdLiDzGiFKBgsS0jxPHY3i93", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial adaptation phase with minimal noticeable physical changes. Users might not observe significant fat loss yet.\",\n        \"Effect 2: Some users may experience a slight increase in energy levels as the body begins to utilize fat stores more efficiently.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\",\n        \"Effect 4: Mental effects are likely minimal, but some users might report a placebo effect of feeling more motivated or focused on weight management goals.\",\n        \"Effect 5: Side effects, if any, such as mild gastrointestinal discomfort, might begin to manifest as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start noticing subtle changes in body composition, such as a slight reduction in body fat percentage.\",\n        \"Effect 2: Continued increase in energy levels as fat metabolism becomes more pronounced.\",\n        \"Effect 3: Biomarkers related to fat metabolism, such as free fatty acids, might show slight changes, although this is inferred from similar compounds.\",\n        \"Effect 4: Cognitive effects remain minimal, but users might feel more encouraged by initial physical changes.\",\n        \"Effect 5: Side effects, if present, are likely to stabilize or diminish as the body adapts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable physical changes, such as a reduction in waist circumference or overall body fat, may become apparent.\",\n        \"Effect 2: Users might experience improved endurance and stamina due to enhanced energy utilization.\",\n        \"Effect 3: Possible improvements in lipid profiles, such as reduced triglycerides, although this is speculative based on the mechanism of action.\",\n        \"Effect 4: Mental effects might include increased motivation and focus on health goals due to visible results.\",\n        \"Effect 5: Any side effects are likely to have peaked and should be monitored, but no new side effects are expected.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in body fat with more pronounced changes in body composition.\",\n        \"Effect 2: Sustained energy levels and possible improvements in physical performance.\",\n        \"Effect 3: Long-term biomarkers such as body mass index (BMI) and body fat percentage might show significant improvements.\",\n        \"Effect 4: Users might experience enhanced mental clarity and focus as a result of improved physical health.\",\n        \"Effect 5: Long-term side effects are still unknown due to limited research, but users should be cautious of any new symptoms.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available research and inferred effects from similar compounds. AOD-9604 is not approved for weight loss, and its long-term safety and efficacy remain under investigation. Users should be aware of the experimental nature of this compound and consult with a healthcare professional before considering its use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 663, "completion_tokens": 651, "total_tokens": 1314, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a24f608190abd3305afa2a198f", "custom_id": "drug91_effects_timeline", "response": {"status_code": 200, "request_id": "f7f94cf2188c9c03aad9c2564012e38f", "body": {"id": "chatcmpl-B9MVOada6hPSxNIFnwFIsBiIYq8cH", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial cellular effects may begin, such as a reduction in reactive oxygen species (ROS) within mitochondria, although these changes might not be noticeable to the user.\",\n        \"Effect 2: Some users might experience a slight increase in energy levels due to improved mitochondrial efficiency, but this is largely speculative and based on animal studies.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in ROS could lead to subtle improvements in cellular health, potentially resulting in minor increases in physical endurance or recovery times.\",\n        \"Effect 2: Mental clarity might improve slightly as mitochondrial function enhances, although this is inferred from the compound's mechanism rather than documented effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice more pronounced physical benefits, such as reduced muscle soreness or quicker recovery from physical exertion, as muscle health begins to improve.\",\n        \"Effect 2: Biomarkers such as oxidative stress markers could show measurable improvements, indicating reduced cellular damage.\",\n        \"Effect 3: Potential side effects, if any, might begin to manifest, such as mild gastrointestinal discomfort, although specific side effects are not well-documented for SS-31.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in muscle health and function might be observed, particularly in populations at risk of muscle deterioration, such as the elderly.\",\n        \"Effect 2: Cognitive benefits, such as improved focus and memory, might become more noticeable due to enhanced mitochondrial function and reduced oxidative stress.\",\n        \"Effect 3: Long-term biomarkers, such as markers of inflammation or mitochondrial health, could show sustained improvements.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: The protective benefits against age-related decline might become more evident, with sustained improvements in muscle mass and strength.\",\n        \"Effect 2: Users might experience a plateau in benefits, as the compound's effects stabilize over time.\",\n        \"Effect 3: Any side effects would likely have peaked earlier and stabilized, assuming no new adverse reactions develop.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is largely speculative and based on the mechanism of action of SS-31 and similar compounds. Human studies are limited, and effects can vary significantly between individuals. The compound is still in the research phase, and its safety and efficacy in humans have not been fully established.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 643, "completion_tokens": 565, "total_tokens": 1208, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a25e288190b93d5d48ffef1fb5", "custom_id": "drug92_effects_timeline", "response": {"status_code": 200, "request_id": "5a998a8801a51ba2a1531d31b71dc4be", "body": {"id": "chatcmpl-B9MVNgVdkqvQVvISPkZUevcJ3MZwj", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects might be subtle, with some users reporting slight improvements in sleep quality due to potential influences on the pineal gland. This is inferred from the compound's proposed mechanism of action.\",\n        \"Effect 2: Mental clarity and mood might see minor improvements as a result of better sleep, though these effects are largely anecdotal and not well-documented.\",\n        \"Effect 3: No significant changes in biomarkers such as telomere length are expected this early, as these processes typically require more time to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice more consistent improvements in sleep patterns, potentially leading to increased daytime energy and vitality. This is inferred from the compound's interaction with the pineal gland.\",\n        \"Effect 2: Cognitive effects such as enhanced focus and memory retention might start to become more noticeable, although these are not well-documented and are based on user reports.\",\n        \"Effect 3: Some users might report a general sense of well-being, possibly linked to improved sleep and mood.\",\n        \"Effect 4: Side effects, if any, might start to appear, such as mild headaches or digestive discomfort, though these are not commonly reported and are largely anecdotal.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: More pronounced physical effects might include improved skin elasticity and overall vitality, inferred from the compound's potential anti-aging properties.\",\n        \"Effect 2: Continued cognitive improvements might be observed, with some users reporting better stress management and emotional resilience.\",\n        \"Effect 3: Biomarkers such as telomere length might begin to show slight changes, although significant alterations typically require longer periods of use and are best measured in a research setting.\",\n        \"Effect 4: Any side effects experienced might stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Users might experience more noticeable anti-aging benefits, such as improved skin appearance and energy levels, though these effects are largely anecdotal and require more scientific validation.\",\n        \"Effect 2: Enhanced cognitive function and mood stability might continue, contributing to an overall sense of well-being.\",\n        \"Effect 3: More significant changes in telomere length could potentially be observed, but these would require scientific measurement to confirm.\",\n        \"Effect 4: Long-term side effects are not well-documented, but users should monitor for any unusual symptoms and consult with a healthcare professional if necessary.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of Epithalon are largely based on preliminary research and anecdotal reports. The timeline provided is speculative and should be interpreted with caution. More rigorous scientific studies are needed to confirm these effects and establish a comprehensive understanding of the compound's safety and efficacy.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 638, "total_tokens": 1325, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a26d0c81908e1ef9a15fe2bcdb", "custom_id": "drug95_effects_timeline", "response": {"status_code": 200, "request_id": "0753ff042a46d70c13d12a0200dc8f45", "body": {"id": "chatcmpl-B9MVOVz7VsBg0VYDbOpIKxa4TiMt4", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial administration of DSIP may lead to subtle improvements in sleep onset latency, as users might fall asleep slightly faster. This is inferred from its potential role in sleep regulation.\",\n        \"Effect 2: Some users might experience a mild reduction in perceived stress levels due to DSIP's potential interaction with stress hormones like cortisol. This is an inferred effect based on its proposed mechanism of action.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may notice a more consistent sleep pattern, with fewer awakenings during the night. This is inferred from DSIP's potential to promote deeper sleep stages.\",\n        \"Effect 2: There might be a slight improvement in mood and cognitive clarity during the day, possibly due to better sleep quality. This is an inferred effect.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage, as DSIP's effects are primarily neurological.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in sleep quality, with users potentially experiencing more vivid dreams and feeling more refreshed upon waking. This is inferred from ongoing sleep regulation.\",\n        \"Effect 2: Enhanced effectiveness of pain-relief medications might become noticeable, as DSIP could potentially modulate pain perception pathways. This is an inferred effect.\",\n        \"Effect 3: Some users might begin to notice a reduction in stress-related symptoms, such as tension headaches or irritability, due to DSIP's potential impact on cortisol levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might experience a more pronounced improvement in overall sleep architecture, with longer periods of deep sleep. This is inferred from DSIP's role in sleep regulation.\",\n        \"Effect 2: Cognitive benefits, such as improved focus and memory retention, could become more apparent as a result of sustained better sleep quality.\",\n        \"Effect 3: Any initial side effects, such as mild headaches or transient fatigue, might begin to diminish as the body adjusts to DSIP. These are inferred potential side effects.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: The full spectrum of DSIP's potential benefits, including optimal sleep quality and stress management, might be realized by this period.\",\n        \"Effect 2: Users might observe a stabilization in mood and a more resilient response to stress, inferred from DSIP's potential modulation of stress hormones.\",\n        \"Effect 3: Long-term use might lead to measurable changes in biomarkers related to stress and sleep, such as reduced cortisol levels, although this is speculative and requires further research.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline and effects described are largely inferred from DSIP's proposed mechanisms and similar compounds, as direct human studies are limited. Individual responses to DSIP can vary significantly, and more research is needed to confirm these effects. DSIP is still in the research phase and not approved for medical use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 675, "total_tokens": 1360, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a27ab08190850d41cd610b26ad", "custom_id": "drug96_effects_timeline", "response": {"status_code": 200, "request_id": "4f31e7a00aa640232402ab693307955b", "body": {"id": "chatcmpl-B9MVW8pXXncTvL5u2vfiDmdjem1TX", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle improvements in focus and concentration, potentially due to enhanced communication between brain cells. These effects are inferred based on similar cognitive enhancers.\",\n        \"Effect 2: Some users may experience mild headaches or slight insomnia as the body adjusts to the compound, which is a common initial side effect of nootropic substances.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Cognitive enhancements such as improved memory retention and problem-solving skills might become more noticeable. This is inferred from the compound's proposed mechanism of supporting neuroplasticity.\",\n        \"Effect 2: Users may observe increased motivation and mental clarity, potentially linked to the compound's influence on brain pathways related to learning and cognition.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: The benefits of enhanced creative thinking and overall cognitive performance might become more pronounced, as the compound's effects on neuroplasticity and brain cell communication continue to develop.\",\n        \"Effect 2: Any initial side effects like headaches or insomnia should begin to subside as the body acclimates to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Users might experience peak cognitive benefits, including sustained improvements in memory, focus, and problem-solving abilities. This is based on the compound's potential to optimize brain activity.\",\n        \"Effect 2: Physiological measurements such as increased brain activity in regions associated with cognition might be observed, although this is speculative and would require specific imaging studies.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is largely speculative and based on the proposed mechanisms of N-acetylsemaxamidate and similar cognitive enhancers. There is limited direct research on this compound, so effects and timelines are inferred. Individual responses can vary significantly, and long-term effects or side effects are not well-documented. Researchers should proceed with caution and conduct thorough monitoring during studies.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 664, "completion_tokens": 449, "total_tokens": 1113, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a28afc8190a7700b4305e44cf7", "custom_id": "drug97_effects_timeline", "response": {"status_code": 200, "request_id": "17a4b17e643373b2a7daf409c3a7d832", "body": {"id": "chatcmpl-B9MVMXrlp6cR4SjyMdDr9uqy8S5lM", "object": "chat.completion", "created": 1741571160, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a slight increase in skin pigmentation, particularly in areas with higher natural melanin concentration, such as moles or freckles. This is due to the activation of melanocytes.\",\n        \"Effect 2: Some users might experience mild nausea or flushing as the body adjusts to the compound. These side effects are common with peptides that affect melanocyte activity.\",\n        \"Effect 3: No significant mental or cognitive effects are expected during this period, as melanotani primarily affects skin pigmentation.\",\n        \"Effect 4: Biomarkers such as melanin levels in the skin may begin to show slight increases, but these changes are typically not measurable without specialized equipment.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Noticeable darkening of the skin may begin to appear, particularly in individuals with lighter skin tones. This is due to continued melanin production.\",\n        \"Effect 2: Users might experience a stabilization of initial side effects such as nausea, as the body becomes more accustomed to the compound.\",\n        \"Effect 3: No significant changes in mental or cognitive functions are expected.\",\n        \"Effect 4: Increased melanin production becomes more apparent, and users may start to see the desired tanning effect without sun exposure.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Skin pigmentation continues to darken, reaching a more noticeable level. This is the period where the tanning effect is most pronounced.\",\n        \"Effect 2: Some users might experience new side effects such as increased libido or appetite changes, which have been reported anecdotally with similar compounds.\",\n        \"Effect 3: No significant cognitive changes are expected, but users should monitor for any unusual symptoms.\",\n        \"Effect 4: The benefits of enhanced pigmentation are typically fully realized by the end of this period, with the skin appearing significantly darker.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Skin pigmentation may stabilize, with maintenance doses required to sustain the desired level of tan.\",\n        \"Effect 2: Long-term side effects, if any, might begin to manifest. These could include changes in skin texture or unexpected pigmentation in unintended areas.\",\n        \"Effect 3: Users should monitor for any adverse reactions, as long-term safety data is limited.\",\n        \"Effect 4: Continued use may lead to diminishing returns, with the body adapting to the compound's effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred from similar compounds, as there is limited scientific data specifically on melanotani. Users should exercise caution and consult with a healthcare professional before using unregulated compounds. The safety and efficacy of melanotani have not been thoroughly evaluated, and its use is not approved by health authorities.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 683, "completion_tokens": 633, "total_tokens": 1316, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a299508190aedcd9f127d334ca", "custom_id": "drug98_effects_timeline", "response": {"status_code": 200, "request_id": "ea6c02a017e511f1b036a43638012964", "body": {"id": "chatcmpl-B9MVOiO4LwS3ILDcTLJY3qrbg2xB8", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of GHK-Cu may lead to slight improvements in skin hydration and texture. Users might notice a subtle increase in skin softness and smoothness.\",\n        \"Effect 2: Some users may experience mild skin irritation or redness as the skin adjusts to the compound, particularly if they have sensitive skin. This is generally transient.\",\n        \"Effect 3: No significant mental or cognitive effects are expected during this period as GHK primarily acts on skin and tissue.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may start to show more noticeable improvements in skin elasticity and firmness as collagen production is stimulated.\",\n        \"Effect 2: Reduction in minor skin inflammation might be observed, leading to a calmer skin appearance.\",\n        \"Effect 3: Biomarkers such as skin moisture levels might show slight improvements, though these changes are often subtle and may require specific measurement tools to detect.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may begin to see a reduction in the appearance of fine lines and wrinkles as collagen synthesis continues to improve skin structure.\",\n        \"Effect 2: Enhanced skin repair processes may lead to faster healing of minor cuts or abrasions.\",\n        \"Effect 3: Any initial skin irritation should subside by this time, with the skin adapting to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in overall skin texture and tone are likely, with many users reporting a more youthful appearance.\",\n        \"Effect 2: Potential benefits in hair growth might start to become noticeable, particularly in areas of thinning.\",\n        \"Effect 3: Biomarkers related to skin health, such as increased collagen density, might be measurable through advanced imaging techniques.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained improvements in skin elasticity and reduction in deeper wrinkles may be evident.\",\n        \"Effect 2: Continued support for tissue repair might be observed, potentially benefiting other areas of the body beyond the skin.\",\n        \"Effect 3: Side effects are generally minimal, but prolonged use should be monitored for any unexpected skin reactions.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical user experiences and inferred effects from the known mechanisms of GHK-Cu. Individual responses may vary, and more research is needed to fully understand the long-term effects and optimal usage of GHK. Users should consult with a healthcare professional before starting any new treatment regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 589, "total_tokens": 1274, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a2a7bc8190a3b9f96d6be61ca8", "custom_id": "drug99_effects_timeline", "response": {"status_code": 200, "request_id": "e628793785ebf4fcad1ee5d632370c6e", "body": {"id": "chatcmpl-B9MVOBKHdpDCODskjbEzI2F2tEAOM", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial mild calming effect may be noticed, potentially due to modulation of serotonin levels. This is inferred from similar compounds that affect neurotransmitter systems.\",\n        \"Effect 2: Some users might experience a slight increase in focus and mental clarity, although this is more likely to be subtle at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Enhanced mood and reduced anxiety may become more noticeable as serotonin modulation continues. This is based on the compound's proposed mechanism of action.\",\n        \"Effect 2: Cognitive effects such as improved focus and memory retention might start to appear, although these are likely to be mild initially.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this stage, as the compound's effects are primarily neurological.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in anxiety and stress levels, potentially leading to improved social interactions and overall well-being.\",\n        \"Effect 2: Cognitive enhancements such as better memory recall and learning ability may become more pronounced.\",\n        \"Effect 3: Some users might begin to notice changes in sleep patterns, potentially experiencing more restful sleep due to reduced anxiety.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Peak cognitive benefits might be observed, with users experiencing significant improvements in mental clarity and focus.\",\n        \"Effect 2: Sustained mood enhancement and anxiety reduction, contributing to a more stable emotional state.\",\n        \"Effect 3: Potential minor physiological changes, such as improved stress response, might be observed, although these are speculative and based on the compound's interaction with the immune system.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term cognitive benefits, including enhanced learning and memory retention, are likely to stabilize.\",\n        \"Effect 2: Users may experience a plateau in mood and anxiety improvements, maintaining a consistent level of benefit.\",\n        \"Effect 3: Any side effects, such as mild headaches or gastrointestinal discomfort, might manifest or peak during this period, although these are inferred from similar compounds and not well-documented for N-acetylselankamidate.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the proposed mechanisms of action of N-acetylselankamidate and similar compounds. As this compound is still under research, the effects and their timing are speculative and may vary among individuals. Additionally, the long-term effects and safety profile are not well-established, and further research is needed to confirm these observations.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 597, "total_tokens": 1273, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a2b62881909c5c92e3aeeda85d", "custom_id": "drug100_effects_timeline", "response": {"status_code": 200, "request_id": "48e0851028ca68a150f85e36e05f7376", "body": {"id": "chatcmpl-B9MVXVfQdaNpOeqvUvcOqacUBfuxL", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial appetite suppression may begin, leading to a slight reduction in food intake. Users might notice feeling fuller sooner during meals.\",\n        \"Effect 2: Some users might experience mild gastrointestinal discomfort as the body adjusts, such as nausea or bloating, which is common with appetite-regulating compounds.\",\n        \"Effect 3: No significant changes in biomarkers like blood sugar levels are expected yet, as these effects typically take longer to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued appetite suppression with potentially more noticeable reductions in daily caloric intake.\",\n        \"Effect 2: Initial mental effects might include increased focus or alertness due to reduced blood sugar fluctuations, although this is inferred from similar compounds.\",\n        \"Effect 3: Early signs of weight loss might begin to appear, although this will vary depending on individual metabolic rates and lifestyle factors.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More consistent weight loss may be observed as appetite suppression stabilizes and caloric intake remains reduced.\",\n        \"Effect 2: Users might notice improved mood or energy levels as a result of more stable blood sugar levels, inferred from similar compounds.\",\n        \"Effect 3: Biomarkers such as fasting blood glucose levels might begin to show improvement, indicating better blood sugar regulation.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant weight loss may be evident, with users potentially losing several pounds depending on adherence to dietary changes.\",\n        \"Effect 2: Enhanced cognitive function and mood stabilization might be more pronounced due to sustained metabolic improvements.\",\n        \"Effect 3: Blood sugar levels and insulin sensitivity are likely to show measurable improvements, benefiting those with type 2 diabetes.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Continued weight management benefits, with potential plateauing of weight loss as the body adjusts to new metabolic set points.\",\n        \"Effect 2: Long-term improvements in metabolic health markers, including cholesterol levels and blood pressure, may begin to manifest.\",\n        \"Effect 3: Side effects such as gastrointestinal discomfort are likely to diminish as the body fully adapts to the compound.\"\n      ]\n    }\n  ],\n  \"notes\": \"This timeline is based on the typical effects observed with similar appetite-regulating and blood sugar-modulating compounds. Individual responses can vary widely based on genetic, lifestyle, and health factors. The effects described are inferred from the known mechanisms of action of mazdutide and similar compounds, as specific clinical data on mazdutide's timeline of effects is limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 661, "completion_tokens": 600, "total_tokens": 1261, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a2c4b48190b023a15ecca1df9d", "custom_id": "drug101_effects_timeline", "response": {"status_code": 200, "request_id": "63bb81465639582685cbc1aa0f67d818", "body": {"id": "chatcmpl-B9MVRCKTmrZyyudewmJU0SdJV0bhb", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial immune modulation may begin, but physical effects are likely subtle and not immediately noticeable.\",\n        \"Effect 2: Some users might experience a mild increase in energy levels, although this is more anecdotal and not well-documented.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected this early.\",\n        \"Effect 4: Side effects, if any, such as mild injection site reactions, might begin to manifest but are generally minimal.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued support of the thymus gland may start to enhance T-cell production, potentially leading to a slight improvement in immune response.\",\n        \"Effect 2: Users might notice a slight improvement in recovery from minor illnesses or infections, although this is inferred from similar compounds.\",\n        \"Effect 3: No significant cognitive effects are expected at this stage.\",\n        \"Effect 4: Side effects remain minimal; any injection site reactions typically subside.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in immune function might be observed, such as reduced frequency of colds or quicker recovery times.\",\n        \"Effect 2: Some users might report a general sense of well-being or vitality, although this is largely anecdotal.\",\n        \"Effect 3: Biomarkers such as white blood cell count might show slight improvements, but this varies among individuals.\",\n        \"Effect 4: The potential benefits related to immune health and aging might begin to manifest, though these are not officially recognized.\",\n        \"Effect 5: Side effects remain unlikely, but users should monitor for any unexpected reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained use may lead to more pronounced immune system support, with users potentially experiencing fewer infections.\",\n        \"Effect 2: Cognitive effects remain minimal, but some users might report improved mental clarity or focus.\",\n        \"Effect 3: Continued monitoring of biomarkers might show further improvements in immune-related parameters.\",\n        \"Effect 4: Benefits related to slowing the aging process are speculative and not well-documented, but some users might report subjective improvements in skin health or energy levels.\",\n        \"Effect 5: Long-term side effects are not well-documented, but users should remain vigilant for any changes in health.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of Thymalin are primarily inferred from its proposed mechanism of action and anecdotal reports, as comprehensive clinical studies are limited. Users should approach this compound with caution and under the guidance of a qualified professional. The timeline and effects can vary significantly between individuals.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 686, "completion_tokens": 599, "total_tokens": 1285, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a2d3348190baeda0e8411a7e9d", "custom_id": "drug102_effects_timeline", "response": {"status_code": 200, "request_id": "ab900d132dcc81cc622dab4c61e6afc4", "body": {"id": "chatcmpl-B9MVNLHiB2yEo99GUR6Xi0MERBqQ9", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Due to the lack of specific data on Adamax, any physical effects are speculative. Users might not notice any immediate physical changes, as the compound's interaction with the body is unknown.\",\n        \"Effect 2: Mental or cognitive effects are also unclear. If Adamax shares properties with other research chemicals, users might experience mild cognitive changes, but this is purely hypothetical.\",\n        \"Effect 3: No documented changes in biomarkers or physiological measurements are available. Any observations would be anecdotal and not scientifically validated.\",\n        \"Effect 4: Since the benefits of Adamax are not established, no specific benefits would likely appear in the first week.\",\n        \"Effect 5: Potential side effects are unknown. If Adamax has any adverse effects, they might not manifest immediately, or they could be subtle and easily overlooked.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued lack of specific data means physical effects remain speculative. Users might start to notice changes if Adamax has cumulative effects, but this is unconfirmed.\",\n        \"Effect 2: Cognitive effects, if any, might become more noticeable, but without research, this remains speculative.\",\n        \"Effect 3: No reliable data on changes in biomarkers or physiological measurements. Any noted changes should be approached with skepticism.\",\n        \"Effect 4: Without established benefits, no specific advantages are expected to appear.\",\n        \"Effect 5: Side effects, if present, might start to become more apparent, but this is purely hypothetical.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: If Adamax has any delayed physical effects, they might start to manifest, but this is speculative.\",\n        \"Effect 2: Users might report cognitive changes, but these would be anecdotal and not scientifically validated.\",\n        \"Effect 3: Any changes in biomarkers or physiological measurements remain undocumented and speculative.\",\n        \"Effect 4: Without scientific validation, no specific benefits are expected to appear.\",\n        \"Effect 5: Potential side effects might peak during this period if Adamax has any adverse effects, but this is speculative.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on speculative inferences due to the lack of specific research data on Adamax. Effects are hypothetical and should be approached with caution. Further research is needed to establish any reliable effects or side effects of this compound.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 599, "completion_tokens": 536, "total_tokens": 1135, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a2e2c48190aa9836b3892e8fb4", "custom_id": "drug103_effects_timeline", "response": {"status_code": 200, "request_id": "a17359315cace5b37d62d1f03e4a7a2b", "body": {"id": "chatcmpl-B9MVNQzOVA61a4kNrFIhqYndN4dKf", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial immune modulation may begin, with LL-37 starting to interact with immune cells, potentially leading to a slight reduction in inflammation. This is inferred from its mechanism of action.\",\n        \"Effect 2: Users might notice minor improvements in wound healing, particularly in superficial wounds, as LL-37 begins to exert its antimicrobial effects.\",\n        \"Effect 3: No significant mental or cognitive effects are expected at this stage, as LL-37 primarily acts on the immune system and skin.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued enhancement in wound healing could be observed, with more noticeable reductions in redness and swelling around wounds.\",\n        \"Effect 2: Biomarkers such as cytokine levels might start to show changes, indicating modulation of the immune response, though this would typically require laboratory testing to confirm.\",\n        \"Effect 3: Users may begin to experience mild skin irritation or localized reactions at the site of application, if applicable, as a side effect.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The antimicrobial effects of LL-37 might become more pronounced, potentially leading to a decrease in the frequency or severity of minor infections.\",\n        \"Effect 2: Further improvements in wound healing and reduction in chronic inflammation could be observed, with skin conditions showing signs of improvement.\",\n        \"Effect 3: Side effects such as skin irritation might peak during this period but are generally expected to be mild and localized.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as improved management of chronic inflammatory conditions might start to become evident, with users experiencing less frequent flare-ups.\",\n        \"Effect 2: Sustained modulation of the immune response could lead to more balanced cytokine levels, reducing unnecessary inflammation.\",\n        \"Effect 3: Any initial side effects are likely to stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the known mechanisms of LL-37 and its role in immune modulation and wound healing. Direct human studies on LL-37 are limited, so some effects are inferred from its biological activity and studies on similar peptides. Individual responses may vary, and further research is needed to fully understand the long-term effects and safety profile of LL-37.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 641, "completion_tokens": 536, "total_tokens": 1177, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a2f3708190ad6289dc95642005", "custom_id": "drug104_effects_timeline", "response": {"status_code": 200, "request_id": "f185dbfd717982a40426feca4071ca2f", "body": {"id": "chatcmpl-B9MVOybT35IWBjCwnSIcenz1w8yPO", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial appetite suppression may begin to be noticeable as Survodutide starts interacting with hunger-regulating receptors. Users might feel slightly less hungry than usual.\",\n        \"Effect 2: Some users might experience mild gastrointestinal discomfort as the body adjusts to the compound, such as nausea or bloating.\",\n        \"Effect 3: Early changes in blood sugar levels could be observed, with potential slight improvements in fasting glucose levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued appetite suppression, potentially leading to a noticeable reduction in food intake.\",\n        \"Effect 2: Users might start to experience mild weight loss as a result of decreased calorie consumption.\",\n        \"Effect 3: Further stabilization of blood sugar levels, with possible improvements in postprandial glucose readings.\",\n        \"Effect 4: Some users might experience improved mood or energy levels due to better blood sugar management.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced weight loss might be observed as appetite suppression continues and metabolic effects take hold.\",\n        \"Effect 2: Users could experience enhanced mental clarity and cognitive function as a result of stabilized blood sugar levels.\",\n        \"Effect 3: Improvements in biomarkers such as HbA1c might begin to be detectable, indicating better long-term glucose control.\",\n        \"Effect 4: Any initial side effects like gastrointestinal discomfort might begin to subside as the body adapts.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant weight loss might be achieved, with users potentially reaching a plateau as the body adjusts to new metabolic conditions.\",\n        \"Effect 2: Sustained improvements in blood sugar control, with potential reductions in insulin resistance.\",\n        \"Effect 3: Users might notice improvements in cardiovascular markers, such as reduced blood pressure or cholesterol levels, although these effects are still under investigation.\",\n        \"Effect 4: Side effects, if any, are likely to have stabilized, with most users experiencing fewer adverse effects.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term weight maintenance might be achieved, with users continuing to benefit from appetite suppression and improved metabolic function.\",\n        \"Effect 2: Continued improvements in metabolic health markers, potentially leading to reduced risk of diabetes-related complications.\",\n        \"Effect 3: Users might experience sustained improvements in overall well-being and energy levels.\",\n        \"Effect 4: Any cardiovascular benefits, if present, might become more evident during this period.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar compounds that target appetite and blood sugar regulation. Survodutide is still under investigation, and individual responses can vary. The effects and side effects mentioned are hypothetical and should be interpreted with caution until more clinical data is available.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 625, "completion_tokens": 648, "total_tokens": 1273, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a3021081909db0e47421a5be46", "custom_id": "drug105_effects_timeline", "response": {"status_code": 200, "request_id": "b070e1ac73daad5fd38b305b92fc7f52", "body": {"id": "chatcmpl-B9MVNG3jX6dPYABzXCV4ksAx5cK9M", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial cellular response to PE22-28 may begin, with early activation of protective pathways in neurons. This is inferred from similar compounds that act on neuronal receptors.\",\n        \"Effect 2: No significant physical effects are expected to be noticeable at this stage, as the compound primarily acts at the cellular level.\",\n        \"Effect 3: Mental/cognitive effects are unlikely to be noticeable in the first week, as neuroprotective benefits typically take longer to manifest.\",\n        \"Effect 4: Biomarkers related to oxidative stress, such as reduced levels of reactive oxygen species (ROS), might begin to show slight changes, but these would likely require sensitive laboratory measurements to detect.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued activation of neuroprotective pathways, potentially leading to a reduction in oxidative damage markers in laboratory settings.\",\n        \"Effect 2: Physical effects remain minimal, as PE22-28 is not expected to cause noticeable changes in physical health or appearance.\",\n        \"Effect 3: Cognitive benefits, such as improved resilience to stress, might start to develop, but these would be subtle and more evident in controlled experimental conditions.\",\n        \"Effect 4: No significant side effects are expected to manifest, based on the compound's mechanism of action and current research data.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Potential for observable improvements in cognitive resilience and stress response, inferred from the compound's neuroprotective properties.\",\n        \"Effect 2: Continued reduction in oxidative stress markers, which might be more pronounced by this stage in laboratory tests.\",\n        \"Effect 3: No major physical changes expected; the compound's effects are primarily neurological.\",\n        \"Effect 4: Side effects, if any, would likely be minimal and related to the compound's interaction with neuronal receptors, but specific side effects are not well-documented.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained neuroprotective effects could lead to more noticeable cognitive benefits, such as improved memory or learning capacity, in experimental settings.\",\n        \"Effect 2: Continued stability or improvement in biomarkers of oxidative stress, indicating ongoing cellular protection.\",\n        \"Effect 3: Physical effects remain negligible, as the compound is not designed to affect physical parameters directly.\",\n        \"Effect 4: Long-term side effects are not well-documented, but ongoing monitoring would be necessary to identify any delayed adverse effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar neuroprotective peptides and the known mechanism of action of PE22-28. As this compound is still in the research phase, specific effects and side effects are not fully documented. Researchers should exercise caution and conduct thorough monitoring during studies.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 628, "total_tokens": 1317, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a30fe08190b66c5f614b09790c", "custom_id": "drug106_effects_timeline", "response": {"status_code": 200, "request_id": "2acdcb612729b2039d741ad8346647de", "body": {"id": "chatcmpl-B9MVNw6TaWSM1OFRS9aWz4mXOinaG", "object": "chat.completion", "created": 1741571161, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial cellular response may involve increased expression of p21 in response to DNA damage, leading to a temporary halt in cell cycle progression. This is primarily an intracellular effect and may not be noticeable physically.\",\n        \"Effect 2: No significant mental or cognitive effects are expected as p21 primarily functions at the cellular level.\",\n        \"Effect 3: Biomarker changes might include increased levels of p21 protein in cell samples, detectable through laboratory assays.\",\n        \"Effect 4: No specific benefits related to cancer cell growth inhibition would be noticeable yet, as these processes are gradual.\",\n        \"Effect 5: No side effects are expected to manifest at this stage, as p21 functions as a natural regulatory protein within cells.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Continued regulation of the cell cycle with potential stabilization of cell growth in tissues under study, particularly in response to DNA damage.\",\n        \"Effect 2: Still no direct mental or cognitive effects expected due to the intracellular nature of p21's action.\",\n        \"Effect 3: Further increases in p21 levels might be observed in response to ongoing cellular stress or experimental conditions.\",\n        \"Effect 4: Early signs of reduced proliferation in cancerous cells might begin to appear in experimental models, though this would be subtle and require specific assays to detect.\",\n        \"Effect 5: No significant side effects expected, as p21 is a natural part of cellular regulation.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: More pronounced effects on cell cycle regulation could be observed, with potential stabilization or reduction in tumor growth in experimental settings.\",\n        \"Effect 2: No mental or cognitive effects anticipated.\",\n        \"Effect 3: Sustained high levels of p21 in response to experimental conditions could be measured, indicating ongoing cell cycle arrest.\",\n        \"Effect 4: Potential benefits in terms of slowing cancer cell proliferation might become more evident, particularly in controlled research environments.\",\n        \"Effect 5: Side effects are unlikely, but any unintended cellular responses would be closely monitored in a research setting.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term stabilization of cell growth and potential reduction in tumor size in experimental models might be observed.\",\n        \"Effect 2: No cognitive effects expected.\",\n        \"Effect 3: Consistent biomarker levels indicating effective cell cycle regulation could be confirmed through ongoing assays.\",\n        \"Effect 4: More definitive benefits in terms of cancer cell growth inhibition might be documented in research studies.\",\n        \"Effect 5: Continued monitoring for any long-term cellular changes or unintended effects would be necessary, though p21's role as a natural regulator suggests minimal side effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects described are based on the cellular role of p21 as a natural regulator of the cell cycle. Since p21 is not a compound administered externally but a protein expressed within cells, the timeline reflects potential outcomes in a research context rather than direct user experiences. Effects are inferred from the biological function of p21 and its role in cancer research, with no direct administration to humans or animals outside experimental settings.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 680, "completion_tokens": 708, "total_tokens": 1388, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a320fc8190ac6a2e1f6f4c911e", "custom_id": "drug110_effects_timeline", "response": {"status_code": 200, "request_id": "68e547c9db9b2137e84bc35d1d813a01", "body": {"id": "chatcmpl-B9MVOpTf2tPujIPyvFPN9yGivtTvi", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "\n{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users with a Vitamin B12 deficiency may begin to notice a slight increase in energy levels and a reduction in fatigue as red blood cell production starts to improve.\",\n        \"Effect 2: Some individuals might experience a mild improvement in mood and cognitive clarity, particularly if they were deficient.\",\n        \"Effect 3: Biomarkers such as serum Vitamin B12 levels may start to increase, indicating improved absorption and utilization.\",\n        \"Effect 4: Initial improvements in nervous system function might be observed, such as reduced tingling or numbness in extremities for those with deficiency-related neuropathy.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels and reduction in symptoms of anemia, such as pallor and shortness of breath, as red blood cell counts normalize.\",\n        \"Effect 2: Cognitive functions, including memory and concentration, may show further enhancement, especially in individuals with prior deficiencies.\",\n        \"Effect 3: Homocysteine levels may begin to decrease, as Vitamin B12 is involved in its metabolism, potentially reducing cardiovascular risk.\",\n        \"Effect 4: Pregnant women might experience improved fetal development support, although this is more preventative and long-term.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained energy levels and overall vitality, with most deficiency symptoms significantly reduced or resolved.\",\n        \"Effect 2: Long-term cognitive benefits, such as improved mental clarity and reduced brain fog, become more pronounced.\",\n        \"Effect 3: Further stabilization of biomarkers, including continued maintenance of healthy red blood cell levels and nerve function.\",\n        \"Effect 4: For those with severe deficiencies, full recovery of neurological symptoms might be observed, although some nerve damage could be permanent if not addressed early.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Maintenance of optimal energy levels and cognitive function, assuming continued adequate intake of Vitamin B12.\",\n        \"Effect 2: Long-term health benefits, such as reduced risk of neurological disorders and cardiovascular diseases, due to sustained normal homocysteine levels.\",\n        \"Effect 3: No significant side effects are expected with normal supplementation, but excessive intake could potentially lead to minor side effects like acne or skin rashes.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline assumes that the user was initially deficient in Vitamin B12. Effects may vary for individuals with normal baseline levels, who might not experience noticeable changes. The timeline is based on documented effects of Vitamin B12 supplementation and inferred from its known mechanisms of action. Side effects are rare and typically associated with excessive doses far above recommended levels.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 675, "completion_tokens": 603, "total_tokens": 1278, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a32fc48190bf842c8674fb6e76", "custom_id": "drug111_effects_timeline", "response": {"status_code": 200, "request_id": "b30b4c523326b7a5959f56d1fd3e17b0", "body": {"id": "chatcmpl-B9MVOhuTkGEenJTFKyYZoUnjF7Fj6", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "\n{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight increase in energy levels as the B vitamins help convert food into energy more efficiently.\",\n        \"Effect 2: Some individuals might experience a mild improvement in mood due to the support of neurotransmitter production, although this can vary widely among users.\",\n        \"Effect 3: Initial improvements in skin hydration and texture might be observed, as B vitamins support cell growth and repair.\",\n        \"Effect 4: Any side effects, such as mild gastrointestinal discomfort, might begin to manifest, especially if taken on an empty stomach.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels, with users potentially feeling less fatigued during the day.\",\n        \"Effect 2: Cognitive effects such as improved focus and concentration may start to become noticeable as brain health is supported.\",\n        \"Effect 3: Some users might observe stronger nails and healthier hair, as B vitamins contribute to keratin production.\",\n        \"Effect 4: Any initial side effects may start to subside as the body adjusts to the supplementation.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Enhanced mood stabilization and reduced feelings of stress and anxiety, as the nervous system becomes more resilient.\",\n        \"Effect 2: Further improvements in cognitive functions, such as memory retention, may be observed.\",\n        \"Effect 3: Biomarkers such as homocysteine levels might show improvement, particularly with adequate B6, B9, and B12 intake.\",\n        \"Effect 4: Skin and hair health continue to improve, with more noticeable changes in texture and strength.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Users might experience a more consistent level of energy throughout the day, reducing the need for stimulants like caffeine.\",\n        \"Effect 2: Continued support for mood and cognitive functions, with some users reporting a more positive outlook and better stress management.\",\n        \"Effect 3: Physiological measurements such as red blood cell count may improve, particularly with adequate B12 intake.\",\n        \"Effect 4: By this time, any side effects should have diminished, assuming proper dosage and no underlying health issues.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects can vary significantly among individuals due to factors such as diet, lifestyle, and baseline nutritional status. The effects described are based on typical responses to B-complex supplementation and may not be experienced by everyone. It is important to consult with a healthcare provider before starting any new supplement regimen, especially for individuals with pre-existing health conditions or those taking medications.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 589, "total_tokens": 1278, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a33fd08190aa039b94ce060c19", "custom_id": "drug112_effects_timeline", "response": {"status_code": 200, "request_id": "888cde20dc7d24f50b2b27d4b76ed2ab", "body": {"id": "chatcmpl-B9MVVuMbrLh51pDbKgVug886LrJKZ", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial boost in energy levels may be noticed due to improved iron absorption, especially in individuals with low iron levels.\",\n        \"Effect 2: Some users might experience a slight improvement in mood and cognitive function as oxidative stress is reduced, though this is more anecdotal.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced skin appearance may begin to be noticeable, with slight improvements in skin texture and hydration due to increased collagen synthesis.\",\n        \"Effect 2: Minor improvements in immune function might be observed, such as a reduced incidence of minor colds or quicker recovery from them.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in skin health, with potential reduction in fine lines and wrinkles becoming more apparent.\",\n        \"Effect 2: Further enhancement in energy levels and reduction in fatigue, particularly in those with previously low Vitamin C levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Noticeable improvement in wound healing speed, as collagen production is further enhanced.\",\n        \"Effect 2: Sustained improvements in immune response, with a more robust defense against infections.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as reduced risk of chronic diseases like heart disease might begin to manifest, though these are more preventive and less immediately observable.\",\n        \"Effect 2: Continued maintenance of skin health and elasticity, with ongoing collagen support.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Vitamin C can vary significantly based on individual health status, baseline Vitamin C levels, and dietary intake. Most effects are subtle and accumulate over time. Side effects are rare at recommended doses but can include gastrointestinal discomfort at very high doses. The benefits related to chronic disease prevention are inferred from long-term studies and may not be immediately noticeable.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 451, "total_tokens": 1136, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a34eb081908737c077c94841f5", "custom_id": "drug113_effects_timeline", "response": {"status_code": 200, "request_id": "db6d4f92dbcef6e8da4dfd27a4999821", "body": {"id": "chatcmpl-B9MVQcF6vM6oEoKr2VWvnkYkiJaqr", "object": "chat.completion", "created": 1741571164, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as improved erectile function may be noticeable within 15 to 30 minutes after taking avanafil, with peak effects occurring around 30 to 45 minutes. This rapid onset is due to the drug's quick absorption and action on PDE5.\",\n        \"Effect 2: Mental effects might include increased confidence and reduced anxiety related to sexual performance due to the improved ability to achieve and maintain an erection.\",\n        \"Effect 3: Biomarkers such as increased blood flow to the penile region can be observed through improved erectile response.\",\n        \"Effect 4: Side effects such as headaches, flushing, or nasal congestion may begin to manifest shortly after administration, peaking within the first few hours.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in erectile function with consistent use as needed, maintaining the ability to achieve erections more reliably.\",\n        \"Effect 2: Mental effects may include sustained improvements in mood and self-esteem due to successful sexual encounters.\",\n        \"Effect 3: No significant changes in long-term biomarkers are expected within the first week.\",\n        \"Effect 4: Side effects such as dizziness or back pain may occur but are generally mild and transient.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: For conditions like Raynaud's phenomenon, users might start noticing a reduction in symptoms such as cold and numb fingers or toes due to improved peripheral blood flow.\",\n        \"Effect 2: Mental effects remain stable, with potential improvements in overall quality of life due to reduced symptoms of erectile dysfunction and possibly Raynaud's phenomenon.\",\n        \"Effect 3: Physiological measurements such as blood pressure might show slight improvements due to vasodilation effects, although this is not the primary action of avanafil.\",\n        \"Effect 4: Side effects are likely to stabilize, with users adapting to the medication. Persistent side effects should be evaluated by a healthcare provider.\"\n      ]\n    },\n    {\n      \"period\": \"Month 1-3\",\n      \"effects\": [\n        \"Effect 1: Potential benefits for benign prostatic hyperplasia (BPH) symptoms might start to appear, such as reduced urinary frequency and improved flow, although this is not a primary indication for avanafil.\",\n        \"Effect 2: Mental effects include sustained improvements in sexual health-related quality of life.\",\n        \"Effect 3: Long-term biomarkers such as improved endothelial function might be observed, although specific studies on avanafil for these effects are limited.\",\n        \"Effect 4: Long-term side effects are generally rare, but monitoring for any unusual symptoms is advised.\"\n      ]\n    }\n  ],\n  \"notes\": \"Avanafil is primarily used for erectile dysfunction, and its effects are rapid and short-lived, typically requiring administration shortly before sexual activity. The timeline provided includes potential off-label benefits based on its mechanism of action, but these are inferred from similar compounds and not extensively documented for avanafil itself. Users should consult healthcare providers for personalized advice and monitoring.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 665, "total_tokens": 1352, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a35d648190a4778933f6f899c1", "custom_id": "drug114_effects_timeline", "response": {"status_code": 200, "request_id": "016f230a26ae081e3b6a370566b9b777", "body": {"id": "chatcmpl-B9MVOMpRXXPThRjPl67aGDv0iqQVV", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Physical effects may include a reduction in symptoms related to high prolactin levels, such as breast tenderness or galactorrhea (unwanted milk production).\",\n        \"Effect 2: Mental/cognitive effects might include improved mood and reduced anxiety, as dopamine levels are influenced.\",\n        \"Effect 3: Biomarkers such as serum prolactin levels may begin to decrease, which can be measured through blood tests.\",\n        \"Effect 4: Initial benefits for conditions like prolactinomas may start to appear, with a reduction in tumor-related symptoms.\",\n        \"Effect 5: Side effects such as nausea, dizziness, or headaches might begin to manifest as the body adjusts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in prolactin-related symptoms, potentially leading to further physical relief.\",\n        \"Effect 2: Cognitive improvements may stabilize, with users experiencing a more consistent mood.\",\n        \"Effect 3: Further decrease in prolactin levels, which can be confirmed through follow-up blood tests.\",\n        \"Effect 4: For bodybuilders, a reduction in prolactin-induced side effects like gynecomastia may start to become noticeable.\",\n        \"Effect 5: Side effects such as gastrointestinal discomfort or dizziness may persist but often diminish as the body adapts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Physical effects include continued management of prolactin levels, with significant symptom relief for most users.\",\n        \"Effect 2: Mental effects may include enhanced motivation and energy levels due to stabilized dopamine activity.\",\n        \"Effect 3: Biomarkers should show a significant reduction in prolactin, approaching normal levels for many users.\",\n        \"Effect 4: Benefits for movement disorders like Parkinson's disease may begin to emerge, with improved motor function.\",\n        \"Effect 5: Side effects may peak and then start to decline, with most users experiencing fewer adverse effects.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained physical benefits, with prolactin levels maintained at target levels, reducing associated health risks.\",\n        \"Effect 2: Cognitive effects may include improved focus and cognitive clarity as dopamine levels stabilize.\",\n        \"Effect 3: Long-term biomarkers should reflect stable prolactin levels, with regular monitoring recommended.\",\n        \"Effect 4: Continued benefits for prolactinomas, with potential tumor size reduction and symptom alleviation.\",\n        \"Effect 5: Side effects are generally minimal, with most users experiencing only mild or no adverse effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for cabergoline can vary based on individual factors such as dosage, duration of use, and the specific condition being treated. While this timeline provides a general overview, individual experiences may differ. It is important to monitor prolactin levels regularly and consult with a healthcare provider to adjust treatment as needed. Some effects, particularly cognitive and mood-related changes, are inferred based on cabergoline's mechanism of action and its impact on dopamine levels.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 691, "total_tokens": 1378, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a36b348190ac3f202af1964ccf", "custom_id": "drug115_effects_timeline", "response": {"status_code": 200, "request_id": "3f7bb986fec01c414acd09244197b27a", "body": {"id": "chatcmpl-B9MVYrXqIZgpzaFTmYPiT96NFph7J", "object": "chat.completion", "created": 1741571172, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Physical effects may include a slight reduction in water retention due to decreased estrogen levels, which might be noticeable in reduced bloating.\",\n        \"Effect 2: Mental/cognitive effects are generally minimal at this stage, but some users might experience a slight improvement in mood due to hormonal balance adjustments.\",\n        \"Effect 3: Biomarkers such as serum estrogen levels begin to decrease as exemestane starts inhibiting the aromatase enzyme.\",\n        \"Effect 4: Initial benefits in terms of estrogen suppression might begin to appear, but significant changes in muscle definition or strength are unlikely this early.\",\n        \"Effect 5: Side effects such as mild joint pain or hot flashes might begin to manifest as estrogen levels drop.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical effects might include a more noticeable reduction in estrogen-related side effects, such as gynecomastia in men using anabolic steroids.\",\n        \"Effect 2: Some users may experience a slight increase in energy levels as testosterone levels begin to rise due to lower estrogen.\",\n        \"Effect 3: Further reduction in estrogen levels can be observed in blood tests, with a potential slight increase in testosterone levels.\",\n        \"Effect 4: Benefits such as improved muscle definition and reduced estrogenic side effects in bodybuilders might start to become more apparent.\",\n        \"Effect 5: Side effects like joint discomfort or mood swings could become more noticeable as the body adjusts to lower estrogen levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Physical effects include continued reduction in estrogen-related side effects and potential improvements in muscle strength and definition.\",\n        \"Effect 2: Cognitive effects might include improved focus and motivation, although this varies among individuals.\",\n        \"Effect 3: Biomarkers such as testosterone levels may show a more significant increase, while estrogen levels remain suppressed.\",\n        \"Effect 4: Benefits such as enhanced physical performance and muscle gains in athletes might be more pronounced.\",\n        \"Effect 5: Side effects could peak around this time, with joint pain and hot flashes being the most common complaints.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical effects stabilize, with users experiencing consistent benefits in terms of muscle definition and reduced estrogenic side effects.\",\n        \"Effect 2: Cognitive effects are generally stable, with some users reporting sustained improvements in mood and energy.\",\n        \"Effect 3: Biomarkers should show a stable pattern of low estrogen and potentially elevated testosterone levels.\",\n        \"Effect 4: Long-term benefits such as sustained muscle gains and improved physical performance are likely well-established.\",\n        \"Effect 5: Side effects may decrease as the body adapts, but some users might continue to experience joint discomfort or mood changes.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed in clinical and anecdotal reports. Individual responses can vary significantly based on factors such as dosage, individual physiology, and concurrent use of other substances. The effects described are inferred from the mechanism of action of exemestane and similar compounds, as well as documented clinical outcomes. It is important to monitor biomarkers regularly to assess the compound's impact and adjust usage accordingly.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 688, "completion_tokens": 713, "total_tokens": 1401, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a37988819084291748fda187e8", "custom_id": "drug116_effects_timeline", "response": {"status_code": 200, "request_id": "92708e3c4f0fd872aa0613f04fb7f7ec", "body": {"id": "chatcmpl-B9MVOgu5SBuYOoGt2od3GRvbZaxo0", "object": "chat.completion", "created": 1741571162, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels, potentially leading to more effective workouts. This is inferred from the compound's mechanism of enhancing fat metabolism.\",\n        \"Effect 2: Initial changes in appetite or food cravings may occur as the body starts adjusting to increased fat metabolism, although this is more anecdotal and not well-documented.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected yet, as the compound's effects are just beginning to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Some users may start to observe minor reductions in body fat, particularly if combined with a calorie-controlled diet and exercise. This is inferred from the compound's targeted action on fat cells.\",\n        \"Effect 2: Mental clarity and focus might improve slightly due to increased energy levels, although this is more anecdotal.\",\n        \"Effect 3: Users might notice a slight decrease in body weight, primarily due to water loss and initial fat reduction.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable reductions in body fat may become apparent, especially around the midsection, as the compound continues to promote fat breakdown.\",\n        \"Effect 2: Enhanced endurance and performance during physical activities might be observed, contributing to improved workout results.\",\n        \"Effect 3: Users may start to see changes in body composition, with a leaner appearance due to fat loss while maintaining muscle mass.\",\n        \"Effect 4: Any side effects, such as mild headaches or fatigue, might begin to manifest but are generally considered rare and mild.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in body composition should be noticeable, with continued fat loss and muscle preservation.\",\n        \"Effect 2: Users might experience sustained energy levels and improved recovery times post-exercise.\",\n        \"Effect 3: Biomarkers such as body fat percentage and muscle mass measurements may show positive changes, reflecting the compound's targeted effects.\",\n        \"Effect 4: Side effects, if any, should stabilize or diminish as the body adapts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3\",\n      \"effects\": [\n        \"Effect 1: Users may reach a plateau in fat loss, which is common with prolonged use of fat-targeting compounds.\",\n        \"Effect 2: Continued maintenance of lean muscle mass and energy levels should be expected.\",\n        \"Effect 3: Long-term users might observe improved metabolic markers, such as lipid profiles, although this is more speculative.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from the compound's mechanism of action and anecdotal reports, as specific clinical data on Fragment 176-191 is limited. Individual responses can vary significantly, and users should monitor their own progress and consult with a healthcare professional if considering use in a research setting.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 658, "completion_tokens": 657, "total_tokens": 1315, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a38b748190bdcabf0165f73dce", "custom_id": "drug117_effects_timeline", "response": {"status_code": 200, "request_id": "cd4bba012289588b1e86eff8d4a416fd", "body": {"id": "chatcmpl-B9MVRfIVkoapAlYPg2Vx0LUOrJ1Ll", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight increase in energy levels and improved sleep quality, as the body starts to respond to elevated growth hormone levels.\",\n        \"Effect 2: Initial physical effects might include a subtle increase in muscle pump during workouts due to enhanced blood flow.\",\n        \"Effect 3: Some users might experience mild water retention as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced recovery times from workouts may become noticeable, with reduced muscle soreness and quicker healing of minor injuries.\",\n        \"Effect 2: Users might start to observe slight improvements in mood and cognitive function, potentially due to better sleep and increased energy.\",\n        \"Effect 3: Biomarkers such as IGF-1 levels may begin to rise, indicating increased growth hormone activity.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced muscle growth and strength gains may start to appear, especially if combined with resistance training.\",\n        \"Effect 2: Reduction in body fat might become noticeable as metabolism is enhanced by higher growth hormone levels.\",\n        \"Effect 3: Users may report further improvements in sleep quality and overall well-being.\",\n        \"Effect 4: Some users might experience joint discomfort or tingling sensations, which are potential side effects of increased growth hormone.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and fat loss, with more significant changes in body composition.\",\n        \"Effect 2: Potential improvements in bone density might begin, although this is a longer-term effect and may not be immediately noticeable.\",\n        \"Effect 3: Enhanced recovery from injuries and surgeries could be more evident, with faster healing times.\",\n        \"Effect 4: Side effects such as water retention or joint discomfort may peak during this period.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as improved bone health and sustained muscle mass gains become more apparent.\",\n        \"Effect 2: Users may experience a plateau in some of the initial benefits as the body adjusts to the compound.\",\n        \"Effect 3: Monitoring of biomarkers like IGF-1 and growth hormone levels should continue to ensure they remain within a healthy range.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed with growth hormone secretagogues and may vary between individuals. Effects are inferred from the mechanism of action and similar compounds, as specific long-term studies on hexarelin are limited. Users should be aware of potential side effects and consult with a healthcare professional before use. Continuous monitoring of physiological markers is recommended to avoid adverse effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 618, "total_tokens": 1305, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a39958819081bdd5528f2aeb58", "custom_id": "drug118_effects_timeline", "response": {"status_code": 200, "request_id": "5445db581140c4f84a74f22eb145bc32", "body": {"id": "chatcmpl-B9MVYOliIRGxMPTCIpS5hNGjzWLRU", "object": "chat.completion", "created": 1741571172, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight increase in energy and motivation, potentially leading to more intense workouts. This is an inferred effect based on the compound's mechanism of action.\",\n        \"Effect 2: Some users might experience a mild increase in muscle fullness and vascularity due to initial water retention and muscle glycogen storage.\",\n        \"Effect 3: No significant changes in biomarkers are typically observed this early, but some users might notice a slight increase in appetite.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Initial increases in strength and endurance may become noticeable. Users might find they can lift slightly heavier weights or perform more repetitions.\",\n        \"Effect 2: Mental focus and cognitive drive during workouts could improve, potentially due to increased motivation and energy levels.\",\n        \"Effect 3: Biomarkers such as testosterone levels might remain stable, but slight changes in liver enzymes could begin to appear, although this is more common with prolonged use.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Muscle mass gains may become more apparent, with users noticing increased muscle size and definition.\",\n        \"Effect 2: Recovery times between workouts might decrease, allowing for more frequent training sessions.\",\n        \"Effect 3: Users might start to experience mild side effects such as headaches or fatigue, although these are typically not severe.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Continued improvements in strength and endurance are likely, with users potentially setting new personal records in their workouts.\",\n        \"Effect 2: Some users might experience mood enhancements, feeling more positive and driven.\",\n        \"Effect 3: Biomarkers such as cholesterol levels might begin to show slight changes, with potential decreases in HDL (good cholesterol).\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-6\",\n      \"effects\": [\n        \"Effect 1: Muscle gains and fat loss become more pronounced, contributing to a leaner, more defined physique.\",\n        \"Effect 2: Users might experience a plateau in strength gains, which is common as the body adapts to the compound.\",\n        \"Effect 3: Side effects such as mild suppression of natural testosterone production could begin to manifest, requiring monitoring.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-8\",\n      \"effects\": [\n        \"Effect 1: Users may continue to experience steady improvements in muscle mass and strength, although at a slower rate compared to earlier weeks.\",\n        \"Effect 2: Mental and cognitive effects might stabilize, with users maintaining high levels of focus and motivation.\",\n        \"Effect 3: Side effects such as potential liver enzyme elevation or cholesterol changes should be monitored, especially if the compound is used beyond this period.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and the known mechanism of action of LGD-4033. Individual responses can vary significantly, and long-term safety data is limited. Users should be aware of the potential for side effects and the importance of post-cycle therapy (PCT) to restore natural hormone levels after discontinuation. This compound is not approved for human use outside of research settings, and all effects are inferred from limited studies and user reports.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 722, "total_tokens": 1413, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a3a8dc8190b10e3b06a395355c", "custom_id": "drug119_effects_timeline", "response": {"status_code": 200, "request_id": "2e8dbb9aa0952baf01f5677baedca41e", "body": {"id": "chatcmpl-B9MVP23GpVZIVAW4BAEMbPl3PKCxl", "object": "chat.completion", "created": 1741571163, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of Matrixyl may lead to slight improvements in skin hydration and texture due to its moisturizing properties. Users might notice their skin feeling softer and more supple.\",\n        \"Effect 2: No significant mental or cognitive effects are expected as Matrixyl is a topical skincare ingredient.\",\n        \"Effect 3: Biomarkers such as skin hydration levels might show slight improvement, but collagen production increases are not yet measurable.\",\n        \"Effect 4: No visible reduction in wrinkles or fine lines is expected at this stage.\",\n        \"Effect 5: Some users might experience mild skin irritation or redness as the skin adjusts to the new product, but this is generally uncommon.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight improvement in skin tone and texture as collagen production starts to increase gradually.\",\n        \"Effect 2: Continued use may lead to a more even skin tone, with some users observing a subtle glow.\",\n        \"Effect 3: Physiological measurements such as skin elasticity might begin to show minor improvements, although these changes are often not immediately visible.\",\n        \"Effect 4: Initial signs of reduced fine lines might start to appear, although significant changes are still developing.\",\n        \"Effect 5: Any initial irritation should subside, and the skin should start to adapt to the peptide.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in skin firmness and elasticity as collagen production continues to increase.\",\n        \"Effect 2: Users might observe a reduction in the appearance of fine lines and wrinkles, with skin appearing smoother and more rejuvenated.\",\n        \"Effect 3: Biomarkers such as collagen density in the skin may show measurable improvements, although typically assessed in clinical settings.\",\n        \"Effect 4: Benefits such as a firmer skin structure and a more lifted appearance become more apparent.\",\n        \"Effect 5: Side effects are minimal, with most users experiencing no adverse reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-12\",\n      \"effects\": [\n        \"Effect 1: Continued use leads to significant improvements in skin texture and tone, with a marked reduction in wrinkles and fine lines.\",\n        \"Effect 2: Users often report their skin feeling more resilient and youthful, with a noticeable glow.\",\n        \"Effect 3: Physiological measurements such as increased collagen levels and improved skin elasticity are more pronounced.\",\n        \"Effect 4: The full spectrum of benefits, including enhanced skin firmness and reduced signs of aging, is typically observed by this stage.\",\n        \"Effect 5: Long-term use is generally well-tolerated, with minimal risk of side effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects is based on typical user experiences and may vary depending on individual skin types, the concentration of Matrixyl in the product, and the frequency of application. While the effects described are based on documented research and user reports, individual results can vary. Users with sensitive skin should perform a patch test before regular use to minimize the risk of irritation.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 674, "completion_tokens": 682, "total_tokens": 1356, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a3b894819091a6843167d94722", "custom_id": "drug120_effects_timeline", "response": {"status_code": 200, "request_id": "1023d01ced2a5cf3f8d10c3f81faee0d", "body": {"id": "chatcmpl-B9MVPgY0dp5KpaiWaVkyrRCzroiEI", "object": "chat.completion", "created": 1741571163, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial activation of satellite cells may begin, but physical changes in muscle size or strength are unlikely to be noticeable yet.\",\n        \"Effect 2: Users might experience a slight increase in muscle soreness recovery time, although this is more likely to be subtle at this early stage.\",\n        \"Effect 3: No significant mental or cognitive effects are expected at this point.\",\n        \"Effect 4: Biomarkers such as IGF-1 levels might start to show slight increases, but these changes are typically within normal physiological ranges.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users may start to notice a reduction in muscle soreness post-exercise, indicating improved recovery.\",\n        \"Effect 2: Some users might experience a slight increase in muscle fullness or 'pump' due to enhanced protein synthesis.\",\n        \"Effect 3: No significant cognitive changes are expected, although some users might report increased motivation to train due to perceived physical benefits.\",\n        \"Effect 4: Continued slight increases in IGF-1 levels and possibly other growth factors, although still within normal ranges.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle recovery and potential slight increases in muscle strength or endurance.\",\n        \"Effect 2: Users might observe a modest increase in muscle mass, particularly if combined with resistance training.\",\n        \"Effect 3: Mental effects remain minimal, but improved recovery might contribute to better overall mood and training motivation.\",\n        \"Effect 4: Biomarkers related to muscle growth and repair, such as creatine kinase, might show reduced levels post-exercise, indicating less muscle damage.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in muscle recovery and strength are likely, with more pronounced increases in muscle mass.\",\n        \"Effect 2: Users might experience enhanced physical performance, allowing for more intense or frequent training sessions.\",\n        \"Effect 3: Cognitive effects remain minimal, but users might report improved confidence and satisfaction with physical progress.\",\n        \"Effect 4: Biomarkers such as IGF-1 might show sustained elevated levels, supporting ongoing muscle growth and repair.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3-6\",\n      \"effects\": [\n        \"Effect 1: Continued improvements in muscle mass and strength, with potential plateauing as the body adapts.\",\n        \"Effect 2: Users might experience a stabilization of physical performance gains.\",\n        \"Effect 3: Mental effects remain stable, with potential improvements in overall well-being due to physical achievements.\",\n        \"Effect 4: Long-term use might lead to adaptations in muscle tissue, with sustained improvements in recovery and performance.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar compounds and the known mechanism of action of MGF (C-terminal). Individual responses can vary significantly based on factors such as dosage, frequency of use, and individual physiology. Side effects are not well-documented but could include localized irritation at the injection site or potential systemic effects if used improperly. Users should conduct thorough research and consult with a professional before use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 641, "completion_tokens": 704, "total_tokens": 1345, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a3c75881909d4421e6948e8b4b", "custom_id": "drug121_effects_timeline", "response": {"status_code": 200, "request_id": "e2e7db34cd442e8f24a3646ee4553c2f", "body": {"id": "chatcmpl-B9MVQPCfFDJyvXi5CGzhiRWBsMQ8A", "object": "chat.completion", "created": 1741571164, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Physical Effects: Users may begin to notice a slight increase in energy levels and endurance during workouts. Muscle pumps might feel more pronounced.\",\n        \"Mental/Cognitive Effects: Some users report a mild increase in focus and motivation, likely due to enhanced workout performance.\",\n        \"Biomarkers/Physiological Measurements: No significant changes in biomarkers are typically observed this early.\",\n        \"Benefits: Initial signs of improved recovery times may start to appear, allowing for more frequent training sessions.\",\n        \"Side Effects: Minimal side effects are expected at this stage, though some users might experience mild headaches or nausea as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Physical Effects: Noticeable improvements in muscle fullness and slight strength gains may be observed.\",\n        \"Mental/Cognitive Effects: Enhanced motivation and focus during workouts continue, potentially leading to improved training intensity.\",\n        \"Biomarkers/Physiological Measurements: Some users might notice slight changes in body composition, such as reduced water retention.\",\n        \"Benefits: Enhanced muscle recovery becomes more apparent, and users might start to see early signs of muscle growth.\",\n        \"Side Effects: Some users may begin to experience mild joint discomfort or muscle cramps.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Physical Effects: More significant increases in muscle mass and strength are typically reported. Users may also notice improved vascularity.\",\n        \"Mental/Cognitive Effects: Continued improvements in workout focus and motivation, with some users reporting a general sense of well-being.\",\n        \"Biomarkers/Physiological Measurements: Lean muscle mass gains may start to reflect in body composition measurements.\",\n        \"Benefits: Fat loss may become noticeable as metabolism increases due to higher lean muscle mass.\",\n        \"Side Effects: Potential for mild testosterone suppression; users might experience slight mood changes or decreased libido.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-6\",\n      \"effects\": [\n        \"Physical Effects: Users often report significant strength gains and muscle growth. Endurance during workouts continues to improve.\",\n        \"Mental/Cognitive Effects: Sustained motivation and focus, with some users experiencing enhanced cognitive clarity.\",\n        \"Biomarkers/Physiological Measurements: Continued improvements in body composition, with increased muscle definition.\",\n        \"Benefits: Bone health benefits may start to manifest, contributing to overall joint support.\",\n        \"Side Effects: Risk of side effects such as mild testosterone suppression or joint discomfort may increase.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-8\",\n      \"effects\": [\n        \"Physical Effects: Peak muscle growth and strength gains are typically observed during this period.\",\n        \"Mental/Cognitive Effects: Users may experience a plateau in cognitive effects, maintaining previous levels of focus and motivation.\",\n        \"Biomarkers/Physiological Measurements: Further improvements in body composition, with potential reductions in body fat percentage.\",\n        \"Benefits: Continued support for muscle recovery and bone health, with users often reporting enhanced overall physical performance.\",\n        \"Side Effects: Side effects such as testosterone suppression may become more pronounced, necessitating post-cycle therapy (PCT) considerations.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and limited studies on MK-2866. Individual experiences may vary, and effects can be influenced by factors such as dosage, diet, and exercise regimen. Users should be aware of the potential need for post-cycle therapy (PCT) to mitigate testosterone suppression. As with any research chemical, MK-2866 should be used responsibly and under appropriate guidance.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 770, "total_tokens": 1459, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a3d6308190940f97e965930a57", "custom_id": "drug122_effects_timeline", "response": {"status_code": 200, "request_id": "fe257cd7883f6c3ccb23067435b4a174", "body": {"id": "chatcmpl-B9MVP4cpsACSdwRjR1vfI7hCysFER", "object": "chat.completion", "created": 1741571163, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels may be noticed as the compound begins to stimulate growth hormone release. This can lead to a subtle improvement in overall vitality and reduced fatigue.\",\n        \"Effect 2: Some users might experience a slight improvement in sleep quality, as growth hormone plays a role in sleep regulation.\",\n        \"Effect 3: No significant changes in muscle mass or fat loss are expected yet, as these processes take longer to manifest.\",\n        \"Effect 4: Biomarkers such as IGF-1 (Insulin-like Growth Factor 1) levels might begin to rise, indicating increased growth hormone activity.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued increase in energy and potential improvements in recovery times post-exercise, allowing for more frequent and effective training sessions.\",\n        \"Effect 2: Some users might start to notice slight improvements in skin elasticity, although this effect is generally more pronounced over a longer period.\",\n        \"Effect 3: Mental clarity and focus might improve slightly due to better sleep and increased energy levels.\",\n        \"Effect 4: Side effects such as mild water retention or joint discomfort could begin to appear, although these are generally mild and temporary.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle recovery and potential initial signs of muscle growth due to enhanced protein synthesis.\",\n        \"Effect 2: Users might start to observe a reduction in body fat percentage as the compound aids in fat metabolism.\",\n        \"Effect 3: Skin elasticity improvements may become more apparent, contributing to a youthful appearance.\",\n        \"Effect 4: Biomarkers such as IGF-1 levels should show a more significant increase, correlating with the physiological changes observed.\",\n        \"Effect 5: Any initial side effects are likely to stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in muscle mass and strength, with users experiencing more pronounced gains from their workouts.\",\n        \"Effect 2: Enhanced fat loss and muscle definition become more evident, contributing to improved body composition.\",\n        \"Effect 3: Continued improvements in skin elasticity and overall skin health.\",\n        \"Effect 4: Mental and cognitive benefits, such as improved mood and focus, may be more consistently noticeable.\",\n        \"Effect 5: Long-term side effects are generally minimal, but users should monitor for any signs of excessive growth hormone activity, such as joint pain or carpal tunnel syndrome.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed with similar growth hormone-releasing peptides. Individual responses can vary significantly based on factors such as dosage, frequency of administration, and individual physiology. Users should monitor their response closely and consult with a healthcare professional for personalized guidance. The effects described are inferred from the known mechanism of action of ModGRF1-29 and similar compounds, as specific studies on ModGRF1-29 may be limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 693, "completion_tokens": 673, "total_tokens": 1366, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a3e3dc8190b5edf5ff1348b118", "custom_id": "drug123_effects_timeline", "response": {"status_code": 200, "request_id": "8ca5fd24e086d2155a295fc704b023ae", "body": {"id": "chatcmpl-B9MVVtbC2EZrD4F72wcSY0KuoVcQ8", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in muscle recovery speed, with reduced soreness following workouts. This is due to the initial stimulation of muscle repair processes.\",\n        \"Effect 2: There may be a subtle improvement in muscle pump and fullness, as the compound starts to exert its effects on muscle fibers.\",\n        \"Effect 3: No significant mental or cognitive effects are typically expected at this early stage.\",\n        \"Effect 4: Biomarkers such as IGF-1 levels might begin to show a slight increase, although this may not be significant enough to detect without precise measurements.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced muscle recovery becomes more noticeable, with users experiencing less downtime between workouts.\",\n        \"Effect 2: Some users might start to observe slight improvements in muscle definition and strength.\",\n        \"Effect 3: Increased motivation and focus during workouts could be reported, likely due to improved physical performance.\",\n        \"Effect 4: Biomarkers related to muscle damage, such as creatine kinase, may show reduced levels, indicating less muscle damage post-exercise.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Users may experience more pronounced muscle growth and strength gains, as the compound continues to support muscle repair and hypertrophy.\",\n        \"Effect 2: Improved endurance and performance might become evident, allowing for longer and more intense training sessions.\",\n        \"Effect 3: Some users might report a heightened sense of well-being and confidence, potentially linked to physical improvements.\",\n        \"Effect 4: Side effects, if any, such as localized irritation at injection sites, might begin to manifest but are generally mild.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: The benefits of PEG MGF, such as enhanced muscle definition and increased strength, are likely to be more apparent.\",\n        \"Effect 2: Continued improvements in recovery time and reduced muscle fatigue are expected.\",\n        \"Effect 3: Users might notice a plateau in cognitive effects, as the primary benefits are physical.\",\n        \"Effect 4: Biomarkers such as IGF-1 and muscle repair indicators should show sustained improvements, reflecting ongoing muscle adaptation.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: Users can expect to maintain or further enhance muscle growth and strength, with consistent use.\",\n        \"Effect 2: The compound's effects on endurance and performance should stabilize, providing a reliable boost to physical activities.\",\n        \"Effect 3: Any side effects, such as injection site reactions, should remain minimal if proper administration techniques are followed.\",\n        \"Effect 4: Long-term biomarkers related to muscle health and recovery should continue to show positive trends, supporting the compound's efficacy.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical user experiences and inferred effects from similar compounds. Individual responses can vary significantly, and the effects described are for research purposes only. Users should be aware of the potential for side effects and the importance of proper dosing and administration techniques. Additionally, long-term effects and safety profiles of PEG MGF are not well-documented, necessitating caution in its use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 686, "completion_tokens": 718, "total_tokens": 1404, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a3f1c4819097a66a591d23d4db", "custom_id": "drug124_effects_timeline", "response": {"status_code": 200, "request_id": "eaa43ceeb5d9c056f4b12424dae4b3cf", "body": {"id": "chatcmpl-B9MVR0DU2aDyNw8JlCFpTqzTpCDqb", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Physical Effects: Users might begin to notice a slight increase in energy levels and endurance during workouts. Initial water retention may occur, but significant muscle growth is not yet apparent.\",\n        \"Mental/Cognitive Effects: Some users report a mild increase in focus and motivation, likely due to increased energy levels.\",\n        \"Biomarkers/Physiological Changes: No significant changes in biomarkers are typically observed at this early stage.\",\n        \"Benefits: Initial improvements in workout performance may be noticed, but muscle growth and fat loss effects are not yet significant.\",\n        \"Side Effects: Some users might experience mild vision changes, such as a yellow tint or difficulty adjusting to darkness, which are known side effects of S4.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Physical Effects: Users may start to see slight improvements in muscle definition and a reduction in body fat percentage.\",\n        \"Mental/Cognitive Effects: Continued enhancement in focus and motivation, potentially aiding in more consistent workout routines.\",\n        \"Biomarkers/Physiological Changes: Some users might notice slight changes in lipid profiles, such as reduced HDL cholesterol, although this is more likely to become apparent in later weeks.\",\n        \"Benefits: Enhanced endurance and recovery times become more noticeable, allowing for longer and more intense training sessions.\",\n        \"Side Effects: Vision-related side effects may persist or become more noticeable. Users should monitor for any other adverse effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Physical Effects: More pronounced muscle growth and fat loss are typically observed. Users may notice increased vascularity and muscle hardness.\",\n        \"Mental/Cognitive Effects: Sustained improvements in mental clarity and workout motivation.\",\n        \"Biomarkers/Physiological Changes: Some users might begin to observe changes in liver enzymes, although this is more common with prolonged use.\",\n        \"Benefits: Significant improvements in muscle mass and strength are typically reported by this stage.\",\n        \"Side Effects: Vision issues may peak around this time. Users should be cautious and consider adjusting dosage if side effects become problematic.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Physical Effects: Continued muscle growth and fat loss, with users often reporting a more defined and toned physique.\",\n        \"Mental/Cognitive Effects: Consistent mental and physical energy levels, contributing to sustained workout performance.\",\n        \"Biomarkers/Physiological Changes: Potential for further changes in lipid profiles and liver enzymes; regular monitoring is advised.\",\n        \"Benefits: Peak benefits in terms of muscle growth, fat loss, and endurance are typically experienced by this point.\",\n        \"Side Effects: Vision side effects may persist; users should be vigilant about any other emerging side effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-6\",\n      \"effects\": [\n        \"Physical Effects: Users may continue to experience muscle growth and fat loss, although the rate of change may begin to stabilize.\",\n        \"Mental/Cognitive Effects: Sustained focus and motivation, although some users might experience mental fatigue if not cycling off appropriately.\",\n        \"Biomarkers/Physiological Changes: Continued monitoring of liver enzymes and lipid profiles is recommended to prevent potential long-term adverse effects.\",\n        \"Benefits: Users typically maintain the gains achieved in muscle mass and fat loss, with ongoing improvements in endurance and recovery.\",\n        \"Side Effects: Vision-related side effects should be closely monitored, and users should consider cycling off if adverse effects become too pronounced.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred from the mechanism of action of S4. Individual responses can vary significantly, and users should approach research with caution, particularly due to the potential for vision-related side effects. Regular monitoring of health markers is advised to mitigate risks.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 664, "completion_tokens": 816, "total_tokens": 1480, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a4006881909b624f50de651970", "custom_id": "drug125_effects_timeline", "response": {"status_code": 200, "request_id": "c963f3f4f19337edf90bb068ec0e54bb", "body": {"id": "chatcmpl-B9MVcrgJ7OojiS1qqN557yZge6mTO", "object": "chat.completion", "created": 1741571176, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of Snap-8 may lead to a slight improvement in skin texture as the peptide begins to interact with facial muscles. Users might notice a subtle softening of fine lines, although significant changes are not yet apparent.\",\n        \"Effect 2: There are typically no mental or cognitive effects associated with topical application of Snap-8, as it primarily acts on the skin's surface.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected during this initial period.\",\n        \"Effect 4: Users might start to feel a slight relaxation in facial tension, but visible benefits such as reduced wrinkle depth are not yet noticeable.\",\n        \"Effect 5: Side effects, if any, such as mild skin irritation or redness, might occur in sensitive individuals but are generally minimal.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to more noticeable improvements in skin smoothness and a reduction in the appearance of fine lines as the peptide accumulates in the skin.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: Still no significant changes in biomarkers or physiological measurements.\",\n        \"Effect 4: Some users may begin to see a slight reduction in wrinkle depth, particularly around areas of frequent muscle contraction, such as the forehead and around the eyes.\",\n        \"Effect 5: Any initial side effects like irritation should subside as the skin adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: By this time, users may observe a more pronounced reduction in the depth and appearance of wrinkles, with the skin appearing smoother and more youthful.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements.\",\n        \"Effect 4: The benefits of Snap-8 in reducing visible signs of aging should be more evident, with a noticeable improvement in skin texture and elasticity.\",\n        \"Effect 5: Side effects are unlikely to manifest at this stage unless the user has a sensitivity to the product.\"\n      ]\n    },\n    {\n      \"period\": \"Week 8\",\n      \"effects\": [\n        \"Effect 1: Users may experience maximum benefits in terms of wrinkle reduction and skin smoothness, with continued use maintaining these effects.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements.\",\n        \"Effect 4: The full anti-aging benefits of Snap-8 should be apparent, with a significant reduction in the appearance of fine lines and wrinkles.\",\n        \"Effect 5: Long-term use is generally well-tolerated, with minimal risk of side effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Snap-8 is based on its mechanism of action as a topical peptide similar to other anti-aging compounds. While individual results may vary, the effects described are inferred from its known properties and user reports. Clinical studies specifically detailing the week-by-week effects of Snap-8 are limited, so this timeline is an educated approximation.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 674, "completion_tokens": 687, "total_tokens": 1361, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a40f608190857102753c47399e", "custom_id": "drug126_effects_timeline", "response": {"status_code": 200, "request_id": "4362bd0db8beecca30d8e90ba6e2e03f", "body": {"id": "chatcmpl-B9MVRgW4cH6Ox3A1LjldhMiP3yEKF", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight increase in energy levels and stamina during workouts, as SR9009 starts to influence cellular energy production. This is an inferred effect based on its mechanism of action.\",\n        \"Effect 2: Some users might experience a mild improvement in mood and focus due to enhanced energy metabolism, although this is not well-documented.\",\n        \"Effect 3: Initial changes in biomarkers such as a slight increase in metabolic rate might be observed, but significant changes are unlikely in the first week.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced endurance and stamina may become more noticeable, allowing for longer and more intense workouts. This aligns with the compound's purported effects on physical performance.\",\n        \"Effect 2: Users might start to see a modest reduction in body fat percentage as metabolism continues to increase.\",\n        \"Effect 3: Some users could experience minor side effects such as disrupted sleep patterns due to its impact on circadian rhythms, although this is speculative.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Continued improvements in endurance and energy levels are likely, with users potentially achieving new personal bests in physical activities.\",\n        \"Effect 2: Cognitive effects such as improved focus and mental clarity may become more pronounced, though this is based on anecdotal reports.\",\n        \"Effect 3: Biomarkers such as resting heart rate and blood pressure might show slight improvements due to increased cardiovascular efficiency.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Users may notice more significant changes in body composition, with increased muscle definition and reduced fat mass.\",\n        \"Effect 2: Enhanced recovery times post-exercise might be observed, allowing for more frequent training sessions.\",\n        \"Effect 3: Potential side effects such as mild gastrointestinal discomfort or headaches could manifest, although these are not commonly reported.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: The full benefits of SR9009 on endurance and metabolism are likely to be realized, with users experiencing peak performance improvements.\",\n        \"Effect 2: Sustained improvements in mood and cognitive function may be reported, contributing to overall well-being.\",\n        \"Effect 3: Long-term changes in biomarkers such as improved lipid profiles and glucose metabolism might be observed, though these effects require further research.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of SR9009 are largely based on preclinical studies and anecdotal reports, as human clinical trials are limited. Users should be cautious of potential side effects and the lack of regulatory approval for human use. The timeline provided is an educated inference based on the compound's mechanism of action and similar compounds.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 619, "total_tokens": 1306, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a41da08190871a460b4b897cb6", "custom_id": "drug127_effects_timeline", "response": {"status_code": 200, "request_id": "77954929b1024a5230319ae5d9308a0c", "body": {"id": "chatcmpl-B9MVYOHUUdXIFV2ABqL8hOcJiVPvF", "object": "chat.completion", "created": 1741571172, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include mild nausea or hot flashes as the body begins to adjust to the medication.\",\n        \"Effect 2: Some users might experience slight fatigue or dizziness as the body adapts to changes in hormone levels.\",\n        \"Effect 3: Biomarkers such as estrogen levels in the blood may begin to show slight decreases, although significant changes might not be immediately apparent.\",\n        \"Effect 4: Early mental effects might include mood swings or mild headaches as the body adjusts to hormonal changes.\",\n        \"Effect 5: Side effects such as hot flashes and nausea are common and may begin to manifest during this period.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as hot flashes and nausea may continue, but some users might start to notice a reduction in breast tenderness.\",\n        \"Effect 2: Mental effects could include continued mood swings or irritability, but these may begin to stabilize as the body adjusts.\",\n        \"Effect 3: Biomarkers like estrogen levels may show more noticeable decreases, particularly in individuals with estrogen-receptor-positive breast cancer.\",\n        \"Effect 4: Benefits such as reduction in breast cancer cell proliferation may begin to appear, although this is more likely to be observed through clinical assessments rather than physical symptoms.\",\n        \"Effect 5: Side effects such as vaginal discharge or irregular menstrual cycles might start to appear or become more pronounced.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as reduction in gynecomastia in men might start to become noticeable, particularly if the condition was mild.\",\n        \"Effect 2: Mental effects may continue to stabilize, with some users reporting improved mood as they adjust to the medication.\",\n        \"Effect 3: Continued decrease in estrogen levels might be observed in blood tests, contributing to the therapeutic effects in breast cancer treatment.\",\n        \"Effect 4: Benefits in terms of reduced risk of breast cancer recurrence might be more evident in clinical settings, although not necessarily felt by the user.\",\n        \"Effect 5: Side effects such as leg cramps or increased risk of thromboembolic events might begin to manifest, requiring monitoring.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical benefits such as further reduction in gynecomastia or stabilization of breast cancer symptoms may become more pronounced.\",\n        \"Effect 2: Mental effects are likely to stabilize, with users generally adapting to any initial mood changes.\",\n        \"Effect 3: Biomarkers such as estrogen levels should be significantly reduced, contributing to the ongoing therapeutic effects.\",\n        \"Effect 4: Long-term benefits such as reduced risk of breast cancer recurrence or progression are more likely to be observed in clinical follow-ups.\",\n        \"Effect 5: Side effects such as hot flashes might peak and then gradually decrease as the body fully adapts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as improved breast cancer outcomes or further reduction in gynecomastia are likely to be sustained.\",\n        \"Effect 2: Mental effects should be stable, with any initial cognitive disruptions largely resolved.\",\n        \"Effect 3: Biomarkers will likely continue to reflect reduced estrogen activity, supporting the ongoing therapeutic effects.\",\n        \"Effect 4: Long-term benefits in terms of cancer prevention or treatment efficacy are more likely to be confirmed through medical evaluations.\",\n        \"Effect 5: Side effects such as increased risk of endometrial changes or thromboembolic events should be monitored, although they may not be immediately apparent.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Tamoxifen Citrate can vary based on individual factors such as dosage, duration of use, and the specific condition being treated. Clinical monitoring is essential to assess the therapeutic benefits and manage potential side effects. Some effects are inferred based on the mechanism of action and clinical studies of similar SERMs.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 875, "total_tokens": 1566, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a42c448190af88199d5d1d66e7", "custom_id": "drug128_effects_timeline", "response": {"status_code": 200, "request_id": "9a1fd47a6dde06b9121368ea4748bd13", "body": {"id": "chatcmpl-B9MVQrKJpvIRXYgpDiWRn3Xk8MwBq", "object": "chat.completion", "created": 1741571164, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial anti-inflammatory effects may begin to manifest, potentially leading to a slight reduction in swelling and discomfort in areas of injury.\",\n        \"Effect 2: Users might notice a subtle increase in energy levels and a general sense of well-being, although cognitive effects are typically minimal at this stage.\",\n        \"Effect 3: Early cellular changes might be observed in biomarkers related to inflammation, such as a decrease in C-reactive protein levels, although these changes might not be significant yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced tissue repair processes become more noticeable, with accelerated healing of minor cuts and wounds.\",\n        \"Effect 2: Some users might start to observe improved skin texture and elasticity due to increased collagen production, although this is more subtle.\",\n        \"Effect 3: Continued reduction in inflammation could lead to further decreases in biomarkers associated with inflammatory responses.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Muscle recovery and repair are more pronounced, especially in individuals engaging in physical activities or recovering from muscle injuries.\",\n        \"Effect 2: Hair growth stimulation might begin to be noticeable, particularly in areas of thinning hair.\",\n        \"Effect 3: Users might experience a slight improvement in flexibility and joint mobility due to ongoing collagen synthesis.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in wound healing and scar reduction may be observed, with scars appearing less prominent.\",\n        \"Effect 2: Enhanced athletic performance might be noted, with users experiencing quicker recovery times post-exercise.\",\n        \"Effect 3: Any potential side effects, such as mild headaches or fatigue, could manifest, although these are generally rare and mild.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained improvements in skin elasticity and muscle growth become more evident.\",\n        \"Effect 2: Users might notice a more substantial improvement in hair density and thickness.\",\n        \"Effect 3: Continued reduction in inflammation and enhanced recovery from injuries and surgeries are likely to be maintained.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical observations and inferred effects from similar peptides and mechanisms of action. Individual responses can vary significantly based on factors such as dosage, frequency of use, and individual health conditions. Clinical data on Thymosin Beta-4 is limited, and most effects are extrapolated from preclinical studies and anecdotal reports. Users should be aware of potential side effects and consult with a healthcare professional before use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 589, "total_tokens": 1280, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a43a2c8190b39d35ce9199f3ad", "custom_id": "drug129_effects_timeline", "response": {"status_code": 200, "request_id": "0079c5ea3528388587afd7d3fe897c5b", "body": {"id": "chatcmpl-B9MVRz8tFiv960fOj7UBUbsUaKDlq", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial stabilization of estrogen levels may begin, but physical effects are generally minimal at this stage.\",\n        \"Effect 2: Some users might experience mild nausea or hot flashes as the body adjusts to the medication.\",\n        \"Effect 3: No significant changes in biomarkers such as cholesterol levels or bone density are expected yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued adjustment to the medication; some users may notice a slight reduction in breast cancer-related symptoms.\",\n        \"Effect 2: Mild cognitive effects such as mood swings or fatigue might be observed as the body adapts to hormonal changes.\",\n        \"Effect 3: Side effects like hot flashes or nausea may persist but typically do not worsen.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable reduction in breast cancer symptoms as the drug's effects on estrogen receptors become more pronounced.\",\n        \"Effect 2: Potential improvement in bone density may begin, although this is typically a longer-term effect.\",\n        \"Effect 3: Some users might start to see slight improvements in cholesterol levels, though significant changes usually take longer.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued suppression of estrogen-related cancer growth, with more pronounced benefits in reducing cancer spread.\",\n        \"Effect 2: Possible stabilization of mood and cognitive effects as the body becomes accustomed to the medication.\",\n        \"Effect 3: Initial improvements in bone density and cholesterol levels might be measurable in some users.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Sustained benefits in cancer treatment, with ongoing prevention of cancer spread.\",\n        \"Effect 2: Noticeable improvements in bone density for those with osteoporosis, contributing to reduced fracture risk.\",\n        \"Effect 3: More significant reductions in cholesterol levels, contributing to improved heart health.\"\n      ]\n    },\n    {\n      \"period\": \"Month 6+\",\n      \"effects\": [\n        \"Effect 1: Long-term maintenance of reduced cancer symptoms and prevention of cancer progression.\",\n        \"Effect 2: Continued support for bone health and potential further improvements in cholesterol levels.\",\n        \"Effect 3: Side effects such as hot flashes may diminish over time, but regular monitoring is advised.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Toremifene Citrate can vary based on individual factors such as dosage, overall health, and specific medical conditions. The effects described are based on typical usage patterns and may not apply to all users. Some effects, particularly those related to bone density and cholesterol, are inferred based on the drug's mechanism of action and similar compounds, as long-term data specific to Toremifene Citrate may be limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 680, "completion_tokens": 634, "total_tokens": 1314, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a448708190a77c1a49695fd3a8", "custom_id": "drug130_effects_timeline", "response": {"status_code": 200, "request_id": "a6cfbc09af30b94367765580de3156d7", "body": {"id": "chatcmpl-B9MVceI4TVakduTIIcNU2qCNDZAdQ", "object": "chat.completion", "created": 1741571176, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1\",\n      \"effects\": [\n        \"Effect 1: Albuterol typically begins to work within minutes of inhalation, providing rapid relief from symptoms such as wheezing, coughing, and shortness of breath. Users may notice an immediate improvement in breathing.\",\n        \"Effect 2: Mental effects are generally minimal, but users might experience a sense of relief and reduced anxiety due to improved breathing.\",\n        \"Effect 3: Physiological measurements such as peak expiratory flow rate (PEFR) may show improvement shortly after administration, indicating better airway function.\",\n        \"Effect 4: The primary benefit of opening airways and improving lung function is noticeable almost immediately, making it effective for acute asthma attacks or exercise-induced bronchoconstriction.\",\n        \"Effect 5: Side effects such as mild tremors, nervousness, or palpitations may begin to manifest shortly after use, peaking within the first few hours.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued use as prescribed will maintain improved breathing and reduced respiratory symptoms. Users should experience consistent relief from asthma or COPD symptoms.\",\n        \"Effect 2: Cognitive effects remain minimal, but consistent relief from respiratory symptoms can lead to improved overall mood and reduced stress levels.\",\n        \"Effect 3: Regular monitoring may show sustained improvements in lung function tests, such as spirometry, reflecting ongoing airway dilation.\",\n        \"Effect 4: Benefits for exercise-induced bronchoconstriction are maintained with pre-exercise administration, allowing for better physical performance.\",\n        \"Effect 5: Side effects such as jitteriness or increased heart rate may persist but often diminish as the body adjusts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users should continue to experience effective management of acute respiratory symptoms with regular use.\",\n        \"Effect 2: Mental clarity and reduced anxiety related to breathing difficulties may be more pronounced as users become accustomed to improved respiratory function.\",\n        \"Effect 3: Biomarkers such as oxygen saturation levels may remain stable, reflecting effective management of respiratory conditions.\",\n        \"Effect 4: The preventive benefits for exercise-induced bronchoconstriction continue with appropriate use before physical activities.\",\n        \"Effect 5: Any persistent side effects should be monitored, and users should consult healthcare providers if they experience significant discomfort or new symptoms.\"\n      ]\n    }\n  ],\n  \"notes\": \"Albuterol is primarily used for short-term relief of acute symptoms and is not typically associated with long-term cumulative effects. The timeline reflects its rapid onset and short duration of action. Users should follow prescribed dosages and consult healthcare providers for any concerns about side effects or efficacy. The effects described are based on typical use and may vary depending on individual health conditions and response to the medication.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 598, "total_tokens": 1283, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a4581c819095129257194df287", "custom_id": "drug131_effects_timeline", "response": {"status_code": 200, "request_id": "9e963d99b41804955fd088588f30e366", "body": {"id": "chatcmpl-B9MVSXMKVKascUMqw7HDvzVxMZ5LO", "object": "chat.completion", "created": 1741571166, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of Argireline may lead to a slight feeling of skin tightness as the compound begins to interact with facial muscles. This is a subtle effect and may not be noticeable to all users.\",\n        \"Effect 2: Users might notice a slight improvement in skin texture due to the moisturizing components often included in Argireline formulations, though this is more related to the product base than Argireline itself.\",\n        \"Effect 3: No significant mental or cognitive effects are expected, as Argireline is a topical compound with localized action.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Some users may begin to notice a reduction in the depth of fine lines, particularly around the eyes and forehead, as muscle relaxation effects start to manifest.\",\n        \"Effect 2: Continued improvement in skin hydration and texture, contributing to a smoother appearance.\",\n        \"Effect 3: No changes in biomarkers or physiological measurements are expected, as Argireline does not penetrate deeply enough to affect systemic physiology.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: More noticeable reduction in the appearance of expression lines, with some users reporting a visible decrease in wrinkle depth.\",\n        \"Effect 2: Users may experience increased satisfaction with their skin's appearance, potentially boosting self-esteem and confidence.\",\n        \"Effect 3: No significant side effects are typically reported, but some users might experience mild skin irritation or redness, especially if they have sensitive skin.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Maximum visible reduction in fine lines and wrinkles for most users, as the compound reaches its peak efficacy with regular use.\",\n        \"Effect 2: Users may continue to experience improved skin smoothness and elasticity.\",\n        \"Effect 3: Any initial skin irritation should subside as the skin adjusts to the compound. If irritation persists, discontinuation or consultation with a dermatologist may be necessary.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained reduction in wrinkle appearance with continued use, maintaining a youthful skin appearance.\",\n        \"Effect 2: Users should continue to experience satisfaction with the product's effects, though some may notice diminishing returns if the skin becomes accustomed to the compound.\",\n        \"Effect 3: Long-term use is generally well-tolerated, but users should monitor for any delayed skin reactions or sensitivities.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical user experiences and may vary depending on individual skin types, the concentration of Argireline in the product, and the formulation's overall composition. While Argireline is generally considered safe for topical use, users with sensitive skin should perform a patch test before full application. The effects described are inferred from the compound's mechanism of action and user reports, as comprehensive clinical data specifically detailing a week-by-week timeline is limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 656, "completion_tokens": 659, "total_tokens": 1315, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a466dc8190ae4a6c32cc184c7f", "custom_id": "drug132_effects_timeline", "response": {"status_code": 200, "request_id": "042ee09c878179e7c1478337eef85616", "body": {"id": "chatcmpl-B9MVQeEV7GitahTtj3u9K7sartEUT", "object": "chat.completion", "created": 1741571164, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial onset of action typically occurs within 1-3 hours after taking Dapoxetine HCl, as it is a fast-acting medication. Users may notice a delay in ejaculation during sexual activity.\",\n        \"Effect 2: Some users might experience mild side effects such as nausea, dizziness, or headache shortly after taking the medication. These effects are generally transient and subside as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Consistent use may lead to a noticeable improvement in control over ejaculation timing during sexual activity.\",\n        \"Effect 2: Users might experience a reduction in performance-related anxiety due to increased confidence in managing premature ejaculation.\",\n        \"Effect 3: Side effects such as nausea and dizziness may continue but often decrease in intensity as the body adapts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Enhanced control over ejaculation timing is typically well-established, leading to more satisfying sexual experiences.\",\n        \"Effect 2: Continued reduction in anxiety and stress related to sexual performance, contributing to improved mood during sexual activity.\",\n        \"Effect 3: Any initial side effects are likely to have diminished significantly by this point, though some users may still experience mild symptoms.\"\n      ]\n    },\n    {\n      \"period\": \"Month 1-3\",\n      \"effects\": [\n        \"Effect 1: Users generally maintain improved control over ejaculation, with consistent benefits in sexual performance and satisfaction.\",\n        \"Effect 2: Long-term use may lead to sustained reductions in anxiety and stress, with potential improvements in overall mood and confidence.\",\n        \"Effect 3: Biomarkers such as serotonin levels in the brain remain elevated, supporting the medication's efficacy in delaying ejaculation.\"\n      ]\n    }\n  ],\n  \"notes\": \"Dapoxetine HCl is designed for on-demand use, typically taken 1-3 hours before anticipated sexual activity. The timeline of effects may vary based on individual response and dosage. While the medication is effective for many users, it is not intended for daily use and should be taken only as prescribed. Users should be aware of potential side effects and consult with a healthcare provider if they experience persistent or severe symptoms. The timeline provided is based on documented effects of Dapoxetine HCl and similar fast-acting selective serotonin reuptake inhibitors (SSRIs).\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 532, "total_tokens": 1177, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a4755c81909633d7d4fdc3c62d", "custom_id": "drug133_effects_timeline", "response": {"status_code": 200, "request_id": "98e8d9807aaf47d0911079889a7769a7", "body": {"id": "chatcmpl-B9MVRnRhG1vMkUXPL0edMMz7T5ZQY", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a mild increase in energy levels and alertness due to enhanced oxygen delivery and improved mitochondrial function.\",\n        \"Effect 2: Some users might notice a slight improvement in mood and cognitive clarity as methylene blue begins to influence neurotransmitter systems.\",\n        \"Effect 3: Biomarker changes could include a reduction in methemoglobin levels, leading to improved oxygenation of tissues.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in cognitive performance, including memory and attention, as methylene blue's effects on brain enzymes and neurotransmitters become more pronounced.\",\n        \"Effect 2: Users might experience a more noticeable improvement in mood, particularly if they have underlying mood disorders.\",\n        \"Effect 3: Antioxidant effects may start to manifest, potentially reducing oxidative stress markers in the body.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Enhanced cognitive benefits, such as improved memory retention and learning capacity, may become more evident.\",\n        \"Effect 2: Physical endurance and stamina might improve due to better oxygen utilization and mitochondrial efficiency.\",\n        \"Effect 3: Users may observe a stabilization of mood improvements, with potential reductions in symptoms of depression or anxiety.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term cognitive benefits, such as sustained memory enhancement and neuroprotection, may be more pronounced.\",\n        \"Effect 2: Continued antioxidant effects could lead to a reduction in biomarkers of oxidative stress and inflammation.\",\n        \"Effect 3: Side effects, if any, might include mild gastrointestinal disturbances or changes in urine color (blue or green), which are typically harmless.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Potential slowing of neurodegenerative processes in individuals with conditions like Alzheimer's disease, although this is still under investigation.\",\n        \"Effect 2: Sustained improvements in mood and cognitive function, with a possible plateau effect as the body adapts to the compound.\",\n        \"Effect 3: Regular monitoring of blood parameters might show stable hemoglobin levels and reduced oxidative stress markers.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for methylene blue is based on both documented research and inferred effects from its mechanisms of action. Individual responses can vary, and the compound's long-term effects are still being studied. Users should be aware of potential side effects, such as changes in urine color, and consult with a healthcare professional before use, especially at higher doses or for extended periods.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 647, "completion_tokens": 595, "total_tokens": 1242, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a483408190bf442f431c9afd0a", "custom_id": "drug134_effects_timeline", "response": {"status_code": 200, "request_id": "2e9e55017f65cff6475c9410c6733c2c", "body": {"id": "chatcmpl-B9MVYXmruYFARko7opROCcySNTOTX", "object": "chat.completion", "created": 1741571172, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in basal metabolic rate as the mitochondrial uncoupling begins, potentially leading to a slight increase in body temperature and energy expenditure.\",\n        \"Effect 2: Some users might notice a mild increase in energy levels due to enhanced metabolic activity, although this is inferred based on the mechanism of action.\",\n        \"Effect 3: Minor changes in biomarkers such as a slight decrease in body weight or fat percentage could be observed, but significant changes are unlikely this early.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued increase in energy expenditure, potentially leading to more noticeable weight loss or reduction in body fat.\",\n        \"Effect 2: Improved insulin sensitivity might begin to manifest, inferred from similar compounds, potentially leading to more stable blood sugar levels.\",\n        \"Effect 3: Users might experience mild gastrointestinal discomfort as a side effect, which is common with mitochondrial uncouplers.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced weight loss and fat reduction as the body adapts to the increased metabolic rate.\",\n        \"Effect 2: Enhanced cognitive clarity or focus might be reported, inferred from increased energy availability.\",\n        \"Effect 3: Biomarkers such as blood glucose levels and insulin sensitivity could show measurable improvement, supporting potential benefits for metabolic disorders.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Stabilization of weight loss effects as the body reaches a new metabolic equilibrium.\",\n        \"Effect 2: Long-term benefits for liver health might begin to appear, with potential reductions in liver fat accumulation.\",\n        \"Effect 3: Side effects such as gastrointestinal discomfort might decrease as the body adjusts, but monitoring for any adverse effects is recommended.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in metabolic health, with continued benefits for weight management and insulin sensitivity.\",\n        \"Effect 2: Potential long-term cognitive benefits due to improved metabolic efficiency, although this is speculative.\",\n        \"Effect 3: Regular monitoring of biomarkers is advised to ensure continued positive effects and to check for any delayed side effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the mechanism of action of BAM-15 and similar mitochondrial uncouplers. Direct human studies on BAM-15 are limited, so some effects are inferred from animal studies or related compounds. Individual responses may vary, and long-term safety and efficacy are not fully established.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 653, "completion_tokens": 576, "total_tokens": 1229, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a492388190ba0953626c282c08", "custom_id": "drug135_effects_timeline", "response": {"status_code": 200, "request_id": "7ae504a086cbef1311a2123a78ba3798", "body": {"id": "chatcmpl-B9MVRc0Fzc9GYexwKCQTq6KanQ96w", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial administration of Gonadorelin may lead to a rapid increase in the levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) within a few hours. This is due to its direct stimulation of the pituitary gland.\",\n        \"Effect 2: Users might experience mild physical sensations such as warmth or flushing, which are common with hormone fluctuations.\",\n        \"Effect 3: There may be no significant mental or cognitive effects observed in this short period.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued administration can lead to more stable increases in LH and FSH levels, which are measurable through blood tests.\",\n        \"Effect 2: In women, there might be initial signs of menstrual cycle regulation or ovulation induction, depending on individual baseline hormone levels.\",\n        \"Effect 3: Men might begin to notice subtle changes in libido or energy levels as testosterone production is indirectly stimulated.\",\n        \"Effect 4: Side effects such as headaches or abdominal discomfort might begin to manifest as the body adjusts to hormone level changes.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: In women, more pronounced effects on the menstrual cycle may be observed, including more regular cycles or ovulation, which can be confirmed through ovulation tests.\",\n        \"Effect 2: Men might experience improved sperm production, which can be measured through semen analysis.\",\n        \"Effect 3: Some users might report improved mood or cognitive clarity as hormone levels stabilize.\",\n        \"Effect 4: Side effects such as mood swings or mild fatigue may peak during this period as the body continues to adjust.\"\n      ]\n    },\n    {\n      \"period\": \"Month 1-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as improved fertility outcomes in both men and women may become more apparent, with increased chances of conception.\",\n        \"Effect 2: Physical effects such as increased energy levels and improved sexual function may be more noticeable.\",\n        \"Effect 3: Biomarkers such as LH, FSH, and testosterone levels should stabilize, reflecting the therapeutic effects of Gonadorelin.\",\n        \"Effect 4: Any persistent side effects should be monitored, although they may diminish as the body acclimates.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Gonadorelin can vary significantly based on individual physiological differences, baseline hormone levels, and the specific dosing regimen used. The effects described are based on typical responses observed in clinical settings. Inferences are made based on the known mechanism of action of Gonadorelin and similar compounds. It is important to conduct regular monitoring of hormone levels and consult with healthcare professionals to tailor treatment to individual needs.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 612, "total_tokens": 1299, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a4a2048190bcc98216a1edf027", "custom_id": "drug136_effects_timeline", "response": {"status_code": 200, "request_id": "5fbe809e1a62fc1b5f0741b058eb09f5", "body": {"id": "chatcmpl-B9MVRZE6hxdrzOuIdiDCETUQ7YGtY", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels and overall vitality, potentially due to the antioxidant properties of C60 fullerene starting to reduce oxidative stress.\",\n        \"Effect 2: Some users may experience mild improvements in mental clarity and focus as C60 fullerene begins to cross the blood-brain barrier and exert its effects on brain health.\",\n        \"Effect 3: Initial changes in biomarkers such as a slight reduction in oxidative stress markers might be observed, although significant changes are unlikely this early.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels and possibly a more noticeable enhancement in cognitive function, including better focus and memory retention.\",\n        \"Effect 2: Users might start to observe subtle improvements in skin texture and appearance, potentially due to increased collagen production.\",\n        \"Effect 3: Biomarkers related to inflammation and oxidative stress may show more measurable improvements, indicating reduced cellular damage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Enhanced immune function might become more apparent, with users experiencing fewer minor illnesses or quicker recovery from colds.\",\n        \"Effect 2: Cognitive benefits such as improved mood and reduced mental fatigue could become more pronounced.\",\n        \"Effect 3: Skin health improvements might be more visible, with users noticing firmer and more youthful-looking skin.\",\n        \"Effect 4: Any potential side effects, such as mild digestive discomfort or headaches, might manifest or peak during this period, although these are generally rare and mild.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users might experience sustained energy levels and cognitive benefits, with some reporting enhanced creativity and problem-solving abilities.\",\n        \"Effect 2: Long-term skin health benefits, such as reduced fine lines and improved elasticity, could become more evident.\",\n        \"Effect 3: Biomarkers related to aging, such as telomere length or cellular repair markers, might show positive trends, although these changes are typically subtle and require longer-term observation.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Potential long-term benefits such as improved cardiovascular health and reduced risk of neurodegenerative diseases might begin to manifest, although these effects are more speculative and require further research.\",\n        \"Effect 2: Users may report a general sense of well-being and resilience against stressors, both physical and mental.\",\n        \"Effect 3: Any side effects are likely to have stabilized or diminished, with most users experiencing minimal adverse effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of C60 fullerene are still under investigation, and much of the timeline is based on preliminary research and anecdotal reports. The compound's long-term safety and efficacy require further study. Users should approach its use cautiously and consult with a healthcare professional before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 655, "total_tokens": 1346, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a4b03881908854c7d31774aa42", "custom_id": "drug137_effects_timeline", "response": {"status_code": 200, "request_id": "4a842f8e769826a676e7832465f57599", "body": {"id": "chatcmpl-B9MVQwz8gJNFUd7IBel49PzdtC0VX", "object": "chat.completion", "created": 1741571164, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include mild fatigue or lethargy as the body begins to adjust to the compound. This is inferred from similar compounds that affect cellular metabolism.\",\n        \"Effect 2: Some users might notice a slight decrease in appetite, which is a common early response in weight loss interventions.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected yet, as the compound is just beginning to exert its effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice a slight reduction in body weight, primarily due to water loss and initial fat cell apoptosis.\",\n        \"Effect 2: Improved energy levels might be observed as the body starts adapting to the metabolic changes.\",\n        \"Effect 3: Initial changes in biomarkers such as a slight decrease in fasting blood glucose levels could be observed, inferred from the compound's potential impact on insulin sensitivity.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable weight loss may occur as fat cell apoptosis continues and the body begins to clear out dead cells.\",\n        \"Effect 2: Users might experience improved mood and cognitive function due to potential reductions in systemic inflammation.\",\n        \"Effect 3: More significant changes in biomarkers, such as further reductions in blood glucose levels and possibly improved lipid profiles, might be observed.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Continued weight loss is likely, with a more pronounced reduction in body fat percentage.\",\n        \"Effect 2: Enhanced insulin sensitivity and better blood sugar control could become more evident, benefiting users with type 2 diabetes.\",\n        \"Effect 3: Side effects such as mild dehydration or electrolyte imbalances might peak, requiring monitoring and management.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3\",\n      \"effects\": [\n        \"Effect 1: Stabilization of weight loss as the body reaches a new equilibrium, with ongoing fat reduction.\",\n        \"Effect 2: Sustained improvements in energy levels and cognitive function due to better metabolic health.\",\n        \"Effect 3: Long-term benefits such as reduced risk of obesity-related conditions might start to manifest, inferred from the compound's mechanism.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and educated inferences from similar compounds. Individual responses can vary significantly, and long-term effects are still under investigation. Monitoring by healthcare professionals is recommended due to potential side effects and the experimental nature of Adipotide.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 683, "completion_tokens": 575, "total_tokens": 1258, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a4be40819096882abfb3a786fb", "custom_id": "drug138_effects_timeline", "response": {"status_code": 200, "request_id": "950e018925613e9e79177540e24c36ae", "body": {"id": "chatcmpl-B9MVWbdzNJ9i0awwIgj5s97xxOPNk", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial administration of demoxytocin may lead to noticeable uterine contractions in pregnant women, facilitating labor. This is the primary physical effect expected in medical settings.\",\n        \"Effect 2: Some users might experience a mild increase in milk flow if they are postpartum, due to stimulation of the mammary glands.\",\n        \"Effect 3: In terms of mental effects, users might begin to notice a subtle reduction in social anxiety and an increased sense of calmness, although these effects are more pronounced with continued use.\",\n        \"Effect 4: Biomarkers such as oxytocin levels in the blood may show an initial increase, reflecting the compound's action.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to more consistent uterine contractions if used for labor induction, though this is typically a short-term application.\",\n        \"Effect 2: Users might experience a more noticeable improvement in social interactions and reduced anxiety in social settings as the compound's effects on oxytocin receptors in the brain become more pronounced.\",\n        \"Effect 3: Physiological measurements such as heart rate and blood pressure may remain stable, but some users could experience slight variations due to reduced anxiety.\",\n        \"Effect 4: Side effects such as mild headaches or nausea might begin to manifest, although these are generally not severe.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: For non-pregnant users, the primary effects would be mental, with a continued enhancement in social bonding and emotional resilience.\",\n        \"Effect 2: Cognitive effects might include improved mood and a greater sense of trust and connection with others.\",\n        \"Effect 3: Biomarkers related to stress, such as cortisol levels, might begin to decrease, reflecting reduced anxiety and stress.\",\n        \"Effect 4: Any side effects experienced in the first week may stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 1-3\",\n      \"effects\": [\n        \"Effect 1: Long-term use could lead to sustained improvements in social behavior and emotional well-being, particularly in individuals with social anxiety.\",\n        \"Effect 2: Users might notice a more profound and lasting reduction in anxiety and stress-related symptoms.\",\n        \"Effect 3: Physiological measurements such as heart rate variability might improve, indicating better stress management.\",\n        \"Effect 4: Side effects, if any, are likely to be minimal and manageable, with the most common being mild headaches or digestive discomfort.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the known effects of oxytocin and similar compounds, as specific longitudinal studies on demoxytocin are limited. Effects can vary significantly based on individual differences and the specific context of use (e.g., medical vs. research settings). Always consult with a healthcare professional before considering the use of such compounds.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 665, "completion_tokens": 646, "total_tokens": 1311, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a4cc988190a433e962a13fbab6", "custom_id": "drug139_effects_timeline", "response": {"status_code": 200, "request_id": "9cf27d0f8a074c5e6b956a6dbdc44d52", "body": {"id": "chatcmpl-B9MVR3UctmKTJO8gp778qUXRi6ySt", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial administration of triptorelin may cause a temporary surge in sex hormones, leading to a potential flare in symptoms such as increased pain or discomfort in conditions like prostate cancer or endometriosis.\",\n        \"Effect 2: Some individuals might experience mood swings or emotional changes due to the initial hormone surge.\",\n        \"Effect 3: Biomarkers such as testosterone in men and estrogen in women might initially increase before starting to decline.\",\n        \"Effect 4: Side effects such as hot flashes, headaches, or nausea may begin to appear as the body adjusts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Hormone levels begin to decrease as the body downregulates production in response to continuous triptorelin administration.\",\n        \"Effect 2: Physical symptoms related to hormone-sensitive conditions, such as prostate cancer or uterine fibroids, may start to stabilize or improve.\",\n        \"Effect 3: Mental effects such as mood stabilization might occur as hormone levels begin to decline.\",\n        \"Effect 4: Biomarkers such as testosterone and estrogen levels should show a noticeable decrease.\",\n        \"Effect 5: Side effects like hot flashes or fatigue may persist but often become more manageable.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in hormone levels leads to more pronounced benefits in managing conditions like prostate cancer, endometriosis, or uterine fibroids.\",\n        \"Effect 2: Physical improvements such as reduced pain or tumor size may become more evident.\",\n        \"Effect 3: Cognitive effects such as improved focus or mood stabilization may continue as hormone levels stabilize.\",\n        \"Effect 4: Biomarkers should reflect sustained low levels of sex hormones.\",\n        \"Effect 5: Side effects may persist but are often outweighed by the therapeutic benefits.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits in managing hormone-related conditions are typically well-established by this period.\",\n        \"Effect 2: Physical symptoms related to hormone-sensitive conditions should be significantly reduced.\",\n        \"Effect 3: Mental and cognitive effects are generally stable, with most individuals adapting to the hormone changes.\",\n        \"Effect 4: Biomarkers remain at low levels, indicating effective suppression of sex hormones.\",\n        \"Effect 5: Side effects may diminish in intensity as the body fully adjusts to the treatment.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects can vary based on individual response, dosage, and specific condition being treated. Initial hormone surge effects are inferred based on the mechanism of action and similar GnRH analogs. Continuous monitoring of hormone levels and side effects is recommended to optimize treatment and manage any adverse effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 617, "total_tokens": 1306, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a4d9d081909737f488259ad48f", "custom_id": "drug140_effects_timeline", "response": {"status_code": 200, "request_id": "01e56226b78aed2caaa555ce2c2e3030", "body": {"id": "chatcmpl-B9MVZEHH9GLvC7Cr4DXP0M5VYTEt3", "object": "chat.completion", "created": 1741571173, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a slight reduction in the frequency of urination as the bladder begins to relax due to beta-3 adrenergic receptor activation.\",\n        \"Effect 2: Some users might experience mild side effects such as headache, dizziness, or dry mouth as the body adjusts to the medication.\",\n        \"Effect 3: No significant mental or cognitive effects are typically associated with Mirabegron use.\",\n        \"Effect 4: Biomarkers or physiological measurements such as blood pressure may show slight changes, as Mirabegron can cause a mild increase in blood pressure in some individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in bladder control, with a noticeable decrease in urgency and frequency of urination.\",\n        \"Effect 2: Users may start to experience the benefits of reduced urinary incontinence, particularly during physical activities.\",\n        \"Effect 3: Side effects such as dry mouth or headache may persist but often begin to subside as the body acclimates to the medication.\",\n        \"Effect 4: Monitoring of blood pressure is recommended, as any increases should be evaluated by a healthcare provider.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Maximum therapeutic effects are typically observed, with significant improvement in symptoms of overactive bladder.\",\n        \"Effect 2: Users may report a substantial reduction in the number of bathroom visits and fewer accidental leaks.\",\n        \"Effect 3: Side effects, if present, generally continue to diminish in intensity.\",\n        \"Effect 4: Any changes in biomarkers such as blood pressure should be stable by this time, but ongoing monitoring is advised.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained improvement in bladder function and quality of life, with stable management of urinary symptoms.\",\n        \"Effect 2: Long-term side effects are rare, but users should remain vigilant for any new symptoms.\",\n        \"Effect 3: Regular follow-up with a healthcare provider is recommended to ensure continued efficacy and safety.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical user experiences and clinical studies of Mirabegron. Individual responses may vary, and some users may experience effects sooner or later than described. It is important to consult with a healthcare provider for personalized advice and monitoring. The effects described are primarily documented, but some inferences are made based on the mechanism of action and similar compounds.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 688, "completion_tokens": 562, "total_tokens": 1250, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a4e91c81909afae8fa9f7fb3c2", "custom_id": "drug142_effects_timeline", "response": {"status_code": 200, "request_id": "9c4887c608344e6af705ad3a900d0968", "body": {"id": "chatcmpl-B9MVTXv0nHFI944O1CSAj03pxclNP", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of Acetylhexapeptide-3 may lead to a slight improvement in skin texture and hydration as the compound begins to interact with the skin's surface.\",\n        \"Effect 2: Users might notice a subtle reduction in the appearance of fine lines, particularly around the eyes and forehead, as muscle relaxation begins.\",\n        \"Effect 3: No significant mental or cognitive effects are expected, as Acetylhexapeptide-3 primarily acts locally on the skin.\",\n        \"Effect 4: No measurable changes in biomarkers or physiological measurements are anticipated at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to more noticeable smoothing of fine lines and wrinkles, as the compound's effects on muscle relaxation become more pronounced.\",\n        \"Effect 2: Skin may appear more vibrant and youthful, with a slight increase in elasticity and firmness.\",\n        \"Effect 3: No mental or cognitive effects are expected.\",\n        \"Effect 4: Users might observe a slight improvement in overall skin tone and texture.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: The reduction in the appearance of expression lines becomes more evident, particularly in areas prone to dynamic wrinkles.\",\n        \"Effect 2: Skin continues to feel smoother and more supple, with a more even complexion.\",\n        \"Effect 3: No mental or cognitive effects are expected.\",\n        \"Effect 4: No significant changes in biomarkers or physiological measurements are expected.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Maximum benefits in terms of wrinkle reduction and skin smoothness are typically observed around this time, with continued use maintaining these effects.\",\n        \"Effect 2: Skin appears more relaxed and youthful, with a noticeable reduction in the depth of wrinkles.\",\n        \"Effect 3: No mental or cognitive effects are expected.\",\n        \"Effect 4: Users should not expect changes in physiological measurements, as the compound's action is localized to the skin.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical usage patterns and the mechanism of action of Acetylhexapeptide-3. Individual results may vary depending on factors such as skin type, age, and the specific formulation of the product used. The effects described are inferred from the compound's mechanism of action and its similarity to other peptides used in skincare. Side effects are generally minimal, with some users potentially experiencing mild skin irritation or redness, particularly if they have sensitive skin. These side effects, if they occur, are likely to manifest early in the usage period and should diminish with continued use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 696, "completion_tokens": 595, "total_tokens": 1291, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a4f7a08190b49289bf5a88f156", "custom_id": "drug143_effects_timeline", "response": {"status_code": 200, "request_id": "fd99a7c87fba0d23ff8d07b1f237ad82", "body": {"id": "chatcmpl-B9MVRDVk4bDT5BRtIW6HWrfecQMkp", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application may lead to a slight improvement in skin hydration and texture as the peptide begins to interact with the skin's surface.\",\n        \"Effect 2: Users might notice a subtle increase in skin firmness, although significant changes are not expected this early.\",\n        \"Effect 3: No significant mental or cognitive effects are anticipated as AHK(tripeptide-3) primarily acts on skin and hair.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may result in a noticeable improvement in skin elasticity, with some users reporting a smoother skin appearance.\",\n        \"Effect 2: Early signs of reduced fine lines and wrinkles might start to appear, although these changes are typically subtle.\",\n        \"Effect 3: Hair may begin to feel slightly thicker or healthier, but significant changes in hair growth are unlikely at this stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced improvements in skin firmness and elasticity are likely, with users observing a more youthful skin appearance.\",\n        \"Effect 2: Reduction in the appearance of fine lines and wrinkles becomes more evident.\",\n        \"Effect 3: Some users may notice an improvement in hair texture and a slight reduction in hair loss.\",\n        \"Effect 4: Enhanced blood circulation to the skin and hair follicles might be observed, potentially measurable by increased skin temperature or slight redness due to improved microcirculation.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in skin rejuvenation, with a marked reduction in wrinkles and fine lines.\",\n        \"Effect 2: Hair growth benefits become more noticeable, with users reporting thicker and healthier hair.\",\n        \"Effect 3: Overall skin tone and texture continue to improve, contributing to a vibrant and youthful appearance.\",\n        \"Effect 4: No significant side effects are typically reported, but some users might experience mild skin irritation if sensitive to peptides.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Maximum benefits in terms of skin and hair health are generally observed, with sustained improvements in elasticity, firmness, and hair density.\",\n        \"Effect 2: Users may experience a plateau in effects as the compound reaches its peak efficacy.\",\n        \"Effect 3: Long-term use is generally well-tolerated, with minimal side effects reported.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical user experiences and inferred effects from similar peptides. Individual results may vary due to differences in skin type, hair condition, and overall health. As with any research compound, it is important to monitor for any adverse reactions and adjust usage accordingly. Clinical studies specific to AHK(tripeptide-3) are limited, so these effects are partly inferred from its known mechanisms of action.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 648, "completion_tokens": 641, "total_tokens": 1289, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a507608190826c28eaaab8cf24", "custom_id": "drug144_effects_timeline", "response": {"status_code": 200, "request_id": "cbe6389f2c3ec155cacfca6e5329f25e", "body": {"id": "chatcmpl-B9MVRMnV2FdyKE2ffCIjA898QkUMo", "object": "chat.completion", "created": 1741571165, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial activation of AMPK may lead to a slight increase in energy levels and endurance, as the body begins to enhance glucose uptake and fatty acid oxidation.\",\n        \"Effect 2: Some users might notice a mild improvement in exercise performance, particularly in endurance activities, although significant changes are not yet expected.\",\n        \"Effect 3: Initial changes in biomarkers such as a slight decrease in blood glucose levels may be observed, but these changes are typically subtle at this stage.\",\n        \"Effect 4: Mental effects are generally minimal, but some users might experience a slight increase in mental clarity due to improved energy metabolism.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued activation of AMPK could lead to more noticeable improvements in endurance and stamina during physical activities.\",\n        \"Effect 2: Users may begin to experience a modest reduction in body fat as metabolic rate increases, although significant weight loss is unlikely at this stage.\",\n        \"Effect 3: Further improvements in blood glucose regulation might be observed, with potential reductions in fasting glucose levels.\",\n        \"Effect 4: Some users might experience mild gastrointestinal discomfort as a side effect, which could peak during this period.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Enhanced endurance and stamina become more pronounced, with users potentially noticing improved performance in aerobic exercises.\",\n        \"Effect 2: Weight management benefits may start to manifest more clearly, with some users observing gradual weight loss and changes in body composition.\",\n        \"Effect 3: Improvements in insulin sensitivity and blood sugar control could become more evident, particularly for individuals with metabolic concerns.\",\n        \"Effect 4: Cognitive effects such as improved focus and mental energy might be reported, likely due to better overall metabolic efficiency.\",\n        \"Effect 5: Any side effects, such as gastrointestinal issues, may begin to stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-8\",\n      \"effects\": [\n        \"Effect 1: Users may experience sustained improvements in endurance and physical performance, with some reaching a plateau in benefits.\",\n        \"Effect 2: Continued weight loss and fat reduction may be observed, particularly if combined with a healthy diet and exercise regimen.\",\n        \"Effect 3: Long-term improvements in metabolic health markers, such as lower fasting glucose and improved lipid profiles, might be more apparent.\",\n        \"Effect 4: Mental clarity and cognitive benefits may continue, although these effects can vary widely among individuals.\",\n        \"Effect 5: Any persistent side effects should be monitored, and users may need to adjust dosage or discontinue use if adverse effects outweigh benefits.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the typical effects observed with AMPK activation and similar compounds. Individual responses to AICAR can vary significantly, and the effects described are inferred from its mechanism of action and limited available research. Long-term use and high doses of AICAR may carry risks, and its use should be carefully monitored in a research setting.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 686, "completion_tokens": 672, "total_tokens": 1358, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a519ec819092e91339013dc683", "custom_id": "drug145_effects_timeline", "response": {"status_code": 200, "request_id": "91e623cbb2039e055a5695c4994d60ed", "body": {"id": "chatcmpl-B9MVS5CdFq3DvfzF5tYFDQ1I0UdVS", "object": "chat.completion", "created": 1741571166, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial reduction in nerve pain may be observed, particularly in conditions like diabetic neuropathy. This is due to Ara-290's action on specific receptors that help modulate pain.\",\n        \"Effect 2: Some users might notice a slight decrease in inflammation-related symptoms, such as reduced swelling or stiffness, as the compound begins to exert its anti-inflammatory effects.\",\n        \"Effect 3: No significant changes in cognitive function are expected at this stage, as Ara-290 primarily targets physical symptoms.\",\n        \"Effect 4: Biomarkers related to inflammation, such as C-reactive protein (CRP), might begin to show slight reductions, although significant changes might not be evident yet.\",\n        \"Effect 5: Side effects, if any, are likely to be mild and could include minor injection site reactions or transient fatigue.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in pain management, with users potentially experiencing more consistent relief from nerve pain.\",\n        \"Effect 2: Further reduction in inflammation may be observed, contributing to decreased pain and improved joint mobility.\",\n        \"Effect 3: Users might begin to notice subtle improvements in mood or mental well-being as chronic pain levels decrease.\",\n        \"Effect 4: Biomarkers of inflammation and tissue repair, such as interleukin-6 (IL-6) and other cytokines, may show more noticeable changes, indicating reduced inflammation and enhanced healing.\",\n        \"Effect 5: Side effects remain minimal, but users should monitor for any unusual symptoms and report them to their research team.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Significant pain relief is likely to be evident, with many users experiencing a marked reduction in neuropathic pain symptoms.\",\n        \"Effect 2: Enhanced wound healing and tissue repair might be noticeable, particularly in individuals recovering from injuries or surgeries.\",\n        \"Effect 3: Improved physical comfort can lead to better sleep quality and overall mental health, as chronic pain and inflammation are further reduced.\",\n        \"Effect 4: Continued positive changes in biomarkers related to inflammation and healing, supporting the observed physical improvements.\",\n        \"Effect 5: Side effects are generally mild and stable, with no new adverse effects expected to emerge at this stage.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained pain relief and inflammation reduction, with users likely experiencing significant improvements in quality of life.\",\n        \"Effect 2: Ongoing support for tissue repair and healing, beneficial for long-term recovery from chronic conditions or injuries.\",\n        \"Effect 3: Enhanced mental well-being due to reduced pain and improved physical function, potentially leading to increased activity levels.\",\n        \"Effect 4: Biomarkers should reflect continued low levels of inflammation and ongoing tissue repair processes.\",\n        \"Effect 5: Long-term side effects are not well-documented, but continued monitoring is advised to ensure safety and efficacy.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on limited available data and inferred effects from similar compounds. Ara-290's specific effects can vary depending on individual health conditions and the nature of the study. Researchers should closely monitor participants for any unexpected reactions and adjust protocols as necessary.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 665, "completion_tokens": 719, "total_tokens": 1384, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a529548190aee5409554a90110", "custom_id": "drug146_effects_timeline", "response": {"status_code": 200, "request_id": "fd68c5f2394f252e244030a9810ab7c3", "body": {"id": "chatcmpl-B9MVUndRXTZHMGUhxtRByfKpQ6eqQ", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial administration of B7-33 may not produce noticeable physical effects immediately, as the compound begins to interact with the relaxin pathway.\",\n        \"Effect 2: Some users might experience mild changes in inflammation markers, as the compound starts to exert its anti-inflammatory effects.\",\n        \"Effect 3: No significant mental or cognitive effects are expected at this stage, as B7-33 primarily targets physical tissue repair mechanisms.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight reduction in inflammation-related symptoms, such as decreased swelling or discomfort in affected areas.\",\n        \"Effect 2: Biomarkers related to collagen production might start to show minor changes, indicating the beginning of reduced fibrosis activity.\",\n        \"Effect 3: There may be a subtle improvement in wound healing rates, particularly in areas prone to excessive scarring.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable physical effects might include improved flexibility and reduced stiffness in tissues previously affected by fibrosis.\",\n        \"Effect 2: Continued reduction in inflammation markers, potentially leading to improved overall comfort and mobility.\",\n        \"Effect 3: Users might observe a more significant decrease in scar tissue formation, particularly in ongoing wound healing scenarios.\",\n        \"Effect 4: Side effects, if any, such as mild gastrointestinal discomfort or skin reactions, might begin to manifest but are generally expected to be minimal.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: The benefits of B7-33 in reducing fibrosis and promoting tissue repair are likely to become more pronounced, with users experiencing improved organ function in areas previously affected by scarring.\",\n        \"Effect 2: Biomarkers for collagen and fibrosis should show more substantial changes, reflecting the compound's ongoing impact on tissue remodeling.\",\n        \"Effect 3: Long-term side effects are not well-documented, but continued monitoring for any adverse reactions is recommended.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the expected mechanism of action of B7-33 and similar compounds that interact with the relaxin pathway. As B7-33 is still under research, specific effects and their onset may vary among individuals. Clinical trials and further studies are necessary to confirm these effects and establish a comprehensive safety profile.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 534, "total_tokens": 1210, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a53868819096fd4e2badbdd2a7", "custom_id": "drug148_effects_timeline", "response": {"status_code": 200, "request_id": "11a584d4bc5c15f0cf638c8057b901c8", "body": {"id": "chatcmpl-B9MVWvH5RDKtalPFlXcH94OubKVTj", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial relief in breathing difficulties may be noticeable as Bronchogen begins to relax airway muscles, leading to a slight improvement in airflow.\",\n        \"Effect 2: Users might experience a reduction in anxiety related to breathing issues due to the initial easing of symptoms.\",\n        \"Effect 3: Some users may notice a mild increase in heart rate as a side effect due to beta-2 adrenergic receptor activation.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Significant improvement in breathing efficiency and reduction in symptoms of asthma or COPD as airways remain more open.\",\n        \"Effect 2: Enhanced endurance and stamina during physical activities for athletes, as improved airflow supports better oxygen delivery.\",\n        \"Effect 3: Potential for mild side effects such as jitteriness or slight tremors due to systemic beta-2 receptor activation.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in respiratory function, with users experiencing more consistent relief from chronic symptoms.\",\n        \"Effect 2: Mental clarity and reduced cognitive fatigue as a result of improved oxygenation and reduced respiratory distress.\",\n        \"Effect 3: Biomarkers such as peak expiratory flow rate (PEFR) may show measurable improvement, indicating better lung function.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Stabilization of respiratory benefits, with users experiencing sustained ease in breathing and reduced frequency of acute episodes.\",\n        \"Effect 2: Further enhancement in athletic performance, with users potentially noticing improved recovery times post-exercise.\",\n        \"Effect 3: Side effects like increased heart rate or tremors may diminish as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits in managing chronic respiratory conditions, with a noticeable decrease in the need for rescue inhalers or emergency interventions.\",\n        \"Effect 2: Improved quality of life and daily functioning due to sustained respiratory relief and reduced anxiety.\",\n        \"Effect 3: Monitoring of biomarkers such as blood oxygen levels may show sustained improvements, reflecting better overall respiratory health.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the typical action of beta-2 adrenergic agonists and similar compounds. Individual responses may vary, and long-term use should be monitored for potential side effects such as cardiovascular strain. The effects described are inferred from the mechanism of action and similar compounds, as specific data on Bronchogen may be limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 686, "completion_tokens": 581, "total_tokens": 1267, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a5473c8190a2e4843784f98ca7", "custom_id": "drug149_effects_timeline", "response": {"status_code": 200, "request_id": "98c218604ed6f9719ec808746cbd9528", "body": {"id": "chatcmpl-B9MVUDEuhfskGoBK4wDhcHwB8RtwX", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight increase in energy levels and endurance, potentially enhancing exercise performance. This is likely due to the initial effects of increased nitric oxide production, improving blood flow.\",\n        \"Effect 2: Some users might experience mild calming effects, which could help in managing stress and anxiety. This effect is inferred based on the compound's potential impact on stress-related pathways.\",\n        \"Effect 3: Initial improvements in circulation might be observed, potentially leading to a slight reduction in blood pressure, although significant changes in biomarkers may not be evident yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced blood flow and reduced strain on the heart may become more noticeable, with users potentially experiencing improved cardiovascular endurance during physical activities.\",\n        \"Effect 2: Continued calming effects might contribute to better mental clarity and reduced anxiety levels, inferred from similar compounds with stress-reducing properties.\",\n        \"Effect 3: Users might start to observe measurable changes in blood pressure and heart rate, indicating improved cardiovascular function.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The anti-inflammatory properties of Cardiogen may begin to manifest, potentially reducing inflammation markers in the body, inferred from its mechanism of action.\",\n        \"Effect 2: Users might experience a more pronounced increase in energy levels and stamina, supporting longer and more intense exercise sessions.\",\n        \"Effect 3: Improvements in heart health and blood vessel function could lead to more stable blood pressure readings and enhanced overall cardiovascular health.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained energy levels, improved exercise performance, and enhanced cardiovascular health are likely to be more evident.\",\n        \"Effect 2: Users might notice a consistent reduction in stress and anxiety, contributing to better mental well-being.\",\n        \"Effect 3: Biomarkers such as blood pressure, heart rate, and inflammation levels might show significant improvements, reflecting the compound's cumulative effects.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Cardiogen's full potential in supporting heart health and physical fitness may be realized, with users experiencing optimal benefits in energy, endurance, and cardiovascular function.\",\n        \"Effect 2: Long-term use might lead to sustained mental clarity and reduced anxiety, inferred from the compound's calming effects.\",\n        \"Effect 3: Continued improvements in cardiovascular biomarkers, such as reduced blood pressure and inflammation markers, are likely to be observed.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the inferred effects of Cardiogen, as specific studies on this compound may be limited. Effects may vary among individuals, and the timeline is an approximation based on similar compounds and their mechanisms of action. Users should monitor for any adverse effects and consult with a healthcare professional if necessary.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 683, "completion_tokens": 649, "total_tokens": 1332, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a5555c8190857174d020d30096", "custom_id": "drug150_effects_timeline", "response": {"status_code": 200, "request_id": "3e182a734888cff61b5be0b9800dd575", "body": {"id": "chatcmpl-B9MVTNf6SrCMLraPp1xiIbkuqQTua", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects might include a slight reduction in joint discomfort due to the anti-inflammatory properties of peptides. However, significant changes in joint function are unlikely at this early stage.\",\n        \"Effect 2: Users may experience a placebo effect, feeling optimistic about potential improvements in joint health.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected yet, as the peptides begin to interact with cellular processes.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Some users might notice a gradual improvement in joint mobility and a slight decrease in stiffness, particularly in the morning.\",\n        \"Effect 2: Mental effects may include increased motivation to engage in physical activities due to perceived improvements in joint comfort.\",\n        \"Effect 3: Biomarkers related to inflammation, such as C-reactive protein (CRP), might begin to show slight reductions, although this is inferred from similar compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in joint function and flexibility may occur as peptides continue to support collagen production and tissue repair.\",\n        \"Effect 2: Users might experience enhanced overall mobility, contributing to a more active lifestyle.\",\n        \"Effect 3: Continued reduction in joint discomfort, with some users reporting less reliance on pain relief medications.\",\n        \"Effect 4: Side effects, if any, such as mild digestive discomfort, might begin to manifest but are generally not severe.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in joint health and function are expected, with users experiencing sustained reductions in discomfort and increased range of motion.\",\n        \"Effect 2: Enhanced mental well-being due to improved physical capabilities and reduced pain.\",\n        \"Effect 3: Biomarkers indicating joint health, such as cartilage oligomeric matrix protein (COMP), may show improvements, although this is inferred.\",\n        \"Effect 4: Anti-aging benefits, such as improved skin elasticity and connective tissue health, might begin to appear.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Users may reach a plateau in joint health improvements, maintaining benefits achieved in previous months.\",\n        \"Effect 2: Long-term users might notice sustained improvements in overall mobility and flexibility.\",\n        \"Effect 3: Continued monitoring of biomarkers may show stable improvements in joint health indicators.\",\n        \"Effect 4: Any side effects are likely to have stabilized or diminished by this period.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar peptide-based compounds, as specific clinical data on Cartalax is limited. Individual responses may vary, and the presence of side effects or the rate of improvement can differ based on personal health conditions and concurrent treatments.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 628, "completion_tokens": 637, "total_tokens": 1265, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a566308190b774fa0c7e71929b", "custom_id": "drug151_effects_timeline", "response": {"status_code": 200, "request_id": "1b774c2336837e4167f803defb6707ed", "body": {"id": "chatcmpl-B9MVSGQGF6AsMyHJLFo75fTKPrmXo", "object": "chat.completion", "created": 1741571166, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle improvements in mental clarity and focus. This is due to the initial action of growth factors promoting neural activity.\",\n        \"Effect 2: Some individuals may experience a slight increase in energy levels and motivation, potentially linked to enhanced neurotransmitter function.\",\n        \"Effect 3: Initial mild side effects such as headache or dizziness might occur as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Cognitive improvements, such as better memory recall and attention span, may become more noticeable as neuroplasticity is enhanced.\",\n        \"Effect 2: Users recovering from neurological events like strokes might start to observe slight improvements in rehabilitation progress.\",\n        \"Effect 3: Some users may report improved mood and reduced anxiety, potentially due to enhanced brain function and neuroprotection.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued cognitive benefits, with more pronounced improvements in memory and learning capabilities.\",\n        \"Effect 2: For Alzheimer's patients, there might be a noticeable slowing in the progression of memory loss.\",\n        \"Effect 3: Biomarkers such as brain-derived neurotrophic factor (BDNF) levels might show slight increases, indicating enhanced neurogenesis.\",\n        \"Effect 4: Side effects, if present, typically stabilize or diminish as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained cognitive enhancements, with users experiencing significant improvements in mental clarity and cognitive resilience.\",\n        \"Effect 2: Stroke recovery patients may see more substantial gains in physical and cognitive rehabilitation.\",\n        \"Effect 3: Long-term users might report improved overall brain health and resilience, with fewer cognitive lapses.\",\n        \"Effect 4: Any initial side effects are likely to have resolved, with a stable side effect profile.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Cerebrolysin can vary significantly between individuals due to differences in baseline cognitive function, the severity of neurological conditions, and individual physiological responses. The effects described are based on documented research and inferred from the compound's mechanism of action. Long-term safety and efficacy are still under investigation, and users should be monitored for any adverse effects throughout the treatment period.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 662, "completion_tokens": 528, "total_tokens": 1190, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a575988190896334b1124b2cdc", "custom_id": "drug152_effects_timeline", "response": {"status_code": 200, "request_id": "86e1179cd9c4e1cb1905e0916b0754b1", "body": {"id": "chatcmpl-B9MVTehpV9OEIujMUZIrFeT7zH5cr", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a slight improvement in breathing ease, particularly noticeable in individuals with mild respiratory issues. This is due to the early action of peptides on lung tissue repair.\",\n        \"Effect 2: Some users might experience a subtle increase in energy levels and endurance during physical activities, although this is more likely to be psychological as the body begins to respond to the compound.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\",\n        \"Effect 4: Side effects, if any, might include mild gastrointestinal discomfort as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users may start to notice a reduction in respiratory symptoms such as shortness of breath and coughing, particularly in those with chronic conditions.\",\n        \"Effect 2: Improved mental clarity and focus might be observed as a secondary effect of enhanced oxygenation and respiratory function.\",\n        \"Effect 3: Biomarkers related to lung function, such as peak expiratory flow rate, might show slight improvements.\",\n        \"Effect 4: Skin health benefits, such as increased elasticity, may begin to appear, although these effects are typically subtle at this stage.\",\n        \"Effect 5: Any initial side effects are likely to stabilize or diminish as the body acclimates to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in lung function and respiratory health, with more noticeable reductions in symptoms for individuals with asthma or chronic bronchitis.\",\n        \"Effect 2: Enhanced physical endurance and performance during exercise, as lung capacity and efficiency improve.\",\n        \"Effect 3: Users might observe further improvements in skin texture and firmness due to increased collagen production.\",\n        \"Effect 4: Mental effects such as improved mood and cognitive function may become more pronounced as overall health improves.\",\n        \"Effect 5: Side effects remain minimal, with most users experiencing no adverse reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in chronic respiratory conditions, with many users reporting a substantial decrease in the frequency and severity of symptoms.\",\n        \"Effect 2: Long-term skin benefits become more evident, with noticeable reductions in wrinkles and sagging.\",\n        \"Effect 3: Biomarkers such as lung function tests and skin elasticity measurements may show marked improvements.\",\n        \"Effect 4: Users may experience sustained increases in physical and mental performance, contributing to overall well-being.\",\n        \"Effect 5: Any side effects are typically well-managed and rare at this stage.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the general mechanisms of action of peptides similar to Chonluten and anecdotal reports. As Chonluten is a research chemical, comprehensive clinical data is limited. Effects can vary significantly based on individual health conditions, dosage, and duration of use. Researchers should exercise caution and conduct thorough monitoring when using this compound.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 681, "completion_tokens": 666, "total_tokens": 1347, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a583a081909180e1de3b73e91f", "custom_id": "drug153_effects_timeline", "response": {"status_code": 200, "request_id": "dbf40dea517530be0263403912bcf4b5", "body": {"id": "chatcmpl-B9MVaKMbKGqGbmHLXKhtuKpVMcjZS", "object": "chat.completion", "created": 1741571174, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice slight improvements in sleep quality, feeling more rested upon waking. This is due to the initial increase in growth hormone levels.\",\n        \"Effect 2: Some users might experience a mild increase in energy levels and a slight improvement in mood, attributed to better sleep and hormonal balance.\",\n        \"Effect 3: Initial changes in biomarkers such as a slight increase in IGF-1 levels might be observed, indicating the compound's activity in stimulating growth hormone release.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as enhanced recovery times from workouts may start to become noticeable, allowing for more frequent and intense training sessions.\",\n        \"Effect 2: Users might begin to observe subtle improvements in skin texture and hydration, as growth hormone can influence skin health.\",\n        \"Effect 3: Continued increase in IGF-1 levels, which may be measured through blood tests, reflecting ongoing stimulation of growth hormone release.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced muscle growth and strength gains may be observed, especially in conjunction with resistance training.\",\n        \"Effect 2: Users might experience further improvements in sleep quality and cognitive function, including better focus and mental clarity.\",\n        \"Effect 3: Fat loss effects may start to become noticeable, particularly in individuals with a higher baseline body fat percentage.\",\n        \"Effect 4: Some users might begin to experience side effects such as water retention or joint pain, which are common with increased growth hormone levels.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in muscle mass and reduction in body fat may be evident, contributing to a more defined physique.\",\n        \"Effect 2: Enhanced recovery and reduced muscle soreness continue to support more frequent and effective training sessions.\",\n        \"Effect 3: Users may report sustained improvements in skin health, including reduced wrinkles and a more youthful appearance.\",\n        \"Effect 4: Side effects such as carpal tunnel syndrome or numbness in extremities might manifest or peak, requiring monitoring and potential adjustment of dosage.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term users may experience plateauing of benefits, as the body adjusts to the elevated growth hormone levels.\",\n        \"Effect 2: Continued maintenance of muscle mass and low body fat percentage with ongoing training and diet.\",\n        \"Effect 3: Persistent improvements in overall well-being, energy levels, and sleep quality.\",\n        \"Effect 4: Monitoring for long-term side effects is crucial, as prolonged use of growth hormone analogs can lead to complications such as insulin resistance.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed in users of growth hormone-releasing peptides and may vary depending on individual factors such as dosage, frequency of administration, and personal health conditions. Effects are inferred from the known mechanisms of action of CJC-1295 DAC and similar compounds. It is important to conduct regular health assessments and consult with a healthcare professional during research involving this compound.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 701, "total_tokens": 1392, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a591408190a00dea5e4a52139f", "custom_id": "drug154_effects_timeline", "response": {"status_code": 200, "request_id": "8c528995b326c5093bce2efc595bfc0b", "body": {"id": "chatcmpl-B9MVYnlRbFoShSL9Cgdofuu5aH2sM", "object": "chat.completion", "created": 1741571172, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may be subtle, with some users potentially noticing slight improvements in energy levels and overall alertness.\",\n        \"Effect 2: Early mental effects could include a mild enhancement in focus and concentration, as the compound begins to interact with neural receptors.\",\n        \"Effect 3: Biomarkers such as stress hormone levels might start to show minor changes, but these would likely be within normal variability ranges.\",\n        \"Effect 4: Initial mood improvements could be observed, with some users reporting a slight reduction in anxiety or depressive symptoms.\",\n        \"Effect 5: Side effects, if any, might include mild headaches or gastrointestinal discomfort as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical effects may become more noticeable, with increased energy and a sense of well-being.\",\n        \"Effect 2: Cognitive enhancements, such as improved memory recall and learning capacity, might start to manifest more clearly.\",\n        \"Effect 3: Biomarkers related to neural growth factors could begin to show slight increases, indicating potential neuroprotective effects.\",\n        \"Effect 4: Users might experience more pronounced mood stabilization and reduced anxiety levels.\",\n        \"Effect 5: Side effects, if present, may stabilize or decrease as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Physical stamina and resilience might continue to improve, with users feeling more physically capable and less fatigued.\",\n        \"Effect 2: Cognitive benefits such as enhanced problem-solving skills and quicker information processing could become more evident.\",\n        \"Effect 3: Biomarkers indicating reduced oxidative stress or inflammation might be observed, suggesting protective effects on brain cells.\",\n        \"Effect 4: Significant improvements in mood and emotional regulation could be reported, with users feeling more balanced and positive.\",\n        \"Effect 5: Any initial side effects are likely to have diminished, though individual responses can vary.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained physical and cognitive improvements, with users potentially experiencing peak benefits in energy, focus, and mental clarity.\",\n        \"Effect 2: Long-term cognitive enhancements, such as improved long-term memory and learning retention, may become more pronounced.\",\n        \"Effect 3: Biomarkers related to neural repair and growth could show more significant changes, supporting the compound's neuroprotective claims.\",\n        \"Effect 4: Continued mood stabilization and reduction in anxiety or depressive symptoms, contributing to overall mental well-being.\",\n        \"Effect 5: Side effects are generally minimal, but long-term monitoring is advised to ensure safety and efficacy.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar neuroprotective peptides and compounds, as specific documented studies on Cortagen are limited. Individual responses can vary widely, and long-term effects are still under investigation. Researchers should monitor subjects closely for any adverse reactions and adjust dosages accordingly.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 667, "completion_tokens": 666, "total_tokens": 1333, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a5a0508190882fd951304f3678", "custom_id": "drug155_effects_timeline", "response": {"status_code": 200, "request_id": "50e0754580c4d76f65365cb02991e1f0", "body": {"id": "chatcmpl-B9MVURV6iODBNnkxzGkHNUDOcALoQ", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of Decapeptide-12 may result in slight skin irritation or redness as the skin adjusts to the new compound. This is a common initial reaction to new skincare ingredients.\",\n        \"Effect 2: Users might notice a slight improvement in skin texture as the peptide begins to interact with the skin's surface, although significant changes in pigmentation are unlikely at this stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Some users may start to notice a subtle reduction in the intensity of dark spots or hyperpigmentation as melanin production begins to decrease.\",\n        \"Effect 2: Skin may appear slightly more radiant and even-toned, although these changes are typically mild and gradual.\",\n        \"Effect 3: Continued mild irritation or dryness might be experienced, particularly in individuals with sensitive skin.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in skin tone and a reduction in the appearance of dark spots are likely to become apparent as the inhibitory effects on tyrosinase accumulate.\",\n        \"Effect 2: Users may experience increased confidence due to visible improvements in skin appearance, although this is a subjective mental effect.\",\n        \"Effect 3: Any initial irritation should begin to subside as the skin acclimates to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Significant lightening of hyperpigmented areas and a more uniform skin tone are typically observed by this time, with many users reporting a clearer and more luminous complexion.\",\n        \"Effect 2: The risk of new dark spots forming is reduced due to ongoing suppression of melanin production.\",\n        \"Effect 3: Skin may feel smoother and appear healthier overall, contributing to a youthful appearance.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3 and beyond\",\n      \"effects\": [\n        \"Effect 1: Maximum benefits in terms of skin lightening and evenness are generally achieved, with maintenance of results dependent on continued use.\",\n        \"Effect 2: Long-term users may notice sustained improvements in skin texture and tone, with minimal side effects if the compound is well-tolerated.\",\n        \"Effect 3: Any side effects such as irritation are typically resolved, and the compound is integrated into the user's skincare routine.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses to topical peptides that target melanin production. Individual results may vary based on skin type, concentration of Decapeptide-12 in the formulation, and frequency of use. The effects described are inferred from the mechanism of action of Decapeptide-12 and similar compounds, as specific clinical data on this peptide may be limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 677, "completion_tokens": 612, "total_tokens": 1289, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a5af108190abb44f3695149a16", "custom_id": "drug156_effects_timeline", "response": {"status_code": 200, "request_id": "b750a9a20abf674648ea9d632feb26ea", "body": {"id": "chatcmpl-B9MVWwkGPvm7QLawR3wa85nrUcNTO", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial cognitive enhancement may begin to be noticeable, with slight improvements in focus and mental clarity. Users might experience a subtle increase in alertness and concentration.\",\n        \"Effect 2: Some users may notice a mild mood lift, feeling slightly more positive and less anxious, although these effects are typically subtle at this early stage.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected within this short timeframe.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Cognitive benefits such as improved memory retention and sharper focus become more pronounced. Users may find it easier to concentrate on tasks and retain information.\",\n        \"Effect 2: Enhanced mood and reduced anxiety might become more noticeable, with users feeling more at ease in social situations and experiencing a general sense of calm.\",\n        \"Effect 3: Some users might begin to experience mild side effects such as headaches or slight insomnia, as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in cognitive functions, with users experiencing sustained focus and mental clarity. Learning capabilities may be enhanced, making it easier to absorb new information.\",\n        \"Effect 2: Mood-lifting effects are more consistent, potentially helping users with mild symptoms of depression to maintain a more positive outlook.\",\n        \"Effect 3: Biomarkers related to neurotransmitter activity, such as dopamine and serotonin levels, might show slight alterations, although these are typically not measured outside of a clinical setting.\",\n        \"Effect 4: Side effects, if present, may stabilize or diminish as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Cognitive enhancements reach a stable level, with users consistently experiencing improved memory, focus, and mental clarity.\",\n        \"Effect 2: Emotional well-being is likely to be more balanced, with reduced anxiety and stress levels, contributing to a more relaxed state of mind.\",\n        \"Effect 3: Users might notice improved social interactions due to reduced anxiety and enhanced mood.\",\n        \"Effect 4: Any initial side effects are likely to have subsided, but if persistent, users should consider evaluating dosage or discontinuing use.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed with cognitive enhancers affecting dopamine and serotonin pathways. Individual experiences may vary, and not all users will experience every effect. The effects described are inferred from the compound's mechanism of action and similar compounds, as specific studies on Proxofim may be limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 675, "completion_tokens": 583, "total_tokens": 1258, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a5bc2c8190a74835ecb105a9cd", "custom_id": "drug157_effects_timeline", "response": {"status_code": 200, "request_id": "68559b3337181e232ac316db4132f104", "body": {"id": "chatcmpl-B9MVgaJa4CaNRf3DmMOqWuTyYdpJE", "object": "chat.completion", "created": 1741571180, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvements in mood, as growth hormone levels begin to rise.\",\n        \"Effect 2: Some users may notice slight improvements in sleep quality, as growth hormone can influence sleep patterns.\",\n        \"Effect 3: No significant changes in muscle mass or fat reduction are expected at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued increase in energy and potential improvements in cognitive function, such as better focus and mental clarity.\",\n        \"Effect 2: Early signs of enhanced recovery from exercise or minor injuries may begin to appear, as tissue repair processes are supported.\",\n        \"Effect 3: Some users might start to notice subtle changes in skin texture, although significant improvements are not expected yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Noticeable improvements in muscle tone and slight reductions in body fat may begin to manifest, as growth hormone levels stabilize.\",\n        \"Effect 2: Enhanced recovery times from physical activity become more apparent, with reduced muscle soreness.\",\n        \"Effect 3: Skin may start to appear healthier and more vibrant due to increased cell renewal.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in muscle mass and strength are likely, especially if combined with resistance training.\",\n        \"Effect 2: Continued fat loss and improved body composition become more evident.\",\n        \"Effect 3: Skin texture and appearance may show more noticeable improvements, with a smoother and more youthful look.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3\",\n      \"effects\": [\n        \"Effect 1: Peak benefits in terms of muscle growth and fat reduction are typically observed around this time.\",\n        \"Effect 2: Cognitive benefits, such as improved memory and concentration, may be more pronounced.\",\n        \"Effect 3: Any side effects, such as joint pain or swelling, might become more noticeable if they occur, although these are not common.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline and effects described are based on general observations and may vary between individuals. The effects of GHRH can be influenced by factors such as dosage, individual health status, and concurrent use of other compounds. Some effects are inferred based on the mechanism of action and similar compounds, as specific longitudinal studies on GHRH alone are limited. Users should be aware of potential side effects and consult with a healthcare professional before use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 562, "total_tokens": 1249, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a5cccc8190ab451b492fb9ab28", "custom_id": "drug158_effects_timeline", "response": {"status_code": 200, "request_id": "3ea747120a8d4ca46335f13af64e0f3b", "body": {"id": "chatcmpl-B9MVUuurORSmvz1WTECiaYugYT0vv", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial cellular protective effects may begin, with humanin starting to bind to cell receptors and initiating protective pathways. This might not be noticeable physically but could be occurring at a cellular level.\",\n        \"Effect 2: Some users might experience a slight increase in energy levels as cells begin to cope better with oxidative stress, although this is more inferred from its mechanism rather than documented.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued cellular protection could lead to subtle improvements in muscle recovery and endurance, inferred from humanin's potential role in preserving muscle function.\",\n        \"Effect 2: Cognitive effects might start to become noticeable, such as improved mental clarity or focus, as humanin supports brain cell health, though this is largely speculative at this stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Potential improvements in cardiovascular health markers, such as reduced oxidative stress markers in blood tests, might begin to appear, inferred from humanin's protective effects on heart cells.\",\n        \"Effect 2: Users might notice a slight improvement in overall well-being and reduced fatigue, as cellular resilience continues to build.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: More pronounced cognitive benefits could be observed, such as better memory retention and cognitive processing, as neuroprotective effects accumulate.\",\n        \"Effect 2: Muscle strength and function might show noticeable improvements, particularly in older individuals, as humanin helps preserve muscle tissue.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term cardiovascular benefits might become more evident, with potential reductions in risk factors for heart-related issues, inferred from ongoing cellular protection.\",\n        \"Effect 2: Sustained cognitive and physical benefits, with users potentially experiencing a higher quality of life due to improved cellular health.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for humanin is largely inferred from its proposed mechanisms and effects observed in preclinical studies. Humanin's effects in humans are still under investigation, and individual responses may vary. Side effects are not well-documented, but as with any compound, monitoring for adverse reactions is advised. This timeline is speculative and should be used as a guide for research purposes only.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 677, "completion_tokens": 532, "total_tokens": 1209, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a5db2881908148ff32b12b2de0", "custom_id": "drug159_effects_timeline", "response": {"status_code": 200, "request_id": "3b84b661aa5574c7bd148662e6f3ab4a", "body": {"id": "chatcmpl-B9MVVaQbkfxBQbkdwkrJqmwFbQZ8g", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial antibacterial effects may begin to manifest, with lipopeptides starting to disrupt bacterial cell membranes, leading to a reduction in bacterial load.\",\n        \"Effect 2: Users might notice minor skin irritation or redness at the site of application if used topically, as the compound begins to interact with skin cells.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Enhanced antibacterial activity continues, potentially leading to noticeable improvements in infection symptoms, such as reduced redness, swelling, or pain in affected areas.\",\n        \"Effect 2: Early signs of wound healing might be observed, including reduced inflammation and beginning stages of new skin cell growth.\",\n        \"Effect 3: Biomarkers such as white blood cell count may start to normalize as the immune response is modulated.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in wound healing, with more significant skin regeneration and closure of wounds.\",\n        \"Effect 2: Users might experience enhanced skin texture and elasticity if used in skincare applications.\",\n        \"Effect 3: Potential cognitive effects could include a slight increase in mental clarity or focus due to reduced systemic inflammation, although this is inferred and not well-documented.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Peak antibacterial effects, with most bacterial infections significantly reduced or cleared.\",\n        \"Effect 2: Further improvement in skin condition, with visible rejuvenation and reduction in scars or blemishes.\",\n        \"Effect 3: If used in cancer research contexts, early signs of tumor reduction might be observed, though this is highly variable and context-dependent.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits in skin health and appearance may become more pronounced, with sustained use leading to ongoing skin cell regeneration.\",\n        \"Effect 2: Any side effects such as skin irritation or allergic reactions may have either resolved or stabilized by this point.\",\n        \"Effect 3: Continued monitoring of physiological markers such as immune response indicators may show sustained improvement.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on general mechanisms of action and effects observed in similar compounds. Specific effects and their onset can vary widely depending on the formulation, dosage, and individual user response. Clinical data on lipopeptides is still emerging, and many effects, particularly those related to cancer treatment, are inferred from preliminary research and should be interpreted with caution.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 662, "completion_tokens": 573, "total_tokens": 1235, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a5e96c8190bc50d66a55611db7", "custom_id": "drug160_effects_timeline", "response": {"status_code": 200, "request_id": "bc3d0aff3a5a3f55a5dbbdf0137754ec", "body": {"id": "chatcmpl-B9MVTGEHDq9YeyJZBweMzsoBQnOFs", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial adjustment period where users might experience mild nausea or gastrointestinal discomfort as the body adapts to the medication. This is a common side effect when starting liraglutide.\",\n        \"Effect 2: Some users may notice a slight decrease in appetite, which is part of the weight management benefits of liraglutide.\",\n        \"Effect 3: Blood sugar levels may begin to stabilize, with potential reductions in postprandial glucose spikes.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in appetite, leading to potential early signs of weight loss as caloric intake decreases.\",\n        \"Effect 2: Users might experience improved glycemic control, with more consistent blood sugar readings.\",\n        \"Effect 3: Mild nausea may persist but often starts to subside as the body adjusts to the medication.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Noticeable weight loss may begin to manifest, especially in individuals who are also following a calorie-restricted diet.\",\n        \"Effect 2: Enhanced feeling of satiety after meals, contributing to reduced overall food intake.\",\n        \"Effect 3: Blood sugar levels continue to improve, with potential reductions in HbA1c becoming more apparent.\",\n        \"Effect 4: Any initial side effects like nausea or gastrointestinal issues typically decrease significantly by this time.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained weight loss is likely, with users potentially seeing significant changes in body composition.\",\n        \"Effect 2: Improved cardiovascular markers may begin to appear, such as reduced blood pressure and improved lipid profiles, especially in users with type 2 diabetes and heart disease.\",\n        \"Effect 3: Continued stabilization of blood glucose levels, with further reductions in HbA1c.\",\n        \"Effect 4: Users may experience increased energy levels and improved overall well-being as a result of better glycemic control and weight loss.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as reduced risk of cardiovascular events (e.g., heart attacks, strokes) become more pronounced in users with type 2 diabetes and heart disease.\",\n        \"Effect 2: Continued maintenance of weight loss, with potential plateauing as the body adjusts to the new weight.\",\n        \"Effect 3: Further improvements in metabolic health markers, including insulin sensitivity and lipid profiles.\",\n        \"Effect 4: Most users experience minimal side effects at this stage, with the medication being well-tolerated.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for liraglutide can vary based on individual factors such as dosage, adherence to treatment, lifestyle changes, and baseline health conditions. The initial side effects like nausea are common but typically resolve within the first few weeks. The weight loss and glycemic control benefits are more pronounced with concurrent lifestyle modifications such as diet and exercise. Cardiovascular benefits are more relevant for users with pre-existing heart conditions.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 690, "completion_tokens": 684, "total_tokens": 1374, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a5f75881909d22a6197dbf05a9", "custom_id": "drug161_effects_timeline", "response": {"status_code": 200, "request_id": "277bb622b7f9b3c1716aff95424c7a71", "body": {"id": "chatcmpl-B9MVajdolPck3Uj28kCXR5LPxpTmT", "object": "chat.completion", "created": 1741571174, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels and a general sense of well-being. This is likely due to the initial engagement of Livagen with cellular processes that promote repair and vitality.\",\n        \"Effect 2: Some users may experience a mild improvement in mental clarity and focus as the compound starts to influence cognitive functions.\",\n        \"Effect 3: Initial changes in biomarkers such as slight improvements in skin hydration or elasticity might be observed, although these changes are typically subtle at this stage.\",\n        \"Effect 4: Side effects, if any, are generally minimal during the first week, but some users might experience mild headaches or gastrointestinal discomfort as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as enhanced skin appearance may become more noticeable, with users reporting smoother or more radiant skin.\",\n        \"Effect 2: Cognitive benefits, including sharper focus and improved memory recall, might become more pronounced as Livagen continues to support neuronal health.\",\n        \"Effect 3: Biomarkers related to oxidative stress or inflammation might show slight improvements, indicating a reduction in these processes.\",\n        \"Effect 4: Users might start to feel more energetic and less fatigued, aligning with the compound's reputation for boosting vitality.\",\n        \"Effect 5: Side effects remain minimal for most users, but those sensitive to peptides might experience transient symptoms like mild nausea.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The rejuvenating effects on the skin are likely to be more evident, with users observing a reduction in fine lines and improved skin tone.\",\n        \"Effect 2: Mental clarity and cognitive performance continue to improve, potentially leading to enhanced productivity and concentration.\",\n        \"Effect 3: Physiological measurements such as improved sleep quality or reduced markers of cellular aging might be observed, although these changes can vary widely among individuals.\",\n        \"Effect 4: The compound's benefits in slowing down the aging process might start to manifest more clearly, with users feeling more youthful and vibrant.\",\n        \"Effect 5: Any side effects are generally mild and tend to stabilize, with most users not experiencing significant adverse reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term users may notice sustained improvements in skin health and appearance, with ongoing benefits in elasticity and hydration.\",\n        \"Effect 2: Cognitive enhancements are likely to be well-established, with users experiencing consistent mental sharpness and reduced brain fog.\",\n        \"Effect 3: Biomarkers related to cellular health, such as telomere length or antioxidant levels, might show positive trends, although these require specific testing to confirm.\",\n        \"Effect 4: Overall vitality and energy levels are typically high, with users reporting a general sense of well-being and resilience.\",\n        \"Effect 5: Side effects are rare at this stage, but continued monitoring is advised to ensure no delayed adverse reactions occur.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects of Livagen are inferred based on its proposed mechanisms of action and similarities to other peptides with regenerative properties. Individual responses can vary significantly, and more research is needed to fully understand the compound's long-term effects and safety profile. Users should consult with a healthcare professional before starting any new supplement regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 655, "completion_tokens": 728, "total_tokens": 1383, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a60584819084fd3c752075dbf0", "custom_id": "drug162_effects_timeline", "response": {"status_code": 200, "request_id": "03bf4828c09afb9bb8f3e5dda16ea377", "body": {"id": "chatcmpl-B9MViPuehncoauEjHP350VHJGI4UT", "object": "chat.completion", "created": 1741571182, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might notice a slight increase in energy levels and overall vitality, although these changes could be subtle.\",\n        \"Effect 2: Some users may experience mild improvements in mental clarity and focus, as the compound begins to influence cognitive processes.\",\n        \"Effect 3: Initial changes in biomarkers such as reduced oxidative stress markers might be observed, although these would typically require laboratory testing to confirm.\",\n        \"Effect 4: No significant side effects are expected to manifest at this early stage, but some users might experience mild digestive discomfort as the body adjusts.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-4\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as improved skin texture and resilience may start to become noticeable, as cellular repair mechanisms are enhanced.\",\n        \"Effect 2: Users might experience further improvements in memory and concentration, with cognitive benefits becoming more pronounced.\",\n        \"Effect 3: Biomarkers related to inflammation and cellular health, such as C-reactive protein levels, might show improvement.\",\n        \"Effect 4: Benefits related to heart health, such as improved circulation, may begin to manifest, although these changes are typically gradual.\",\n        \"Effect 5: Any initial side effects are likely to stabilize, with most users not experiencing significant adverse effects.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users may notice a more youthful appearance, with healthier skin and potentially improved hair quality.\",\n        \"Effect 2: Enhanced cognitive functions, including better problem-solving skills and quicker mental processing, might be evident.\",\n        \"Effect 3: Continued improvements in biomarkers related to cellular repair and autophagy, such as increased levels of sirtuins, could be observed.\",\n        \"Effect 4: The compound's protective effects on heart health might become more apparent, with potential reductions in blood pressure and cholesterol levels.\",\n        \"Effect 5: Any side effects are expected to be minimal, with most users tolerating the compound well.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Users might experience sustained improvements in physical vitality and endurance, contributing to a more active lifestyle.\",\n        \"Effect 2: Long-term cognitive benefits, including enhanced memory retention and reduced cognitive decline, could be more pronounced.\",\n        \"Effect 3: Significant improvements in biomarkers of aging, such as telomere length and mitochondrial function, might be observed.\",\n        \"Effect 4: The compound's full range of benefits, including robust heart health and reduced risk of age-related diseases, are likely to be more evident.\",\n        \"Effect 5: Side effects remain minimal, with the compound being well-tolerated by most users.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline and effects described are based on educated inferences from similar compounds and mechanisms of action, as specific data on Longevity is limited. Individual responses may vary, and long-term studies are needed to confirm these potential benefits and side effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 674, "completion_tokens": 659, "total_tokens": 1333, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a615c081908df2e6497f552123", "custom_id": "drug163_effects_timeline", "response": {"status_code": 200, "request_id": "7e6d9460dadc2327eebd7b0c9b284895", "body": {"id": "chatcmpl-B9MVUuDzgGgjPkDI0UaBRQQqLTPbB", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application may lead to slight skin irritation or redness as the skin adjusts to the compound. This is inferred based on typical responses to topical skin treatments.\",\n        \"Effect 2: No significant changes in skin tone or hair growth are expected yet, as the compound begins to interact with tyrosinase enzymes.\",\n        \"Effect 3: Users might notice a slight increase in skin sensitivity, particularly to sunlight, due to the inhibition of melanin production.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Some users may start to notice a subtle lightening of dark spots or hyperpigmented areas, although this is likely minimal at this stage.\",\n        \"Effect 2: Continued mild skin irritation or dryness might occur as the skin adapts to the compound.\",\n        \"Effect 3: No significant changes in hair growth patterns are expected yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable lightening of skin tone may begin for some users, particularly in areas with hyperpigmentation.\",\n        \"Effect 2: Users might start to observe a more even skin tone, with reduced contrast between dark spots and surrounding skin.\",\n        \"Effect 3: Initial signs of slowed hair growth may become apparent, especially in areas where the compound is applied regularly.\",\n        \"Effect 4: Any initial skin irritation should begin to subside as the skin acclimates to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Significant improvement in skin lightening and evenness of skin tone is expected for most users.\",\n        \"Effect 2: Continued reduction in the appearance of dark spots and sun damage.\",\n        \"Effect 3: More pronounced effects on hair growth reduction may be observed, with slower regrowth in treated areas.\",\n        \"Effect 4: Users may experience increased confidence or satisfaction with their skin appearance, although this is subjective and inferred.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3 and beyond\",\n      \"effects\": [\n        \"Effect 1: Maximum skin lightening effects are likely reached, with maintenance of results dependent on continued use.\",\n        \"Effect 2: Sustained reduction in unwanted hair growth, with potential for longer-term management of hair growth patterns.\",\n        \"Effect 3: Any side effects such as skin irritation should be minimal if the compound is well-tolerated.\",\n        \"Effect 4: Long-term use may require monitoring for any delayed side effects or skin sensitivity issues.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses to skin-lightening agents and tyrosinase inhibitors. Individual responses can vary widely based on skin type, concentration of the compound, and application frequency. Inferred effects are noted where direct data on Melanostatindm is limited, and comparisons are made with similar compounds like hydroquinone or kojic acid. Users should be cautious of potential skin sensitivity and consult with a dermatologist for personalized advice.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 671, "total_tokens": 1356, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a62480819090346129295ed0c7", "custom_id": "drug164_effects_timeline", "response": {"status_code": 200, "request_id": "aed2d01277555787016cedd4d2179977", "body": {"id": "chatcmpl-B9MVVsZm2y21L9wboQI6gQ1Fopf69", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in muscle protein synthesis may begin, but physical changes in muscle size or strength are unlikely to be noticeable yet.\",\n        \"Effect 2: Some users might experience a slight increase in energy levels or motivation due to the anticipation of starting a new regimen, though this is more psychological than physiological.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start to notice slight improvements in muscle recovery times, allowing for more frequent or intense workouts.\",\n        \"Effect 2: Some users could experience a mild increase in muscle fullness or 'pump' during workouts, though this is subtle.\",\n        \"Effect 3: Initial changes in biomarkers such as increased levels of IGF-1 in the blood might be detectable, though this would require specific testing.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle recovery and slight increases in muscle strength or endurance may begin to manifest.\",\n        \"Effect 2: Users might experience enhanced mood or cognitive focus, potentially due to improved physical performance and recovery.\",\n        \"Effect 3: Continued increase in IGF-1 levels and possible changes in muscle-related biomarkers such as creatine kinase, indicating enhanced muscle repair.\",\n        \"Effect 4: Benefits related to muscle growth and repair, as mentioned in 'what it does', may start to become more apparent.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in muscle mass and strength could be observed, especially if combined with a rigorous training program.\",\n        \"Effect 2: Enhanced recovery times and reduced muscle soreness after workouts are likely to be more pronounced.\",\n        \"Effect 3: Potential side effects such as joint pain or swelling might begin to manifest, though this varies among individuals.\",\n        \"Effect 4: Users might notice a plateau in the rate of muscle gains as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3 and beyond\",\n      \"effects\": [\n        \"Effect 1: Continued maintenance of muscle mass and strength gains achieved in earlier months, with diminishing returns if no changes in training or dosage are made.\",\n        \"Effect 2: Long-term users might experience more pronounced side effects, such as insulin resistance or changes in glucose metabolism, if not monitored properly.\",\n        \"Effect 3: Sustained improvements in muscle recovery and reduced injury risk due to stronger muscle fibers.\",\n        \"Effect 4: Potential need to cycle off the compound to prevent receptor desensitization and maintain efficacy.\"\n      ]\n    }\n  ],\n  \"notes\": \"The effects and timeline described are based on the general mechanisms of action of IGF-1 related compounds and anecdotal reports, as specific clinical data on MGF-IGF-1Ec is limited. Individual responses can vary significantly based on factors such as dosage, frequency of use, individual physiology, and concurrent training regimens. Users should monitor for side effects and consult with a healthcare professional for personalized advice.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 678, "completion_tokens": 693, "total_tokens": 1371, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a632fc819098a77ab3b950ba40", "custom_id": "drug168_effects_timeline", "response": {"status_code": 200, "request_id": "2ebcefd9b55d55fa8a7b111ee715c97b", "body": {"id": "chatcmpl-B9MVT8Xarlz98WjwfPjQrd2kxTkPP", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial improvements in sleep onset latency may be observed, with users potentially falling asleep more quickly due to the compound's interaction with melatonin receptors. This effect is inferred based on its mechanism of action.\",\n        \"Effect 2: Some users might experience a mild improvement in mood and mental clarity, as the compound begins to exert its antioxidant effects, though these changes are likely subtle at this stage.\",\n        \"Effect 3: There may be a slight reduction in markers of inflammation, such as C-reactive protein (CRP), as the compound starts to exert its anti-inflammatory properties. This is an inferred effect based on similar compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in sleep quality, with users potentially experiencing longer durations of uninterrupted sleep.\",\n        \"Effect 2: Enhanced mood stabilization and a slight increase in overall mental well-being may become more noticeable as antioxidant effects accumulate.\",\n        \"Effect 3: Further reduction in inflammation markers might be observed, contributing to a decrease in symptoms associated with chronic inflammatory conditions.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Users might notice a more pronounced improvement in sleep patterns, with a more regular sleep-wake cycle becoming established.\",\n        \"Effect 2: Cognitive benefits, such as improved focus and concentration, may start to manifest as sleep quality and antioxidant effects improve.\",\n        \"Effect 3: Skin health might begin to show signs of improvement, potentially appearing more youthful due to ongoing antioxidant protection.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Sleep benefits are likely to be well-established, with users experiencing consistent restorative sleep.\",\n        \"Effect 2: Users may report a significant enhancement in mood and mental well-being, potentially feeling more energetic and positive.\",\n        \"Effect 3: Biomarkers of oxidative stress might show a noticeable decrease, reflecting the compound's antioxidant activity.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from the compound's mechanism of action and similar compounds, as specific documented studies on N-Acetylepithalonamidate are limited. Individual responses may vary, and side effects, if any, are not well-documented but could include mild digestive disturbances or headaches as with other melatonin-related compounds.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 699, "completion_tokens": 526, "total_tokens": 1225, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a641348190b3c5aa5335ff82f4", "custom_id": "drug169_effects_timeline", "response": {"status_code": 200, "request_id": "e170e9a4bb0c16846535d0478f762f93", "body": {"id": "chatcmpl-B9MVVzQ49L4d0RIlIf7n5rjaAF32y", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of Nonapeptide-1 may result in a slight improvement in skin texture as the compound begins to interact with the skin's surface.\",\n        \"Effect 2: Users might notice a minor reduction in redness due to the anti-inflammatory properties of the peptide.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\",\n        \"Effect 4: Mental/cognitive effects are unlikely as Nonapeptide-1 is not known to affect cognitive functions.\",\n        \"Effect 5: Side effects such as mild irritation or redness could occur, especially in individuals with sensitive skin, but these are generally minimal.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users may begin to observe a subtle lightening of dark spots and a more even skin tone as melanin production starts to decrease.\",\n        \"Effect 2: Continued reduction in redness and a smoother complexion might be noticeable.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected.\",\n        \"Effect 4: The benefits of a brighter and more even skin tone may start to become more apparent.\",\n        \"Effect 5: Any initial side effects such as irritation should begin to subside as the skin adjusts to the peptide.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: More pronounced improvement in skin brightness and reduction of hyperpigmentation as the inhibition of tyrosinase becomes more effective.\",\n        \"Effect 2: Users may notice a significant reduction in the appearance of age spots and blemishes.\",\n        \"Effect 3: No changes in biomarkers or physiological measurements are expected.\",\n        \"Effect 4: The benefits of a more radiant and youthful appearance should be more evident.\",\n        \"Effect 5: Side effects are generally minimal at this stage, with most users experiencing no adverse reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Week 8\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in skin tone uniformity and clarity, with dark spots further diminished.\",\n        \"Effect 2: Overall skin health appears enhanced, contributing to a more youthful appearance.\",\n        \"Effect 3: No changes in biomarkers or physiological measurements are expected.\",\n        \"Effect 4: The full benefits of Nonapeptide-1, including a clearer and more consistent complexion, are typically realized by this time.\",\n        \"Effect 5: Long-term use is generally well-tolerated, with side effects being rare.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical use cases and individual results may vary. The effects described are inferred from the known mechanism of action of Nonapeptide-1 and similar compounds targeting melanin production. Users with sensitive skin should conduct a patch test before full application to minimize the risk of irritation.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 667, "completion_tokens": 627, "total_tokens": 1294, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a64ed48190abc1722115c5332f", "custom_id": "drug170_effects_timeline", "response": {"status_code": 200, "request_id": "742c2d858d938ab74f677880ebf5f376", "body": {"id": "chatcmpl-B9MVTKAIe0ZV7MH0qzTfW6IM8Jn36", "object": "chat.completion", "created": 1741571167, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a slight increase in energy levels as the liver begins to function more efficiently, though this might be subtle.\",\n        \"Effect 2: Users might notice a mild improvement in digestion and a slight reduction in bloating as liver detoxification processes start to enhance.\",\n        \"Effect 3: Mental clarity could begin to improve slightly due to better detoxification, though significant cognitive effects are not expected this early.\",\n        \"Effect 4: Biomarkers such as liver enzyme levels (e.g., ALT, AST) might start to show minor improvements, but significant changes are unlikely within the first week.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical effects may include further improvements in energy levels and reduced fatigue as liver function continues to enhance.\",\n        \"Effect 2: Users might experience better stress management and mood stabilization as the liver supports hormonal balance.\",\n        \"Effect 3: Some users might notice clearer skin as a result of improved detoxification processes.\",\n        \"Effect 4: Liver enzyme levels might show more noticeable improvements, indicating enhanced liver health.\",\n        \"Effect 5: Side effects, if any, such as mild gastrointestinal discomfort, might begin to manifest but are generally expected to be minimal.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in overall energy and vitality are likely to be more noticeable as liver regeneration processes continue.\",\n        \"Effect 2: Cognitive effects such as improved focus and mental clarity might become more pronounced.\",\n        \"Effect 3: Users might observe a more consistent mood and better stress resilience due to improved liver function.\",\n        \"Effect 4: Biomarkers such as liver enzyme levels and bilirubin might show significant improvements, reflecting enhanced liver health.\",\n        \"Effect 5: Any initial side effects are likely to stabilize or diminish as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users are likely to experience sustained improvements in energy levels and overall well-being.\",\n        \"Effect 2: Enhanced liver function may lead to better metabolic efficiency, potentially aiding in weight management.\",\n        \"Effect 3: Long-term cognitive benefits such as sustained mental clarity and focus are likely to be evident.\",\n        \"Effect 4: Continued improvements in liver-related biomarkers, indicating ongoing liver health and regeneration.\",\n        \"Effect 5: Any side effects should be minimal or non-existent at this stage, assuming proper dosage and usage.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar compounds and the general mechanism of action of peptides involved in liver health. Individual responses may vary, and the timeline might differ based on factors such as dosage, individual health status, and concurrent use of other supplements or medications. It is important to monitor liver function through regular biomarker assessments to ensure safety and efficacy.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 647, "total_tokens": 1292, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a6625c81908e9c7d2fa7fc0219", "custom_id": "drug171_effects_timeline", "response": {"status_code": 200, "request_id": "1ccac2eed7aebec211bb46da0219bb26", "body": {"id": "chatcmpl-B9MVU3aBpjtCFbJ9cYryfcX48SeoY", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice a slight increase in alertness and focus within the first few hours of administration, as Pal-ahk starts to elevate dopamine and norepinephrine levels.\",\n        \"Effect 2: Initial mood enhancement may be observed, with users feeling a mild improvement in well-being and reduction in stress or anxiety.\",\n        \"Effect 3: Some users might experience minor physical effects such as increased heart rate or slight jitteriness, similar to the effects of caffeine.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Cognitive benefits such as improved concentration and mental clarity become more pronounced, aiding in tasks that require sustained mental effort.\",\n        \"Effect 2: Users may notice a more consistent mood enhancement, with a greater sense of motivation and positivity.\",\n        \"Effect 3: Biomarkers such as heart rate variability might show slight changes due to increased norepinephrine activity, though this is inferred from similar compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced focus and cognitive performance are likely to stabilize, providing reliable support for demanding mental tasks.\",\n        \"Effect 2: Users might experience a plateau in mood enhancement, maintaining a steady sense of well-being and reduced anxiety.\",\n        \"Effect 3: Potential side effects such as insomnia or increased anxiety could begin to manifest if the compound is taken in high doses or late in the day.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The cognitive and mood-enhancing effects continue to be sustained, with users reporting consistent benefits in productivity and mental resilience.\",\n        \"Effect 2: Some users might experience a tolerance build-up, requiring careful management of dosage to maintain efficacy.\",\n        \"Effect 3: Physiological measurements such as blood pressure might show slight increases, particularly in sensitive individuals, inferred from similar stimulant-like compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Long-term users may experience a stabilization of effects, with the compound integrating into their daily routine for cognitive support.\",\n        \"Effect 2: Potential for side effects such as dependency or withdrawal symptoms if usage is abruptly discontinued, inferred from compounds with similar mechanisms.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline is based on the typical effects of compounds that enhance dopamine and norepinephrine levels. Individual responses can vary significantly, and long-term effects are inferred from similar nootropic and stimulant compounds. Users should monitor their response closely and adjust usage as necessary to mitigate potential side effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 651, "completion_tokens": 583, "total_tokens": 1234, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a6719c8190811fc2a38a19383f", "custom_id": "drug172_effects_timeline", "response": {"status_code": 200, "request_id": "5ac9b788c922406374fd83fbf1983805", "body": {"id": "chatcmpl-B9MVUdDaPKUHbciDI5KckUzVjPGl6", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial hydration improvement may be noticed, as Palmitoyldipeptide-6 begins to enhance the skin's barrier function, leading to better moisture retention.\",\n        \"Effect 2: Some users might experience a slight improvement in skin texture, feeling smoother to the touch due to initial cellular communication enhancements.\",\n        \"Effect 3: No significant mental/cognitive effects are expected, as this compound primarily targets skin physiology.\",\n        \"Effect 4: Biomarkers such as skin hydration levels might show a slight increase, though this is more likely to be subtle at this stage.\",\n        \"Effect 5: Side effects are generally minimal, but some users might experience mild irritation or redness as the skin adjusts to the new compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in skin hydration and texture, with some users beginning to notice a slight reduction in fine lines.\",\n        \"Effect 2: Enhanced skin elasticity might start to become apparent as collagen production is gradually stimulated.\",\n        \"Effect 3: No cognitive effects are expected, as the compound's action is localized to the skin.\",\n        \"Effect 4: Biomarkers such as skin elasticity and firmness might show measurable improvement, though this would require specific dermatological assessments.\",\n        \"Effect 5: Any initial irritation should subside, with the skin adapting to the compound. If irritation persists, usage should be reviewed.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: Noticeable reduction in the appearance of fine lines and wrinkles, as collagen synthesis is more pronounced.\",\n        \"Effect 2: Skin appears firmer and more resilient, with improved overall tone and texture.\",\n        \"Effect 3: No mental/cognitive effects are anticipated.\",\n        \"Effect 4: Biomarkers related to skin health, such as collagen density, might show significant improvement if measured.\",\n        \"Effect 5: Side effects are unlikely at this stage, assuming no adverse reactions occurred initially.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-12\",\n      \"effects\": [\n        \"Effect 1: Maximum benefits in terms of anti-aging effects, with significant reduction in wrinkles and enhanced skin firmness.\",\n        \"Effect 2: Skin barrier function is optimized, providing better protection against environmental stressors.\",\n        \"Effect 3: Continued absence of cognitive effects, as expected.\",\n        \"Effect 4: Long-term biomarkers such as sustained collagen levels and skin hydration should be at their peak.\",\n        \"Effect 5: Long-term use is generally well-tolerated, with minimal risk of side effects if the compound is used as directed.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed with peptides that enhance collagen production and skin barrier function. Individual results may vary based on skin type, age, and other factors. The effects described are inferred from the compound's mechanism of action and similar peptides, as specific longitudinal studies on Palmitoyldipeptide-6 may be limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 692, "completion_tokens": 667, "total_tokens": 1359, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a6805081908504e576dc50359f", "custom_id": "drug173_effects_timeline", "response": {"status_code": 200, "request_id": "e93bdf32cd9f549b8f78cdfb6ba56110", "body": {"id": "chatcmpl-B9MVWNoOYmUQsnGEgOpSJLbjjzh0U", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial improvement in digestive comfort may be observed, such as reduced bloating and more regular bowel movements, as Pancragen begins to enhance enzyme activity.\",\n        \"Effect 2: Some users might notice a slight increase in energy levels due to more efficient nutrient absorption, although this effect is likely subtle at this stage.\",\n        \"Effect 3: Biomarkers such as blood glucose levels might start to show minor improvements, but significant changes are not expected yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in digestive efficiency, with users potentially experiencing less discomfort after meals.\",\n        \"Effect 2: Mental clarity and focus might improve slightly as a result of better nutrient absorption and stabilized blood sugar levels.\",\n        \"Effect 3: More noticeable changes in biomarkers like blood glucose and lipid profiles could begin to appear, indicating improved metabolic health.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience more consistent energy levels throughout the day, reflecting enhanced metabolic balance.\",\n        \"Effect 2: Protective benefits for the pancreas might start to manifest, potentially reducing inflammation-related symptoms.\",\n        \"Effect 3: Any side effects, such as mild gastrointestinal discomfort, might peak during this period as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as improved overall metabolic health and sustained energy levels are likely to be more pronounced.\",\n        \"Effect 2: Cognitive benefits, including better concentration and mood stability, might be more noticeable due to ongoing metabolic improvements.\",\n        \"Effect 3: Biomarkers should show significant improvements, particularly in blood sugar regulation and possibly in pancreatic enzyme levels.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on general observations and educated inferences from similar compounds that support pancreatic health and metabolic function. Individual responses may vary, and the effects described are not guaranteed. Additionally, the safety and efficacy of Pancragen for these purposes have not been fully established in clinical settings, and any use should be under the guidance of a qualified professional.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 638, "completion_tokens": 491, "total_tokens": 1129, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a68e18819083f30dd7f1fd2ee3", "custom_id": "drug174_effects_timeline", "response": {"status_code": 200, "request_id": "dabcb08e32f8a5a4d12edcca5ab08e95", "body": {"id": "chatcmpl-B9MVeHavhYrdgSP6dc03jiLPoj0Je", "object": "chat.completion", "created": 1741571178, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of Leuphasyl may lead to a slight improvement in skin texture as the compound begins to interact with facial muscles. Users might notice a subtle relaxation of facial expressions, particularly in areas prone to dynamic wrinkles, such as around the eyes and forehead.\",\n        \"Effect 2: No significant mental or cognitive effects are expected, as Leuphasyl primarily acts locally on the skin and does not penetrate deeply enough to affect systemic functions.\",\n        \"Effect 3: There are no expected changes in biomarkers or physiological measurements during the first week, as the compound's action is localized to the skin.\",\n        \"Effect 4: Some users might start to notice a minor reduction in the appearance of fine lines, but significant changes are unlikely this early.\",\n        \"Effect 5: Side effects, if any, such as mild skin irritation or redness, might begin to manifest, particularly in individuals with sensitive skin.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to more noticeable relaxation of facial muscles, with a slight reduction in the depth of dynamic wrinkles.\",\n        \"Effect 2: As in the first week, no mental or cognitive effects are expected.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are anticipated.\",\n        \"Effect 4: Users may start to observe a more consistent improvement in skin smoothness and a reduction in fine lines, particularly when used in conjunction with other skincare ingredients.\",\n        \"Effect 5: Any initial skin irritation should begin to subside as the skin adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: By the end of the first month, users are likely to experience a more pronounced reduction in the appearance of wrinkles, with smoother and more youthful-looking skin.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: There are still no expected changes in systemic biomarkers or physiological measurements.\",\n        \"Effect 4: The benefits of Leuphasyl should be more evident, with a noticeable improvement in skin texture and tone, especially when used consistently.\",\n        \"Effect 5: Side effects should be minimal by this stage, with most users experiencing no adverse reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to further improvements in skin appearance, with a sustained reduction in wrinkle depth and enhanced skin smoothness.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: No changes in systemic biomarkers or physiological measurements are anticipated.\",\n        \"Effect 4: The anti-aging benefits of Leuphasyl should be well-established, with users enjoying a more youthful and refreshed appearance.\",\n        \"Effect 5: Long-term side effects are unlikely, but users should monitor for any delayed skin reactions.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical user experiences with topical peptides similar to Leuphasyl. Individual results may vary depending on skin type, the concentration of the compound in the product, and the presence of other active ingredients. The effects described are inferred from the mechanism of action of Leuphasyl and similar peptides, as specific clinical data on Leuphasyl alone may be limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 666, "completion_tokens": 731, "total_tokens": 1397, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a69c08819091b7e4c284c000c7", "custom_id": "drug175_effects_timeline", "response": {"status_code": 200, "request_id": "228cb8a3240053bf36554d86662d3a52", "body": {"id": "chatcmpl-B9MVoJjF30y5QbQeKlGuADa6D6qd8", "object": "chat.completion", "created": 1741571188, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may be minimal, but some users might notice a slight increase in alertness and energy levels.\",\n        \"Effect 2: Early mental effects could include a subtle improvement in focus and concentration, although significant cognitive changes are unlikely at this stage.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected this early.\",\n        \"Effect 4: Users might begin to feel a slight reduction in mental fatigue, but this is more likely to be noticeable in subsequent days.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Physical effects might include a noticeable increase in energy and reduced feelings of tiredness.\",\n        \"Effect 2: Cognitive effects such as improved memory recall and enhanced clarity in thinking may start to become apparent.\",\n        \"Effect 3: No significant changes in biomarkers are typically observed, but some users might report feeling more balanced emotionally.\",\n        \"Effect 4: Benefits related to mood enhancement and reduced stress might begin to manifest, although they are likely to be subtle.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in physical energy levels and sustained alertness throughout the day.\",\n        \"Effect 2: More pronounced cognitive benefits, including better memory retention and quicker information processing.\",\n        \"Effect 3: Users might observe improvements in emotional well-being, with a noticeable reduction in stress and anxiety levels.\",\n        \"Effect 4: Any side effects, if present, such as mild headaches or gastrointestinal discomfort, might begin to appear or peak during this period.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Physical stamina and endurance may continue to improve, with users feeling less fatigued during mental tasks.\",\n        \"Effect 2: Cognitive enhancements are likely to be more stable, with consistent improvements in memory and learning capabilities.\",\n        \"Effect 3: Emotional resilience and mood stabilization are expected to be more pronounced, contributing to overall well-being.\",\n        \"Effect 4: If side effects were experienced, they might start to diminish as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical and cognitive benefits are likely to be well-established, with users experiencing sustained improvements in mental clarity and energy.\",\n        \"Effect 2: Long-term cognitive benefits, such as enhanced problem-solving skills and creativity, may become more evident.\",\n        \"Effect 3: Users might notice a significant improvement in their ability to manage stress and maintain a positive mood.\",\n        \"Effect 4: Any persistent side effects should be monitored, and users should consider adjusting dosage or frequency if necessary.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred effects from similar compounds, as specific clinical data on Pinealon is limited. Individual responses may vary, and users should approach research chemicals with caution, monitoring for any adverse effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 671, "completion_tokens": 667, "total_tokens": 1338, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a6ab7481908b0da646ab88d470", "custom_id": "drug176_effects_timeline", "response": {"status_code": 200, "request_id": "4abf2b5a17a0cf719fb23c2774b1dbfb", "body": {"id": "chatcmpl-B9MVUocvqHrWdlJLLxYtbsyPDWxiL", "object": "chat.completion", "created": 1741571168, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial cellular response may begin, with PNC-27 binding to cancer cell membranes. This could lead to early signs of necrosis in targeted cancer cells, although these effects might not be immediately noticeable at a macroscopic level.\",\n        \"Effect 2: No significant mental or cognitive effects are expected, as PNC-27 is designed to target cancer cells specifically.\",\n        \"Effect 3: Biomarkers such as tumor markers in blood tests might begin to show slight changes, but significant alterations are unlikely this early.\",\n        \"Effect 4: Side effects, if any, might start to manifest as mild local reactions at the site of administration, such as redness or swelling.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued necrosis of cancer cells may lead to a reduction in tumor size, potentially observable through imaging techniques.\",\n        \"Effect 2: The immune response might start to be enhanced, with immune cells beginning to recognize and attack cancer cells more effectively.\",\n        \"Effect 3: Biomarkers related to immune activity, such as increased levels of certain cytokines, might be detectable.\",\n        \"Effect 4: Side effects could include mild flu-like symptoms as the immune system becomes more active.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: More pronounced reduction in tumor size could be observed, with potential improvements in symptoms related to tumor burden.\",\n        \"Effect 2: Enhanced immune response might lead to further recognition and elimination of cancer cells.\",\n        \"Effect 3: Significant changes in tumor markers might be observed, indicating a response to treatment.\",\n        \"Effect 4: Side effects might peak during this period, with possible fatigue or mild systemic reactions due to immune activation.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-12\",\n      \"effects\": [\n        \"Effect 1: Stabilization or continued reduction in tumor size, with potential for improved quality of life and symptom relief.\",\n        \"Effect 2: Sustained immune response could continue to target residual cancer cells.\",\n        \"Effect 3: Biomarkers may show sustained or further improvement, reflecting ongoing treatment efficacy.\",\n        \"Effect 4: Side effects might begin to subside as the body adjusts to the treatment, though monitoring for any long-term effects is necessary.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the expected mechanism of action of PNC-27 and similar compounds. As PNC-27 is still experimental, specific effects and their timing may vary significantly between individuals. Clinical data on PNC-27 is limited, so some effects are inferred from its mechanism and early research findings. Continuous monitoring and adjustment of treatment protocols are essential in a research setting.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 650, "completion_tokens": 610, "total_tokens": 1260, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a6b9e48190ad7f191786081d58", "custom_id": "drug177_effects_timeline", "response": {"status_code": 200, "request_id": "c76d3e5489aa1f631deb5f7a23823ea9", "body": {"id": "chatcmpl-B9MVWp5S7nsGABiF3XPHDoONT7V7c", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a slight reduction in urinary frequency, particularly at night, as the compound begins to influence hormone levels and reduce prostate swelling.\",\n        \"Effect 2: Mental/cognitive effects are likely minimal at this stage, but some users might experience a placebo effect, feeling hopeful about symptom improvement.\",\n        \"Effect 3: Biomarkers such as prostate-specific antigen (PSA) levels may not show significant changes yet, as the compound's effects are just beginning to manifest.\",\n        \"Effect 4: No significant benefits related to bladder health or urinary tract infection prevention are expected this early.\",\n        \"Effect 5: Side effects, if any, might include mild gastrointestinal discomfort as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might notice a more pronounced decrease in urinary urgency and frequency, indicating the compound's ongoing impact on prostate size and function.\",\n        \"Effect 2: Cognitive effects remain minimal, though improved sleep due to reduced nocturia could enhance overall mental well-being.\",\n        \"Effect 3: Some users might observe slight improvements in urinary flow rate, though this is still early in the treatment.\",\n        \"Effect 4: Anti-inflammatory effects may begin to subtly manifest, potentially reducing discomfort associated with prostate inflammation.\",\n        \"Effect 5: Side effects might include mild headaches or dizziness, as the body continues to adapt to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Significant improvement in urinary symptoms is likely, with many users experiencing easier urination and less frequent nighttime awakenings.\",\n        \"Effect 2: Enhanced quality of life due to improved urinary symptoms may lead to better mood and cognitive function.\",\n        \"Effect 3: Biomarkers such as PSA levels might begin to show slight reductions, indicating a positive response to the compound.\",\n        \"Effect 4: Benefits related to bladder health and urinary tract infection prevention could start to become noticeable, particularly in users prone to these issues.\",\n        \"Effect 5: Side effects should stabilize, with any initial discomforts diminishing as the body becomes accustomed to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users are likely to experience sustained improvements in prostate-related symptoms, with a marked reduction in urinary frequency and urgency.\",\n        \"Effect 2: Mental and cognitive benefits may include improved concentration and mood due to better sleep and reduced discomfort.\",\n        \"Effect 3: Physiological measurements such as PSA levels and urinary flow rate should show more consistent improvements.\",\n        \"Effect 4: The compound's anti-inflammatory properties may contribute to overall prostate and bladder health, reducing the risk of urinary tract infections.\",\n        \"Effect 5: Long-term side effects are generally minimal, but users should monitor for any unusual symptoms and consult with a healthcare provider if necessary.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar compounds and the proposed mechanisms of action of Prostamax. As a research compound, individual responses can vary significantly, and comprehensive clinical data is limited. Users should be monitored closely for any adverse reactions or unexpected changes in health status.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 660, "completion_tokens": 706, "total_tokens": 1366, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a6c8148190a57aaff216cf1376", "custom_id": "drug178_effects_timeline", "response": {"status_code": 200, "request_id": "3ee53d51f13fe806b63e66e508f179a0", "body": {"id": "chatcmpl-B9MVVcb0vlv4WnAIm0LHykycAwdJ4", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial application of Rigin may lead to a slight improvement in skin hydration and texture as the peptide begins to interact with the skin's surface.\",\n        \"Effect 2: Users might notice a mild reduction in skin redness and irritation due to the anti-inflammatory properties of Rigin.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may result in further reduction of redness and a more noticeable calming effect on irritated skin.\",\n        \"Effect 2: Some users might start to observe a subtle improvement in skin firmness as collagen synthesis is gradually stimulated.\",\n        \"Effect 3: Mental/cognitive effects are not typically associated with topical application of Rigin.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: By the end of the first month, users may experience a more pronounced improvement in skin elasticity and a reduction in fine lines.\",\n        \"Effect 2: The skin may appear more vibrant and resilient, reflecting enhanced overall skin health.\",\n        \"Effect 3: Biomarkers such as skin elasticity measurements might show slight improvements, although these are more likely to be observed in controlled study settings.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued application is likely to result in further enhancement of skin firmness and texture, with more noticeable smoothing of wrinkles.\",\n        \"Effect 2: The anti-inflammatory effects may contribute to a sustained reduction in skin irritation and redness.\",\n        \"Effect 3: Users might observe a more consistent and even skin tone, contributing to a youthful appearance.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Long-term use may lead to significant improvements in skin structure and resilience, with sustained benefits in elasticity and firmness.\",\n        \"Effect 2: The skin's ability to withstand environmental stressors may be enhanced, reducing the impact of external factors on skin health.\",\n        \"Effect 3: No significant side effects are typically associated with Rigin, but any adverse reactions would likely have manifested earlier in the treatment.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed with similar peptides and the known mechanisms of action of Rigin. Individual results may vary, and the effects described are inferred from the compound's properties and similar compounds, as specific clinical data on Rigin's timeline of effects may be limited. It is important to conduct patch tests and consult with a dermatologist before starting any new skincare regimen.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 656, "completion_tokens": 593, "total_tokens": 1249, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a6d6d081909961befe17f323c4", "custom_id": "drug181_effects_timeline", "response": {"status_code": 200, "request_id": "e9f091d98c06c8928186a8a67220cd3a", "body": {"id": "chatcmpl-B9MVVgGycd9njfzjYHgPjMWDtt9hT", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial application may lead to a slight tingling sensation on the skin as the compound begins to interact with facial muscles.\",\n        \"Effect 2: Users might notice a very subtle relaxation of facial muscles, particularly in areas prone to expression lines, although this may not be immediately visible.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Some users may start to observe a slight smoothing of fine lines, particularly around the eyes and forehead, as muscle contractions are temporarily reduced.\",\n        \"Effect 2: There are generally no mental or cognitive effects associated with topical application of Syn-Ake.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements are expected, as Syn-Ake acts locally on the skin.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to more noticeable reduction in the appearance of fine lines and wrinkles, with skin appearing slightly firmer and more elastic.\",\n        \"Effect 2: Users might experience a more even skin tone and texture, contributing to a youthful appearance.\",\n        \"Effect 3: Any initial tingling sensation typically subsides as the skin adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: The cumulative effect of Syn-Ake may result in a visible reduction in the depth of existing wrinkles, with a smoother skin surface.\",\n        \"Effect 2: The skin may appear more lifted and rejuvenated, with improved firmness.\",\n        \"Effect 3: Regular users might notice that the benefits are more pronounced with consistent application.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Maximum benefits are typically observed, with significant reduction in the appearance of expression lines and improved overall skin texture.\",\n        \"Effect 2: Users may continue to experience a youthful complexion without the need for invasive procedures.\",\n        \"Effect 3: No new side effects are expected; however, if any irritation occurs, it may be due to other ingredients in the formulation rather than Syn-Ake itself.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical usage patterns and the mechanism of action of Syn-Ake. Individual results may vary depending on skin type, product formulation, and frequency of use. The effects described are inferred from the known action of Syn-Ake and similar compounds, as specific longitudinal studies on Syn-Ake's timeline of effects are limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 567, "total_tokens": 1252, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a6e58c819099d0ffe148c09fe8", "custom_id": "drug182_effects_timeline", "response": {"status_code": 200, "request_id": "6f759307f84151efb8dac3279f807c4d", "body": {"id": "chatcmpl-B9MVXXzxBxq6JwqrzhCDPNQfNoJ30", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in skin hydration may be observed, leading to a slightly softer and more supple skin texture. This is due to the moisturizing properties of Syn-Coll.\",\n        \"Effect 2: No significant changes in wrinkles or fine lines are expected at this early stage, as collagen production stimulation takes time.\",\n        \"Effect 3: Users may experience a mild improvement in skin elasticity, although this is typically subtle and not easily noticeable.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in skin hydration and suppleness, with some users noticing a more vibrant skin appearance.\",\n        \"Effect 2: Early signs of increased skin firmness may begin to appear as collagen synthesis starts to take effect.\",\n        \"Effect 3: No significant mental or cognitive effects are expected, as Syn-Coll primarily acts on the skin.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable reduction in the appearance of fine lines and minor wrinkles as collagen production increases.\",\n        \"Effect 2: Enhanced skin elasticity and firmness become more apparent, contributing to a youthful look.\",\n        \"Effect 3: Users may observe a more even skin tone and texture, with a reduction in roughness.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvement in the reduction of wrinkles and fine lines, with many users reporting smoother skin.\",\n        \"Effect 2: Optimal skin hydration levels are maintained, resulting in a consistently soft and plump appearance.\",\n        \"Effect 3: Peak benefits in skin elasticity and firmness are typically reached, providing a more resilient skin structure.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Sustained reduction in wrinkles and fine lines, with ongoing collagen production support.\",\n        \"Effect 2: Long-term maintenance of skin hydration, elasticity, and firmness, contributing to a youthful complexion.\",\n        \"Effect 3: No significant side effects are expected with continued use, as Syn-Coll is generally well-tolerated.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical user experiences and inferred effects from similar collagen-stimulating peptides. Individual results may vary based on skin type, age, and other factors. Syn-Coll is generally considered safe with minimal side effects, but users should monitor for any adverse reactions and consult a dermatologist if necessary.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 560, "total_tokens": 1247, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a6f40c81908c2be3cb0b0387b7", "custom_id": "drug183_effects_timeline", "response": {"status_code": 200, "request_id": "83a3bb63da260a7c0a2c221ae31f5b96", "body": {"id": "chatcmpl-B9MVWqGKnehPFXuBvi96bmcUdAw9P", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include a slight reduction in inflammation around injury sites, potentially leading to minor improvements in pain and swelling. This is inferred from the compound's mechanism of action on actin and cell migration.\",\n        \"Effect 2: Users might notice a subtle increase in flexibility and range of motion as inflammation begins to decrease.\",\n        \"Effect 3: No significant mental or cognitive effects are expected at this stage, as the compound primarily targets physical healing processes.\",\n        \"Effect 4: Biomarkers such as C-reactive protein (CRP) levels might begin to show a slight decrease, indicating reduced inflammation, though this is speculative based on similar compounds.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued reduction in inflammation and pain, with more noticeable improvements in joint mobility and muscle recovery.\",\n        \"Effect 2: Users may start to experience quicker recovery times post-exercise, with less soreness reported.\",\n        \"Effect 3: No significant changes in cognitive function are expected, as the compound's primary effects are physical.\",\n        \"Effect 4: Biomarkers related to muscle damage, such as creatine kinase (CK), might begin to decrease, suggesting improved muscle repair.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in healing of minor injuries, with users potentially experiencing near-normal function in affected areas.\",\n        \"Effect 2: Enhanced performance during physical activities due to reduced pain and increased flexibility.\",\n        \"Effect 3: Users may notice a general sense of well-being due to improved physical condition, though this is more subjective.\",\n        \"Effect 4: Continued decrease in inflammation markers, with potential normalization of CRP and CK levels.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: Sustained improvements in injury recovery, with users likely experiencing full recovery from minor strains and sprains.\",\n        \"Effect 2: Maintenance of enhanced flexibility and reduced risk of re-injury during physical activities.\",\n        \"Effect 3: No significant cognitive effects expected, but users may report improved mood due to physical recovery.\",\n        \"Effect 4: Biomarkers should reflect a stable state of reduced inflammation and muscle damage.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the hypothesized mechanism of action of TB-500 Fragment (17-23) and its similarity to thymosin beta-4. Direct studies on this specific fragment are limited, so the effects are inferred from related compounds and general peptide behavior. Individual responses may vary, and side effects, though not detailed here, could include local irritation at the injection site or allergic reactions, which should be monitored.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 673, "completion_tokens": 605, "total_tokens": 1278, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a704c481908b7a124c684d8601", "custom_id": "drug184_effects_timeline", "response": {"status_code": 200, "request_id": "c57105b11995a4e2de165f452d916976", "body": {"id": "chatcmpl-B9MVV9s7uUjpUmRdvi1XA8gWqV8yO", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels and alertness, potentially feeling more awake and active during the day.\",\n        \"Effect 2: Some users may experience a mild improvement in mood and motivation, possibly due to increased energy.\",\n        \"Effect 3: Initial changes in biomarkers such as a slight increase in testosterone levels might be observed, although significant changes are unlikely this early.\",\n        \"Effect 4: Side effects such as mild headaches or insomnia might begin to manifest as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical performance improvements may become more noticeable, with users experiencing enhanced stamina and endurance during workouts.\",\n        \"Effect 2: Cognitive effects such as improved focus and concentration might be reported, potentially linked to increased energy levels.\",\n        \"Effect 3: Users might start to observe slight increases in muscle mass or strength, although these changes are typically subtle at this stage.\",\n        \"Effect 4: Libido and sexual performance improvements could begin to appear as testosterone levels potentially rise.\",\n        \"Effect 5: Side effects like increased aggression or irritability might start to become apparent if testosterone levels are significantly affected.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Enhanced recovery times post-exercise may be noticeable, with users reporting less soreness and quicker muscle repair.\",\n        \"Effect 2: Continued improvements in physical performance, with potential gains in muscle mass becoming more evident.\",\n        \"Effect 3: Biomarkers such as testosterone levels might show more significant increases, depending on individual response.\",\n        \"Effect 4: Users may experience a plateau in energy level improvements as the body adjusts to the compound.\",\n        \"Effect 5: Side effects such as oily skin or acne could begin to manifest as hormonal changes continue.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Users might experience peak benefits in terms of muscle growth and strength gains, with noticeable physical changes.\",\n        \"Effect 2: Mental effects such as sustained focus and motivation might stabilize, contributing to improved training consistency.\",\n        \"Effect 3: Physiological measurements like body composition could show favorable changes, such as reduced body fat percentage.\",\n        \"Effect 4: Side effects might peak, with some users experiencing more pronounced hormonal-related issues like mood swings or sleep disturbances.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses to compounds with similar mechanisms of action, as specific data on Testagen is limited. Individual responses can vary significantly, and the effects described are inferred from general knowledge of testosterone-boosting compounds. Users should be aware of potential side effects and monitor their health closely.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 617, "completion_tokens": 608, "total_tokens": 1225, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a714808190bdfb15ee38fffaa8", "custom_id": "drug185_effects_timeline", "response": {"status_code": 200, "request_id": "3cc60cf6e79fa4ec30e6b91582708575", "body": {"id": "chatcmpl-B9MVVsTTERmDI84rLuvnGzA9KpCjC", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle increases in energy levels and a slight improvement in overall vitality. These effects are likely due to initial enhancements in immune function.\",\n        \"Effect 2: Some users may experience a mild improvement in mood and cognitive clarity, potentially linked to reduced systemic inflammation and better cellular function.\",\n        \"Effect 3: Biomarkers such as white blood cell count might start to show slight improvements, indicating enhanced immune activity, although these changes may not be significant yet.\",\n        \"Effect 4: Side effects, if any, are likely to be minimal at this stage, but some users might experience mild digestive discomfort as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels and overall well-being, with users potentially noticing a more pronounced sense of vitality.\",\n        \"Effect 2: Cognitive effects such as improved focus and mental clarity may become more noticeable as the compound continues to support immune and cellular functions.\",\n        \"Effect 3: Biomarkers related to immune function, such as T-cell activity, might show more measurable improvements, although individual responses can vary.\",\n        \"Effect 4: Any initial side effects are likely to stabilize, with most users experiencing minimal adverse effects.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience a significant enhancement in their ability to recover from minor illnesses or injuries, reflecting improved immune response.\",\n        \"Effect 2: Enhanced mood and cognitive function might continue to improve, contributing to a greater sense of mental well-being.\",\n        \"Effect 3: Physiological measurements such as inflammation markers could show reductions, indicating better immune regulation.\",\n        \"Effect 4: Benefits related to aging, such as improved skin health or reduced fatigue, might start to become more apparent.\",\n        \"Effect 5: Side effects remain minimal for most users, with the compound generally being well-tolerated.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained energy levels, improved immune resilience, and overall health maintenance are likely to be more evident.\",\n        \"Effect 2: Users might notice a continued enhancement in cognitive functions, including memory and concentration.\",\n        \"Effect 3: Biomarkers of immune health, such as increased thymic peptide activity, could show significant improvements, reflecting the compound's ongoing effects.\",\n        \"Effect 4: Any side effects are expected to be minimal, with most users experiencing no adverse reactions.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on general expectations for compounds with similar mechanisms of action, as specific data on Thymagen's effects in humans is limited. Individual responses can vary significantly, and the effects described are inferred from the compound's proposed role in enhancing immune function and cellular health.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 651, "completion_tokens": 637, "total_tokens": 1288, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a722fc8190b47342d4237780fa", "custom_id": "drug186_effects_timeline", "response": {"status_code": 200, "request_id": "af249c5be5fb470406d23bc34cb5d61e", "body": {"id": "chatcmpl-B9MVVuaAtI17ImN6OtzAZZWG0MrHw", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial administration of Protirelin may lead to an immediate increase in TSH levels, observable through blood tests. This is a direct result of the compound's action on the pituitary gland.\",\n        \"Effect 2: Some users might experience a mild increase in energy levels and alertness due to the stimulation of thyroid hormone production, although this can vary based on individual thyroid function.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued stimulation of the thyroid gland may lead to more noticeable increases in energy and metabolism. Users might report feeling more energetic and mentally clear.\",\n        \"Effect 2: Cognitive effects such as improved mental clarity and focus may begin to manifest as thyroid hormones regulate brain function.\",\n        \"Effect 3: Biomarkers such as TSH and thyroid hormone levels (T3 and T4) should be monitored to assess the compound's impact on thyroid function.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: If Protirelin is being used for its potential antidepressant effects, some users might start to notice mood improvements, although this is more speculative and based on its mechanism of action.\",\n        \"Effect 2: Any initial side effects, such as headaches or nausea, might begin to subside as the body adjusts to the compound.\",\n        \"Effect 3: Continued monitoring of thyroid function is essential to ensure that hormone levels remain within a healthy range.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users might experience a stabilization of energy levels and mood, with potential benefits in reducing fatigue becoming more apparent.\",\n        \"Effect 2: If Protirelin is being explored for neurodegenerative conditions, subtle improvements in neurological symptoms might be observed, although this is largely experimental.\",\n        \"Effect 3: Side effects, if any, should be closely monitored. Persistent side effects may indicate the need for dosage adjustment or discontinuation.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits, such as sustained improvements in mood and energy, may become more pronounced, particularly if Protirelin is used in conjunction with other treatments.\",\n        \"Effect 2: Regular assessment of thyroid and pituitary function is crucial to prevent potential dysregulation of hormone levels.\",\n        \"Effect 3: Any chronic side effects should be evaluated to determine the compound's suitability for continued use.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the known pharmacological action of Protirelin and its effects on the thyroid and pituitary glands. Many of the cognitive and mood-related effects are inferred from its mechanism of action and require further research for confirmation. Individual responses can vary significantly, and close monitoring by medical professionals is recommended when using Protirelin in a research setting.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 644, "total_tokens": 1331, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a730f081909395ed77d8b383ef", "custom_id": "drug187_effects_timeline", "response": {"status_code": 200, "request_id": "893f289ee5252b42359158267880c909", "body": {"id": "chatcmpl-B9MVVRVgp6cMZhqhIDz8Wa0f837cQ", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial hydration improvement may be noticed as Tripeptide-29 helps the skin retain moisture. Users might observe slightly softer and more supple skin.\",\n        \"Effect 2: No significant mental or cognitive effects are expected as Tripeptide-29 is not known to affect these areas.\",\n        \"Effect 3: No measurable changes in biomarkers or physiological measurements are expected at this early stage.\",\n        \"Effect 4: Some users might begin to notice a subtle improvement in skin texture, but significant changes in elasticity or firmness are unlikely this early.\",\n        \"Effect 5: Side effects are rare, but some users might experience mild irritation or redness as the skin adjusts to the new compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in skin hydration and texture. The skin may appear slightly more radiant and healthy.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: Still no significant changes in biomarkers, but users might notice a slight reduction in the appearance of very fine lines.\",\n        \"Effect 4: Early signs of increased skin firmness might begin to appear as collagen production is stimulated.\",\n        \"Effect 5: Any initial irritation should subside, and the skin should start to acclimate to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Noticeable improvement in skin elasticity and firmness. Users might observe a reduction in the appearance of fine lines and wrinkles.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: Biomarkers related to skin health, such as increased collagen levels, might be measurable in a clinical setting.\",\n        \"Effect 4: The benefits of enhanced skin repair and revitalization become more apparent, with a healthier, more youthful complexion.\",\n        \"Effect 5: Side effects are unlikely at this stage unless the user has sensitive skin or an allergy to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in skin firmness and reduction of wrinkles. The skin should feel more resilient and youthful.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: Collagen production should be significantly enhanced, contributing to long-term skin health.\",\n        \"Effect 4: The full spectrum of benefits, including improved hydration, elasticity, and repair, should be evident.\",\n        \"Effect 5: Long-term use is generally well-tolerated, with minimal risk of side effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical effects observed with similar peptides and skincare compounds. Individual results may vary depending on skin type, age, and other factors. Clinical studies specifically on Tripeptide-29 are limited, so some effects are inferred from its mechanism of action and comparison with similar compounds.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 643, "total_tokens": 1334, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a740e481909ebde55625b92e13", "custom_id": "drug188_effects_timeline", "response": {"status_code": 200, "request_id": "40a9248a737c4555acf20723dff8df8a", "body": {"id": "chatcmpl-B9MVVugZEyKoDpdiidKB5jSaMAE87", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial physical effects may include mild headaches or slight dizziness as the body adjusts to Vesilute. These are common with compounds affecting neurotransmitter levels.\",\n        \"Effect 2: Users might notice a subtle improvement in mood and a slight reduction in anxiety as serotonin modulation begins.\",\n        \"Effect 3: Cognitive effects such as enhanced focus and attention may start to emerge, particularly in individuals with ADHD, though these effects are likely to be mild initially.\",\n        \"Effect 4: No significant changes in biomarkers or physiological measurements are expected at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical side effects such as headaches should diminish as the body acclimates to the compound.\",\n        \"Effect 2: Users may experience a more noticeable improvement in mood and reduction in anxiety, as serotonin and dopamine levels stabilize.\",\n        \"Effect 3: Cognitive enhancements, including improved memory retention and sharper thinking, may become more apparent.\",\n        \"Effect 4: Sleep quality might begin to improve, contributing to better overall mental well-being.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Physical side effects are expected to be minimal or absent by this stage.\",\n        \"Effect 2: Significant cognitive benefits, such as enhanced memory and attention, are likely to be more pronounced.\",\n        \"Effect 3: Users might observe a consistent elevation in mood and a stable emotional state, with reduced anxiety levels.\",\n        \"Effect 4: Biomarkers related to neurotransmitter activity, such as serotonin and dopamine levels, might show measurable changes if monitored.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users should experience sustained cognitive benefits, including improved focus and memory, particularly beneficial for those with ADHD.\",\n        \"Effect 2: Mood stabilization and reduced anxiety are expected to be well-established.\",\n        \"Effect 3: Continued improvement in sleep quality, contributing to overall mental and physical health.\",\n        \"Effect 4: Any potential long-term side effects would likely begin to manifest, though these are speculative and should be monitored closely.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Vesilute is largely inferred from its proposed mechanism of action and comparison with similar compounds affecting serotonin and dopamine levels. As Vesilute is still under research, specific effects and their onset may vary among individuals. Continuous monitoring and further studies are necessary to establish a comprehensive understanding of its effects and safety profile.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 632, "completion_tokens": 563, "total_tokens": 1195, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a74f0c8190a8c2153607756e24", "custom_id": "drug189_effects_timeline", "response": {"status_code": 200, "request_id": "154c0f0f2671792d9cb7dff749ad7b5d", "body": {"id": "chatcmpl-B9MVVf5mbpRdfLJZlBI3dUWZmrQTa", "object": "chat.completion", "created": 1741571169, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels and reduced fatigue, as the compound starts to support cellular health and improve blood flow.\",\n        \"Effect 2: Initial improvements in mental clarity and focus could be observed, potentially due to enhanced oxygen and nutrient delivery to the brain.\",\n        \"Effect 3: Biomarkers such as blood pressure might begin to show minor improvements, although significant changes are not typically expected this early.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in stamina and reduction in fatigue as cardiovascular support becomes more pronounced.\",\n        \"Effect 2: Users may experience a slight improvement in mood and cognitive function, possibly due to better circulation and cellular health.\",\n        \"Effect 3: Some users might start to notice minor improvements in heart rate variability, indicating better cardiovascular resilience.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Noticeable improvements in physical endurance and recovery times, particularly for those engaging in physical activities.\",\n        \"Effect 2: Enhanced mental acuity and sustained focus, likely due to improved blood flow and cellular support.\",\n        \"Effect 3: More significant changes in biomarkers such as blood pressure and cholesterol levels might begin to manifest, reflecting improved cardiovascular health.\",\n        \"Effect 4: Specific benefits related to heart performance and resilience could start to become apparent, especially in individuals recovering from heart-related conditions.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users may experience a sustained increase in overall vitality and well-being, with consistent improvements in energy levels and stamina.\",\n        \"Effect 2: Cognitive benefits such as improved memory and mental clarity are likely to be more pronounced.\",\n        \"Effect 3: Continued positive trends in cardiovascular biomarkers, with potential reductions in markers of inflammation and oxidative stress.\",\n        \"Effect 4: Long-term benefits such as enhanced heart performance and resilience are more likely to be observed, contributing to overall cardiovascular health.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the general mechanism of action of peptides similar to Vesugen and inferred effects from its role in cardiovascular support. Individual responses may vary, and the timeline could differ based on dosage, individual health status, and other factors. As with any research compound, side effects are possible, though specific side effects for Vesugen are not well-documented. Users should monitor for any adverse reactions, particularly in the early stages of use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 652, "completion_tokens": 560, "total_tokens": 1212, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a75d9881909eead9570cafb6b3", "custom_id": "drug190_effects_timeline", "response": {"status_code": 200, "request_id": "5d4a6231d3eb3358db17104133bbe44e", "body": {"id": "chatcmpl-B9MVWWiaey3ah2VveGHQiU0kRL7yM", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial application may lead to a slight tingling sensation on the skin, which is a common response to topical agents.\",\n        \"Effect 2: Users might notice a mild reduction in muscle tension in the treated areas, though significant changes are unlikely at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Some users may begin to observe a subtle smoothing of fine lines and wrinkles as the muscles start to relax.\",\n        \"Effect 2: For those using Vialox for hyperhidrosis, a slight decrease in sweating might be noticed, particularly in areas where the compound is applied.\",\n        \"Effect 3: Initial relief from tension headaches could be experienced, especially if the headaches are related to muscle tension in the treated areas.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: More noticeable reduction in the appearance of wrinkles and fine lines as muscle relaxation becomes more pronounced.\",\n        \"Effect 2: Continued decrease in excessive sweating, with users potentially observing less need for antiperspirants.\",\n        \"Effect 3: Enhanced relief from tension headaches, with users reporting fewer occurrences or reduced intensity of headaches.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Maximum cosmetic benefits are typically observed, with significant smoothing of wrinkles and improved skin firmness.\",\n        \"Effect 2: For hyperhidrosis, users may experience optimal reduction in sweating, leading to improved comfort and confidence.\",\n        \"Effect 3: Sustained relief from muscle tension-related headaches, contributing to improved quality of life.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: The effects on wrinkles and skin firmness may plateau, maintaining the improved appearance achieved in the first month.\",\n        \"Effect 2: Continued management of hyperhidrosis, with consistent reduction in sweat production.\",\n        \"Effect 3: Persistent relief from tension headaches, though users should monitor for any changes in headache patterns.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the typical response to compounds with similar mechanisms of action, such as muscle relaxants used in cosmetic and therapeutic applications. Individual responses may vary, and the onset and duration of effects can differ based on factors like dosage, application method, and individual physiology. Side effects, if any, are generally mild and may include temporary skin irritation or discomfort at the application site. Users should monitor for any adverse reactions and consult with a healthcare professional if concerns arise.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 686, "completion_tokens": 577, "total_tokens": 1263, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a76c148190bd05c1f76af918f6", "custom_id": "drug191_effects_timeline", "response": {"status_code": 200, "request_id": "88cb4d3c8db06690b416175777989c8e", "body": {"id": "chatcmpl-B9MVW3lMV2g5wUkL3nYoI7sRr9uW3", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial modulation of immune response may begin, with users potentially noticing a slight increase in energy levels and overall well-being as the body starts to adjust to the compound.\",\n        \"Effect 2: Some users might experience mild improvements in wound healing, although significant changes are not typically observed this early.\",\n        \"Effect 3: Mental clarity and focus might improve slightly as inflammation begins to decrease, but these effects are subtle at this stage.\",\n        \"Effect 4: Biomarkers such as C-reactive protein (CRP) levels may start to show a minor decrease, indicating reduced inflammation, but this is often not significant yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced immune function may become more noticeable, with users potentially experiencing fewer minor illnesses or quicker recovery from colds.\",\n        \"Effect 2: Improvements in skin texture and appearance might start to be observed, although these changes are typically gradual.\",\n        \"Effect 3: Users might notice a further reduction in inflammation-related symptoms, such as joint pain or stiffness.\",\n        \"Effect 4: Side effects, if any, such as mild headaches or digestive discomfort, could begin to manifest but are generally not severe.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued enhancement of immune response, with users potentially experiencing a more robust defense against infections.\",\n        \"Effect 2: More noticeable improvements in wound healing and skin health, with some users reporting faster recovery from minor cuts or abrasions.\",\n        \"Effect 3: Cognitive benefits, such as improved focus and mental clarity, may become more pronounced as inflammation continues to decrease.\",\n        \"Effect 4: Biomarkers related to inflammation and immune function, such as interleukin levels, might show more significant changes, indicating the compound's ongoing effects.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained immune support and reduced chronic inflammation are likely to be more evident.\",\n        \"Effect 2: Users may experience a more youthful appearance and improved skin resilience due to ongoing tissue regeneration.\",\n        \"Effect 3: Any initial side effects are likely to have subsided, with the body having adjusted to the compound.\",\n        \"Effect 4: Continued monitoring of biomarkers may show stable improvements in immune and inflammatory markers.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar peptides and the described mechanisms of action of Vilon. Individual responses can vary significantly, and the effects mentioned are not guaranteed. Clinical studies on Vilon are limited, so this information should be used as a general guideline rather than definitive outcomes.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 661, "completion_tokens": 603, "total_tokens": 1264, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a77afc819099f6e65ae89a1f99", "custom_id": "drug192_effects_timeline", "response": {"status_code": 200, "request_id": "c54d00a71d4602f9cea6e2ff15d4cb90", "body": {"id": "chatcmpl-B9MVXhcf6YZ0VHQKaGMvtRqYIHuLM", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may notice an initial relaxation of smooth muscles, leading to a slight decrease in blood pressure and improved blood flow. This can result in a feeling of warmth or mild flushing.\",\n        \"Effect 2: Some digestive improvements might be observed, such as smoother bowel movements due to increased intestinal motility and water/electrolyte secretion.\",\n        \"Effect 3: Initial cognitive effects could include a slight improvement in mood or mental clarity, as VIP begins to support brain health and neurotransmitter release.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued cardiovascular benefits, with more noticeable reductions in blood pressure and improved circulation.\",\n        \"Effect 2: Enhanced digestive function, with more regular bowel movements and potentially improved nutrient absorption.\",\n        \"Effect 3: Users might experience a boost in immune function, with increased activity of certain white blood cells, although this may not be immediately perceptible.\",\n        \"Effect 4: Some users may report improved cognitive function, such as better focus or memory, as neuroprotective effects begin to manifest.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Cardiovascular benefits may stabilize, with users experiencing consistent blood pressure regulation and heart function improvement.\",\n        \"Effect 2: Digestive benefits continue, with sustained improvements in gastrointestinal health and comfort.\",\n        \"Effect 3: Enhanced immune response might become more evident, potentially resulting in quicker recovery from minor infections or illnesses.\",\n        \"Effect 4: Cognitive benefits, such as enhanced mental clarity and mood stabilization, may become more pronounced.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Long-term cardiovascular and digestive benefits are maintained, contributing to overall well-being.\",\n        \"Effect 2: Users may notice sustained cognitive improvements, with ongoing neuroprotective effects supporting brain health.\",\n        \"Effect 3: Immune system enhancements continue, potentially leading to a noticeable decrease in the frequency of minor illnesses.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on the known mechanisms of VIP and its effects on similar physiological systems. Individual responses may vary, and some effects might be more pronounced in certain users. Side effects are generally minimal but could include mild gastrointestinal discomfort or transient hypotension. These effects are inferred from the compound's mechanism of action and similar peptides, as detailed longitudinal studies on VIP's effects in humans are limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 683, "completion_tokens": 550, "total_tokens": 1233, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a78ac88190b3209b958dab23c9", "custom_id": "drug193_effects_timeline", "response": {"status_code": 200, "request_id": "48211108fa728b47c93d87d60b5597a3", "body": {"id": "chatcmpl-B9MVXu2t9b0s3PlIa6VuqL3UiXDjT", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice an increase in blood flow, particularly in areas such as the reproductive organs, which could lead to improved erectile function. This effect is due to the inhibition of PDE5, leading to vasodilation.\",\n        \"Effect 2: Some users might experience mild headaches or flushing as the body adjusts to the increased blood flow and vasodilation.\",\n        \"Effect 3: There might be a slight improvement in exercise capacity due to enhanced blood flow and oxygen delivery to muscles, although this may not be immediately noticeable.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in erectile function as the compound maintains its action on PDE5, leading to sustained vasodilation.\",\n        \"Effect 2: Users may start to notice a reduction in symptoms related to an enlarged prostate, such as decreased frequency of urination.\",\n        \"Effect 3: Some individuals might experience mild gastrointestinal discomfort or back pain, which are common side effects of PDE5 inhibitors.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced exercise performance may become more noticeable as improved blood flow and oxygen delivery support physical activity.\",\n        \"Effect 2: Cognitive effects are generally minimal, but some users might report a slight increase in mental clarity or mood due to improved circulation.\",\n        \"Effect 3: Biomarkers such as blood pressure might show slight reductions due to vasodilation, although this varies among individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Benefits for altitude sickness might become apparent, as improved blood flow and oxygen delivery help alleviate symptoms.\",\n        \"Effect 2: Side effects such as headaches or flushing may peak and then stabilize as the body adjusts to the compound.\",\n        \"Effect 3: Users might observe a plateau in the benefits for erectile dysfunction and exercise performance as the body reaches a new equilibrium.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits for prostate health may become more pronounced, with further reduction in urinary symptoms.\",\n        \"Effect 2: Any persistent side effects should be monitored, and users might consider adjusting dosage or frequency under guidance if side effects remain bothersome.\",\n        \"Effect 3: Continued monitoring of blood pressure and other cardiovascular markers is advisable to ensure no adverse effects from prolonged use.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline is based on the typical effects observed with PDE5 inhibitors, as specific data on aminotadalafil is limited. Individual responses can vary widely, and the effects described are inferred from similar compounds like tadalafil. Users should consult with a healthcare professional for personalized advice and monitoring.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 660, "completion_tokens": 615, "total_tokens": 1275, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a79a788190bf481e7512b94a02", "custom_id": "drug194_effects_timeline", "response": {"status_code": 200, "request_id": "94117a67fba79c544e417991829a4656", "body": {"id": "chatcmpl-B9MVe3iA3aCOfbXONBmjf9oKbGhCV", "object": "chat.completion", "created": 1741571178, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial hormonal adjustments may begin, but significant changes in testosterone levels are unlikely to be noticeable yet.\",\n        \"Effect 2: Some users might experience a slight increase in energy levels as the body starts responding to hormonal signals.\",\n        \"Effect 3: No significant changes in biomarkers such as testosterone levels or sperm count are expected at this stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Testosterone levels may begin to rise, leading to subtle improvements in mood and energy.\",\n        \"Effect 2: Some users might notice a slight increase in libido as testosterone production starts to ramp up.\",\n        \"Effect 3: Initial changes in biomarkers, such as a slight increase in testosterone levels, might be detectable in blood tests.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in energy and mood as testosterone levels continue to increase.\",\n        \"Effect 2: Enhanced mental clarity and focus may be experienced due to improved hormonal balance.\",\n        \"Effect 3: Users might start to see improvements in muscle strength and recovery, although these effects are still developing.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in libido and sexual function are likely as testosterone levels stabilize at higher levels.\",\n        \"Effect 2: Users may experience improved physical performance and endurance due to increased testosterone.\",\n        \"Effect 3: Biomarkers such as testosterone levels should show a marked increase, and sperm production might start to improve.\"\n      ]\n    },\n    {\n      \"period\": \"Weeks 5-8\",\n      \"effects\": [\n        \"Effect 1: Continued improvements in muscle mass and strength as testosterone levels remain elevated.\",\n        \"Effect 2: Enhanced mood and cognitive function, with reduced symptoms of fatigue and depression.\",\n        \"Effect 3: Fertility improvements, such as increased sperm count and motility, may become more evident.\"\n      ]\n    },\n    {\n      \"period\": \"Weeks 9-12\",\n      \"effects\": [\n        \"Effect 1: Peak physical and mental benefits are likely, with optimal testosterone levels supporting overall well-being.\",\n        \"Effect 2: Users may experience sustained improvements in libido, energy, and physical performance.\",\n        \"Effect 3: Any side effects, such as potential mood swings or acne, might manifest or peak during this period.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on typical responses observed in clinical settings and inferred from similar compounds like clomiphene. Individual responses may vary, and some effects might be more pronounced in certain users. Monitoring by healthcare professionals is recommended to adjust dosing and manage any side effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 647, "completion_tokens": 604, "total_tokens": 1251, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a7a9d48190b614cc94b4cfd7b7", "custom_id": "drug195_effects_timeline", "response": {"status_code": 200, "request_id": "9bd55d753ae25489db768cbd3d9a166e", "body": {"id": "chatcmpl-B9MVWWJSszSXafkjEVqBI2HpD6TCO", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice slight improvements in sleep quality, feeling more rested upon waking. This is due to ibutamoren's influence on growth hormone release, which can enhance sleep cycles.\",\n        \"Effect 2: Some users may experience an increase in appetite, as ibutamoren mimics ghrelin, a hormone that stimulates hunger.\",\n        \"Effect 3: Initial water retention might occur, leading to a slight increase in body weight. This is a common early effect of increased growth hormone levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2-3\",\n      \"effects\": [\n        \"Effect 1: Physical effects such as improved muscle recovery and slight increases in muscle mass may begin to manifest, especially in individuals engaging in resistance training.\",\n        \"Effect 2: Users might start to notice enhanced skin texture and hydration, as growth hormone can boost collagen production.\",\n        \"Effect 3: Some cognitive improvements, such as better focus and mental clarity, might be observed, although these effects are more anecdotal and less documented.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4-6\",\n      \"effects\": [\n        \"Effect 1: More noticeable muscle growth and strength gains could become apparent, particularly for those maintaining a consistent exercise regimen.\",\n        \"Effect 2: Reduction in body fat may start to be observed, contributing to a leaner physique.\",\n        \"Effect 3: Continued improvements in sleep quality and energy levels throughout the day are likely.\",\n        \"Effect 4: Bone density improvements might begin, although these effects are typically more long-term and subtle.\"\n      ]\n    },\n    {\n      \"period\": \"Week 7-12\",\n      \"effects\": [\n        \"Effect 1: Sustained muscle growth and strength improvements, with potential for more significant changes in body composition.\",\n        \"Effect 2: Enhanced recovery from physical exertion and possible improvements in joint health due to increased collagen synthesis.\",\n        \"Effect 3: Potential stabilization of appetite as the body adjusts to the compound.\",\n        \"Effect 4: Skin may appear firmer and more youthful, reflecting ongoing collagen production.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3-6\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as improved bone density and structural integrity may become more evident.\",\n        \"Effect 2: Users might experience a plateau in muscle and strength gains, which is typical as the body adapts.\",\n        \"Effect 3: Continued maintenance of improved sleep patterns and overall energy levels.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for ibutamoren can vary significantly between individuals due to factors such as dosage, individual physiology, and concurrent lifestyle factors like diet and exercise. While some effects are well-documented, others are inferred based on the compound's mechanism of action and anecdotal reports. Users should be aware of potential side effects, such as increased appetite, water retention, and insulin resistance, which might manifest at different stages of use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 703, "completion_tokens": 652, "total_tokens": 1355, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a7c1e88190a142e043e6f1bbc7", "custom_id": "drug196_effects_timeline", "response": {"status_code": 200, "request_id": "5ec9223925d2a7e8687bb5ee867eb688", "body": {"id": "chatcmpl-B9MVWvT4hHijXsydnfw1b6cXrPrg2", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial administration of MT-2 may lead to mild nausea, which is a common side effect as the body begins to adjust to the compound.\",\n        \"Effect 2: Some users might notice a slight increase in libido due to the activation of receptors related to sexual arousal.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users may start to notice a subtle darkening of the skin as melanin production begins to increase, although significant changes are not yet visible.\",\n        \"Effect 2: Appetite suppression might become noticeable, leading to a reduced desire to eat and potentially aiding in weight management.\",\n        \"Effect 3: Mild headaches or fatigue could occur as the body continues to adapt to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Skin darkening becomes more apparent as melanin levels increase, with users observing a more pronounced tan without sun exposure.\",\n        \"Effect 2: Libido enhancement may become more consistent, with increased sexual arousal and performance reported by some users.\",\n        \"Effect 3: Appetite suppression effects are typically stable, helping users maintain a lower caloric intake.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: The tanning effect reaches a peak, with users achieving a noticeable and even skin tone.\",\n        \"Effect 2: Continued appetite suppression and libido enhancement, with effects stabilizing at this point.\",\n        \"Effect 3: Some users might experience side effects such as flushing or mild fatigue, although these often diminish over time.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Skin tone remains stable with continued use, although some users may choose to reduce dosage to maintain their desired level of tan.\",\n        \"Effect 2: Appetite suppression and libido effects remain consistent, with users reporting sustained benefits in these areas.\",\n        \"Effect 3: Long-term side effects, if any, should be monitored, including potential changes in blood pressure or other biomarkers, although significant changes are not commonly reported.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for MT-2 can vary based on individual factors such as dosage, frequency of use, and personal physiology. While the above timeline provides a general guideline, users may experience variations in the onset and intensity of effects. Additionally, the long-term safety and efficacy of MT-2 are not well-documented, and users should proceed with caution, especially regarding potential side effects and interactions with other substances.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 603, "completion_tokens": 582, "total_tokens": 1185, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a7cfc881909a71625467a7a3d9", "custom_id": "drug197_effects_timeline", "response": {"status_code": 200, "request_id": "ea5f60c9390d0d1f9f12aa583a0e92be", "body": {"id": "chatcmpl-B9MVfyHXM2AgfbjJU9kQu2helj30y", "object": "chat.completion", "created": 1741571179, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in growth hormone levels may begin, but physical changes are typically not noticeable yet.\",\n        \"Effect 2: Some users might experience a slight increase in energy levels and improved sleep quality due to elevated growth hormone levels.\",\n        \"Effect 3: Biomarkers such as IGF-1 (Insulin-like Growth Factor 1) levels may start to rise, indicating increased growth hormone activity.\",\n        \"Effect 4: No significant muscle growth or fat loss is expected at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice subtle improvements in recovery times after workouts, with less muscle soreness.\",\n        \"Effect 2: Some individuals may experience enhanced mood and cognitive function, potentially due to better sleep and recovery.\",\n        \"Effect 3: Continued increase in IGF-1 levels, which can be measured through blood tests.\",\n        \"Effect 4: Skin may start to feel slightly more elastic, but visible changes are unlikely at this point.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More noticeable improvements in muscle tone and strength may begin to appear, especially if combined with resistance training.\",\n        \"Effect 2: Users might observe a reduction in body fat percentage, although this can vary based on diet and exercise.\",\n        \"Effect 3: Enhanced recovery and repair of tissues become more apparent, aiding in quicker recovery from injuries or intense workouts.\",\n        \"Effect 4: Some users may start to notice improvements in skin texture and reduction in fine lines.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Significant improvements in muscle mass and strength are likely, particularly for those engaging in regular strength training.\",\n        \"Effect 2: Continued fat loss and improved body composition may be observed.\",\n        \"Effect 3: Skin elasticity and overall appearance might show more visible improvements, contributing to a more youthful look.\",\n        \"Effect 4: Side effects such as water retention or joint pain might begin to manifest, although these vary among individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4 and beyond\",\n      \"effects\": [\n        \"Effect 1: Long-term benefits such as sustained muscle growth and fat loss are expected to stabilize.\",\n        \"Effect 2: Users may experience plateauing effects as the body adjusts to the compound.\",\n        \"Effect 3: Potential side effects, if any, may peak or stabilize, requiring monitoring and possible adjustment of dosage.\",\n        \"Effect 4: Continuous monitoring of biomarkers like IGF-1 is recommended to ensure levels remain within a safe range.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline and effects described are based on anecdotal reports and inferred from the mechanism of action of CJC-1295-DAC. Individual responses can vary widely, and the compound should be used under professional supervision. Long-term safety and efficacy are not well-documented, and users should be cautious of potential side effects.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 672, "total_tokens": 1363, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a7deb48190989913f29a6645ab", "custom_id": "drug198_effects_timeline", "response": {"status_code": 200, "request_id": "8e0c097a52544a089ec3f1269619880a", "body": {"id": "chatcmpl-B9MVoZLOKeUtdYgEIN9yEDHYQSJlK", "object": "chat.completion", "created": 1741571188, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1-2\",\n      \"effects\": [\n        \"Effect 1: Users may not notice any significant physical changes in hair growth during the first two weeks. The compound is beginning to take effect at the follicular level, but visible results are not yet apparent.\",\n        \"Effect 2: Some users might experience initial shedding of hair. This is often referred to as 'shedding phase' and is considered a normal part of the process as weaker hairs are shed to make way for new growth.\",\n        \"Effect 3: No significant mental or cognitive effects are typically associated with topical minoxidil use.\",\n        \"Effect 4: There are no expected changes in biomarkers or physiological measurements during this early period.\",\n        \"Effect 5: Some users might experience mild skin irritation or itching at the application site as a side effect.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued shedding may occur, but some users might start to notice a slight increase in hair density or the appearance of fine, soft hairs.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements.\",\n        \"Effect 4: The benefits of reduced hair thinning and initial signs of new hair growth may begin to appear, although they are typically subtle at this stage.\",\n        \"Effect 5: Skin irritation or itching may persist but often diminishes as the scalp adjusts to the treatment.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users may start to see more noticeable hair growth, with new hairs becoming thicker and more pigmented.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements.\",\n        \"Effect 4: The benefits of increased hair density and reduced hair loss become more apparent.\",\n        \"Effect 5: Side effects such as scalp irritation are typically reduced, but some users may still experience them.\"\n      ]\n    },\n    {\n      \"period\": \"Month 4-6\",\n      \"effects\": [\n        \"Effect 1: Significant improvement in hair growth is often observed, with many users experiencing fuller, thicker hair.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements.\",\n        \"Effect 4: The full benefits of minoxidil, including increased hair density and reduced hair thinning, are typically realized during this period.\",\n        \"Effect 5: Side effects are generally minimal, but continued monitoring for scalp irritation is advised.\"\n      ]\n    },\n    {\n      \"period\": \"Month 6 and beyond\",\n      \"effects\": [\n        \"Effect 1: Users who continue treatment may maintain or further improve hair growth, with ongoing use necessary to sustain results.\",\n        \"Effect 2: No mental or cognitive effects are expected.\",\n        \"Effect 3: No significant changes in biomarkers or physiological measurements.\",\n        \"Effect 4: Long-term benefits include sustained hair growth and maintenance of hair density.\",\n        \"Effect 5: Long-term use is generally well-tolerated, but users should monitor for any persistent side effects.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for minoxidil can vary between individuals. Some users may experience faster or slower results based on factors such as genetics, the severity of hair loss, and adherence to the treatment regimen. It is important to note that discontinuation of minoxidil typically results in the reversal of its effects, with hair returning to its pre-treatment state.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 632, "completion_tokens": 776, "total_tokens": 1408, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a7f074819089b8f5bcb6f4b924", "custom_id": "drug199_effects_timeline", "response": {"status_code": 200, "request_id": "bc0d7ed99bad3c893e3da2126651a89c", "body": {"id": "chatcmpl-B9MVXde4fdXQ6jVX4AFKw62i4N2VD", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels, as the body starts to shift its energy source from carbohydrates to fats.\",\n        \"Effect 2: Initial reduction in water retention might occur, leading to a minor decrease in body weight.\",\n        \"Effect 3: No significant changes in mental or cognitive effects are expected at this stage.\",\n        \"Effect 4: Biomarkers such as blood sugar levels should remain stable, as HGH Frag 176-191 does not typically affect glucose metabolism.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users might start to observe a gradual reduction in body fat, particularly in stubborn areas, as the peptide continues to target fat cells.\",\n        \"Effect 2: Some users may report improved recovery times post-exercise, although this can vary.\",\n        \"Effect 3: Skin elasticity might begin to improve slightly, though noticeable changes are more likely in later weeks.\",\n        \"Effect 4: No significant side effects are typically reported, but some users might experience mild injection site reactions.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: More pronounced fat loss may become evident, with users potentially noticing changes in body composition.\",\n        \"Effect 2: Enhanced muscle definition might be observed due to the reduction in fat mass.\",\n        \"Effect 3: Users may experience a slight boost in overall fitness levels and endurance.\",\n        \"Effect 4: Continued stability in blood sugar levels, with no significant changes expected.\",\n        \"Effect 5: Any initial side effects, such as injection site irritation, typically subside.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Sustained fat loss and improved muscle tone are likely, with users often reporting a leaner physique.\",\n        \"Effect 2: Skin elasticity improvements may become more noticeable, contributing to a more youthful appearance.\",\n        \"Effect 3: Users might experience enhanced recovery from exercise or minor injuries.\",\n        \"Effect 4: Mental clarity and focus could improve slightly, although this is more anecdotal and less documented.\",\n        \"Effect 5: Long-term side effects are uncommon, but users should monitor for any unexpected changes in health.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline and effects described are based on anecdotal reports and inferred from the mechanism of action of HGH Frag 176-191. Individual responses can vary significantly, and the compound is intended for research purposes only. Users should be cautious and consult with a healthcare professional before considering any experimental compounds.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 605, "completion_tokens": 579, "total_tokens": 1184, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a803e48190b0f436d1705f1f61", "custom_id": "drug200_effects_timeline", "response": {"status_code": 200, "request_id": "35542b6fc6c4a0b74c01824d089fd181", "body": {"id": "chatcmpl-B9MVWdMjelPbOK3cnJcfdSwozPjuw", "object": "chat.completion", "created": 1741571170, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels, particularly if they were previously deficient in B-12. This can manifest as reduced fatigue and a general feeling of increased vitality.\",\n        \"Effect 2: Some users may experience improved mental clarity and focus, as B-12 supports brain function. This effect might be subtle initially.\",\n        \"Effect 3: Biomarkers such as serum B-12 levels may start to increase, indicating improved B-12 status in the body.\",\n        \"Effect 4: Initial improvements in mood might be observed, especially in individuals with low B-12 levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in energy levels and reduction in fatigue, as the body adjusts to adequate B-12 levels.\",\n        \"Effect 2: Enhanced cognitive effects, such as better concentration and memory, may become more noticeable.\",\n        \"Effect 3: Further stabilization of biomarkers related to red blood cell production, potentially improving hemoglobin levels if they were low.\",\n        \"Effect 4: Users might start to notice a more significant improvement in mood and mental well-being.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Sustained energy levels and reduced feelings of exhaustion, with users feeling more consistently alert and active.\",\n        \"Effect 2: Cognitive benefits such as improved mental clarity and reduced brain fog are likely to be more pronounced.\",\n        \"Effect 3: Continued improvement in biomarkers related to anemia, such as increased red blood cell count and improved oxygen transport.\",\n        \"Effect 4: Cardiovascular benefits might begin to manifest, such as improved homocysteine levels, which are associated with heart health.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users are likely to experience stable energy levels and overall improved physical endurance.\",\n        \"Effect 2: Long-term cognitive benefits, including sustained focus and memory retention, are likely to be evident.\",\n        \"Effect 3: Biomarkers related to nerve health, such as myelin integrity, may show improvement, although this is more difficult to measure directly.\",\n        \"Effect 4: Continued support for cardiovascular health, with potential reductions in risk factors for heart disease.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for Vitamin B12 can vary significantly depending on the individual's baseline B-12 levels, absorption efficiency, and overall health status. Individuals with a deficiency may notice more pronounced effects more quickly, while those with adequate levels may experience subtler changes. Side effects are generally rare and mild, but excessive doses can lead to skin reactions or gastrointestinal discomfort. The effects described are based on typical responses observed in individuals supplementing with B-12, and individual experiences may vary.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 622, "completion_tokens": 624, "total_tokens": 1246, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a8130081909dd8685924a7cbf5", "custom_id": "drug201_effects_timeline", "response": {"status_code": 200, "request_id": "f140577699d6f352029e191b647da1dd", "body": {"id": "chatcmpl-B9MVXB14EaIIfoFz2Dx9azz0CL04V", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may notice an immediate increase in energy and alertness within 30 minutes to an hour after ingestion, similar to the effects of caffeine.\",\n        \"Effect 2: Enhanced focus and mental clarity might be experienced, making tasks that require concentration feel easier.\",\n        \"Effect 3: Some users may experience a slight increase in heart rate and blood pressure due to vasoconstriction effects.\",\n        \"Effect 4: Initial side effects such as jitteriness, restlessness, or mild headaches may occur as the body adjusts to the stimulant.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued enhancement of energy and endurance during workouts, with users reporting workouts feel easier and more intense.\",\n        \"Effect 2: Cognitive effects such as improved focus and mental performance are sustained, particularly beneficial for studying or tasks requiring concentration.\",\n        \"Effect 3: Users might observe increased motivation and mood elevation due to neurotransmitter release.\",\n        \"Effect 4: Side effects such as insomnia or increased anxiety might become more noticeable, especially if taken late in the day.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Physical performance benefits, such as improved strength and endurance, may become more pronounced as users adapt to the compound.\",\n        \"Effect 2: Mental clarity and alertness remain elevated, potentially leading to improved productivity in daily tasks.\",\n        \"Effect 3: Users might notice slight weight loss due to increased energy expenditure and possible appetite suppression.\",\n        \"Effect 4: Tolerance to some of the stimulant effects may begin to develop, requiring careful management of dosage to maintain benefits.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience a plateau in energy and performance benefits as tolerance develops further.\",\n        \"Effect 2: Cognitive enhancements might still be present but could diminish if tolerance increases.\",\n        \"Effect 3: Some users may experience a decrease in the intensity of side effects as the body becomes accustomed to the compound.\",\n        \"Effect 4: Potential for increased blood pressure and heart rate persists, warranting monitoring of these biomarkers.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline of effects for DMAA HCl is inferred from its mechanism of action and similarities to other stimulants like caffeine. Individual responses can vary significantly based on factors such as dosage, frequency of use, and personal sensitivity to stimulants. Long-term use is not well-documented and could lead to increased risk of cardiovascular side effects. Users should be cautious of potential legal restrictions and health risks associated with DMAA HCl.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 574, "completion_tokens": 588, "total_tokens": 1162, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a8279c8190a0d25a9c05932329", "custom_id": "drug202_effects_timeline", "response": {"status_code": 200, "request_id": "fe798f5970728a913b15d40773d860c6", "body": {"id": "chatcmpl-B9MVXRcibO4c7Y0rsgeNcaVGq6hsZ", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvements in sleep quality may be noticed as the body begins to respond to increased growth hormone levels.\",\n        \"Effect 2: Some users might experience mild water retention or bloating as the body adjusts to hormonal changes.\",\n        \"Effect 3: No significant changes in muscle mass or fat loss are typically observed at this early stage.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced recovery times from physical exertion may become noticeable, with reduced muscle soreness after workouts.\",\n        \"Effect 2: Some users might report slight improvements in mood and cognitive clarity due to better sleep and recovery.\",\n        \"Effect 3: Biomarkers such as IGF-1 levels may start to show an increase, although this might not be clinically significant yet.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may begin to notice subtle changes in body composition, such as slight increases in muscle mass and reductions in body fat.\",\n        \"Effect 2: Improvements in skin elasticity and vitality might start to become apparent, contributing to a more youthful appearance.\",\n        \"Effect 3: Side effects like joint pain or tingling sensations could start to manifest in some individuals, although these are generally mild.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2\",\n      \"effects\": [\n        \"Effect 1: More pronounced improvements in muscle strength and endurance are likely, especially if combined with regular exercise.\",\n        \"Effect 2: Continued enhancements in recovery times and energy levels, supporting more intense training sessions.\",\n        \"Effect 3: Biomarkers such as IGF-1 levels should show a more significant increase, correlating with the physical changes observed.\"\n      ]\n    },\n    {\n      \"period\": \"Month 3\",\n      \"effects\": [\n        \"Effect 1: Users may experience noticeable improvements in body composition, with increased muscle definition and reduced fat mass.\",\n        \"Effect 2: Anti-aging effects, such as improved skin texture and reduced appearance of fine lines, could become more evident.\",\n        \"Effect 3: Side effects, if present, might peak around this time, but they often remain manageable with proper dosing and monitoring.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred effects from similar compounds, as specific clinical data on CJC-1295 is limited. Individual responses can vary significantly based on factors such as dosage, frequency of administration, and personal health conditions. Users should be aware of potential side effects and consult with a healthcare professional before starting any new research compound.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 662, "completion_tokens": 585, "total_tokens": 1247, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a836c08190bcf903bc17ba9860", "custom_id": "drug203_effects_timeline", "response": {"status_code": 200, "request_id": "1f8742fb8b60fb88a435eef05d07cbd4", "body": {"id": "chatcmpl-B9MVYjxOUsoy7Hmv54UoLk14HMPWC", "object": "chat.completion", "created": 1741571172, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may experience an immediate increase in energy and alertness within 30 minutes to an hour after ingestion, similar to a strong stimulant effect.\",\n        \"Effect 2: Enhanced focus and mental clarity may be noticeable, aiding in tasks requiring concentration.\",\n        \"Effect 3: Physical effects such as increased heart rate and blood pressure may be observed, reflecting the compound's stimulating properties.\",\n        \"Effect 4: Initial benefits such as improved workout performance and endurance might be experienced during physical activities.\"\n      ]\n    },\n    {\n      \"period\": \"Day 4-7\",\n      \"effects\": [\n        \"Effect 1: Continued use may lead to a tolerance build-up, potentially requiring higher doses to achieve the same stimulating effects.\",\n        \"Effect 2: Users might notice a more pronounced thermogenic effect, possibly aiding in weight loss efforts.\",\n        \"Effect 3: Side effects such as jitteriness, anxiety, or insomnia may begin to manifest, especially if taken in higher doses or late in the day.\",\n        \"Effect 4: Some users might experience headaches or a 'crash' as the effects wear off, leading to fatigue.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: The stimulating effects may become less pronounced as tolerance continues to develop.\",\n        \"Effect 2: Users might experience diminished returns in terms of energy and focus, requiring careful management of dosage.\",\n        \"Effect 3: Cardiovascular strain could become more apparent, with increased heart rate and blood pressure persisting.\",\n        \"Effect 4: Side effects such as mood swings or irritability might become more frequent.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience a plateau in performance enhancement and energy levels due to tolerance.\",\n        \"Effect 2: The risk of adverse effects, including cardiovascular issues, may increase with prolonged use.\",\n        \"Effect 3: Psychological dependence might develop, with users feeling the need to take DMAA to achieve normal energy levels.\",\n        \"Effect 4: Withdrawal symptoms such as fatigue and depression could occur if usage is abruptly stopped.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and the known pharmacological action of DMAA. Individual responses can vary significantly, and the compound's legal status and safety profile are controversial. Users should be aware of the potential for serious side effects, particularly concerning cardiovascular health. The effects described are inferred from the stimulant nature of DMAA and similar compounds, as detailed clinical studies on long-term use are limited.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 610, "completion_tokens": 574, "total_tokens": 1184, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a845c0819095a2eff5adc0de0e", "custom_id": "drug204_effects_timeline", "response": {"status_code": 200, "request_id": "11111c5df461d329607d1f1c7d3e1248", "body": {"id": "chatcmpl-B9MVX7IqfwjonO0R4OPvF0pP9BemQ", "object": "chat.completion", "created": 1741571171, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels and mental clarity as the compound starts interacting with neurotransmitter production. This is inferred from similar compounds that affect neurotransmitter balance.\",\n        \"Effect 2: Some users may experience mild improvements in mood and a reduction in stress and anxiety, although these effects are typically subtle at this stage.\",\n        \"Effect 3: Initial changes in sleep patterns might be observed, with some users reporting slightly improved sleep quality.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced mental clarity and focus may become more pronounced as neurotransmitter regulation stabilizes.\",\n        \"Effect 2: Users might notice a more consistent improvement in mood and a further reduction in stress levels.\",\n        \"Effect 3: Physical effects such as slight improvements in exercise performance and recovery could start to manifest, inferred from the compound's interaction with amino acids and protein synthesis.\",\n        \"Effect 4: Some users might begin to observe changes in biomarkers such as reduced cortisol levels, although this is speculative and would require specific testing.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Continued enhancement of energy levels and mental clarity, with users often reporting a more sustained ability to focus and concentrate.\",\n        \"Effect 2: Noticeable improvements in mood stability and a further reduction in anxiety symptoms.\",\n        \"Effect 3: More significant improvements in exercise performance and muscle recovery, as the compound's effects on protein synthesis become more pronounced.\",\n        \"Effect 4: Users might experience improved sleep quality, with deeper and more restful sleep patterns.\",\n        \"Effect 5: Potential side effects such as mild headaches or gastrointestinal discomfort might begin to manifest, although these are generally reported as mild and transient.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Users may experience peak benefits in terms of energy, mental clarity, and mood enhancement, as the compound's effects are fully realized.\",\n        \"Effect 2: Consistent improvements in exercise performance and muscle growth, with users often reporting better endurance and strength gains.\",\n        \"Effect 3: Continued improvements in sleep quality and overall brain health, with some users noting enhanced cognitive function.\",\n        \"Effect 4: Any side effects typically stabilize or diminish, as the body adjusts to the compound.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar compounds and mechanisms of action, as specific data on Tri-Amino is limited. Individual responses can vary significantly based on factors such as dosage, individual physiology, and concurrent use of other supplements or medications. It is important to conduct thorough research and consult with a healthcare professional before using any research chemical.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 589, "completion_tokens": 609, "total_tokens": 1198, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a854ac8190aa701055ef02c3b0", "custom_id": "drug205_effects_timeline", "response": {"status_code": 200, "request_id": "feedfeea38928d88f9582c9b585c43de", "body": {"id": "chatcmpl-B9MVaCUfSqnuLcWZA99db332Rr7vT", "object": "chat.completion", "created": 1741571174, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Initial increase in energy levels and slight improvement in mood due to the androgenic activity of trestolone acetate.\",\n        \"Effect 2: Some users might notice a slight increase in muscle fullness and pump during workouts, although significant muscle growth is not yet apparent.\",\n        \"Effect 3: Possible mild suppression of natural testosterone production, which could be observed through a decrease in libido or slight changes in mood.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Noticeable increase in strength and endurance during workouts as the compound begins to exert its anabolic effects.\",\n        \"Effect 2: Enhanced recovery times post-exercise, allowing for more frequent and intense training sessions.\",\n        \"Effect 3: Potential onset of side effects such as mild acne or oily skin due to increased androgen levels.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3\",\n      \"effects\": [\n        \"Effect 1: Significant muscle growth and increased muscle definition become more apparent, with users often reporting visible changes in physique.\",\n        \"Effect 2: Further suppression of natural testosterone production, which may lead to decreased sperm production and libido.\",\n        \"Effect 3: Possible mood swings or irritability as hormonal levels fluctuate.\"\n      ]\n    },\n    {\n      \"period\": \"Week 4\",\n      \"effects\": [\n        \"Effect 1: Continued muscle growth and strength gains, with many users reaching new personal bests in their lifts.\",\n        \"Effect 2: Increased sense of vitality and overall well-being, although some may experience heightened aggression or impatience.\",\n        \"Effect 3: Potential for more pronounced side effects such as hair loss or gynecomastia in susceptible individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Week 5-6\",\n      \"effects\": [\n        \"Effect 1: Peak muscle growth and strength gains, with users often achieving their desired physical transformations.\",\n        \"Effect 2: Stabilization of energy levels and mood as the body adjusts to the hormonal changes.\",\n        \"Effect 3: Monitoring of biomarkers such as liver enzymes and lipid profiles is recommended, as prolonged use may impact these parameters.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and the known pharmacological profile of trestolone acetate. Individual responses can vary significantly, and the compound's effects are inferred from its similarity to other anabolic-androgenic steroids. Long-term use and high doses increase the risk of adverse effects, and users should be cautious and conduct regular health monitoring.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 618, "completion_tokens": 556, "total_tokens": 1174, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
{"id": "batch_req_67ce44a863388190b5c12ac05d6783cb", "custom_id": "drug206_effects_timeline", "response": {"status_code": 200, "request_id": "16d476660a49feb687dc97a3e8ac90e8", "body": {"id": "chatcmpl-B9MVZyVb1pBMHGec8zz2Owh4oFq9Z", "object": "chat.completion", "created": 1741571173, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Users may notice an immediate increase in alertness and wakefulness within a few hours of administration. This is due to the rapid onset of action as fladrafinil increases dopamine levels.\",\n        \"Effect 2: Cognitive enhancements such as improved focus and concentration may be observed, allowing for better task performance.\",\n        \"Effect 3: Some users might experience a mild increase in heart rate and blood pressure as physiological responses to heightened alertness.\",\n        \"Effect 4: Initial side effects could include mild headaches or nausea as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Continued enhancement in mental performance, including improved memory recall and cognitive speed, as the compound maintains elevated neurotransmitter levels.\",\n        \"Effect 2: Users might experience smoother social interactions with increased verbal fluency and confidence.\",\n        \"Effect 3: Sleep patterns may be disrupted due to increased wakefulness, potentially leading to insomnia if taken too late in the day.\",\n        \"Effect 4: Side effects such as irritability or anxiety may begin to manifest as a result of prolonged dopamine elevation.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Users may experience a stabilization of cognitive benefits, with sustained improvements in focus and alertness.\",\n        \"Effect 2: Tolerance to some of the stimulating effects might begin to develop, requiring careful management of dosage to maintain efficacy.\",\n        \"Effect 3: Biomarkers such as cortisol levels might show slight elevation due to increased stress response from prolonged wakefulness.\",\n        \"Effect 4: Side effects like headaches or anxiety could peak, necessitating a review of dosage or frequency of use.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Cognitive benefits may plateau, with users experiencing consistent levels of enhanced mental performance.\",\n        \"Effect 2: Some users might report a decrease in the intensity of initial side effects as their bodies adapt to the compound.\",\n        \"Effect 3: Long-term use could lead to more pronounced sleep disturbances, requiring strategies to manage sleep hygiene.\",\n        \"Effect 4: Potential for increased tolerance, necessitating periodic breaks or dosage adjustments to maintain effectiveness.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on anecdotal reports and inferred effects from similar compounds like modafinil. Individual responses to fladrafinil can vary significantly, and long-term effects are not well-documented. Users should approach with caution and under appropriate research conditions.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 623, "completion_tokens": 570, "total_tokens": 1193, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a87168819080e920fb87e78981", "custom_id": "drug207_effects_timeline", "response": {"status_code": 200, "request_id": "380d89328945fb36b0994644daaadb67", "body": {"id": "chatcmpl-B9MVg0WScVH092AaqW9t0BigTwrGm", "object": "chat.completion", "created": 1741571180, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Users might begin to notice a slight increase in energy levels and stamina, potentially due to enhanced cellular energy efficiency. This is inferred from the compound's proposed mechanism of action.\",\n        \"Effect 2: Some users may experience mild improvements in mental clarity and focus, as the compound may start influencing metabolic processes in the brain.\",\n        \"Effect 3: Initial changes in biomarkers such as increased ATP production or altered metabolic rates might be observed, though specific data on this compound is limited.\",\n        \"Effect 4: Side effects such as mild headaches or gastrointestinal discomfort could begin to manifest as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Enhanced physical stamina might become more noticeable, with users potentially experiencing less fatigue during physical activities.\",\n        \"Effect 2: Cognitive effects such as improved mental clarity and reduced mental fatigue may become more pronounced.\",\n        \"Effect 3: Users might observe slight changes in stress-related biomarkers, such as cortisol levels, if the compound has calming effects.\",\n        \"Effect 4: Any initial side effects might peak during this period, with some users experiencing mild anxiety or restlessness as the compound interacts with nerve pathways.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users could experience a stabilization of energy levels, with consistent improvements in physical performance.\",\n        \"Effect 2: Mental clarity and focus might continue to improve, potentially leading to better productivity and cognitive performance.\",\n        \"Effect 3: Continued monitoring might show more stable biomarkers related to energy metabolism, though specific data is limited.\",\n        \"Effect 4: Calming effects might become more evident, potentially aiding in stress management and reducing anxiety-related symptoms.\",\n        \"Effect 5: Side effects might begin to diminish as the body adapts, though this varies among individuals.\"\n      ]\n    },\n    {\n      \"period\": \"Month 2-3\",\n      \"effects\": [\n        \"Effect 1: Long-term users might report sustained improvements in both physical and mental performance, with the compound's effects on cellular health becoming more apparent.\",\n        \"Effect 2: Users might notice a more balanced mood and reduced stress levels, assuming the compound's calming effects are significant.\",\n        \"Effect 3: Physiological measurements such as improved VO2 max or endurance capacity could be observed in athletic individuals.\",\n        \"Effect 4: Any persistent side effects should be monitored, as long-term use data is limited and individual responses can vary.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from the compound's proposed mechanisms of action, as specific data on Diisopropylaminedichloroacetate is limited. Users should approach with caution and monitor for any adverse effects. Consultation with a medical professional is recommended before use.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 665, "completion_tokens": 623, "total_tokens": 1288, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_f9f4fb6dbf"}}, "error": null}
{"id": "batch_req_67ce44a87f848190abf3192baa264014", "custom_id": "drug208_effects_timeline", "response": {"status_code": 200, "request_id": "867a9dab3b8794132390c7703efe080b", "body": {"id": "chatcmpl-B9MVnv5fuzcdclUka3FLTGmNLNNF4", "object": "chat.completion", "created": 1741571187, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"timeline\": [\n    {\n      \"period\": \"Day 1-3\",\n      \"effects\": [\n        \"Effect 1: Initial increase in alertness and energy levels may be noticed as DNsp-11 begins to influence dopamine and norepinephrine activity. Users might feel more awake and focused during this period.\",\n        \"Effect 2: Some users might experience a mild sense of euphoria or improved mood as neurotransmitter activity is enhanced.\",\n        \"Effect 3: Physical effects such as slight increases in heart rate or blood pressure could occur as the body adjusts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 1\",\n      \"effects\": [\n        \"Effect 1: Enhanced concentration and cognitive clarity become more pronounced, potentially improving work or study performance.\",\n        \"Effect 2: Users might start noticing a reduction in perceived stress levels and an increased sense of calmness.\",\n        \"Effect 3: Physical endurance and stamina may begin to improve, particularly noticeable during exercise or physical activities.\",\n        \"Effect 4: Side effects such as mild headaches or insomnia could start to manifest as the body adapts to the compound.\"\n      ]\n    },\n    {\n      \"period\": \"Week 2\",\n      \"effects\": [\n        \"Effect 1: Continued improvement in mood and motivation, with users potentially experiencing more consistent energy levels throughout the day.\",\n        \"Effect 2: Cognitive benefits such as improved memory retention and faster information processing might become more evident.\",\n        \"Effect 3: Biomarkers such as heart rate variability might show changes, reflecting the compound's impact on the autonomic nervous system.\",\n        \"Effect 4: Side effects like jitteriness or anxiety could peak during this period, especially if the dosage is not well-tolerated.\"\n      ]\n    },\n    {\n      \"period\": \"Week 3-4\",\n      \"effects\": [\n        \"Effect 1: Users may experience stabilization of effects, with a balance between enhanced focus and mood without significant fluctuations.\",\n        \"Effect 2: Physical performance benefits, such as improved stamina and endurance, might be consistently noticeable.\",\n        \"Effect 3: Long-term side effects, if any, such as potential tolerance development or dependency, could start to be a concern.\"\n      ]\n    }\n  ],\n  \"notes\": \"The timeline provided is based on inferred effects from similar compounds that influence dopamine and norepinephrine. Individual responses can vary significantly, and long-term effects are not well-documented. Users should be cautious of potential side effects and consult with a healthcare professional before use. This compound is for research purposes only and not approved for human consumption.\"\n}", "refusal": null}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 651, "completion_tokens": 540, "total_tokens": 1191, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8"}}, "error": null}
